Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AGRP,Agouti-related protein,42754,-0.198598292042049,0.00500393476897002,-0.208406004189231,-0.188790579894868,0
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,42679,0.15255156133464,0.00311564284123571,0.146444901365818,0.158658221303462,0
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GCG,Pro-glucagon,42346,-0.524332311038987,0.0121094276813824,-0.548066789294496,-0.500597832783477,0
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LDLR,Low-density lipoprotein receptor,42644,-0.196124793575661,0.00495557347160877,-0.205837717580014,-0.186411869571308,0
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MFGE8,Lactadherin,42611,-0.200275559281053,0.0041070777222033,-0.208325431616571,-0.192225686945534,0
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NPY,Pro-neuropeptide Y,42721,-0.252063969097516,0.00621468305229989,-0.264244747880023,-0.239883190315008,0
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,42611,0.147551410807219,0.00314024612482633,0.141396528402559,0.153706293211879,0
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PON3,Serum paraoxonase/lactonase 3,42676,0.110963364500455,0.00275370301042208,0.105566106600028,0.116360622400882,0
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRAP1,Proline-rich acidic protein 1,40527,-0.162809880135416,0.00397538385287377,-0.170601632487049,-0.155018127783784,0
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRSS8,Prostasin,42568,-0.16736196209196,0.00404962420167596,-0.175299225527245,-0.159424698656675,0
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APOM,Apolipoprotein M,42663,0.0979609228923837,0.00276787687845369,0.0925358842106144,0.103385961574153,1.94090877366128e-262
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APOF,Apolipoprotein F,40532,0.0817740641327907,0.00233524089256357,0.0771969919833661,0.0863511362822153,3.52975446381475e-255
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMPRSS15,Enteropeptidase,42587,-0.300041057981586,0.00897034719033788,-0.317622938474648,-0.282459177488523,1.17655316441031e-235
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PYY,Peptide YY,40116,-0.337197030462503,0.0100430463108117,-0.356881401231694,-0.317512659693312,2.71671580655863e-235
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGSF9,Protein turtle homolog A,40511,-0.271987232929783,0.00812663429326868,-0.28791543614459,-0.256059029714977,2.87270488626141e-234
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,42495,-0.0996066726329763,0.00299305028414587,-0.105473051189902,-0.0937402940760504,2.46878158184932e-233
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADIPOQ,Adiponectin,40539,0.225934909561104,0.00678479685108779,0.212636707732972,0.239233111389236,4.5481410083577e-232
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LGALS4,Galectin-4,42618,-0.176784907863361,0.00559558832754122,-0.187752260985342,-0.16581755474138,2.2399851738247e-211
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LPL,Lipoprotein lipase,42636,0.141633689824082,0.00461411125129647,0.132590031771541,0.150677347876623,4.7743480073779e-200
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,42495,-0.103300212323066,0.00336744441347755,-0.109900403373482,-0.0967000212726502,9.83903074622546e-200
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPR37,Prosaposin receptor GPR37,42357,-0.206755995833974,0.00676860409146051,-0.220022459853237,-0.193489531814711,4.73244739855286e-198
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RTN4R,Reticulon-4 receptor,42721,-0.101335769147254,0.00341068012255985,-0.108020702187472,-0.0946508361070369,5.60062062897279e-188
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,42770,0.348347303619648,0.0119378765478438,0.324949065585874,0.371745541653422,1.32198696726393e-181
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MVK,Mevalonate kinase,42370,-0.227480810726617,0.00791446442774614,-0.242993161004999,-0.211968460448235,2.91296675503079e-176
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NFASC,Neurofascin,42754,-0.0820043394354573,0.00288629309338606,-0.087661473898494,-0.0763472049724207,1.56177721617307e-172
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCN1,CCN family member 1,42569,-0.205871438965632,0.00731294282459575,-0.22020480690184,-0.191538071029425,1.89444634147967e-169
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42679,-0.0975375745469944,0.00349454879101471,-0.104386890177383,-0.0906882589166056,1.0156320333896e-166
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACY1,Aminoacylase-1,42636,-0.165899710823278,0.00602227652825208,-0.177703372818652,-0.154096048827904,1.47682920207567e-162
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UPB1,Beta-ureidopropionase,40511,-0.245023048003641,0.00893906959679482,-0.262543624413359,-0.227502471593923,3.28112019878442e-160
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD4,T-cell surface glycoprotein CD4,42570,-0.0842427619118963,0.00308117633070102,-0.0902818675200703,-0.0782036563037223,3.34692987486247e-160
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C9,Complement component C9,40532,0.144704123848843,0.00529924659378625,0.134317600525022,0.155090647172665,4.62737670595988e-159
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACE2,Angiotensin-converting enzyme 2,42357,-0.141253250533424,0.00536874715483976,-0.15177599495691,-0.130730506109938,9.89563198356853e-149
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CES1,Liver carboxylesterase 1,42661,-0.212512607293701,0.00808213410210008,-0.228353590133817,-0.196671624453585,1.22366279539333e-148
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,42721,-0.085734162536699,0.00326793813681118,-0.092139321284849,-0.0793290037885491,5.18605508809111e-148
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,42357,-0.212890390948518,0.00812337459541179,-0.228812205155525,-0.196968576741511,1.302490231664e-147
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MUC13,Mucin-13,42311,-0.134602995907981,0.00521792171584205,-0.144830122471031,-0.12437586934493,3.51677571863392e-143
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,42585,-0.139756633604678,0.00543893193201968,-0.150416940191436,-0.129096327017919,3.54782120978432e-142
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NHLRC3,NHL repeat-containing protein 3,40013,-0.0825995103952877,0.00322564729943385,-0.0889217791021781,-0.0762772416883974,1.84158297706993e-140
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTSD,Cathepsin D,41747,-0.1066066928309,0.00421229057402827,-0.114862782355996,-0.0983506033058049,7.14456803357889e-138
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FURIN,Furin,42679,-0.08236330234103,0.00325841714295732,-0.0887497999412263,-0.0759768047408336,8.97459023282123e-138
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APOD,Apolipoprotein D,40033,0.110196382038743,0.00435643212908457,0.101657775065738,0.118734989011749,3.28918685352856e-137
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OXT,Oxytocin-neurophysin 1,42711,-0.347744133801265,0.0138111133061337,-0.374813915881287,-0.320674351721243,9.50879999866447e-137
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,42705,-0.117822697162457,0.00470502146649913,-0.127044539236796,-0.108600855088119,2.54500535185812e-135
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAMDC4,Apical endosomal glycoprotein,40451,-0.137712046766552,0.00550270256403099,-0.148497343792053,-0.126926749741051,1.44892706912489e-134
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,42587,-0.0837922708804224,0.00335582828749014,-0.0903696943239031,-0.0772148474369418,1.54079954514457e-134
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPM,Carboxypeptidase M,42655,-0.0830898448438433,0.00336793240148683,-0.0896909923507575,-0.0764886973369292,1.7881880230395e-131
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLTP,Phospholipid transfer protein,42752,0.0878200911401662,0.00358592645639514,0.0807916752856317,0.0948485069947007,1.20672009691768e-129
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL16,C-C motif chemokine 16,42794,-0.127983534012258,0.00523103329876153,-0.138236359277831,-0.117730708746686,2.07972414864876e-129
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GDF15,Growth/differentiation factor 15,42794,-0.113073823857398,0.00464728602317893,-0.122182504462829,-0.103965143251968,4.91289034639781e-128
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,INHBC,Inhibin beta C chain,42611,-0.0997109695176602,0.00410064940577894,-0.107748242352987,-0.0916736966823335,7.62253434384036e-128
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,42587,-0.169311040179083,0.00697471002478624,-0.182981471827664,-0.155640608530502,1.99973187986666e-127
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPY,Pancreatic prohormone,42600,-0.251834269097659,0.0103746617940124,-0.272168606213923,-0.231499931981394,2.03563254339494e-127
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,42370,-0.13460821853236,0.00556882110467312,-0.145523107897519,-0.123693329167201,2.43410441245886e-126
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RBP5,Retinol-binding protein 5,42587,-0.134909788186886,0.0055878257558111,-0.145861926668276,-0.123957649705496,4.24193264801562e-126
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",42311,-0.131540562172266,0.00548802879533143,-0.142297098611116,-0.120784025733417,2.72512740042453e-124
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTH,Parathyroid hormone,40182,-0.196688881071487,0.00821084535274479,-0.212782137962867,-0.180595624180107,1.179528154495e-123
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NTRK3,NT-3 growth factor receptor,42711,0.0521519682933888,0.00218294455677089,0.0478733969621179,0.0564305396246598,1.37268711741175e-123
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGF21,Fibroblast growth factor 21,42689,-0.278714049908664,0.0117214075690752,-0.301688008744051,-0.255740091073276,1.82180843104962e-122
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,42443,-0.114785229278664,0.00483242479039666,-0.124256781867841,-0.105313676689486,3.58506189376303e-122
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PGF,Placenta growth factor,42754,-0.0632292158716274,0.00266727565199187,-0.0684570761495315,-0.0580013555937234,9.3195610839982e-122
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42679,-0.0873920352971017,0.00370014520111484,-0.0946443198912868,-0.0801397507029167,6.96127364090711e-121
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,42636,-0.0725149030473845,0.00307745013029633,-0.0785467053027653,-0.0664831007920036,2.48133871434763e-120
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPHA1,Ephrin type-A receptor 1,42658,-0.0780332518905087,0.00331245215077795,-0.0845256581060335,-0.071540845674984,2.80227857466443e-120
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,42587,-0.191086912205522,0.00815938994209545,-0.207079316492029,-0.175094507919015,6.56573469261631e-119
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCG2,Secretogranin-2,42636,-0.0803266322150046,0.00343160203719315,-0.0870525722079032,-0.073600692222106,8.31687233891819e-119
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,40283,0.073130572364602,0.00313718172375373,0.0669816961860447,0.0792794485431594,2.2205796389822e-117
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC39A5,Zinc transporter ZIP5,42594,-0.125155724201898,0.00538642240499756,-0.135713112115693,-0.114598336288103,4.06718893133748e-117
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",42587,-0.187929550500274,0.00809022934899462,-0.203786400024303,-0.172072700976244,4.68598156331992e-117
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,42692,-0.0565648765671999,0.00243571622363029,-0.0613388803655153,-0.0517908727688845,5.15943892513995e-117
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHI3L1,Chitinase-3-like protein 1,42416,-0.19271797756225,0.00829710449100881,-0.208980302364628,-0.176455652759873,5.24674466264038e-117
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HGF,Hepatocyte growth factor,42754,-0.0809496800715167,0.00349114713002334,-0.0877923284463624,-0.0741070316966709,1.1264147008375e-116
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APOC1,Apolipoprotein C-I,40516,0.0859702177369113,0.00370968203294506,0.0786992409523389,0.0932411945214836,4.0421091379227e-116
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,42754,-0.0959833648822913,0.00417196971380344,-0.104160425521346,-0.0878063042432365,6.2524689901145e-115
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,42346,-0.147897084598932,0.00647321570551513,-0.160584587381742,-0.135209581816123,2.45097841184666e-113
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,40527,-0.0782541670272579,0.00343160517734166,-0.0849801131748475,-0.0715282208796682,1.39942753563744e-112
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,42408,-0.109408071372981,0.0048148526157451,-0.118845182499842,-0.0999709602461211,3.69020051592056e-112
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,40511,-0.168402742205179,0.00745445760307571,-0.183013479107207,-0.15379200530315,1.45282766493851e-110
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCLY,Selenocysteine lyase,42674,-0.105596366561455,0.00468577450021536,-0.114780484581877,-0.096412248541033,2.01683845825071e-110
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GSTA1,Glutathione S-transferase A1,42611,-0.18559312721809,0.00828151455792035,-0.201824895751613,-0.169361358684566,3.10423430166943e-109
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,42754,-0.0902087325256634,0.00402673961026887,-0.0981011421617904,-0.0823163228895364,3.52835482764091e-109
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLUL1,Clusterin-like protein 1,42621,0.100161135547381,0.00451814006485631,0.091305581020263,0.1090166900745,5.65963169633925e-107
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MME,Neprilysin,42587,-0.180894288910317,0.00816086744775576,-0.196889589107919,-0.164898988712716,6.05012440356543e-107
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,42477,-0.332549836741543,0.0150653078571217,-0.362077840141502,-0.303021833341585,4.49853844842759e-106
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MENT,Protein MENT,40283,0.0517147148415717,0.00233904044451214,0.0471301955703279,0.0562992341128155,4.9204317880852e-106
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,40462,-0.189573733480124,0.00859401818249922,-0.206418009117822,-0.172729457842425,1.32620962702625e-105
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AMBP,Protein AMBP,42706,-0.0460504121350007,0.00210525030060562,-0.0501767027241877,-0.0419241215458136,2.92650569594775e-104
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GIP,Gastric inhibitory polypeptide,40223,-0.128939611367892,0.00590478797286071,-0.140512995794699,-0.117366226941085,1.60098401628049e-103
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,42711,-0.077512542543275,0.00357163487087196,-0.084512946890184,-0.0705121381963659,1.09567217684204e-102
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FAM3B,Protein FAM3B,42587,-0.0771519706396092,0.00355494792721337,-0.0841196685769474,-0.070184272702271,1.12581916269783e-102
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL15,C-C motif chemokine 15,42794,-0.0977231682075522,0.00450980368251488,-0.106562383425281,-0.088883952989823,2.14869222393832e-102
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,42663,0.0653722941192768,0.00303786302359648,0.0594180825930277,0.0713265056455259,5.12951195623629e-101
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,42495,-0.126402721765671,0.00589050773621873,-0.13794811692866,-0.114857326602683,1.89448678291072e-100
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,42733,-0.0678564055813264,0.00316440932992189,-0.0740586478679733,-0.0616541632946795,2.42397588551776e-100
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTSO,Cathepsin O,42754,-0.0662099803377505,0.00309125809041445,-0.0722688461949628,-0.0601511144805382,4.06500697717747e-100
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,REN,Renin,42636,-0.182458081066987,0.0086393865677955,-0.199391278739867,-0.165524883394108,2.0053776074455e-97
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GLA,Alpha-galactosidase A,40267,-0.0794235356190906,0.0037625249223981,-0.0867980844669909,-0.0720489867711903,5.26806522968021e-97
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SHBG,Sex hormone-binding globulin,40532,0.105935596601851,0.00511016558895424,0.0959196720475007,0.115951521156201,9.97440431289783e-94
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AREG,Amphiregulin,42587,-0.0888617773512217,0.00429974571051211,-0.0972892789438255,-0.080434275758618,1.96735166441706e-93
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,40483,-0.156967647854701,0.00758632133374859,-0.171836837668848,-0.142098458040554,2.23451674450208e-93
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,42495,-0.0805870377672847,0.00391330643721343,-0.088257118384223,-0.0729169571503464,8.80672298075759e-93
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL18R1,Interleukin-18 receptor 1,42754,-0.0681278001740138,0.00332221270811354,-0.0746393370819164,-0.0616162632661113,4.64217680414291e-92
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,42679,-0.0459620758883959,0.0022546219142476,-0.0503811348403212,-0.0415430169364706,5.23948132945188e-91
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,40277,-0.0955308916148924,0.00469952606299276,-0.104741962698358,-0.0863198205314266,3.19018173335138e-90
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,42346,-0.120844682613929,0.0059578515898753,-0.132522071730084,-0.109167293497773,4.29056357996975e-90
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD300LG,CMRF35-like molecule 9,42611,0.0785272418573182,0.00387371505113864,0.0709347603570864,0.0861197233575499,5.05759930381585e-90
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CA14,Carbonic anhydrase 14,42721,0.0735765783849785,0.00363089793632137,0.0664600184297886,0.0806931383401684,5.75449981486222e-90
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL17RB,Interleukin-17 receptor B,42416,0.107887291317947,0.0053654817029975,0.0973709471800723,0.118403635455823,1.3277384792431e-88
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MCAM,Cell surface glycoprotein MUC18,42689,0.0682127084253367,0.00339383542434684,0.0615607909936169,0.0748646258570565,1.4806979133221e-88
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL27,C-C motif chemokine 27,42636,-0.119117440779515,0.00594759140616604,-0.130774719935601,-0.10746016162343,6.01112488330722e-88
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRIP2,Cysteine-rich protein 2,42495,-0.073246913566294,0.00368427852918265,-0.080468099483492,-0.066025727649096,1.0751262771095e-86
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGF23,Fibroblast growth factor 23,42711,-0.109187340986624,0.00549413738779424,-0.119955850266701,-0.0984188317065474,1.18825627484979e-86
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,42587,-0.0723709082406599,0.00365226383281972,-0.0795293453529866,-0.0652124711283333,3.74574826549499e-86
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LGALS9,Galectin-9,42620,-0.0645096333325424,0.00325615474009248,-0.0708916966231236,-0.0581275700419611,3.9999467495047e-86
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,42370,-0.091612098034391,0.00464860914560442,-0.100723371959776,-0.0825008241090063,3.1289052467766e-85
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OCLN,Occludin,40482,-0.089793942599623,0.00455159073717747,-0.0987150604444909,-0.0808728247547552,3.34729419159913e-85
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MET,Hepatocyte growth factor receptor,42654,0.039515900242946,0.00200973262699198,0.0355768242940417,0.0434549761918503,7.01785269922507e-85
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPA2,Carboxypeptidase A2,42670,-0.129817515609391,0.0066626496363414,-0.14287630889662,-0.116758722322162,2.08488675678571e-83
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FAM20A,Pseudokinase FAM20A,40511,-0.0556024693587847,0.00285573706345056,-0.0611997140031478,-0.0500052247144216,4.4380300363157e-83
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GSTA3,Glutathione S-transferase A3,42346,-0.149421273513805,0.00770782350609979,-0.164528607585761,-0.134313939441849,1.4413492620978e-82
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,42594,-0.101314655879718,0.00522893059602146,-0.11156335984792,-0.0910659519115163,1.6555078423094e-82
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HAO1,Hydroxyacid oxidase 1,42721,-0.243929913128714,0.0126019632836923,-0.268629761164751,-0.219230065092678,2.32706069918528e-82
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,42357,-0.108481017134952,0.00560341336453591,-0.119463707329443,-0.0974983269404619,2.3435608629893e-82
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CST3,Cystatin-C,42659,-0.0591066224236001,0.00305367373597477,-0.0650918229461106,-0.0531214219010895,2.38074556233208e-82
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,F9,Coagulation factor IX,42663,-0.0352742143370353,0.0018233673835175,-0.0388480144087296,-0.031700414265341,2.88754635016567e-82
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,40451,-0.11134308631413,0.00575035349318858,-0.12261377916078,-0.10007239346748,3.42510778096503e-82
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AGRN,Agrin,42676,-0.0710003772086925,0.00367516909752692,-0.0782037086398452,-0.0637970457775397,4.76638425290739e-82
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,40283,-0.0972760002953884,0.00503119547813349,-0.10713714343253,-0.0874148571582467,6.09139286822312e-82
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NCS1,Neuronal calcium sensor 1,42721,-0.0561528830703743,0.00291696159565137,-0.061870127797851,-0.0504356383428976,1.71467413519059e-81
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KYNU,Kynureninase,42754,-0.0861813837662369,0.00448227904919525,-0.0949666507026596,-0.0773961168298143,2.64171197019304e-81
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINF1,Pigment epithelium-derived factor,40351,-0.0517048119505044,0.00269738101154865,-0.0569916787331398,-0.0464179451678691,1.33029933388681e-80
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,40283,-0.0734686522533659,0.00383337266623484,-0.0809820626791862,-0.0659552418275456,1.43160169946955e-80
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,42636,0.0523309647977551,0.002740631175631,0.0469593276935183,0.0577026019019918,3.22501072532677e-80
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EFNA4,Ephrin-A4,42475,-0.0654431353886278,0.00342804382116219,-0.0721621012781057,-0.0587241694991499,3.57538481376979e-80
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,42587,-0.152651695739317,0.0080081384883008,-0.168347647176387,-0.136955744302248,5.95113122770383e-80
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNASET2,Ribonuclease T2,42749,-0.0531257428326545,0.00279549193743242,-0.058604907030022,-0.0476465786352869,1.69965125311319e-79
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",42357,-0.177151236563732,0.00933951415655749,-0.195456684310585,-0.15884578881688,3.56013960315693e-79
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCARB2,Lysosome membrane protein 2,42302,-0.0669172288595818,0.00353011703885842,-0.0738362582557443,-0.0599981994634193,4.47645807105178e-79
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL23,C-C motif chemokine 23,42676,-0.0803434973014153,0.00424065520780915,-0.0886551815087212,-0.0720318130941094,5.04895931817311e-79
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,40367,-0.065675785690911,0.00346749869519399,-0.0724720831334912,-0.0588794882483307,9.02757924126211e-79
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,42611,-0.0872560008970657,0.00461550116842093,-0.0963023831871707,-0.0782096186069607,1.08990253811901e-78
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UMOD,Uromodulin,42764,0.105443920273903,0.00558578997108333,0.0944957719305798,0.116392068617226,1.77443583597801e-78
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DPY30,Protein dpy-30 homolog,42651,-0.114462807227241,0.00607071022582978,-0.126361399269868,-0.102564215184615,2.72521301486806e-78
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PIGR,Polymeric immunoglobulin receptor,42464,-0.06798433473491,0.0036168010968294,-0.0750732648846957,-0.0608954045851244,8.19295878274081e-78
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DSG2,Desmoglein-2,42611,0.0515266101725925,0.00274701407457276,0.0461424625864299,0.0569107577587551,1.64931487444069e-77
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",42346,-0.154581397348448,0.00824488621181314,-0.170741374323602,-0.138421420373294,2.0181810552552e-77
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLXNB2,Plexin-B2,42743,-0.0457575178309586,0.00244400371287786,-0.0505477651081992,-0.040967270553718,3.06130599172657e-77
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42638,-0.0602887509222392,0.00322049638369665,-0.0666009238342846,-0.0539765780101937,3.23238983005497e-77
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MEP1A,Meprin A subunit alpha,40449,-0.136862835083123,0.00734024060269351,-0.151249706664402,-0.122475963501844,1.93434028006584e-76
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FUOM,Fucose mutarotase,40283,-0.119587307198015,0.00641775639797303,-0.132166109738042,-0.107008504657987,2.48739212894193e-76
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,42721,-0.0683380724063044,0.00367487927731117,-0.0755408357898343,-0.0611353090227745,3.08000863669981e-76
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,42721,-0.064558965347645,0.00347720580122641,-0.0713742887180488,-0.0577436419772413,5.28076071368704e-76
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AGR3,Anterior gradient protein 3,42326,-0.11183496159833,0.00605266556005404,-0.123698186096036,-0.0999717371006245,2.83853072714814e-75
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FABP1,"Fatty acid-binding protein, liver",42618,-0.176318969294688,0.00955381902661823,-0.19504445458686,-0.157593484002517,4.00346226850008e-75
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SELE,E-selectin,42794,-0.0946876367206616,0.00513183503832235,-0.104746033395773,-0.0846292400455498,4.2113097618206e-75
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NPPC,C-type natriuretic peptide,42594,-0.0932053767807766,0.00505781674545121,-0.103118697601861,-0.0832920559596922,6.5818070367093e-75
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AGR2,Anterior gradient protein 2 homolog,42215,-0.189142065738125,0.0102722513967555,-0.209275678475766,-0.169008453000484,9.17617610660413e-75
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",42562,-0.131015747755148,0.00712376438673439,-0.144978325953147,-0.117053169557148,1.27913552376244e-74
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXCL13,C-X-C motif chemokine 13,42711,-0.116151182771488,0.00632277920764812,-0.128543830018479,-0.103758535524498,1.82679795390837e-74
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,42587,-0.159856514153155,0.00873134476854196,-0.176969949899498,-0.142743078406813,5.65553714463018e-74
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42618,-0.0743295940315102,0.00406273310408536,-0.0822925509155175,-0.0663666371475029,7.08986805922382e-74
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42611,-0.0597853314507852,0.00326849231241132,-0.0661915763831114,-0.053379086518459,7.63189701581997e-74
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KHK,Ketohexokinase,40223,-0.115804478053856,0.00634571587296727,-0.128242081164871,-0.10336687494284,2.50412266071712e-73
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,42250,-0.101578319323051,0.00558126863276775,-0.112517605843276,-0.090639032802826,4.13522789962875e-73
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,42587,-0.191947027042095,0.0105490136218223,-0.212623093740867,-0.171270960343324,4.22765056713836e-73
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,42346,-0.149493628749021,0.00821750238441007,-0.165599933422465,-0.133387324075577,4.67765021371363e-73
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42594,0.072324388421473,0.00397997897438226,0.0645236296316837,0.0801251472112622,6.43712455251659e-73
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NECTIN2,Nectin-2,42613,-0.0580792423343194,0.00319696189041882,-0.0643452876395403,-0.0518131970290985,7.02132446727386e-73
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,40116,-0.103008683180623,0.0056697255983148,-0.11412134535332,-0.0918960210079258,1.07859073265231e-72
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGAV,Integrin alpha-V,42721,0.0298598588430015,0.00165894784122605,0.0266083210741985,0.0331113966118046,1.34796651333811e-71
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TFF3,Trefoil factor 3,42613,-0.0784724906903456,0.00436957497333228,-0.0870368576380769,-0.0699081237426144,2.78964585139605e-71
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,42594,-0.0704321926943201,0.00393678339529437,-0.078148288149097,-0.0627160972395431,9.23819517859811e-71
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,42676,-0.0542211293090946,0.00305079369488198,-0.0602006849510633,-0.0482415736671259,7.18188424263238e-70
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL12A_IL12B,Interleukin-12,42587,-0.147348820651826,0.00829907531625231,-0.163615008271681,-0.131082633031972,9.93434196347112e-70
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FAM3C,Protein FAM3C,42613,-0.0557575851349802,0.00315585667809824,-0.0619430642240528,-0.0495721060459077,4.47375734296828e-69
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TFPI,Tissue factor pathway inhibitor,42618,0.0553229874910288,0.003134566060031,0.049179238013368,0.0614667369686895,6.17382590731709e-69
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEMA3F,Semaphorin-3F,42636,-0.048248526588759,0.00274882230507256,-0.0536362183067012,-0.0428608348708168,3.27955183343828e-68
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,42590,-0.0891288399572389,0.00508084873791825,-0.0990873034835587,-0.0791703764309192,3.94008924110799e-68
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,40171,-0.070057829857903,0.00399275438127311,-0.0778836284451983,-0.0622320312706077,5.36355606406197e-68
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL12B,Interleukin-12 subunit beta,42754,-0.100530860551555,0.00574376436326581,-0.111788638703556,-0.0892730823995542,7.60996150440631e-68
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AMOT,Angiomotin,40283,-0.068791882838155,0.00393887351966121,-0.076512074936691,-0.0610716907396191,2.10992263082005e-67
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,42636,-0.0617278810153766,0.00354300749883018,-0.0686721757130838,-0.0547835863176695,3.04909589173267e-67
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,42794,-0.0669936746306238,0.00385152017815422,-0.0745426541798061,-0.0594446950814415,4.85505638183622e-67
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,42794,-0.0695821684922261,0.00400130698041967,-0.0774247301738486,-0.0617396068106035,5.21824564113806e-67
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,40451,-0.09137677921707,0.00526529673384977,-0.101696760815416,-0.0810567976187245,1.3366807915848e-66
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,F11R,Junctional adhesion molecule A,42611,-0.0968460293590789,0.00560416953948406,-0.107830201656468,-0.0858618570616902,3.39649177443043e-66
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,42587,-0.0696021073823348,0.00402842243529303,-0.0774978153555091,-0.0617063994091605,3.60302388752969e-66
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,XCL1,Lymphotactin,42721,-0.0980900965738954,0.0056824255618445,-0.109227650675111,-0.0869525424726802,4.63027638984056e-66
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ELN,Elastin,40511,-0.0641495708656785,0.00372130038208818,-0.0714433196145713,-0.0568558221167857,9.41137343469825e-66
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HEG1,Protein HEG homolog 1,40283,-0.0471940953835877,0.00274234793351708,-0.0525690973332812,-0.0418190934338942,1.59717090963359e-65
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD5,T-cell surface glycoprotein CD5,42706,-0.0626830816850767,0.00365139479340592,-0.0698398154801523,-0.0555263478900011,2.31535000927476e-65
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPB1,Carboxypeptidase B,42794,-0.105458072685701,0.00614967242951648,-0.117511430647553,-0.0934047147238488,3.12079399366149e-65
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EGFR,Epidermal growth factor receptor,42794,0.0282947702456933,0.00165409675681728,0.0250527406023315,0.0315367998890552,6.39999629255133e-65
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,42611,-0.0533509301477573,0.00312149290373288,-0.0594690562390737,-0.0472328040564408,8.32284572792653e-65
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",42794,-0.0887337284985472,0.00519448035764258,-0.0989149099995266,-0.0785525469975677,9.50625721702684e-65
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",40223,-0.0987726924062606,0.00579486299012594,-0.110130623866907,-0.0874147609456137,2.53422411754462e-64
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GZMA,Granzyme A,42754,-0.0611413645616807,0.00359725217407684,-0.0681919788228713,-0.0540907503004901,4.00360551150771e-64
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPO,Erythropoietin,42594,-0.127051594085967,0.00747983713829792,-0.141712074877031,-0.112391113294904,4.88210442803968e-64
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IDUA,Alpha-L-iduronidase,42721,-0.0793912702451086,0.00468680550525613,-0.0885774090354106,-0.0702051314548066,1.04578402642636e-63
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LSP1,Lymphocyte-specific protein 1,42594,-0.0674671715445884,0.00401450871568964,-0.0753356086273401,-0.0595987344618367,9.69741619753868e-63
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GHR,Growth hormone receptor,40283,-0.0485152658569205,0.00288487997251962,-0.054169630603059,-0.0428609011107821,1.09106687297159e-62
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NOMO1,Nodal modulator 1,42611,-0.0391945281766441,0.00233902082735452,-0.043779008998259,-0.0346100473550293,2.17288864748775e-62
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,42346,-0.063731566983809,0.00381311545477767,-0.0712052732751733,-0.0562578606924448,4.53889220659306e-62
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,42591,-0.0740548693187621,0.00444061696305934,-0.0827584785663584,-0.0653512600711658,8.12192232613697e-62
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HJV,Hemojuvelin,40482,-0.0746660265324424,0.00447669227613217,-0.0834403433936615,-0.0658917096712234,1.02099557600179e-61
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,REG4,Regenerating islet-derived protein 4,42638,-0.088914099974635,0.00534658417611815,-0.0993934049598265,-0.0784347949894434,1.73435782514126e-61
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HEPH,Hephaestin,40511,-0.044779397103895,0.00269293153749574,-0.0500575429173866,-0.0395012512904033,2.31122865041037e-61
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BPIFB1,BPI fold-containing family B member 1,42573,0.10479441881855,0.00633758162355178,0.0923727588363888,0.117216078800712,8.17761886367352e-61
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRSS2,Trypsin-2,42689,-0.0936832966514465,0.00566703030960993,-0.104790676058282,-0.082575917244611,8.64057541843697e-61
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNASE6,Ribonuclease K6,40468,-0.0573521033084459,0.00347570371648392,-0.0641644825927544,-0.0505397240241375,1.84581207094791e-60
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,42476,-0.122495541981468,0.00743321874826155,-0.137064650728061,-0.107926433234875,2.04758495042634e-60
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,40504,0.0825186685317016,0.0050256930354992,0.0726683101821231,0.09236902688128,6.83955997603832e-60
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,40199,-0.0742541597217514,0.00452936417035592,-0.083131713495649,-0.0653766059478538,1.07474340925377e-59
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADM,Pro-adrenomedullin,42721,-0.0445352842042508,0.00272017074226812,-0.0498668188590963,-0.0392037495494053,1.13062679226416e-59
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,42594,-0.106104575885812,0.00649636469286806,-0.118837450683833,-0.0933717010877901,2.15526476379331e-59
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,42689,-0.0680813701000696,0.0041698150627829,-0.0762542076231241,-0.0599085325770152,2.34137940449802e-59
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FSTL3,Follistatin-related protein 3,42574,-0.0560744685136457,0.0034386672718332,-0.0628142563664388,-0.0493346806608527,3.2724080968799e-59
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42638,-0.0595918655435103,0.00365560096713714,-0.0667568434390991,-0.0524268876479216,3.55303707822928e-59
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL3,C-C motif chemokine 3,42594,-0.0944374782960178,0.00581290409028291,-0.105830770312972,-0.0830441862790633,8.65870197027274e-59
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGA11,Integrin alpha-11,42594,0.0552808104354547,0.00343799702464642,0.0485423362671477,0.0620192846037616,1.23127053998704e-57
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,40223,0.0990572851559424,0.00616299800178168,0.0869778090724503,0.111136761239434,1.77283670892376e-57
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AFM,Afamin,40539,-0.032550049380438,0.00202645400973758,-0.0365218992395237,-0.0285781995213523,2.00264151769704e-57
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42611,-0.0623803629616159,0.00388723514909037,-0.069999343853833,-0.0547613820693987,2.03563961428207e-57
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,42501,-0.0476208075279626,0.0029724454898254,-0.0534468006880204,-0.0417948143679048,3.13638189824788e-57
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AGXT,Serine--pyruvate aminotransferase,42636,-0.122494417782427,0.0076501444464434,-0.137488700897456,-0.107500134667398,3.5547561400472e-57
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",42587,-0.0959920106335039,0.00601394905371191,-0.107779350778779,-0.0842046704882286,7.90622575443191e-57
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EGLN1,Egl nine homolog 1,42594,-0.0894116345010571,0.00560228063145593,-0.100392104538711,-0.0784311644634035,8.11495245587342e-57
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,42754,0.0412941313499976,0.00258785841378056,0.0362219288589877,0.0463663338410075,8.3869355893719e-57
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANGPT2,Angiopoietin-2,42721,-0.0611996126491866,0.00383564649024949,-0.0687174797700756,-0.0536817455282976,8.59631094265039e-57
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,40449,-0.0476299990320585,0.00298343681950525,-0.0534775351982888,-0.0417824628658282,9.41609927924904e-57
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SULT2A1,Bile salt sulfotransferase,42594,-0.0903845521801082,0.00567248337511985,-0.101502619595343,-0.0792664847648733,1.22100402615667e-56
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,40116,-0.109835274282849,0.00688737162238991,-0.123334522662734,-0.0963360259029652,1.2920904741676e-56
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GRP,Gastrin-releasing peptide,40223,-0.0907472598031143,0.00569843838653107,-0.101916199040715,-0.0795783205655134,1.80875595993823e-56
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42611,-0.0483775661381883,0.00305047856505333,-0.0543565041256928,-0.0423986281506838,3.93780319574799e-56
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,42555,-0.0527141051975458,0.00332422770139333,-0.0592295914922767,-0.0461986189028149,4.04824603585689e-56
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD72,B-cell differentiation antigen CD72,40283,-0.0716721033351184,0.00452022698865904,-0.0805317482328901,-0.0628124584373466,5.2712739148884e-56
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTSB,Cathepsin B,42659,0.0863010695937159,0.00546571312147856,0.075588271875618,0.0970138673118139,1.15890822406157e-55
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,42746,-0.0607784776832925,0.003853677532878,-0.0683316856477334,-0.0532252697188516,1.52189401546574e-55
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APOA1,Apolipoprotein A-I,40539,0.044230929595118,0.00281194596710432,0.0387195154995935,0.0497423436906424,3.61952140338911e-55
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",42587,-0.0699381836902637,0.00446009146756126,-0.0786799629666838,-0.0611964044138436,6.28960474121674e-55
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MTSS1,Protein MTSS 1,40449,-0.177437937796841,0.0113448095086305,-0.199673764433756,-0.155202111159925,1.44632178183694e-54
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,42794,0.0540534699726459,0.00346330532097734,0.0472653915435303,0.0608415484017614,1.91945469495875e-54
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SORD,Sorbitol dehydrogenase,42658,-0.105530333815674,0.00676440460238408,-0.118788566836346,-0.0922721007950009,2.14946123865822e-54
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGBL1,Integrin beta-like protein 1,40527,-0.0615894657580243,0.00395958926904181,-0.0693502607253463,-0.0538286707907024,5.35335166409099e-54
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,42618,-0.043220913454847,0.00278185265650203,-0.048673344661591,-0.037768482248103,5.76970720570817e-54
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PXN,Paxillin,42311,-0.080237479247056,0.00518705025141653,-0.0904040977398324,-0.0700708607542796,1.67106476623743e-53
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD27,CD27 antigen,42679,-0.0696152946678187,0.00450172267279464,-0.0784386711064962,-0.0607919182291412,1.74241154757608e-53
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HYAL1,Hyaluronidase-1,42544,-0.0364204756221241,0.00235641978457222,-0.0410390583998857,-0.0318018928443626,1.99833458524009e-53
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPIND1,Heparin cofactor 2,40516,-0.0441920647055788,0.00285766644418497,-0.0497930909361814,-0.0385910384749763,2.11836315082228e-53
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNASE4,Ribonuclease 4,40169,-0.0461494266598873,0.00298546711064184,-0.0520009421967453,-0.0402979111230293,2.42654312896592e-53
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTGR1,Prostaglandin reductase 1,40511,-0.131807135181294,0.00853169789789615,-0.14852926306117,-0.115085007301417,2.67362420326549e-53
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,42346,-0.0800581739778101,0.00518620998373793,-0.0902231455459364,-0.0698932024096837,2.7164190329484e-53
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LEP,Leptin,42636,-0.103900736480411,0.00673691574582344,-0.117105091342225,-0.0906963816185971,3.29266055975135e-53
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42683,-0.0482702892017012,0.00313030928297508,-0.0544056953963324,-0.0421348830070701,3.397809302265e-53
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLAT,Tissue-type plasminogen activator,42760,-0.0788326612547523,0.00512292487795767,-0.0888735940155493,-0.0687917284939552,5.50128248511931e-53
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,42676,-0.0435336904200714,0.0028314388689652,-0.0490833106032432,-0.0379840702368996,6.75442287783212e-53
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDH1,Cadherin-1,42188,-0.0621403369857957,0.00404878311351507,-0.0700759518882852,-0.0542047220833061,1.05988858018179e-52
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXCL17,C-X-C motif chemokine 17,42754,-0.0630667965723931,0.0041155828098455,-0.0711333388796903,-0.0550002542650959,1.45875713266322e-52
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,42594,-0.0588694494686021,0.00384675314649095,-0.0664090856357244,-0.0513298133014798,2.00437794163378e-52
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,42636,-0.0582425522043803,0.00380868074463139,-0.0657075664638578,-0.0507775379449028,2.38122158152736e-52
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL16,Pro-interleukin-16,42754,-0.0638939402602586,0.00418547741728006,-0.0720974759981275,-0.0556904045223897,3.51664200386162e-52
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,42594,0.0543524102150158,0.00356374006515246,0.047367479687317,0.0613373407427147,4.40156987654276e-52
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",40511,-0.114400650219704,0.00750832771915659,-0.129116972549251,-0.099684327890157,6.61826509544633e-52
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,42594,-0.106829475297258,0.0070375412840293,-0.120623056213956,-0.0930358943805609,1.28966178113168e-51
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GFRA1,GDNF family receptor alpha-1,42689,-0.0457130895892705,0.00301342421779986,-0.0516194010561583,-0.0398067781223828,1.49071728326721e-51
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD2AP,CD2-associated protein,42636,-0.0979026919995134,0.00645443057638756,-0.110553375929233,-0.0852520080697938,1.53094000072873e-51
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAB6A,Ras-related protein Rab-6A,42594,0.0705090085535739,0.00465365151267524,0.0613878515887304,0.0796301655184174,1.97948003188855e-51
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HLA_E,,42594,-0.0473371691910229,0.00312473234976019,-0.0534616445965529,-0.041212693785493,2.04381664955989e-51
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXCL6,C-X-C motif chemokine 6,42754,-0.117148397400582,0.00775324637765843,-0.132344760300792,-0.101952034500371,3.65133467734889e-51
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",40483,-0.0643321530012746,0.00426303076056792,-0.0726876932919877,-0.0559766127105615,5.84810260250768e-51
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,POSTN,Periostin,40527,0.0591816233570245,0.0039251263597738,0.0514883756918678,0.0668748710221811,7.07022707905247e-51
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLA2G15,Phospholipase A2 group XV,42679,-0.0406126374997964,0.00270095617768318,-0.0459065116080555,-0.0353187633915374,1.09153196670835e-50
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTSZ,Cathepsin Z,42648,-0.0491922676535339,0.00327584526093458,-0.0556129243649657,-0.0427716109421022,1.46605579852261e-50
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDH2,Cadherin-2,42636,-0.0541592322884356,0.00360943375769547,-0.0612337224535187,-0.0470847421233525,1.74662402953716e-50
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MLN,Promotilin,42594,-0.134758652662169,0.00898480660481036,-0.152368873607597,-0.117148431716741,1.92620892107266e-50
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ERMAP,Erythroid membrane-associated protein,40199,-0.0683256682175367,0.00456290387353304,-0.0772689598096614,-0.0593823766254119,3.37658797628217e-50
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NUCB2,Nucleobindin-2,42683,-0.0559508598054583,0.00374224226622715,-0.0632856546472635,-0.048616064963653,3.85691462154468e-50
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,40511,-0.101942680353627,0.00681350841750584,-0.115297156851938,-0.0885882038553154,3.92544495401209e-50
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COLEC12,Collectin-12,42618,-0.0423092723478517,0.00284830788011851,-0.047891955792884,-0.0367265889028195,1.61576542618585e-49
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PAXX,Protein PAXX,40283,-0.0687988786946049,0.00463299357249294,-0.077879546096691,-0.0597182112925187,2.08007312595242e-49
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STC1,Stanniocalcin-1,42711,-0.0678080231888771,0.00458057208195082,-0.0767859444695007,-0.0588301019082535,3.38031036931083e-49
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,42594,-0.0411596360282735,0.0027847196522065,-0.0466176865465982,-0.0357015855099487,4.75842163641163e-49
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEL1L,Protein sel-1 homolog 1,40223,-0.0492274225464295,0.00332808623744429,-0.0557504715718204,-0.0427043735210387,4.89705647976961e-49
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,S100P,Protein S100-P,42357,-0.081915256492774,0.005549384943382,-0.0927920509818027,-0.0710384620037453,6.41577762650135e-49
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,42636,-0.0413427488770315,0.00281108217064674,-0.0468524699314991,-0.0358330278225639,1.38469001335966e-48
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL21,C-C motif chemokine 21,42676,-0.0631236052070284,0.00429639858856133,-0.0715445464406086,-0.0547026639734482,1.71374201834491e-48
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,42706,-0.0988874708990962,0.0067324149412563,-0.112083004183959,-0.0856919376142338,1.81156174558256e-48
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",40482,-0.0930454008335703,0.00633062267080489,-0.105453421268348,-0.0806373803987928,1.86871933021176e-48
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,42754,-0.0715303345724787,0.00487168279824111,-0.0810788328570313,-0.0619818362879262,1.95291807266954e-48
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,THBS2,Thrombospondin-2,42611,-0.0577531834071811,0.00394531028829373,-0.0654859915722368,-0.0500203752421254,3.75305873687034e-48
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSME1,Proteasome activator complex subunit 1,42480,-0.05478788508663,0.0037595529534181,-0.0621566088753295,-0.0474191612979305,9.74018609060964e-48
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42689,-0.063315054295691,0.00434692913216912,-0.0718350353947424,-0.0547950731966395,1.07135682504466e-47
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LBR,Delta(14)-sterol reductase LBR,42711,-0.0980156890937504,0.00673646423522033,-0.111219158994782,-0.0848122191927186,1.3364631833697e-47
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TGFA,Protransforming growth factor alpha,42594,-0.0699535082858268,0.00480932830382857,-0.0793797917613308,-0.0605272248103228,1.43899210778254e-47
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,42711,-0.0762916060351316,0.00525040197906107,-0.0865823939140913,-0.0660008181561719,1.76656699871494e-47
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,42547,-0.0415754588051816,0.00286136021711765,-0.0471837248307322,-0.035967192779631,1.80131348188953e-47
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,42689,-0.0621654697605057,0.00429105067701106,-0.0705759290874474,-0.053755010433564,3.29721656326477e-47
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,42587,-0.0870071778769584,0.0060113679416831,-0.0987894590426573,-0.0752248967112596,4.02325019517284e-47
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,42580,-0.0301654355174621,0.0020845345543659,-0.0342511232440192,-0.0260797477909049,4.18408154548531e-47
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",42570,-0.153988757545698,0.0106494732520342,-0.174861725119685,-0.133115789971711,4.92224474098148e-47
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPA1,Carboxypeptidase A1,42794,-0.0918062761236636,0.00634996615645553,-0.104252209790316,-0.0793603424570107,4.99780468384075e-47
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL18BP,Interleukin-18-binding protein,42689,-0.0475908977237164,0.00329244769992319,-0.0540440952155658,-0.0411377002318669,5.26384598826155e-47
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENO3,Beta-enolase,40223,-0.0864158609722933,0.0060005633063557,-0.0981769650527505,-0.0746547568918362,1.34271503669201e-46
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CALCA,Calcitonin,42476,-0.092071410433356,0.00640809215824185,-0.10463127106351,-0.079511549803202,1.83196193628902e-46
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GUSB,Beta-glucuronidase,42711,-0.0883373627880199,0.00615361535224353,-0.100398448878417,-0.0762762766976226,2.16220005676143e-46
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VEGFA,Vascular endothelial growth factor A,42716,-0.0850557458924032,0.00593866006866067,-0.0966955196269781,-0.0734159721578283,3.45179520569281e-46
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ULBP2,UL16-binding protein 2,42495,-0.0580235687703212,0.00405963882749055,-0.0659804608722026,-0.0500666766684397,5.31553555208298e-46
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,42587,-0.0632301703160407,0.00442495641008229,-0.071903084879802,-0.0545572557522794,5.54352906835378e-46
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD209,CD209 antigen,42668,0.0565324955982726,0.00395745484908751,0.0487758840940611,0.0642891071024841,5.87059600503932e-46
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,42746,-0.0586497104157346,0.00410665019194719,-0.0666987447919511,-0.0506006760395181,6.13451717119651e-46
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,40449,-0.0441899180322275,0.00309218015480263,-0.0502505911356407,-0.0381292449288144,6.28823827071593e-46
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,40199,-0.0998425462161165,0.00698942361065454,-0.113541816492999,-0.0861432759392336,6.99229025106615e-46
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DKK4,Dickkopf-related protein 4,42477,-0.0670814672936546,0.0047081128445087,-0.0763093684688917,-0.0578535661184175,1.00086881670148e-45
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,42640,-0.0578927596449452,0.00407815588000416,-0.0658859451697534,-0.0498995741201371,2.06905610395423e-45
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PALM2,Paralemmin-2,40483,-0.0545562672145328,0.00384562953659055,-0.0620937011062502,-0.0470188333228153,2.71648574633271e-45
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TGFBR2,TGF-beta receptor type-2,42679,-0.0517064117387788,0.00365150698495997,-0.0588633654293003,-0.0445494580482572,3.39955487480454e-45
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CFI,Complement factor I,40539,-0.0281719856038896,0.001993553862093,-0.0320793511735918,-0.0242646200341873,5.83752343393613e-45
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,42668,0.0438495128350267,0.00310792648861001,0.0377579769173511,0.0499410487527023,6.98113935957938e-45
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EZR,Ezrin,42711,-0.0341049404445632,0.00242041376714473,-0.0388489514281669,-0.0293609294609595,9.00395554861477e-45
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OMD,Osteomodulin,42676,0.0605484280367718,0.0043030214091738,0.0521145060747911,0.0689823499987524,1.18233385927988e-44
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,42636,-0.0621315741059116,0.00441701025091989,-0.0707889141977146,-0.0534742340141086,1.26525288411475e-44
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNTN3,Contactin-3,42611,-0.0444376950300446,0.00316516565454345,-0.0506414197129497,-0.0382339703471394,1.84029118197521e-44
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BMPER,BMP-binding endothelial regulator protein,40283,-0.0333065860091645,0.00237171256135376,-0.0379551426294179,-0.0286580293889111,2.0330557160624e-44
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SHISA5,Protein shisa-5,40527,-0.0398476166190811,0.00283862611528997,-0.0454113238050494,-0.0342839094331128,2.15736702590643e-44
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,42587,0.0356947741721556,0.00254495884763961,0.030706654830782,0.0406828935135293,2.23638122922593e-44
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,42587,-0.0949683695161803,0.00677715309668856,-0.10825158958569,-0.0816851494466707,2.66621617180594e-44
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,42679,-0.0401640099592506,0.00286790253265447,-0.0457850989232533,-0.0345429209952478,2.97944466705299e-44
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNASE1,Ribonuclease pancreatic,40532,-0.0378686939517853,0.00270726930940973,-0.0431749417982284,-0.0325624461053423,4.30057913222227e-44
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",42676,-0.0401328377610872,0.00287961879222877,-0.0457768905938556,-0.0344887849283188,7.61719323483374e-44
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NPL,N-acetylneuraminate lyase,40511,-0.064572707452521,0.00463978096497842,-0.0736666781438787,-0.0554787367611633,1.13989334148345e-43
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD302,CD302 antigen,42587,-0.045282791762388,0.00326358096667768,-0.0516794104570762,-0.0388861730676997,1.78991162058729e-43
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FETUB,Fetuin-B,42663,-0.0453020078223191,0.00326976526598209,-0.051710747743644,-0.0388932679009942,2.35874853515428e-43
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD80,T-lymphocyte activation antigen CD80,40511,-0.0493310191133915,0.0035600584259678,-0.0563087336282884,-0.0423533045984946,2.61098535296202e-43
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,40451,-0.0934062030975939,0.00676111921626171,-0.106657996761467,-0.0801544094337209,4.63169772183816e-43
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,42611,-0.0515368190762819,0.00373727748319777,-0.0588618829433495,-0.0442117552092143,5.75222470083803e-43
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,40283,-0.104646593371846,0.00759515597653833,-0.119533099085861,-0.0897600876578308,7.77759473862813e-43
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,B2M,Beta-2-microglobulin,40539,-0.0441634238199414,0.00320682024195262,-0.0504487914941685,-0.0378780561457143,8.32817124164368e-43
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IMMT,MICOS complex subunit MIC60,40451,-0.063290876384802,0.00461125428460331,-0.0723289347826245,-0.0542528179869795,1.57463742851267e-42
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,42611,-0.0745467643289122,0.00543785170232849,-0.085204953665476,-0.0638885749923483,1.736684701316e-42
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,40532,0.0383996412344917,0.00280031481362526,0.0329110241997862,0.0438882582691972,1.86006799980278e-42
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,42311,-0.03996096260853,0.00292732673687079,-0.0456985230127968,-0.0342234022042633,3.86261532158595e-42
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,40449,-0.082644836919906,0.00605856959544038,-0.0945196333269691,-0.0707700405128429,4.92883966366014e-42
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTSS,Cathepsin S,39872,-0.033858944711035,0.00248504687666394,-0.0387296365892964,-0.0289882528327737,6.36291919772039e-42
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,F7,Coagulation factor VII,42671,-0.0429301583979006,0.0031537969029908,-0.0491116003277625,-0.0367487164680386,6.41232495086102e-42
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXCL9,C-X-C motif chemokine 9,42676,-0.0939524923687422,0.0069043920958203,-0.10748510087655,-0.0804198838609344,6.8189370439599e-42
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,42636,-0.0480514329782738,0.00353269220968418,-0.0549755097092548,-0.0411273562472928,7.3789861909109e-42
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NUMB,Protein numb homolog,40199,-0.113694169501601,0.00838179817000428,-0.130122493914809,-0.0972658450883922,1.40437256906331e-41
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NCAM2,Neural cell adhesion molecule 2,42611,0.0374753600122074,0.00276491242241226,0.0320561316642794,0.0428945883601354,1.41047378979458e-41
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TOP2B,DNA topoisomerase 2-beta,40199,-0.109990101512592,0.00811425888541791,-0.125894048928012,-0.0940861540971733,1.58981496441476e-41
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXCL10,C-X-C motif chemokine 10,42676,-0.093075438400826,0.00687954505472401,-0.106559346708085,-0.0795915300935669,1.95695400669878e-41
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GAST,Gastrin,40483,-0.200811196185565,0.0148488896245245,-0.229915019849633,-0.171707372521497,2.37890243452306e-41
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,42594,-0.0484475999977983,0.00358495657341674,-0.0554741148816951,-0.0414210851139015,2.40734701299267e-41
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,42594,-0.0853906629250906,0.00632044968570121,-0.097778744309065,-0.0730025815411163,2.53717527932461e-41
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,42771,0.0850283993751981,0.00630473693768668,0.0726711149773322,0.097385683773064,3.46107447832886e-41
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TTR,Transthyretin,40424,-0.0347199425309485,0.00257469745613785,-0.0397663495449787,-0.0296735355169184,3.99931369644403e-41
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,42594,-0.0788157824929725,0.0058503625980634,-0.0902824931851768,-0.0673490718007682,4.23431379860201e-41
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BECN1,Beclin-1,40223,-0.0820881951174987,0.00609857529133015,-0.0940414026885058,-0.0701349875464916,5.64251660583815e-41
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DCXR,L-xylulose reductase,42679,-0.0717555020986248,0.00533712245659176,-0.0822162621135446,-0.061294742083705,6.07679049165788e-41
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,42587,-0.0378620017754477,0.00282328763926726,-0.0433956455484115,-0.0323283580024838,9.59767995375004e-41
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSTB,Cystatin-B,42437,-0.0580598334669648,0.0043329802219048,-0.0665524747018982,-0.0495671922320314,1.11989834794441e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNCG,Gamma-synuclein,42495,-0.0936294562727247,0.00698802963470382,-0.107325994356744,-0.0799329181887053,1.1313888615501e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ELOA,Elongin-A,42587,-0.0728127411930993,0.00544283690160382,-0.0834807015202428,-0.0621447808659559,1.48590551854572e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,42594,-0.0788551437822255,0.00589743990840662,-0.0904141260027025,-0.0672961615617485,1.62224555307906e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,40199,-0.115144774786948,0.00860751097730435,-0.132015496302465,-0.0982740532714318,1.70053143133082e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAT2,Linker for activation of T-cells family member 2,42587,-0.167158069123027,0.0125156581054595,-0.191688759009727,-0.142627379236326,1.98421316161679e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDHR2,Cadherin-related family member 2,42587,-0.0956966546900534,0.00717470709115593,-0.109759080588719,-0.0816342287913878,2.51368245885912e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPHA2,Ephrin type-A receptor 2,42125,-0.0457118232662972,0.00344496444020106,-0.0524639535690913,-0.0389596929635031,6.37144356000579e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,42495,-0.0978749366786045,0.00738127685400289,-0.11234223931245,-0.0834076340447589,7.08101719170403e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,42495,-0.0610759760799037,0.00460696457095816,-0.0701056266389817,-0.0520463255208257,7.32539141553779e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,42620,-0.0663455239509516,0.00500940051091303,-0.0761639489523411,-0.056527098949562,8.65736664819315e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,42676,-0.0530980093840272,0.00401009437044216,-0.0609577943500939,-0.0452382244179606,8.9981880198494e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,42346,-0.0914130995301687,0.00690446641394165,-0.104945853701494,-0.0778803453588431,9.29427936233328e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GSN,Gelsolin,40488,0.0263420401306415,0.00198903604711504,0.022443529478296,0.030240550782987,9.71229833083583e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CA6,Carbonic anhydrase 6,42581,0.0841560953234691,0.0063593923233567,0.07169168636969,0.0966205042772482,1.0000620294714e-39
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL18,Interleukin-18,42566,-0.0623476707237088,0.00472231901396691,-0.071603415991084,-0.0530919254563337,1.49492491904081e-39
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,42569,-0.0341535918428518,0.00259332787085463,-0.0392365144697269,-0.0290706692159768,2.30157120319112e-39
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CKB,Creatine kinase B-type,40527,0.0808570188639507,0.00614748439398271,0.0688079494517446,0.0929060882761568,3.17370872778788e-39
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,41948,-0.0585466744054345,0.00445558871672697,-0.0672796282902194,-0.0498137205206497,3.48683401853891e-39
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD300E,CMRF35-like molecule 2,42677,-0.0576813629405265,0.00440160862198271,-0.0663085158396126,-0.0490542100414404,5.36267659875835e-39
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,40451,-0.0923977142557196,0.00705727113929641,-0.106229965688741,-0.0785654628226987,6.98150553007495e-39
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,42676,-0.0373674906792588,0.00285871761680804,-0.0429705772082026,-0.0317644041503151,8.25609783675046e-39
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TCOF1,Treacle protein,40511,-0.0429034269192212,0.00328880549278983,-0.0493494856850892,-0.0364573681533531,1.28309442666165e-38
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,42652,0.0472990700113943,0.00364018416926664,0.0401643090396317,0.0544338309831569,2.26316742090351e-38
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,42346,-0.145081920879376,0.011169108210259,-0.166973372971483,-0.123190468787268,2.41310394664475e-38
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TFF2,Trefoil factor 2,42654,-0.0768511395027102,0.00593960440383414,-0.0884927641342251,-0.0652095148711952,4.58578751105248e-38
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PVR,Poliovirus receptor,42711,-0.048308594149483,0.00373503889094042,-0.0556292703757262,-0.0409879179232397,4.8714106443065e-38
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACAN,Aggrecan core protein,42488,0.0365567769824175,0.00283576599467271,0.030998675632859,0.042114878331976,8.48346764444654e-38
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PCDH17,Protocadherin-17,42636,-0.0489597459243431,0.00380031316997798,-0.0564083597375,-0.0415111321111863,9.37424644144813e-38
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GOLM2,Protein GOLM2,42711,-0.0301761004399133,0.00234321315435111,-0.0347687982224415,-0.0255834026573852,9.96506034708802e-38
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,POF1B,Protein POF1B,40199,-0.0615834967778489,0.00478008584615078,-0.0709524650363045,-0.0522145285193934,1.04579128411615e-37
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,42600,-0.0632307588643425,0.0049130230958697,-0.0728602841322472,-0.0536012335964379,1.10931187266998e-37
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,42651,-0.0761645711273473,0.00591857788007492,-0.0877649837722942,-0.0645641584824005,1.12576904494334e-37
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARF6,ADP-ribosylation factor 6,40449,-0.140577918456514,0.010918260271339,-0.161977708588339,-0.11917812832469,1.14032640228757e-37
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,REG1B,Lithostathine-1-beta,42794,-0.0768725202384922,0.00597427172246184,-0.0885820928145174,-0.065162947662467,1.1409758081301e-37
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSME2,Proteasome activator complex subunit 2,42441,-0.0471589597204887,0.0036722300829284,-0.0543565306830284,-0.0399613887579491,1.59564328542128e-37
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPP1,Tripeptidyl-peptidase 1,42545,-0.0588206889917189,0.00459194808543067,-0.0678209072391631,-0.0498204707442748,2.40560482906065e-37
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TXLNA,Alpha-taxilin,42495,-0.11379381937558,0.00888345376025487,-0.131205388745679,-0.0963822500054803,2.40681179158345e-37
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD83,CD83 antigen,42594,-0.0459010838591614,0.00358945106347048,-0.0529364079435636,-0.0388657597747593,3.16675055509934e-37
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CFC1,Cryptic protein,42346,-0.0615811160826861,0.00483501626849608,-0.0710577479689384,-0.0521044841964338,6.12585252481246e-37
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAYN,Layilin,42476,-0.0488666202129838,0.00384787674904099,-0.0564084586411041,-0.0413247817848634,9.71367235119152e-37
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,YES1,Tyrosine-protein kinase Yes,42587,-0.145765053130695,0.0115051414975772,-0.168315130465946,-0.123214975795443,1.4136548724546e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,40483,-0.0614386724548512,0.00484665535814323,-0.0709381169568119,-0.0519392279528904,1.41619610998862e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,42587,0.0253749360849983,0.00200560478647642,0.0214439507035045,0.0293059214664921,1.76304695572809e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CBS,Cystathionine beta-synthase,40223,-0.066358649535713,0.00524769210571762,-0.0766441260629196,-0.0560731730085065,2.12383649146195e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,42595,-0.0417622064168705,0.00330492570026699,-0.0482398607893938,-0.0352845520443472,2.14606432970809e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,40116,-0.0466866224108733,0.00369271521421695,-0.0539243442307386,-0.0394489005910081,2.20119351763404e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNF,Tumor necrosis factor,42339,-0.0495817293616959,0.00392644705241654,-0.0572775655844323,-0.0418858931389594,2.4166314907096e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,42370,-0.0497459375246155,0.0039573563964431,-0.057502356061644,-0.041989518987587,4.93792520139748e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL11,Eotaxin,42754,-0.0468804301884934,0.00373182435067315,-0.0541948059158127,-0.039566054461174,5.39560491624667e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FABP5,Fatty acid-binding protein 5,42678,-0.0859593016134145,0.00685960983559764,-0.0994041368911859,-0.0725144663356431,7.97604756855684e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNAPIN,SNARE-associated protein Snapin,40482,-0.0734972234732838,0.00586784593497015,-0.0849982015058253,-0.0619962454407423,9.36696234734584e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,40169,-0.0626589570683764,0.00502398180389577,-0.0725059614040121,-0.0528119527327407,1.84570213998631e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL20,C-C motif chemokine 20,42754,-0.116215992938568,0.00933278508298455,-0.134508251701217,-0.097923734175918,2.11773376580567e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCN4,CCN family member 4,42721,-0.0507157206769277,0.00407533077559017,-0.0587033689970844,-0.042728072356771,2.33735661745983e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,42676,-0.0511820893488573,0.00411285234038458,-0.059243279936011,-0.0431208987617035,2.34483564023306e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,42475,-0.112171172090325,0.00901636054181753,-0.129843238752288,-0.094499105428363,2.46754369415323e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,42611,-0.0545412357435057,0.00438467756186796,-0.0631352037647669,-0.0459472677222445,2.51150887453912e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,42713,-0.0366496441216995,0.00294919111457043,-0.0424300587062576,-0.0308692295371415,2.90501218676703e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FMNL1,Formin-like protein 1,42311,-0.0781516919913723,0.00629704046365356,-0.0904938913001333,-0.0658094926826113,3.59478818837416e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIAE,Sialate O-acetylesterase,42646,-0.0578258889713832,0.00466025089988548,-0.0669599807351587,-0.0486917972076076,3.66787325515425e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DTYMK,Thymidylate kinase,40511,-0.0858324131084322,0.00692519580623197,-0.0994057968886468,-0.0722590293282175,4.73996658314715e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD248,Endosialin,40527,0.0515896205466148,0.00416549725956974,0.0434252459178581,0.0597539951753715,5.30652374056727e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD300C,CMRF35-like molecule 6,42711,-0.0451696273437333,0.00365869197674138,-0.0523406636181464,-0.0379985910693202,7.9017663186349e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,40283,-0.0378545588834641,0.00306815212081563,-0.0438681370402628,-0.0318409807266655,9.5650286708186e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FUS,RNA-binding protein FUS,42336,-0.04964299742675,0.00405377786466558,-0.0575884020414945,-0.0416975928120055,2.71020093733045e-34
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,42679,0.0545744703364697,0.00446062020443045,0.045831654735786,0.0633172859371534,3.07969914054862e-34
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTSE,Cathepsin E,40283,-0.0642636910430538,0.00525016216212478,-0.0745540088808183,-0.0539733732052892,3.1464602951453e-34
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,42676,-0.0345075428609909,0.00282157638132636,-0.0400378325683906,-0.0289772531535913,3.26722135055686e-34
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,42721,-0.0432416579692727,0.00354953321277535,-0.0501987430663124,-0.0362845728722331,5.81361167148222e-34
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPE,Carboxypeptidase E,42588,0.0477300142258075,0.00393246774759864,0.0400223774405142,0.0554376510111009,1.00565651931772e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAT,Linker for activation of T-cells family member 1,42754,-0.0927919733203914,0.00764544935793064,-0.107777054061935,-0.0778068925788474,1.00713010185861e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LGALS3BP,Galectin-3-binding protein,40539,-0.0379940560942465,0.00313127091524783,-0.0441313470881322,-0.0318567651003608,1.13077111524401e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",42587,-0.0434127026853247,0.00359670358988782,-0.0504622417215048,-0.0363631636491445,2.26296399100346e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHMP6,Charged multivesicular body protein 6,40511,-0.0687884916476347,0.00570954337699222,-0.0799791966665394,-0.0575977866287299,3.17316198167051e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,40223,-0.0398959890171943,0.00331604939825496,-0.0463954458377741,-0.0333965321966146,3.92705676799825e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,42370,-0.0845071443656004,0.00703599128899299,-0.0982976872920267,-0.0707166014391742,4.64561150180306e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",42370,-0.0727668955820865,0.00605860218809564,-0.0846417558707539,-0.060892035293419,4.65595566560383e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,40223,-0.103026846322215,0.00857357096004189,-0.119831045403897,-0.0862226472405328,4.66359387666917e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SARG,Specifically androgen-regulated gene protein,40456,-0.132998768016437,0.011072632807428,-0.154701128318995,-0.111296407713878,4.92072356514657e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,42587,-0.103025583085134,0.00858697236094821,-0.119856048912593,-0.0861951172576756,5.37953108735409e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNAP29,Synaptosomal-associated protein 29,42679,-0.111125289991207,0.00926499456845267,-0.129284679345374,-0.0929659006370397,5.61408610006193e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COL3A1,Collagen alpha-1(III) chain,40527,-0.0286283909141255,0.00238785150807781,-0.033308579869958,-0.023948201958293,6.4022397028957e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RBKS,Ribokinase,42317,-0.0603882849799547,0.00504022642524822,-0.0702671287734413,-0.0505094411864682,6.61360565100062e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDH17,Cadherin-17,42636,-0.0849868585541827,0.00710084624511822,-0.0989045171946144,-0.071069199913751,7.62518665514855e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C19orf12,Protein C19orf12,42311,-0.0775379462739384,0.00647844026443272,-0.0902356891922265,-0.0648402033556503,7.69211731205228e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,40483,-0.077577434240296,0.00648015003817014,-0.0902785283151095,-0.0648763401654825,7.91272413713896e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MTDH,Protein LYRIC,40199,-0.11472271820936,0.00958529575142126,-0.133509897882146,-0.0959355385365745,8.29022685039051e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HNMT,Histamine N-methyltransferase,42439,-0.0582770455264713,0.00487466181828212,-0.0678313826903043,-0.0487227083626384,9.00244370224252e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHCHD6,MICOS complex subunit MIC25,40451,-0.0353512160825661,0.0029563905238685,-0.0411457415093484,-0.0295566906557839,9.35747484295214e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLRD1,Natural killer cells antigen CD94,42754,-0.0572510518656438,0.00479261573242893,-0.0666445787012045,-0.0478575250300831,9.98073599455256e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,42721,-0.0982537391691198,0.00823439813218206,-0.114393159508197,-0.0821143188300429,1.17400469497887e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,40290,-0.0538902386046825,0.00452093562921942,-0.0627512724379526,-0.0450292047714125,1.46837018999415e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AMN,Protein amnionless,42370,-0.0570097126018457,0.00478538835562627,-0.0663890737788732,-0.0476303514248182,1.48280897505779e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SBSN,Suprabasin,40511,0.0426462618680484,0.003578886027216,0.035631645254705,0.0496608784813917,1.52753291054969e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,40483,0.0448555442975282,0.0037769644376889,0.037452693999658,0.0522583945953985,2.45430371411272e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD207,C-type lectin domain family 4 member K,42365,-0.0479321552147905,0.00405057668545241,-0.0558712855182772,-0.0399930249113038,3.81511227234496e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CFHR4,Complement factor H-related protein 4,40509,0.0902519053829786,0.00763638652359429,0.0752845877967338,0.105219222969223,4.82329568129334e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,40482,-0.0639131622515848,0.0054160280889974,-0.0745285773060197,-0.0532977471971499,5.95980352478263e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,42357,-0.0508356894996941,0.00431001027868639,-0.0592833096459194,-0.0423880693534688,6.01258782004597e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTBS,Di-N-acetylchitobiase,40383,-0.0324290038612678,0.00274855231275196,-0.0378161663942616,-0.0270418413282739,6.13663327733613e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEP85,Centrosomal protein of 85 kDa,42346,-0.0767709352251306,0.00651182499498183,-0.089534112215295,-0.0640077582349662,6.40320666421917e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINA4,Kallistatin,40342,-0.0290044378682261,0.00246372324617183,-0.0338333354307228,-0.0241755403057293,8.33399518858383e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD160,CD160 antigen,42754,-0.058826985047101,0.00500131217364058,-0.0686295569074366,-0.0490244131867655,8.71054661834583e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,42660,-0.0633259084524704,0.00539816339511835,-0.0739063087069024,-0.0527455081980384,1.25980749990946e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL1R2,Interleukin-1 receptor type 2,42600,-0.0238033167063637,0.00202947989204224,-0.0277810972947665,-0.0198255361179609,1.29517760399599e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,42311,-0.0610431204557461,0.00520982476513931,-0.0712543769954192,-0.0508318639160731,1.49918801563986e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FAM3D,Protein FAM3D,40449,-0.102908961334961,0.00878703704108792,-0.120131553935493,-0.0856863687344285,1.69571104509384e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,YTHDF3,YTH domain-containing family protein 3,42370,-0.100341082546009,0.00860848940965026,-0.117213721788924,-0.0834684433030948,3.04154509647325e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",40136,-0.0969356585195334,0.00832148280862534,-0.113245764824439,-0.0806255522146277,3.55199717344432e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANG,Angiogenin,42618,-0.0398254276222061,0.00342229132113898,-0.0465331186116385,-0.0331177366327737,3.76786238115104e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,40199,-0.0633880151760854,0.00544629979744946,-0.0740627627790864,-0.0527132675730845,3.98398854575635e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",42587,-0.0402713553572317,0.00346692325186943,-0.0470665249308958,-0.0334761857835677,4.82088255790005e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,42346,-0.056412052698961,0.00486159846604137,-0.0659407856924021,-0.0468833197055199,5.59175862347509e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL25,C-C motif chemokine 25,42754,-0.0566483128430057,0.00488343656215634,-0.0662198485048321,-0.0470767771811793,5.76339992518694e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADA2,Adenosine deaminase 2,42572,-0.052591158253279,0.00453748399641032,-0.0614846268862432,-0.0436976896203147,6.47791235213806e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,42346,-0.0741435252106405,0.00639750352639783,-0.0866826321223803,-0.0616044182989008,6.58618817029886e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIGLEC1,Sialoadhesin,42676,-0.0511151787718089,0.00441168967312263,-0.0597620905311293,-0.0424682670124886,6.77261683880888e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTSL,Cathepsin L1,42636,-0.0293289860306964,0.00253217684587032,-0.0342920526486022,-0.0243659194127906,7.0824541452759e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TFF1,Trefoil factor 1,42556,-0.0979052404040855,0.00845513092415402,-0.114477297015427,-0.0813331837927436,7.35801888571039e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,40483,-0.101227148555899,0.00873928426288986,-0.118356145711163,-0.0840981514006348,7.50751031976816e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,40449,-0.0613096768757747,0.00529341040089643,-0.0716847612615317,-0.0509345924900177,7.58079338406587e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EEF1D,Elongation factor 1-delta,40511,-0.10787851988702,0.00932208459859258,-0.126149805700262,-0.0896072340737789,8.47891003080696e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,INSL5,Insulin-like peptide INSL5,40449,-0.116731302104048,0.0100949242790805,-0.136517353691046,-0.09694525051705,9.42477619605576e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CFH,Complement factor H,39956,-0.0271066822425171,0.00235055743939698,-0.0317137748237352,-0.0224995896612991,1.37585613704797e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINB8,Serpin B8,42754,-0.0675809007033437,0.00587620505292396,-0.0790982626070747,-0.0560635387996127,1.81000886983532e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MDK,Midkine,42638,-0.0597072797271421,0.00519932382678094,-0.0698979544276327,-0.0495166050266515,2.20846773937191e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,42611,0.0615729553214373,0.00536351388562282,0.0510604681056165,0.072085442537258,2.30550022063579e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FEN1,Flap endonuclease 1,42346,-0.0745345603353582,0.00649639879240078,-0.0872675019684638,-0.0618016187022527,2.5071481542305e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,40199,-0.147689051350504,0.0128666282480143,-0.172907642716612,-0.122470459984396,2.51809249635102e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,THOP1,Thimet oligopeptidase,42571,-0.0360595480108797,0.00314427840185958,-0.0422223336785245,-0.0298967623432349,2.63724652014763e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MMP12,Macrophage metalloelastase,42592,-0.0655000218284281,0.005713226789791,-0.0766979463364184,-0.0543020973204377,2.74918519276862e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PENK,Proenkephalin-A,40283,-0.038533942521574,0.00335954536554473,-0.0451186514380416,-0.0319492336051063,2.76568868131654e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,42654,-0.0604554074923087,0.00527797473613336,-0.0708002379751301,-0.0501105770094873,3.08985167175675e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",40223,-0.113454275274866,0.00990355653671105,-0.13286524608682,-0.0940433044629122,3.25452784115284e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL22,C-C motif chemokine 22,42509,-0.0618972645413625,0.00540598673275154,-0.0724929985375555,-0.0513015305451694,3.26493984974375e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,42594,-0.0489747736859575,0.00427928220645242,-0.0573621668106042,-0.0405873805613107,3.45522076522126e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",42587,-0.112651916711716,0.00985512503277057,-0.131967961775946,-0.0933358716474854,4.04655797152795e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,42566,-0.0450406894192497,0.00394048215370222,-0.0527640344405061,-0.0373173443979934,4.07392433981073e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BCAN,Brevican core protein,42495,0.0403052051710784,0.0035277781145972,0.0333907600664679,0.0472196502756889,4.32778156271498e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LMNB2,Lamin-B2,40483,-0.0335176820761074,0.00293382459859059,-0.039267978289345,-0.0277673858628699,4.60983151333873e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGA5,Integrin alpha-5,42611,-0.0290664276049538,0.00254676053962478,-0.0340580782626184,-0.0240747769472893,4.94807093592088e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,40483,-0.0361660781190781,0.00316968512053248,-0.0423786609553217,-0.0299534952828344,5.44109277058981e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DSC2,Desmocollin-2,42488,-0.0411304696990629,0.00361129411659531,-0.0482086061675897,-0.0340523332305361,6.49828772301517e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",40223,-0.0431566632244232,0.00378890631887464,-0.0505829196094175,-0.0357304068394289,6.86695050187685e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RLN2,Prorelaxin H2,40257,-0.0582437203526222,0.0051179624418666,-0.0682749267386807,-0.0482125139665637,7.68363644054001e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FYB1,FYN-binding protein 1,42590,-0.106035642933591,0.00932321400139364,-0.124309142376323,-0.0877621434908599,7.78390951743481e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BACH1,Transcription regulator protein BACH1,42594,-0.084105134179084,0.00740436448735414,-0.0986176885742981,-0.0695925797838698,9.16773745255498e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RPL14,60S ribosomal protein L14,40223,-0.0464897423014475,0.00409620113535075,-0.054518296526735,-0.0384611880761601,1.08986360892102e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,40199,-0.0523471795985754,0.00461291278849102,-0.0613884886640178,-0.043305870533133,1.10954658834289e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,40483,-0.0951714903535015,0.00838859181936382,-0.111613130319455,-0.0787298503875485,1.13210403829763e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DCTN1,Dynactin subunit 1,42721,-0.0743257925288655,0.00656633773849092,-0.0871958144963077,-0.0614557705614233,1.43172685356045e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGR,Tyrosine-protein kinase Fgr,42311,-0.0657819592118706,0.00583555520224446,-0.0772196474082698,-0.0543442710154715,2.44428818411503e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BST2,Bone marrow stromal antigen 2,42711,-0.0587201739994895,0.00521030449635329,-0.068932370812342,-0.0485079771866371,2.49412935620491e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINA9,Serpin A9,42538,-0.0824324421713724,0.00731706470845268,-0.0967738889999396,-0.0680909953428051,2.62577855074045e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,40451,-0.0909442222700941,0.00807014626901752,-0.106761708957368,-0.0751267355828198,2.67206154782631e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MMP7,Matrilysin,42333,-0.0580518727424416,0.00515849459568423,-0.0681625221499826,-0.0479412233349005,3.02366684441334e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,40223,-0.0829956328743905,0.00738364700395489,-0.0974675810021421,-0.0685236847466389,3.71600465552222e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYH9,Myosin-9,40527,-0.130605043323433,0.0116740584972974,-0.153486197978135,-0.10772388866873,6.64277248674406e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DTNB,Dystrobrevin beta,40430,-0.048854246738389,0.00437532102649962,-0.0574298759503283,-0.0402786175264498,8.49084454187443e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DAG1,Dystroglycan,42676,-0.0520396763759308,0.0046690588302318,-0.0611910316831851,-0.0428883210686765,1.00392618129964e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,42638,-0.0396118866661775,0.00355901644512806,-0.0465875588986285,-0.0326362144337265,1.19561818087998e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39983,-0.0561810823470669,0.00504560823272757,-0.0660704744832129,-0.0462916902109209,1.21843297424486e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCN1,Ficolin-1,40515,-0.0635824206871982,0.00571640003367753,-0.0747865647532062,-0.0523782766211903,1.36643591126334e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,40465,-0.0913397366045897,0.00821183961857319,-0.107434942256993,-0.0752445309521863,1.36660518824023e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD274,Programmed cell death 1 ligand 1,42495,-0.0396118866724508,0.00356337554469174,-0.0465961027400466,-0.0326276706048549,1.39512996918011e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,42240,-0.0457864375989094,0.00412380467386194,-0.0538690947596788,-0.03770378043814,1.62848157805551e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATP6AP2,Renin receptor,42346,-0.0457293421217341,0.00411963387952341,-0.0538038245256,-0.0376548597178682,1.67250487629232e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL7,C-C motif chemokine 7,42594,-0.0666541906833871,0.006010278179486,-0.0784343359151796,-0.0548740454515945,1.86485833748309e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SRPK2,SRSF protein kinase 2,42594,-0.0936658498449896,0.00845236525251602,-0.110232485739921,-0.0770992139500582,2.04709489022054e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",40223,-0.0775309290723853,0.00700073725587311,-0.0912523740938966,-0.0638094840508741,2.34818386152552e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTRB1,Chymotrypsinogen B,42611,-0.065348141575639,0.00590866901329598,-0.0769291328416991,-0.0537671503095789,2.60735505900618e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEP20,Centrosomal protein 20,42346,-0.0840921508822106,0.00761883246338991,-0.0990250625104548,-0.0691592392539664,3.35366709220693e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NCAN,Neurocan core protein,42711,0.042650441336503,0.00387380873526828,0.0350577762153772,0.0502431064576288,4.50328158488491e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,42351,-0.0617321090764248,0.00560798441516207,-0.0727237585301424,-0.0507404596227071,4.64069862424826e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",42654,-0.0952353978545786,0.00865425063811994,-0.112197729105294,-0.0782730666038635,4.78883493670619e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",40408,-0.1224010075482,0.0111241614759473,-0.144204364041057,-0.100597651055343,5.1307949011728e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,42346,-0.0555216220968191,0.00505021810012455,-0.0654200495730632,-0.045623194620575,5.41250798029038e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NIT2,Omega-amidase NIT2,40462,-0.0820226111625025,0.00745820609972576,-0.096640695117965,-0.06740452720704,5.4434605776548e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,42587,-0.0596384371575948,0.0054273025057074,-0.0702759500687813,-0.0490009242464083,5.70874832652269e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,42613,-0.0908610547599245,0.00827221695599286,-0.10707459999367,-0.0746475095261785,6.00877786826548e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,40511,-0.0872365021971627,0.00794229498582752,-0.102803400369385,-0.0716696040249408,6.32660834024561e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',40483,-0.048480948499373,0.00441713952457067,-0.0571385419675316,-0.0398233550312145,6.92259198268793e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,42611,-0.025992648680724,0.00237174317400111,-0.0306412653017662,-0.0213440320596818,7.86745680552702e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,40511,-0.0300091949199609,0.00273809650028771,-0.0353758640605248,-0.0246425257793969,8.21959063350948e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,40482,-0.0450651626403766,0.00411758175964083,-0.0531356228892727,-0.0369947023914806,9.72362781195811e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",42611,-0.0433197336127086,0.00396378585181428,-0.0510887538822646,-0.0355507133431526,1.09731715700629e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,42711,-0.0512641774929212,0.00469407117920592,-0.0604645570041648,-0.0420637979816776,1.19290007413321e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,40449,-0.154273669277965,0.0141246415935805,-0.181957966801382,-0.126589371754547,1.24078838140696e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,40449,-0.0497749459185629,0.00456398887789225,-0.0587203641192317,-0.0408295277178941,1.48158761167961e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,42495,-0.0482619573729903,0.00442989971458036,-0.0569445608135678,-0.0395793539324128,1.59847141935214e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD48,CD48 antigen,42654,-0.0344494797401156,0.00316946742836586,-0.0406616358997127,-0.0282373235805185,2.101032949547e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEMA7A,Semaphorin-7A,42760,-0.0315853227789412,0.00290731261921171,-0.0372836555125962,-0.0258869900452863,2.21557145046305e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COL5A1,Collagen alpha-1(V) chain,40283,-0.0460684645540973,0.0042424479587672,-0.054383662553281,-0.0377532665549136,2.48187436315254e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,42495,-0.064991801246387,0.00599252196711632,-0.0767371443019349,-0.053246458190839,2.72529268501118e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,42357,-0.0543771355056091,0.00501413185443249,-0.0642048339402968,-0.0445494370709214,2.75383071339861e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,THY1,Thy-1 membrane glycoprotein,42711,-0.0332709483917263,0.00307153836109376,-0.0392911635794701,-0.0272507332039825,3.14038088659588e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,42495,-0.0260323109209616,0.0024038398227105,-0.0307438369734741,-0.021320784868449,3.24154596411096e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TSPAN8,Tetraspanin-8,40449,-0.113781710779865,0.0105044963550782,-0.134370523635818,-0.0931928979239114,3.31670504758615e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NADK,NAD kinase,42636,-0.0601935906450063,0.00558336934401569,-0.0711369945592771,-0.0492501867307355,5.46462350549802e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,42611,-0.0552884689715828,0.0051351417637414,-0.0653533468285159,-0.0452235911146497,6.36971885125892e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADA,Adenosine deaminase,42754,-0.0379166660306594,0.00353249866044976,-0.0448403634051409,-0.0309929686561779,9.06001320514083e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,42611,-0.0666109729503466,0.00620894494671194,-0.078780505045902,-0.0544414408547912,9.62986780864674e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,42754,-0.106843633082009,0.00996020716119341,-0.126365639117948,-0.0873216270460703,9.72684601294136e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,40283,-0.0421553038697652,0.00392825399680493,-0.0498546817035028,-0.0344559260360275,9.81521060990618e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",42611,-0.0493294641977197,0.00460221753818112,-0.0583498105725547,-0.0403091178228847,1.06737801237373e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,42778,-0.0313226462613005,0.00292267766153032,-0.0370510944779,-0.0255941980447011,1.08165570480132e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNAP23,Synaptosomal-associated protein 23,42636,-0.0945129658346629,0.00881951767005108,-0.111799220467963,-0.0772267112013628,1.0933678871561e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,40116,-0.0694832973900091,0.00648654043809604,-0.0821969166486774,-0.0567696781313409,1.21337881101024e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,JAM2,Junctional adhesion molecule B,42711,-0.0310359585075542,0.00289910325886313,-0.036718200894926,-0.0253537161201825,1.22810748819043e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IFNGR2,Interferon gamma receptor 2,42495,-0.0567595649062595,0.0053026970829671,-0.067152851188875,-0.046366278623644,1.2524135991002e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MTSS2,Protein MTSS 2,40451,-0.10779925684782,0.0100706328578815,-0.127537697249268,-0.0880608164463721,1.30430891593139e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,42238,-0.0215698674867255,0.00201591858780765,-0.0255210679188285,-0.0176186670546225,1.31546657157505e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,42611,0.0488968565314315,0.004574740402584,0.0399303653423669,0.0578633477204962,1.47448600341565e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,42721,-0.0448339977447362,0.0041959935321621,-0.0530581450677739,-0.0366098504216984,1.52748513473794e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDC27,Cell division cycle protein 27 homolog,42346,-0.0655008076889568,0.00613640163575786,-0.0775281548950423,-0.0534734604828714,1.72636664611384e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,40116,-0.0802131716816968,0.00752430195994492,-0.0949608035231888,-0.0654655398402047,2.09884116084315e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEP43,Centrosomal protein 43,42255,-0.0750706665749792,0.0070452071572331,-0.088879272603156,-0.0612620605468023,2.10818008662986e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDH15,Cadherin-15,42692,-0.0676299067836941,0.00635185543878954,-0.0800795434437216,-0.0551802701236666,2.28460092483716e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",42594,-0.10402061375649,0.00978635925122613,-0.123201877888893,-0.0848393496240869,2.77542467739778e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,42594,-0.113845043926385,0.0107271126173129,-0.134870184656318,-0.0928199031964518,3.30057080481474e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,42689,-0.0468884032176395,0.00442018957733354,-0.0555519747892132,-0.0382248316460658,3.47651782992909e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,40483,-0.0748214529264613,0.00705442923280656,-0.0886481342227622,-0.0609947716301605,3.69772723401951e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPP1R9B,Neurabin-2,42754,-0.100865524917659,0.0095144357238562,-0.119513818936417,-0.0822172308989006,3.71918692767223e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IDS,Iduronate 2-sulfatase,42754,0.00944352636795265,0.000891527427214886,0.00769613261061147,0.0111909201252938,4.08242810061367e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINA5,Plasma serine protease inhibitor,40387,-0.0341730144786632,0.00322479713398584,-0.0404936168612754,-0.0278524120960509,4.09275766260914e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINH1,Serpin H1,40302,-0.139671164301573,0.013181135091745,-0.165506189081393,-0.113836139521752,4.13026632806039e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TDRKH,Tudor and KH domain-containing protein,42311,-0.0910837418150481,0.00861008079849067,-0.10795950018009,-0.0742079834500064,4.76174491840487e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,S100A14,Protein S100-A14,40482,-0.0594287556913858,0.00562204517975619,-0.0704479642437079,-0.0484095471390636,5.39093699150031e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,40058,-0.0575452919688135,0.00544897181824251,-0.0682252767325688,-0.0468653072050582,6.0499007278464e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,REG1A,Lithostathine-1-alpha,42575,-0.0563601669837162,0.00534202627498793,-0.0668305384826925,-0.0458897954847399,6.39821203764621e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,40532,-0.023995731844417,0.0022735790735438,-0.0284519468285628,-0.0195395168602712,6.40821166501383e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OGN,Mimecan,42611,-0.047691748152277,0.0045220234338366,-0.0565549140825967,-0.0388285822219572,6.65478661362245e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GH1,Somatotropin,42613,0.18442553367873,0.0175129900228272,0.150100073233988,0.218750994123471,7.85807567206648e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ASAH2,Neutral ceramidase,42495,-0.0573422555289217,0.00544550809831216,-0.0680154514016135,-0.0466690596562299,7.92338058517861e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTSF,Cathepsin F,42679,-0.0425126661209601,0.00404219303613398,-0.0504353644717827,-0.0345899677701375,9.05375391581586e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",40449,-0.112443669982409,0.0106880616515109,-0.13339227081937,-0.0914950691454474,9.15303541506867e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COCH,Cochlin,40511,-0.0504345540304784,0.00479488572924411,-0.0598325300597968,-0.0410365780011599,9.34196068235422e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",42638,0.0367207146944926,0.0034924729895719,0.0298754676349316,0.0435659617540535,9.34902324715111e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,42346,-0.0771399284922479,0.00733880166322577,-0.0915239797521704,-0.0627558772323254,9.69799846039942e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLSCR3,Phospholipid scramblase 3,40457,-0.0622280226902118,0.00591860263739587,-0.0738284838595077,-0.0506275615209159,9.8001953890297e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,QDPR,Dihydropteridine reductase,42581,-0.0455078863073757,0.00433007420504041,-0.0539948317492549,-0.0370209408654965,9.81381770881261e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CES3,Carboxylesterase 3,42587,-0.075420683423834,0.00717796017696531,-0.089489485370686,-0.061351881476982,1.00705688657412e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNTN5,Contactin-5,42640,0.0407969193624034,0.00388328460541053,0.0331856815357987,0.048408157189008,1.0219503965835e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SFRP4,Secreted frizzled-related protein 4,40283,-0.0433757505213941,0.00413227403139149,-0.0514750076229214,-0.0352764934198668,1.1782853738832e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RETN,Resistin,42598,-0.046383166886838,0.00442272241429209,-0.0550517028188505,-0.0377146309548255,1.23951353432803e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VSNL1,Visinin-like protein 1,40483,-0.041185843680866,0.00392611968136994,-0.0488810382563511,-0.0334906491053809,1.25666849911211e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,42587,-0.0473688186156138,0.00452047697090622,-0.05622895347859,-0.0385086837526376,1.35890746341619e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDCD5,Programmed cell death protein 5,42711,-0.0612705786263064,0.00585013598174795,-0.0727368451505324,-0.0498043121020805,1.43450035827385e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,40449,-0.0332154760338159,0.00317145953376171,-0.0394315367199888,-0.0269994153476429,1.50231750479575e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DLK1,Protein delta homolog 1,42794,-0.0587342238773838,0.0056137861641215,-0.0697372447590619,-0.0477312029957056,1.60521182536351e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MMP1,Interstitial collagenase,42136,-0.097556785823337,0.00932405563728186,-0.11583193487241,-0.0792816367742646,1.61636851699971e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,42794,0.0265296411978402,0.00253683089837803,0.0215574526370192,0.0315018297586611,1.68633514418034e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSMG3,Proteasome assembly chaperone 3,42594,-0.0542140709341996,0.00520277348363794,-0.06441150696213,-0.0440166349062692,2.50510737952585e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,42192,-0.0909956321628044,0.00873752201374579,-0.108121175309746,-0.0738700890158627,2.68157977727678e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WDR46,WD repeat-containing protein 46,40451,-0.0382864572928522,0.00367976063653536,-0.0454987881404615,-0.0310741264452429,3.07413397018557e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WIF1,Wnt inhibitory factor 1,42721,0.0365379118085347,0.00351920680040041,0.0296402664797498,0.0434355571373195,3.70547246357329e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OGFR,Opioid growth factor receptor,42587,-0.0343975117204552,0.00331340997830476,-0.0408917952779325,-0.0279032281629779,3.75719830052244e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,40482,-0.0514402613578401,0.00495346512268433,-0.0611490529983014,-0.0417314697173788,3.77760316689642e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,42311,-0.0641256269833192,0.00618439462935405,-0.0762470404568531,-0.0520042135097852,4.29148779786345e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLF4,Krueppel-like factor 4,40136,-0.042660991342748,0.00411436228551123,-0.05072514142235,-0.034596841263146,4.49155128861416e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD63,CD63 antigen,42475,-0.053718785678414,0.00518748049525306,-0.06388624744911,-0.043551323907718,4.92173427639993e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AXIN1,Axin-1,42594,-0.0994175094519814,0.00960251257998586,-0.118238434108754,-0.0805965847952091,5.02482797106363e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ICAM1,Intercellular adhesion molecule 1,42595,-0.0307658708065869,0.002981232979088,-0.0366090874455994,-0.0249226541675744,7.10198671615091e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,42611,0.0433666750169998,0.00420659381358757,0.0351217511423682,0.0516115988916314,7.92440329529079e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLA2,Src-like-adapter 2,40482,-0.109168131720564,0.0105956786520906,-0.129935661878662,-0.0884006015624667,8.78569344427742e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TALDO1,Transaldolase,40499,-0.0463015932634462,0.00449751536764934,-0.0551167233840389,-0.0374864631428535,9.55160344454062e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HSPB6,Heat shock protein beta-6,42721,-0.0413567400876894,0.00402414288857238,-0.0492440601492912,-0.0334694200260875,1.10086210420189e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TREH,Trehalase,40527,-0.0778822876340565,0.00759184895570061,-0.0927623115872297,-0.0630022636808833,1.38553453181425e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DDT,D-dopachrome decarboxylase,40527,-0.0435412918421861,0.00424700371136295,-0.0518654191164575,-0.0352171645679148,1.48004808490388e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,42594,-0.0399350489298364,0.00389831592066993,-0.0475757481343495,-0.0322943497253234,1.54790847613021e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,42357,-0.0985749535575951,0.00962387158811364,-0.117437741870298,-0.0797121652448924,1.57657523404948e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,42681,-0.0285105950434988,0.00278781039200483,-0.0339747034118282,-0.0230464866751693,1.84586519735108e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,40482,-0.101595731900145,0.00993339334116892,-0.121065182848836,-0.0821262809514539,1.90479158649795e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC16A1,Monocarboxylate transporter 1,42311,-0.060031795791052,0.00587250258490401,-0.0715419008574639,-0.0485216907246402,1.94117971105289e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KITLG,Kit ligand,42636,0.0391700376337417,0.00383524510083273,0.0316529572361095,0.0466871180313738,2.12522054998152e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RASSF2,Ras association domain-containing protein 2,42346,-0.0592015056622044,0.00579763287778196,-0.070564866102657,-0.0478381452217517,2.17566015453243e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,42357,-0.0604382380074245,0.00592371569243335,-0.0720487207645939,-0.0488277552502551,2.37433613334819e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,42760,-0.0200597912563063,0.001968935849894,-0.0239189055220985,-0.016200676990514,2.73974985083389e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",40223,-0.0671411518595131,0.00659265847128412,-0.08006276246323,-0.0542195412557962,2.98531607553341e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BCHE,Cholinesterase,40346,-0.0290251311286783,0.0028578017933859,-0.0346264226437147,-0.0234238396136419,3.94937136306646e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,42636,-0.0603891948562,0.00595602456110597,-0.0720630029959677,-0.0487153867164323,4.51870974437352e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,42711,-0.0688500268951142,0.00679666090491506,-0.0821714822687477,-0.0555285715214807,4.95573571046741e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NFX1,Transcriptional repressor NF-X1,40116,-0.0704258203956026,0.00695432093270713,-0.0840562894237085,-0.0567953513674966,5.35599139961775e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IKBKG,NF-kappa-B essential modulator,42594,-0.0933251711940333,0.00922987223259121,-0.111415720769912,-0.0752346216181545,6.00491252522378e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,40451,-0.073717453429301,0.00730124839592135,-0.0880279002853068,-0.0594070065732951,7.22941520269351e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXCL11,C-X-C motif chemokine 11,42711,-0.0819205410216388,0.00812765175740891,-0.0978507384661603,-0.0659903435771173,8.283752714685e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GLB1,Beta-galactosidase,42495,-0.0424015612341364,0.004207903716863,-0.0506490525191878,-0.0341540699490849,8.53003246794406e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL32,Interleukin-32,42594,0.0453971103760145,0.00450671979403754,0.0365639395797009,0.0542302811723281,8.81896384074516e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,42674,0.0249026631805792,0.00247382941821771,0.0200539575208725,0.0297513688402859,9.43084129983319e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,40283,-0.0223394153110618,0.00221829734185338,-0.0266872781010944,-0.0179915525210292,9.43373301245302e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,42737,-0.0320638386366836,0.00318595706335264,-0.0383083144808548,-0.0258193627925124,9.64629979532453e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DLL1,Delta-like protein 1,42679,-0.0323556757892324,0.0032155271227978,-0.0386581089499161,-0.0260532426285488,9.83020641125995e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCGN,Secretagogin,42370,-0.0464368407888103,0.00461564191203025,-0.0554834989363896,-0.037390182641231,1.00320108500809e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",40209,-0.0820277940920811,0.00815174443524774,-0.0980052131851667,-0.0660503749989956,1.02327992876752e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TRIM5,Tripartite motif-containing protein 5,42594,-0.0870711958135015,0.00865682063442605,-0.104038564256977,-0.0701038273700264,1.02700199217471e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,42711,-0.0532666087843315,0.00530402078878981,-0.0636624895303595,-0.0428707280383035,1.19755444093122e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,40287,-0.0666108890418793,0.00663560585962239,-0.0796166765267392,-0.0536051015570194,1.30311825366012e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PQBP1,Polyglutamine-binding protein 1,42346,-0.0583275902128286,0.00581554492523766,-0.0697260582662945,-0.0469291221593628,1.3731988023785e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMSB10,Thymosin beta-10,42611,-0.0755567368514785,0.00753698523116895,-0.0903292279045697,-0.0607842457983874,1.43561156055863e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LYN,Tyrosine-protein kinase Lyn,42587,-0.0855284440916417,0.00853907737882231,-0.102265035754133,-0.06879185242915,1.56680356580739e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MFAP5,Microfibrillar-associated protein 5,42794,-0.0420502083503513,0.00419867718859918,-0.0502796156400057,-0.0338208010606969,1.57826632918158e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,42794,-0.0331933700539471,0.00331586284950817,-0.0396924612389831,-0.0266942788689111,1.65336105775888e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEPTIN8,Septin-8,40470,-0.0332652568515702,0.00332423768410052,-0.0397807627124072,-0.0267497509907332,1.78105557414291e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,40283,-0.0853057402906001,0.00852915183754032,-0.102022877892179,-0.0685886026890211,1.88362958694958e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,42679,-0.0336043075840143,0.00336445701932345,-0.0401986433418883,-0.0270099718261404,2.07375534558493e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GLO1,Lactoylglutathione lyase,42357,-0.059121593696915,0.00592423907505474,-0.0707331022840223,-0.0475100851098077,2.26642756655797e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NAA80,N-alpha-acetyltransferase 80,40182,-0.122915088475606,0.0123166113587068,-0.147055646738671,-0.0987745302125407,2.35309299765248e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARSA,Arylsulfatase A,42611,-0.0452221367306284,0.00453562173622085,-0.0541119553336213,-0.0363323181276356,2.47517091897785e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ISM1,Isthmin-1,42594,-0.0389506019823368,0.00391307849962987,-0.0466202358416113,-0.0312809681230622,2.91879936595562e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,40532,-0.0415813324345729,0.00418042898803915,-0.0497749732511296,-0.0333876916180162,3.24587717629593e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,42737,-0.0432229722741207,0.00435425724504841,-0.0517573164744156,-0.0346886280738259,3.82602174377723e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RFC4,Replication factor C subunit 4,40451,-0.0214601352409242,0.0021636314506745,-0.0257008528842462,-0.0172194175976022,4.29874484354039e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,42794,-0.0665463287178496,0.00672792515806054,-0.0797330620276483,-0.053359595408051,5.44214497094146e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42689,0.0378582403912513,0.00382863748231425,0.0303541109259154,0.0453623698565872,5.60794792139269e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,40483,-0.0649305501612232,0.00657359401123277,-0.0778147944232394,-0.052046305899207,6.45572914778345e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD300A,CMRF35-like molecule 8,40283,-0.0316170247005017,0.00320264236120641,-0.0378942037284663,-0.0253398456725371,6.8300357495127e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,42760,-0.0336250035890102,0.00340884173832913,-0.0403063333961353,-0.0269436737818851,7.1145416239171e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STAB2,Stabilin-2,40527,-0.0282713432835127,0.00286620251501936,-0.0338891002129507,-0.0226535863540748,7.39223724511597e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANXA2,Annexin A2,40054,-0.0733608147767834,0.00743733973643818,-0.0879380006602022,-0.0587836288933645,7.44873676230412e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,42545,-0.0285579118900476,0.00289763857427318,-0.034237283495623,-0.0228785402844722,7.75833533958462e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DPP4,Dipeptidyl peptidase 4,42441,0.028408178994698,0.00288575829183615,0.0227520927426991,0.0340642652466968,8.68768575673997e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,42587,-0.0767175708360015,0.0078022500125551,-0.0920099808606095,-0.0614251608113935,9.7143766267773e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GUCA2A,Guanylin,42563,-0.0364585692351479,0.0037175334168427,-0.0437449347321596,-0.0291722037381362,1.24986421050262e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD59,CD59 glycoprotein,42130,-0.0250345014603178,0.00255933802017488,-0.0300508039798606,-0.020018198940775,1.61599005444552e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDCP1,CUB domain-containing protein 1,42495,-0.0541336657543647,0.00553498474142871,-0.064982235847565,-0.0432850956611644,1.62964187191916e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCRLB,Fc receptor-like B,42346,-0.0650222598739933,0.006652113111914,-0.0780604015733447,-0.0519841181746418,1.7249700672168e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FOXO1,Forkhead box protein O1,42594,-0.0841678999128056,0.00861112895826227,-0.101045712671,-0.0672900871546116,1.72547287200387e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,40449,-0.046933883604952,0.00480650017489203,-0.0563546239477404,-0.0375131432621636,1.95953682887211e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TJAP1,Tight junction-associated protein 1,42679,-0.0817414848661591,0.00837714370202662,-0.0981606865221313,-0.0653222832101869,2.02872482208609e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RTBDN,Retbindin,42587,-0.0296962266154381,0.00305011807839895,-0.0356744580491,-0.0237179951817761,2.5084677233358e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,42311,-0.0773206159910175,0.00795011742058649,-0.092902846135367,-0.0617383858466679,2.78562525027274e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BCR,Breakpoint cluster region protein,42594,-0.0897667308709311,0.00924685866076784,-0.107890573846036,-0.0716428878958261,3.30504299114338e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSAP,Prosaposin,40440,-0.0287765915715557,0.00296626184222159,-0.03459046478231,-0.0229627183608014,3.6358018714474e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNXB,Tenascin-X,42611,0.0255500311633533,0.00263551522632953,0.0203844213197475,0.0307156410069592,3.76094970766895e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NCF2,Neutrophil cytosol factor 2,42578,-0.0816924267885335,0.00843594883109956,-0.0982268864974887,-0.0651579670795784,4.17356418858723e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SOST,Sclerostin,42613,-0.0384977213010215,0.00397771659897887,-0.0462940458350201,-0.0307013967670229,4.40065819052867e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OSM,Oncostatin-M,42534,-0.0689422470687935,0.00713234385069645,-0.0829216410161585,-0.0549628531214284,4.95893034248763e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,40283,-0.0655282614751753,0.0067776879382298,-0.0788125298341057,-0.0522439931162449,5.02544387107268e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,42681,-0.0296290862864137,0.00306629717324888,-0.0356390287459815,-0.0236191438268459,5.11192149279716e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FOLR1,Folate receptor alpha,42600,-0.0299404286065704,0.0030990499226507,-0.0360145664549657,-0.023866290758175,5.19995530678952e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL14,C-C motif chemokine 14,42618,-0.0398366832965892,0.00412406618604651,-0.0479198530212404,-0.0317535135719381,5.28003559646815e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL4,C-C motif chemokine 4,42642,-0.0672937731252464,0.00698437699755693,-0.080983152040458,-0.0536043942100348,6.70220565042183e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,JAM3,Junctional adhesion molecule C,40283,-0.0501076115560219,0.0052029709980244,-0.0603054347121498,-0.0399097883998941,7.23284221669714e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL19,Interleukin-19,42261,-0.0712270760917448,0.00740573084666552,-0.0857423085512093,-0.0567118436322804,7.94093964202294e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,40199,-0.0481668341013642,0.00501665230677272,-0.0579994726226387,-0.0383341955800896,9.59649710519766e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AP3B1,AP-3 complex subunit beta-1,40449,-0.075026069614202,0.00781669717452819,-0.0903467960762773,-0.0597053431521268,9.85470194557577e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,42754,-0.0535969304205574,0.00559862241228424,-0.0645702303486345,-0.0426236304924803,1.21286538349492e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ERBIN,Erbin,42587,-0.0992310162730987,0.0103730436627482,-0.119562181852085,-0.0788998506941122,1.29972107806113e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,40511,-0.0616879007672102,0.00645988907011871,-0.0743492833446429,-0.0490265181897776,1.57266686145848e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATG16L1,Autophagy-related protein 16-1,40449,-0.0822641841143365,0.00863062810345619,-0.0991802151971106,-0.0653481530315624,1.86503813832803e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,40199,-0.0428333375061607,0.00449553620708205,-0.0516445884720416,-0.0340220865402799,1.94003577293356e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ASPN,Asporin,40511,0.0274646959258687,0.00288386519810081,0.0218123201375911,0.0331170717141463,2.01276871046974e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,S100A4,Protein S100-A4,42679,-0.0552039118534956,0.00579920804015266,-0.0665703596121948,-0.0438374640947964,2.03721602710078e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TAX1BP1,Tax1-binding protein 1,40483,-0.0614808029244671,0.00645655036029654,-0.0741356416306483,-0.0488259642182858,2.03950725612778e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,40199,-0.0327222593901331,0.00344064313993915,-0.0394659199444138,-0.0259785988358524,2.2918861148916e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,42495,-0.0515274011751963,0.00542803548104434,-0.0621663507180432,-0.0408884516323494,2.62629822019301e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,40511,-0.0286713001100675,0.00302095342963362,-0.0345923688321494,-0.0227502313879856,2.75066257590212e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,40483,-0.031341165818778,0.00330394754519539,-0.0378169030073609,-0.024865428630195,2.88149689452018e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,42495,-0.0911472127982459,0.00962611949547621,-0.110014407009379,-0.0722800185871125,3.30317716675541e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NBN,Nibrin,42370,-0.0516250782236733,0.00545310933485986,-0.0623131725199986,-0.0409369839273479,3.36023395323311e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCARA5,Scavenger receptor class A member 5,42711,-0.02976353077451,0.00314665405791982,-0.0359309727280328,-0.0235960888209871,3.62198888331604e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,42587,-0.0324696373930345,0.00343657198029097,-0.0392053184744047,-0.0257339563116642,4.00811302704327e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,40532,-0.0633840802481813,0.00670952706888256,-0.0765347533031911,-0.0502334071931715,4.17349377187565e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,40383,-0.0576098636566336,0.00610116622843806,-0.0695681494643722,-0.045651577848895,4.36319620255975e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LEPR,Leptin receptor,42636,0.0300577360093323,0.00318534239215455,0.0238144649207094,0.0363010070979553,4.48863713707588e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHAD,Chondroadherin,40283,0.0503267382027773,0.00534337943018137,0.0398537145196219,0.0607997618859328,5.47941248990222e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,42721,-0.0329030001725149,0.00349519013044943,-0.0397535728281958,-0.026052427516834,5.54744975161492e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,42346,-0.0633462242719417,0.00672939194041539,-0.0765358324751559,-0.0501566160687276,5.59339673963289e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTN,Pleiotrophin,42357,-0.0476472714645542,0.0050640728590618,-0.0575728542683153,-0.0377216886607931,5.8346823271327e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,40302,-0.107649679888087,0.0114406070731602,-0.130073269751481,-0.0852260900246926,5.96836137521659e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,40483,-0.103013485564525,0.0109518053501689,-0.124479024050856,-0.0815479470781941,6.14329674298805e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BSG,Basigin,42746,-0.0208490794078585,0.0022191935166247,-0.0251986987004429,-0.0164994601152741,6.63027909244697e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42636,-0.0605325806639972,0.00644318808079881,-0.0731612293023629,-0.0479039320256316,6.64270000948908e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,42357,0.0205827784569832,0.00219218939245134,0.0162860872477786,0.0248794696661878,7.0298856339983e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NGRN,Neugrin,40483,-0.0222822550448468,0.00237279481407167,-0.0269329328804273,-0.0176315772092663,7.10012055463399e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VWC2,Brorin,42456,-0.0393663733554962,0.00419576857164422,-0.0475900797559189,-0.0311426669550736,7.48297163943386e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,42711,-0.0907675696586343,0.00968325182470702,-0.10974674323506,-0.0717883960822085,8.10195827435387e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,40302,-0.0437912461571539,0.00467372523412847,-0.0529517476160457,-0.0346307446982621,8.68049357563043e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPR,Nucleoprotein TPR,40116,-0.0465878895696282,0.00497778806118551,-0.0563443541695518,-0.0368314249697046,9.61002308587694e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",42311,-0.0490630377743047,0.00524746693828727,-0.0593480729733477,-0.0387780025752616,1.01803258453714e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MBL2,Mannose-binding protein C,40379,0.104519864689892,0.0111758939974745,0.082615112454842,0.126424616924942,1.02098186067836e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNMBP,Dynamin-binding protein,42495,-0.056914012619883,0.00609593634655073,-0.0688620478591224,-0.0449659773806436,1.15283540566506e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,40223,-0.0710464666193314,0.00760787107089162,-0.085957893918279,-0.0561350393203838,1.16389922253038e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPHB4,Ephrin type-B receptor 4,42794,-0.0251751426699581,0.00269981311375354,-0.030466776372915,-0.0198835089670011,1.28135695494695e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,40283,-0.0551803983934782,0.00591937715983882,-0.0667823776267623,-0.0435784191601941,1.35771133093309e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,42475,-0.0253624011917299,0.00272192617720398,-0.0306973764990497,-0.0200274258844101,1.37227780981524e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDH3,Cadherin-3,42711,-0.0355688531980591,0.00382756089655311,-0.0430708725553032,-0.028066833840815,1.72912990691276e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,42721,-0.0376442837282991,0.00405141186531325,-0.0455850509843131,-0.0297035164722851,1.74809372085636e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,40483,-0.0309861596230633,0.00333485933006774,-0.0375224839099961,-0.0244498353361305,1.79802219009504e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LGALS8,Galectin-8,42711,-0.0564679176581966,0.00608571868410757,-0.0683959262790475,-0.0445399090373458,1.9716571153769e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,42346,-0.0360578633058616,0.00388590911243434,-0.0436742451662329,-0.0284414814454903,1.97241361802102e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,42311,-0.0361988458251775,0.00390370305205219,-0.0438501038071998,-0.0285475878431552,2.09018099932777e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DKK1,Dickkopf-related protein 1,42711,-0.0553444696885869,0.00597046795446354,-0.0670465868793354,-0.0436423524978383,2.14528579460843e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HEXIM1,Protein HEXIM1,42594,-0.0758232030189705,0.00818819517791543,-0.0918720655676847,-0.0597743404702562,2.34960299932802e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,42594,-0.097385075151475,0.0105180441280366,-0.118000441642427,-0.0767697086605231,2.37610114704746e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD244,Natural killer cell receptor 2B4,42754,-0.0258334909086915,0.002794120940402,-0.0313099679518794,-0.0203570138655036,2.68197489016861e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NCK2,Cytoplasmic protein NCK2,42676,-0.0984285891633311,0.0106530281724191,-0.119308524381272,-0.0775486539453898,2.84231734587105e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD46,Membrane cofactor protein,42580,-0.0272729448219784,0.00295891594219159,-0.0330724200686739,-0.0214734695752829,3.49840758519939e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,40451,-0.045200142012932,0.00490808522332672,-0.0548199890506523,-0.0355802949752116,3.8616614028585e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,40302,-0.0533542473313777,0.00579676704360906,-0.0647159107368515,-0.041992583925904,4.06000656971834e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EHBP1,EH domain-binding protein 1,40511,-0.0697928340016272,0.00758581006848433,-0.0846610217358564,-0.0549246462673979,4.18824412996755e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,42495,-0.0672001433941663,0.00731037226230744,-0.0815284730282889,-0.0528718137600437,4.40332642956293e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CALB2,Calretinin,42311,-0.0301094695900912,0.00327626991883614,-0.03653095863101,-0.0236879805491723,4.50525716168102e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,42587,-0.0362246217246718,0.0039445391789232,-0.0439559185153612,-0.0284933249339823,4.77838485076875e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,40449,-0.0600191273800982,0.00654838735996079,-0.0728539666056214,-0.0471842881545751,5.78657676696341e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,METAP2,Methionine aminopeptidase 2,42689,-0.0530649778591131,0.00579436697192589,-0.0644219371240879,-0.0417080185941384,6.03636570382954e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,42346,-0.0372587799846929,0.004071221419965,-0.0452383739678243,-0.0292791860015615,6.41782937717979e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EFNA1,Ephrin-A1,42590,-0.0282606758958539,0.00309420447818058,-0.0343253166730878,-0.0221960351186199,7.5764050308842e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GBP1,Guanylate-binding protein 1,40466,-0.0613566866804277,0.00671602203820429,-0.0745200898753081,-0.0481932834855473,7.59459965781042e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEMIP2,Cell surface hyaluronidase,40199,-0.0322876783793292,0.00353428540094003,-0.0392148777651717,-0.0253604789934868,7.64499981911799e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,42346,-0.0308102144377456,0.00337458222642569,-0.0374243956015399,-0.0241960332739512,7.83142686267009e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CES2,Cocaine esterase,42587,-0.0511009731950136,0.00559771774625137,-0.0620724999776663,-0.0401294464123609,7.89823939903568e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,42587,-0.12696574675923,0.0139373050701716,-0.154282864696766,-0.0996486288216933,9.41150156576826e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLIN3,Perilipin-3,42636,-0.0391814350042844,0.00430258017260305,-0.0476144921425864,-0.0307483778659825,9.69391190914516e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APLP1,Amyloid-like protein 1,42636,0.0480140332606937,0.00527776327220622,0.0376696172471695,0.0583584492742179,1.05336519414264e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,40449,-0.0704088636775403,0.00776820136743703,-0.0856345383577169,-0.0551831889973637,1.46878829018123e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,42676,-0.113941179915547,0.0125910294676076,-0.138619597672058,-0.0892627621590364,1.63210756067188e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL6,Interleukin-6,42587,-0.0711436570690191,0.00786422940223473,-0.0865575466973992,-0.055729767440639,1.67724448420862e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,42794,0.0267421109848392,0.00296245159292814,0.0209357058627001,0.0325485161069784,1.99807513572288e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,42495,-0.0985920376253017,0.0109420832577881,-0.120038520810566,-0.077145554440037,2.33069647108318e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAMB1,Laminin subunit beta-1,40223,-0.0280815699971925,0.00311606340213393,-0.034189054265375,-0.02197408572901,2.3591903807092e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD6,T-cell differentiation antigen CD6,42746,-0.0484527840667148,0.00537865209185426,-0.0589949421667492,-0.0379106259666805,2.36786197174187e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,40483,-0.0827399712962818,0.00918460818822098,-0.100741803345195,-0.0647381392473687,2.42285485231443e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DGKA,Diacylglycerol kinase alpha,40199,-0.0504405948820575,0.00560240578907976,-0.0614213102286539,-0.0394598795354612,2.54849076649061e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,40483,-0.0366970934779189,0.00408353367038941,-0.0447008194718822,-0.0286933674839557,2.9545619760111e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,42711,-0.0594451322320241,0.00662307569388805,-0.0724263605920447,-0.0464639038720036,3.18953286871878e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NCAM1,Neural cell adhesion molecule 1,42689,0.027734471957231,0.00309438427311865,0.0216694787819184,0.0337994651325435,3.57487825308532e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLIN1,Perilipin-1,42311,-0.0319267468798558,0.00356350250679763,-0.0389112117931792,-0.0249422819665324,3.70133527534921e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,40451,-0.104009118820828,0.0116187766703775,-0.126781921094768,-0.0812363165468881,4.04444590210946e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRSS22,Brain-specific serine protease 4,40199,-0.033457208461201,0.00375849564641025,-0.0408238599281651,-0.0260905569942369,6.35815616809945e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OTUD7B,OTU domain-containing protein 7B,40482,-0.0562196773006864,0.00633119615094711,-0.0686288217565428,-0.0438105328448301,7.70949468116998e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STK11,Serine/threonine-protein kinase STK11,42357,-0.0655822100751892,0.00739293808631373,-0.0800723687243641,-0.0510920514260143,8.17975248220378e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,42746,-0.0475192871185029,0.00536007465979999,-0.0580250334517109,-0.0370135407852949,8.56276875708075e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,42495,-0.0519270597881395,0.00586227072765506,-0.0634171104143434,-0.0404370091619356,9.18130531568098e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,42679,-0.0861547948815948,0.00973099862491882,-0.105227552186436,-0.0670820375767539,9.51600008994302e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SORT1,Sortilin,42613,-0.033345516364666,0.0037716397102892,-0.0407379301968329,-0.0259531025324992,1.06449370296361e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,42611,-0.0878150059262946,0.00993306463981374,-0.107283812620329,-0.0683461992322596,1.06871954831517e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,42754,-0.0600913642250962,0.00679929036076809,-0.0734179733322017,-0.0467647551179907,1.09423064422653e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,42346,-0.027105862621069,0.00306806261008191,-0.0331192653368296,-0.0210924599053085,1.12822858065366e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,42658,-0.0629701595442478,0.00713537146291597,-0.0769554876115631,-0.0489848314769325,1.22729646971163e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD7,T-cell antigen CD7,40166,-0.040540613013335,0.00459373137897332,-0.0495443265161227,-0.0315368995105473,1.25816083739758e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCARF1,Scavenger receptor class F member 1,42794,-0.0375692564120206,0.00427106552367025,-0.0459405448384143,-0.0291979679856269,1.58335558820482e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ASAH1,Acid ceramidase,40418,-0.0411545042689823,0.00468441625252631,-0.0503359601239338,-0.0319730484140307,1.78405530850838e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,42579,-0.0219174759993002,0.00249877765630933,-0.0268150802056665,-0.0170198717929339,1.97777066048741e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42562,-0.0603356313351279,0.00688145268585513,-0.0738232785994039,-0.0468479840708518,2.0386354080053e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,42587,-0.0285745195098047,0.00326034695302155,-0.034964799537727,-0.0221842394818825,2.10411148686728e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RALY,RNA-binding protein Raly,40451,-0.0426291008476586,0.00486597580312174,-0.0521664134217772,-0.03309178827354,2.21879978110555e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNTN1,Contactin-1,42794,0.0249305555879287,0.00284826334932518,0.0193479594232513,0.030513151752606,2.32190191491728e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PI3,Elafin,42446,-0.0508538895688876,0.00581007297496689,-0.0622416325998227,-0.0394661465379525,2.33243005450085e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,42594,-0.0633023299651805,0.00724125654041592,-0.0774951927843957,-0.0491094671459653,2.56230446380033e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SELP,P-selectin,42689,-0.0498699618949807,0.00570851392419397,-0.0610586491864009,-0.0386812746035605,2.6951267945578e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",42587,0.0369678842495365,0.00423975324973708,0.0286579678800518,0.0452778006190212,3.12437804488177e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LGALS1,Galectin-1,42636,-0.0312330881929335,0.00358498691304661,-0.0382596625425049,-0.0242065138433622,3.32565206705256e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,40449,-0.0356386415361554,0.00408967303780335,-0.0436544006902499,-0.0276228823820608,3.33460923644675e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYDGF,Myeloid-derived growth factor,40511,-0.0873668965006465,0.0100384133200705,-0.107042186607985,-0.0676916063933083,3.67077954546238e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GAL,Galanin peptides,42676,0.0570993379688535,0.0065753907349576,0.0442115721283366,0.0699871038093704,4.26362905967149e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,42311,-0.0589009842561878,0.00678893126204925,-0.0722072895298044,-0.0455946789825713,4.57664048359301e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ASS1,Argininosuccinate synthase,40116,-0.0691834287483059,0.00797460257870616,-0.0848136498025699,-0.0535532076940418,4.70185517323732e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,42594,-0.043156781711103,0.00497653405062922,-0.0529107884503362,-0.0334027749718697,4.72742770736668e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCN3,CCN family member 3,42779,-0.0314476892052451,0.00363111248478495,-0.0385646696754236,-0.0243307087350666,5.21610114990961e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SYTL4,Synaptotagmin-like protein 4,40511,-0.0652635196910669,0.00754301663096669,-0.0800478322877617,-0.0504792070943722,5.73410618158873e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ROBO1,Roundabout homolog 1,42638,-0.0216933826790345,0.00250830095433308,-0.0266096525495273,-0.0167771128085416,5.79704286189707e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,P4HB,Protein disulfide-isomerase,42563,-0.033729129257205,0.00390041867342658,-0.0413739498571211,-0.026084308657289,5.85481388787385e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DHPS,Deoxyhypusine synthase,40451,-0.035860178286274,0.00414967091866949,-0.0439935332868662,-0.0277268232856818,6.28613941659089e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPPK1,Epiplakin,40223,-0.0642172407095722,0.00743799420211824,-0.078795709345724,-0.0496387720734205,6.75724926821438e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,42357,-0.0335970007348245,0.00389492499609013,-0.0412310537271611,-0.0259629477424878,7.08482030696224e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DOK2,Docking protein 2,42636,-0.105678119207084,0.0122601595593137,-0.129708031943339,-0.0816482064708291,7.46052885307432e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COMMD1,COMM domain-containing protein 1,40223,-0.0532516460687214,0.00617768237022483,-0.0653599035143621,-0.0411433886230807,7.60888622775851e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,40449,-0.0727071189168039,0.00845409082528697,-0.0892771369343664,-0.0561371008992415,9.00815967081336e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DBI,Acyl-CoA-binding protein,42562,-0.0668105358841344,0.00777075820572756,-0.0820412219673604,-0.0515798498009084,9.03045865016837e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,40116,-0.0545174016169472,0.00633978496886707,-0.0669433801559267,-0.0420914230779678,9.11907763535921e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42689,0.0390254471777841,0.00454041252017283,0.0301262386382454,0.0479246557173229,9.22335263387752e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLAMF8,SLAM family member 8,42346,-0.0486598985560887,0.0056693039200208,-0.0597717342393295,-0.0375480628728479,1.02678705289588e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPI,Glucose-6-phosphate isomerase,40532,-0.041349281395002,0.00481854240546749,-0.0507936245097183,-0.0319049382802857,1.06021879337674e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,40173,-0.0241764825128607,0.00281929242150579,-0.029702295659012,-0.0186506693667093,1.12018893791648e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,42370,-0.0593377260573179,0.00692549862117031,-0.0729117033548117,-0.0457637487598241,1.16904882074106e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,40199,-0.0780196196750766,0.00911709925605006,-0.0958891342169348,-0.0601501051332185,1.30639164180005e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BCL2L15,Bcl-2-like protein 15,40199,-0.0495059742830354,0.00578553930059931,-0.0608456313122101,-0.0381663172538608,1.31381422590395e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNM3,Dynamin-3,40482,-0.048070377514084,0.00561989956481011,-0.0590853806611119,-0.0370553743670562,1.34687230104216e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GRN,Progranulin,42552,-0.021425944039587,0.00250655139155478,-0.0263387847670344,-0.0165131033121396,1.38752974349786e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VCAM1,Vascular cell adhesion protein 1,42663,-0.0244559229442175,0.00286164640985013,-0.0300647499075238,-0.0188470959809112,1.40893748123097e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OPLAH,5-oxoprolinase,40223,-0.0592157883936645,0.00692691591875428,-0.0727925435944229,-0.0456390331929061,1.40948723736813e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LGALS3,Galectin-3,42669,-0.0261013785401357,0.00305848072436621,-0.0320960007598935,-0.0201067563203779,1.56221813342774e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,42295,-0.0500280125781084,0.00586688641806119,-0.0615271099575084,-0.0385289151987085,1.66268714316688e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCN5,CCN family member 5,42611,-0.0335666648755517,0.00394379423506034,-0.04129650157627,-0.0258368281748334,1.90165963081835e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,40223,-0.0663804930889613,0.00780129661138388,-0.0816710344472737,-0.0510899517306488,1.98278005389046e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,42636,-0.0327268309998577,0.00384887553240841,-0.0402706270433782,-0.0251830349563372,2.04161356500362e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCRL2,Fc receptor-like protein 2,42681,-0.045723409798196,0.00538030337409804,-0.0562688044114281,-0.0351780151849638,2.12414587996482e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CIT,Citron Rho-interacting kinase,40182,-0.0395268476685708,0.00465132783942875,-0.0486434502338511,-0.0304102451032904,2.17835164931514e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDA,Cytidine deaminase,40494,-0.0408506840956392,0.00480949148717591,-0.0502772874105039,-0.0314240807807744,2.2506644313028e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,42679,0.0208069071911259,0.00245461974271958,0.0159958524953955,0.0256179618868563,2.55679545152735e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRTAC1,Cartilage acidic protein 1,42794,0.0259047036402215,0.00305775332113357,0.0199115071307997,0.0318979001496433,2.66213530355059e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLIT2,Slit homolog 2 protein,42311,-0.0455243078988725,0.00537377928400672,-0.0560569152955256,-0.0349917005022193,2.67726171203926e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,40449,-0.0687094589416033,0.00812901862257901,-0.0846423354418581,-0.0527765824413484,3.20574549824962e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,40283,-0.0676971962809367,0.00800972627904761,-0.08339625978787,-0.0519981327740033,3.22483815928424e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,40483,-0.0765731458768197,0.00906523259119302,-0.094341001755558,-0.0588052899980814,3.35719710339101e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNCA,Alpha-synuclein,40283,-0.0996497826607851,0.0118150979120576,-0.122807374568418,-0.0764921907531521,3.75083424600944e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LEFTY2,Left-right determination factor 2,42689,-0.0429296447288978,0.00509208201864456,-0.0529101254854411,-0.0329491639723544,3.78284010016092e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHRDL2,Chordin-like protein 2,42636,-0.0407107348490197,0.00483206754969995,-0.0501815872464316,-0.0312398824516078,3.96700947959416e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NRCAM,Neuronal cell adhesion molecule,42636,-0.0250705299219238,0.00297609698616934,-0.0309036800148157,-0.0192373798290319,4.00610522877251e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TADA3,Transcriptional adapter 3,40451,-0.0340695941006826,0.00405103661872372,-0.0420096258733811,-0.0261295623279841,4.59042112619046e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,42754,-0.0522501965945581,0.00621682193591326,-0.0644351675889481,-0.0400652256001681,4.71566730234437e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLAMF6,SLAM family member 6,42346,-0.0333863500737652,0.00397252362001808,-0.0411724963690007,-0.0256002037785298,4.74266722126061e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,40182,-0.0597555692384483,0.00710867188591525,-0.0736885661348421,-0.0458225723420544,4.76511171030886e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZBP1,Z-DNA-binding protein 1,40199,-0.0345587527190816,0.00411321098741185,-0.0426206462544088,-0.0264968591837543,4.93330490511723e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,42370,0.0340102533423491,0.0040496122515197,0.0260730133293705,0.0419474933553278,4.98571760070851e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GOLGA3,Golgin subfamily A member 3,40482,-0.067297292495485,0.00801436687635861,-0.0830054515731479,-0.0515891334178221,5.12340788363663e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNST,Consortin,42636,-0.0928237400666758,0.0110630720711125,-0.114507361326056,-0.0711401188072953,5.32423693751527e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,42370,-0.0368845844942321,0.00439866169469088,-0.0455059614158262,-0.0282632075726379,5.56490904688913e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ESYT2,Extended synaptotagmin-2,40483,-0.0705003529515933,0.00841108479571898,-0.0869860791512025,-0.0540146267519841,5.82790479966067e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,A1BG,Alpha-1B-glycoprotein,40539,-0.0146039124577442,0.00174300867480651,-0.018020209460365,-0.0111876154551234,5.98791186000591e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADD1,Alpha-adducin,40283,-0.0611262425147823,0.00729731592573992,-0.0754289817292326,-0.0468235033003321,6.10687178467416e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDCD1,Programmed cell death protein 1,42689,-0.0385587102652733,0.0046064038767774,-0.047587261863757,-0.0295301586667896,6.28857866713796e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXCL8,Interleukin-8,42494,-0.0594230697031066,0.00711882321957035,-0.0733759632134644,-0.0454701761927487,7.66785585827664e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,L1CAM,Neural cell adhesion molecule L1,42679,0.0249842154375965,0.00299499138296926,0.0191140323269768,0.0308543985482163,8.00861570686745e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPOCK1,Testican-1,42495,0.0219209523146283,0.00262855337322363,0.01676898770311,0.0270729169261466,8.18572563297964e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGB1,Integrin beta-1,42638,0.0182040916065335,0.00218882405860084,0.0139139964516759,0.0224941867613911,9.89704551820507e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,42676,-0.0241026200140852,0.00290129628791108,-0.0297891607383909,-0.0184160792897794,1.0697233341986e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,40283,-0.02781849739538,0.00335057256371686,-0.0343856196202651,-0.021251375170495,1.13664835901894e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,40283,-0.0604068566526985,0.00727779266815917,-0.0746713302822905,-0.0461423830231065,1.16017084762747e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,42495,-0.0485050869014019,0.00584722642712008,-0.0599656506985572,-0.0370445231042465,1.18560559970504e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDGFC,Platelet-derived growth factor C,42346,-0.024188089922416,0.00291705150414356,-0.0299055108705373,-0.0184706689742946,1.22143882368893e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SH3BP1,SH3 domain-binding protein 1,40449,-0.0406587541553237,0.0049046344680435,-0.050271837712689,-0.0310456705979585,1.26245189074826e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",40482,-0.0656285752831677,0.00791934360167725,-0.0811504887424551,-0.0501066618238803,1.29129480761385e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CMIP,C-Maf-inducing protein,40451,-0.070154431846922,0.00847639103219677,-0.0867681582700277,-0.0535407054238163,1.41204174711274e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL19,C-C motif chemokine 19,42711,-0.110478776444187,0.0133763618465915,-0.136696445663506,-0.0842611072248674,1.60113436059394e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OLFM4,Olfactomedin-4,39870,-0.104956671825685,0.012703815011521,-0.129856149248266,-0.0800571944031039,1.60435396424183e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,40283,-0.0355846777589202,0.00430759563240195,-0.044027565198428,-0.0271417903194124,1.60985339024604e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KAZN,Kazrin,40449,-0.0880644213546284,0.010663978940152,-0.108965820077326,-0.0671630226319304,1.64514061786826e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,42594,-0.0931692100119168,0.0112875072014541,-0.115292724126767,-0.0710456958970668,1.67145143562481e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATXN2L,Ataxin-2-like protein,40482,-0.0407840563618161,0.00493983588855451,-0.0504661347033829,-0.0311019780202492,1.6717463579315e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OGA,Protein O-GlcNAcase,40449,-0.0591378074942191,0.00716869562219301,-0.0731884509137174,-0.0450871640747208,1.76819728344104e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42613,-0.0955900399455291,0.0116072741484181,-0.118340297276429,-0.0728397826146297,1.95474313399291e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CETN2,Centrin-2,42311,-0.0563975175230494,0.0068599764108532,-0.0698430712883217,-0.0429519637577771,2.20226664987556e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42618,-0.0246676783383323,0.0030029823899339,-0.0305535238226027,-0.0187818328540618,2.32622494301396e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BRAP,BRCA1-associated protein,40342,-0.0915693061871134,0.0111566112454493,-0.113436264228194,-0.0697023481460327,2.50416783593527e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EDN1,Endothelin-1,40223,-0.0256406518836616,0.00312502167588316,-0.0317656943683926,-0.0195156093989306,2.56309588826742e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZNRD2,Protein ZNRD2,40449,-0.0586032045635776,0.00714494293168379,-0.0726072927096779,-0.0445991164174774,2.61976323015259e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCRL6,Fc receptor-like protein 6,42594,-0.0586362062855916,0.00715119635003458,-0.0726525511316593,-0.0446198614395238,2.63216590289691e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,42476,-0.0925337530116888,0.0112874420782255,-0.114657139485011,-0.0704103665383669,2.66836220155859e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,40449,-0.0250025910257987,0.00305376571105014,-0.030987971819457,-0.0190172102321405,2.95550257575275e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,40980,0.0264599033204686,0.003238557030764,0.0201123315401711,0.032807475100766,3.39016324910375e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FABP3,"Fatty acid-binding protein, heart",40511,-0.0439718824647685,0.00538716958434437,-0.0545307348500835,-0.0334130300794535,3.63382633576073e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NSFL1C,NSFL1 cofactor p47,42711,-0.0537197539363191,0.00660017992576453,-0.0666561065908176,-0.0407834012818206,4.32708553624983e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGAL,Integrin alpha-L,40199,-0.0373005496995203,0.00458463482856829,-0.0462864339635142,-0.0283146654355265,4.52509598480132e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,40451,-0.056287389606217,0.00692216453167673,-0.0698548320883034,-0.0427199471241306,4.68534908699657e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,42794,-0.0261299365860673,0.00321876713172333,-0.032438720164245,-0.0198211530078896,5.14437798110822e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLK11,Kallikrein-11,42543,-0.0271540322766155,0.00334708399788013,-0.0337143169124605,-0.0205937476407704,5.37889012024189e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MPO,Myeloperoxidase,42611,-0.0385176575525841,0.00474786504735227,-0.0478234730453945,-0.0292118420597736,5.38174465144453e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLK14,Kallikrein-14,42721,0.0390700071707941,0.00482036905513845,0.0296220838227227,0.0485179305188654,5.71583563103492e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,40451,-0.0285808838808963,0.00352568316092968,-0.0354912228763185,-0.0216705448854741,5.74963278710177e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,42357,-0.046086332975088,0.00568842798015509,-0.057235651816192,-0.0349370141339841,5.89135341900095e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C8B,Complement component C8 beta chain,40539,0.0252545265502829,0.00311960840663202,0.0191400940732842,0.0313689590272817,6.28911421177711e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLXNA4,Plexin-A4,42594,-0.0674097057561482,0.00832953811383628,-0.0837356004592673,-0.0510838110530291,6.32771595690788e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,40302,-0.0437432244194941,0.00540608038802292,-0.054339141980019,-0.0331473068589692,6.50759683317227e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DAB2,Disabled homolog 2,42721,-0.0898198355741653,0.0111037291753973,-0.111583144757944,-0.0680565263903866,6.5164574499258e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RSPO3,R-spondin-3,42721,-0.0245658153395953,0.00303912687877717,-0.0305225040219986,-0.0186091266571921,6.84246764991778e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPARCL1,SPARC-like protein 1,42644,0.0229053260381015,0.00283410536566477,0.0173504795213986,0.0284601725548045,6.91027697683403e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AAMDC,Mth938 domain-containing protein,40223,-0.043971227285066,0.00544060314893068,-0.0546348094569702,-0.0333076451131619,7.03333140780286e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,42346,-0.0637402154986018,0.0078909920758573,-0.0792065599672821,-0.0482738710299215,7.17831288315016e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAB27B,Ras-related protein Rab-27B,40511,-0.0680557850652904,0.00842538722860115,-0.0845695440333487,-0.0515420260972322,7.28277464353941e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SWAP70,Switch-associated protein 70,40449,-0.0295074904555004,0.0036592124276555,-0.0366795468137052,-0.0223354340972956,8.13845473741271e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LARP1,La-related protein 1,40451,-0.0505957956299773,0.00627623051750271,-0.0628972074442826,-0.038294383815672,8.29858517563324e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ING1,Inhibitor of growth protein 1,42292,-0.0387464362349844,0.00481124003072302,-0.0481764666952015,-0.0293164057747673,8.75080191004525e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,40527,0.0224080150739169,0.00278545067002709,0.0169485317606638,0.02786749838717,9.50884249766017e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPRR3,Small proline-rich protein 3,40483,-0.0578211421002753,0.0071928277271188,-0.0719190844454281,-0.0437231997551224,9.98233434232552e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WASHC3,WASH complex subunit 3,40483,-0.0615169791729668,0.00765263031952397,-0.0765161345992337,-0.0465178237466998,9.98644260490094e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,42586,-0.0528281665615858,0.00658045499960846,-0.0657258583608184,-0.0399304747623532,1.07255099350497e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCRG1,Scrapie-responsive protein 1,40511,-0.0235076156267667,0.00292990236087072,-0.0292502242540733,-0.0177650069994601,1.13048238938057e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STAT2,Signal transducer and activator of transcription 2,40199,-0.0625096037137142,0.00779174706028372,-0.0777814279518703,-0.0472377794755581,1.14089263039732e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",40482,-0.0652085068173657,0.00813731860914228,-0.0811576512912846,-0.0492593623434469,1.22440631334838e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,42711,-0.0258132938661331,0.00322746795106845,-0.0321391310502272,-0.0194874566820389,1.36683954032587e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,42357,-0.0755236307235921,0.00945519156187419,-0.0940558061848656,-0.0569914552623187,1.49054404279822e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STX4,Syntaxin-4,42587,-0.0484091757910879,0.00606275817578035,-0.0602921818156174,-0.0365261697665584,1.52316869795474e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,42370,-0.0493587500618357,0.00619142591238411,-0.0614939448501086,-0.0372235552735628,1.68769280088251e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL5,C-C motif chemokine 5,42689,-0.0809164154362621,0.0101617629598613,-0.10083347083759,-0.0609993600349339,1.81526554639805e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PCBP2,Poly(rC)-binding protein 2,40482,-0.0586712990930391,0.00736716082268626,-0.0731109343055042,-0.044231663880574,1.82686338643275e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",42569,-0.0621190330605885,0.00780423162638189,-0.077415327048297,-0.04682273907288,1.86346179329842e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,42654,0.0707813387921262,0.0088962724067082,0.0533446448749781,0.0882180327092743,1.91370452695643e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GIMAP8,GTPase IMAP family member 8,40080,-0.0430501026322058,0.00541596633306738,-0.0536653966450178,-0.0324348086193937,2.07031158927646e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,42674,-0.058747058727762,0.00740293597043604,-0.0732568132298167,-0.0442373042257074,2.25860044094187e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CASP10,Caspase-10,42311,-0.0578449128790397,0.00729759238267031,-0.0721481939490735,-0.0435416318090059,2.4339474409157e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,42636,-0.0636083653037686,0.00802727180675331,-0.079341818045005,-0.0478749125625321,2.47938990896999e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,42370,-0.0292739104214352,0.00369657876372551,-0.0365192047983373,-0.0220286160445332,2.5813173624734e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,40030,-0.0272063232387038,0.00343510926220008,-0.033939137392616,-0.0204735090847917,2.60578658921322e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL15,Interleukin-15,42594,-0.0268026159970082,0.00338685633144409,-0.0334408544066386,-0.0201643775873778,2.69347146326582e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IFNG,Interferon gamma,42370,-0.0913088282667006,0.0115387748325169,-0.113924826938434,-0.0686928295949675,2.70767567944435e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC3B,Tetranectin,40269,0.0170833818349585,0.00215883756963285,0.0128520601984781,0.0213147034714389,2.74679466797158e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VASN,Vasorin,42449,0.0223220516220176,0.00282161438338586,0.0167916874305813,0.0278524158134539,2.752823579552e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,40449,-0.017478624297291,0.00221296306109273,-0.0218160318970328,-0.0131412166975493,3.09033742727289e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,40223,-0.0827364076240123,0.0104752505471452,-0.103267898696417,-0.0622049165516078,3.09632720098673e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,42594,-0.0631701519347168,0.00800903466244479,-0.0788678598731086,-0.047472443996325,3.3244147611614e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,40209,-0.0449129879487196,0.00570270293834204,-0.05609028570787,-0.0337356901895692,3.70560406743756e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEZ6L2,Seizure 6-like protein 2,42587,0.0191355958124764,0.00243047689822317,0.014371861091959,0.0238993305329938,3.72200901152074e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,42346,-0.0522436004791601,0.00664195985601235,-0.0652618417969443,-0.0392253591613759,3.95601519180401e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATOX1,Copper transport protein ATOX1,42679,-0.0557379971716442,0.00709541701654179,-0.0696450145240661,-0.0418309798192223,4.28208919979594e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,42618,-0.0420338442768221,0.00535159548417374,-0.0525229714258027,-0.0315447171278416,4.31908793145284e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ESM1,Endothelial cell-specific molecule 1,42618,0.0276088313889233,0.00351519045169709,0.020719058103597,0.0344986046742496,4.32943945716281e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BAP18,Chromatin complexes subunit BAP18,40483,-0.0544478217270199,0.00693726075600155,-0.068044852808783,-0.0408507906452569,4.5866732667305e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GMPR,GMP reductase 1,42754,-0.0394469056337896,0.00503302101727802,-0.0493116268276545,-0.0295821844399247,4.93250070626428e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPON2,Spondin-2,42562,-0.0287709564699997,0.00367198964490975,-0.0359680561740228,-0.0215738567659766,5.03116079296046e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,40527,-0.0187021264515233,0.00238722153204733,-0.023381080654336,-0.0140231722487105,5.13677348070558e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,USO1,General vesicular transport factor p115,42587,-0.0717713143338711,0.00916466414222301,-0.0897340560526282,-0.053808572615114,5.18999517733886e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GMPR2,GMP reductase 2,40283,-0.0540330549102852,0.00690774751830014,-0.0675722400461534,-0.0404938697744169,5.66636350171741e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,40182,-0.0516572837399441,0.00660932442128118,-0.0646115596056552,-0.038703007874233,5.95906532320484e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,42307,-0.062259605101604,0.00797206569468201,-0.0778848538631807,-0.0466343563400272,6.16557956492839e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AZI2,5-azacytidine-induced protein 2,40482,-0.0440124131471142,0.00563485290948138,-0.0550567248496977,-0.0329681014445307,6.18816798613155e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",42636,-0.0583812110993317,0.00747772120945934,-0.073037544669872,-0.0437248775287914,6.27074138323345e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARSB,Arylsulfatase B,42587,-0.0437487567033848,0.00560749251594825,-0.0547394420346434,-0.0327580713721262,6.55136626340488e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,40511,-0.0388268081675776,0.00497662962406629,-0.0485810022307475,-0.0290726141044077,6.6377937049546e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTGES2,Prostaglandin E synthase 2,40102,-0.0435955498808165,0.00558910211960322,-0.0545501900352388,-0.0326409097263942,6.75006482059327e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SH2B3,SH2B adapter protein 3,42346,-0.0774432432826177,0.00993512098039887,-0.0969160804041995,-0.057970406161036,6.92907021747156e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,42346,-0.0347115465322342,0.0044566775612671,-0.0434466345523177,-0.0259764585121507,7.27810392315747e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STAMBP,STAM-binding protein,42476,-0.0498919505369758,0.00642225203788345,-0.0624795645312274,-0.0373043365427243,8.51589949239573e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,42620,-0.0449155664766943,0.0057823030002253,-0.0562488803571359,-0.0335822525962527,8.56599335079935e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,40183,-0.0666559241670638,0.00858057589570011,-0.083473852922636,-0.0498379954114916,8.66712245279723e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,42611,-0.0428676010675906,0.00552003018359941,-0.0536868602274454,-0.0320483419077357,8.69774628823896e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STX8,Syntaxin-8,42594,-0.0377915068773439,0.00486676826712945,-0.0473303726809176,-0.0282526410737701,8.74038144275189e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,42311,-0.0303121749429945,0.00391279513691608,-0.03798125341135,-0.0226430964746389,1.01032898643028e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",40482,-0.0381308029859928,0.00492223345533827,-0.0477783805584559,-0.0284832254135298,1.02425063623065e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NIT1,Deaminated glutathione amidase,40223,-0.0376173403911715,0.00486119814694898,-0.0471452887591915,-0.0280893920231515,1.09560498898324e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,42517,-0.0329431835561347,0.00426643429978958,-0.0413053947837223,-0.0245809723285471,1.23167153761972e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",42476,-0.074952099621071,0.00971113827223043,-0.0939859306346427,-0.0559182686074994,1.26430538202738e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANXA10,Annexin A10,42311,-0.0681912925194953,0.00883734866616912,-0.0855124959051867,-0.0508700891338038,1.28427348461665e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TLR3,Toll-like receptor 3,42754,-0.0481070493014057,0.00623499213699832,-0.0603276338899224,-0.035886464712889,1.28744381926068e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,42565,-0.0341469254777098,0.00442806450310824,-0.0428259319038019,-0.0254679190516176,1.33136111910878e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,42370,-0.0471223612049803,0.00611677019528125,-0.0591112307877315,-0.035133491622229,1.41496398717122e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD164,Sialomucin core protein 24,42611,-0.0214996830843007,0.00279221914935506,-0.0269724326170366,-0.0160269335515648,1.45731650590688e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LTA,Lymphotoxin-alpha,42594,-0.0320372647501668,0.00416419929798499,-0.0401990953742173,-0.0238754341261162,1.53139894959725e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,42587,0.0209231694415992,0.00272002374985513,0.0155919228918831,0.0262544159913152,1.54612448313527e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HPSE,Heparanase,40408,-0.0737515999053222,0.00958832065309064,-0.0925447083853798,-0.0549584914252645,1.5720141965272e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ICAM4,Intercellular adhesion molecule 4,42594,0.0413083628182779,0.00538393926734974,0.0307558418542724,0.0518608837822834,1.80276202387326e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,40482,-0.0590274818206412,0.00769835442076953,-0.0741162564853495,-0.043938707155933,1.89705137330893e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AP2B1,AP-2 complex subunit beta,40182,-0.0379476504515352,0.00494901307907306,-0.0476477160865184,-0.028247584816552,1.89854251305918e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FOXO3,Forkhead box protein O3,42346,-0.0742812368045075,0.00970029239422415,-0.0932938098971869,-0.0552686637118282,2.02598168880072e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,42346,-0.048913943012728,0.00639734166613151,-0.0614527326783458,-0.0363751533471103,2.21724201244016e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DPEP1,Dipeptidase 1,42476,0.0389637027309714,0.00509743326759538,0.0289727335264845,0.0489546719354584,2.25367363813048e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GRSF1,G-rich sequence factor 1,40014,-0.0633707129754021,0.0082896249887744,-0.0796183779534,-0.0471230479974043,2.27380529973905e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C2,Complement C2,42663,-0.0178720064889129,0.00234391046572116,-0.0224660710017264,-0.0132779419760995,2.60612039754204e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IMPACT,Protein IMPACT,40483,-0.043690827705037,0.0057339845463297,-0.0549294374158432,-0.0324522179942308,2.74754868256902e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FOXJ3,Forkhead box protein J3,40199,-0.0341465172046208,0.00448586505305982,-0.0429388127086181,-0.0253542217006235,2.91901468683045e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,42346,-0.0451837536140158,0.00593813067514371,-0.0568224897372974,-0.0335450174907341,2.94787421077988e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,YJU2,Splicing factor YJU2,40451,-0.0253108805786332,0.00332621669879515,-0.0318302653082717,-0.0187914958489947,2.97085867261548e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,40449,-0.0847191110675379,0.0111345625595731,-0.106542853684301,-0.0628953684507747,2.99038700235723e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,40223,-0.0455610150409118,0.0059925595694781,-0.0573064317970889,-0.0338155982847347,3.13005583523972e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CST7,Cystatin-F,42642,-0.0728992909961885,0.00959757263439594,-0.0917105333596045,-0.0540880486327724,3.26569350796081e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,42611,-0.0232516729618538,0.00306737460401335,-0.0292637271857199,-0.0172396187379876,3.67297963533822e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,42370,-0.0410706098089424,0.00541815121696856,-0.0516901861942007,-0.030451033423684,3.68086027553263e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNPEP,Aspartyl aminopeptidase,40483,-0.0444350491120454,0.00586368600814645,-0.0559278736880124,-0.0329422245360783,3.78349535514848e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IFNLR1,Interferon lambda receptor 1,42594,-0.0280570669169855,0.00370941774112636,-0.0353275256895931,-0.0207866081443778,4.17114937246542e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,40449,-0.0397116748792551,0.00525030285647046,-0.0500022684779372,-0.029421081280573,4.22287155268202e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LY96,Lymphocyte antigen 96,42495,-0.0275648851859693,0.00364722957459172,-0.0347134551521691,-0.0204163152197696,4.36855891533871e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EBI3_IL27,Interleukin-27,42689,-0.0238238415750111,0.00315240714566926,-0.0300025595805229,-0.0176451235694994,4.3783365928684e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,F2R,Proteinase-activated receptor 1,42654,-0.0429980527873025,0.005712973008457,-0.0541954798838782,-0.0318006256907268,5.54727233686978e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCN2,CCN family member 2,42624,-0.0423294391718741,0.00563047747313005,-0.053365175019209,-0.0312937033245392,5.9180910771827e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,40223,-0.0402269326225763,0.0053538950755971,-0.0507205669707466,-0.029733298274406,6.19824242386346e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",40449,-0.112002400081827,0.0149145720588952,-0.141234961317262,-0.0827698388463927,6.37947791792737e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,40511,-0.0463190760218137,0.00617238371137742,-0.0584169480961134,-0.034221203947514,6.64153922231931e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,40223,-0.0245482130706792,0.00327119504025123,-0.0309597553495716,-0.0181366707917868,6.64839463805122e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",40481,-0.030619106326557,0.00408429017431583,-0.0386243150682161,-0.022613897584898,7.02904549185526e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TSC22D1,TSC22 domain family protein 1,40482,-0.0500274400148934,0.00667579923510391,-0.0631120065156971,-0.0369428735140898,7.18806730221219e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,40199,-0.0676313464285671,0.0090249975831894,-0.0853203416916183,-0.0499423511655158,7.20519759288662e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",40267,-0.0652117240268396,0.00870848457292675,-0.0822803537897761,-0.0481430942639032,7.50760325042908e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,40449,-0.0432256841369555,0.00577437341997978,-0.0545434560401159,-0.0319079122337952,7.6432384707732e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,42611,-0.0431669053513543,0.00578022870536859,-0.0544961536138767,-0.0318376570888318,8.64273342993872e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,40449,-0.0376598055901489,0.00504949627998753,-0.0475568182989245,-0.0277627928813733,9.42104592342614e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,40449,-0.0483366804364999,0.00648909774876422,-0.0610553120240778,-0.035618048848922,1.01002226729582e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PAMR1,Inactive serine protease PAMR1,42611,-0.0203150484142168,0.00272829759447814,-0.025662511699394,-0.0149675851290396,1.02036199049002e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,42495,-0.059082851169889,0.00794104130853066,-0.0746472921346091,-0.0435184102051689,1.06704467394504e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,40223,-0.0373856932896292,0.0050241098211924,-0.0472329485391663,-0.0275384380400921,1.07150609728991e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,40482,-0.0276433879220433,0.00371613077602822,-0.0349270042430586,-0.020359771601028,1.09010059737975e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LIFR,Leukemia inhibitory factor receptor,42594,-0.0183244332849479,0.00246505883239595,-0.023155948596444,-0.0134929179734519,1.12028713250817e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BID,BH3-interacting domain death agonist,42594,-0.050788751230659,0.00683356492039064,-0.0641825384746246,-0.0373949639866933,1.13234575210409e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CAPG,Macrophage-capping protein,42461,-0.0444764791828895,0.00598655858912458,-0.0562101340175737,-0.0327428243482053,1.15765936595516e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTSV,Cathepsin L2,42677,0.0317869581553671,0.00427966654049649,0.0233988117359939,0.0401751045747402,1.17368346883492e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SH3GLB2,Endophilin-B2,40483,-0.0506302939788381,0.00682421874690495,-0.0640057627227718,-0.0372548252349044,1.26277313652091e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,42346,-0.0397190376816734,0.00536137519021867,-0.050227333054502,-0.0292107423088448,1.35656910902944e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,42346,-0.0384733986837242,0.00519608476864911,-0.0486577248302765,-0.0282890725371719,1.39856488367424e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTSC,Dipeptidyl peptidase 1,42616,-0.0333599972616393,0.00450732969219263,-0.0421943634583368,-0.0245256310649417,1.429008449336e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,42754,-0.0261881723519104,0.00354173138987492,-0.0331299658760653,-0.0192463788277556,1.5063183668315e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,40283,-0.0408595188147537,0.00552714006631035,-0.051692713344722,-0.0300263242847855,1.5444329926226e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FKBPL,FK506-binding protein-like,40449,-0.0442769485774244,0.00599911317555159,-0.0560352104015055,-0.0325186867533433,1.68704000861984e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IFNL1,Interferon lambda-1,42311,-0.0346148692879393,0.00469143587427276,-0.0438100836015139,-0.0254196549743647,1.69949213876246e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,40482,-0.0506616048383198,0.00686896773180702,-0.0641247815926616,-0.0371984280839781,1.75288750181855e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FAM13A,Protein FAM13A,40449,-0.0508207911329651,0.006894047409648,-0.0643331240558751,-0.037308458210055,1.8029031426829e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATXN3,Ataxin-3,40483,-0.0469373253586785,0.00637088897620528,-0.0594242677520409,-0.0344503829653162,1.86026155444362e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,40511,-0.0458821973229946,0.00623191040022016,-0.0580967417074261,-0.0336676529385631,1.93075345052359e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,42357,-0.0566807358997629,0.00770336495830295,-0.0717793312180367,-0.0415821405814891,1.97865189981141e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EREG,Proepiregulin,42476,-0.0601691085858881,0.00818540596976489,-0.0762125042866273,-0.0441257128851489,2.0857627367963e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RRAS,Ras-related protein R-Ras,40182,-0.097499414410048,0.0132661372434157,-0.123501043407143,-0.0714977854129532,2.13083444828797e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,40532,-0.0205012179427615,0.00279281646977151,-0.0259751382235136,-0.0150272976620093,2.27022092151183e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",40223,-0.0650798655533904,0.00888624316843676,-0.0824969021635265,-0.0476628289432544,2.58114080348243e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,42721,-0.039965363820885,0.00546189982896378,-0.050670687485654,-0.029260040156116,2.67624374963753e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRKL,Crk-like protein,42636,-0.0780393121752289,0.0106699228043535,-0.0989523608717618,-0.057126263478696,2.7407637530105e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEC31A,Protein transport protein Sec31A,40223,-0.0573351184769783,0.0078486575192084,-0.0727184872146267,-0.0419517497393298,2.96212680384783e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,40451,-0.0655260257373499,0.00897634960642761,-0.083119670965948,-0.0479323805087518,3.07494870443389e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APOBR,Apolipoprotein B receptor,40223,0.0318994860672387,0.00437990945866781,0.0233148635282498,0.0404841086062276,3.48378544893439e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,40199,0.024609106708447,0.00337917285723692,0.0179859279082627,0.0312322855086314,3.49859214439016e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NUB1,NEDD8 ultimate buster 1,42594,-0.0614863429287095,0.00844663906648773,-0.0780417554990255,-0.0449309303583936,3.5402294963774e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HS1BP3,HCLS1-binding protein 3,40223,-0.0658908044299807,0.00905995891752613,-0.0836483239083319,-0.0481332849516295,3.76122182789065e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL17C,Interleukin-17C,42370,-0.0555119948287602,0.00763759040362712,-0.0704816720198694,-0.0405423176376511,3.84656766429211e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,YWHAQ,14-3-3 protein theta,40283,-0.0547626566212542,0.00754027356160731,-0.0695415928020045,-0.0399837204405039,4.04907816400429e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,40223,-0.0339912715770474,0.00468496488250349,-0.0431738027467543,-0.0248087404073406,4.27376646009703e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,40116,-0.0278706219264961,0.00384411540244292,-0.0354050881152842,-0.0203361557377079,4.44280280818695e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,40189,-0.0261770748566196,0.00361215620523668,-0.0332569010188835,-0.0190972486943557,4.54870569582555e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",40511,-0.022556453294663,0.00311413968606252,-0.0286601670793456,-0.0164527395099805,4.66545552882006e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C3,Complement C3,39989,-0.03505943856409,0.00484572529043199,-0.0445570601333367,-0.0255618169948433,4.96653400673767e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,40116,-0.0498311610731181,0.00689103651377646,-0.06333759264012,-0.0363247295061163,5.10392841866863e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BOLA1,BolA-like protein 1,40136,-0.0402620888763644,0.00557096837051304,-0.05118118688257,-0.0293429908701588,5.2618856886921e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",40527,-0.0304189941435165,0.0042132599190781,-0.0386769835849096,-0.0221610047021234,5.53862124263034e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,40116,-0.0492922232881679,0.00682874193451716,-0.0626765574798215,-0.0359078890965142,5.61187682667838e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VEGFB,Vascular endothelial growth factor B,40199,-0.0219791386324404,0.00304504272447646,-0.0279474223724142,-0.0160108548924665,5.62311720971039e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SDC1,Syndecan-1,42636,-0.0300636548530501,0.00416636191595932,-0.0382297242083303,-0.0218975854977698,5.6489435215779e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GET3,ATPase GET3,40511,-0.0399493964645376,0.00554060373752152,-0.0508089797900798,-0.0290898131389954,5.93890743116736e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,40449,-0.0864104098087399,0.012005439057733,-0.109941070361897,-0.0628797492555833,6.51798551023317e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",42587,-0.050443996757162,0.0070100624855361,-0.0641837192288128,-0.0367042742855112,6.5331635631857e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,42594,-0.0759355839105567,0.0105558321993691,-0.09662501502132,-0.0552461527997933,6.64032527390145e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CA9,Carbonic anhydrase 9,42721,-0.0356348188040298,0.0049577725301269,-0.0453520529630785,-0.0259175846449811,6.93625761269561e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",42370,-0.0524477801553982,0.00729828132163341,-0.0667524115457997,-0.0381431487649967,7.0142872165132e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,42676,-0.0955261107142686,0.0132937566275226,-0.121581873704213,-0.0694703477243243,7.03319118381362e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,40482,-0.0492757900335149,0.00685647138399939,-0.0627144739461537,-0.0358371061208761,7.05335467083859e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LGMN,Legumain,42676,-0.0261995932984825,0.00364935030672807,-0.0333523198996695,-0.0190468666972955,7.37651836035423e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,40482,-0.0447882522540512,0.00624550274067014,-0.0570294376257647,-0.0325470668823377,7.8945270407431e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CASC3,Protein CASC3,40182,-0.0308007468489299,0.00429600532231752,-0.0392209172806723,-0.0223805764171876,8.0033351822665e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,42566,-0.022195547770769,0.00309656158481526,-0.0282648084770069,-0.0161262870645311,8.02076591461487e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,40229,-0.0415973159522869,0.00580254789340703,-0.0529703098233647,-0.0302243220812091,8.04924143765497e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,40511,-0.0295099953296107,0.00411897289966941,-0.0375831822129627,-0.0214368084462587,8.29776530031184e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42582,-0.0499275033068524,0.00698369990028089,-0.063615555111403,-0.0362394515023019,9.1845189697401e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,40482,-0.0610748731860288,0.00856150942625703,-0.0778554316614926,-0.044294314710565,1.03719396253405e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SUSD2,Sushi domain-containing protein 2,42611,0.0210292950913268,0.00295100295756354,0.0152453292945022,0.0268132608881513,1.08484402607549e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL1R1,Interleukin-1 receptor type 1,42590,-0.0171204330540443,0.00240903940584062,-0.021842150289492,-0.0123987158185967,1.24820570804957e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRLF1,Cytokine receptor-like factor 1,42676,-0.0182693455429669,0.0025734117766561,-0.0233132326252129,-0.0132254584607209,1.31694133347955e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,42594,-0.072460956322145,0.0102104032969736,-0.0924733467842133,-0.0524485658600768,1.34121640020853e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DDHD2,Phospholipase DDHD2,40482,-0.0476145892734988,0.00671220072908431,-0.0607705027025041,-0.0344586758444936,1.38349504907233e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACHE,Acetylcholinesterase,40283,-0.0243081820234436,0.00342706296798676,-0.0310252254406976,-0.0175911386061895,1.39223209986439e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NRP1,Neuropilin-1,42705,0.0201288550208381,0.00283903678806009,0.0145643429162403,0.0256933671254358,1.40744051447259e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GDF2,Growth/differentiation factor 2,42636,0.0260022427727363,0.00367132680944382,0.0188064422262265,0.0331980433192462,1.48596029194269e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,40199,-0.0413517689889788,0.00583844385435084,-0.0527951189435064,-0.0299084190344512,1.50034433148168e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,42602,-0.0252493193453486,0.00356625030764339,-0.0322391699483296,-0.0182594687423675,1.51249381469207e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",42679,-0.0436580805247962,0.00618153794535835,-0.0557738948976985,-0.0315422661518938,1.71354214601914e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DPT,Dermatopontin,42794,-0.0182844814531889,0.00258903766410444,-0.0233589952748336,-0.0132099676315442,1.71761587219784e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,40283,-0.0274202244341503,0.00388295174956685,-0.0350308098633013,-0.0198096390049992,1.7432573390449e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAP2,Microtubule-associated protein 2,40483,-0.0336030494345853,0.00475942348568855,-0.0429315194665349,-0.0242745794026358,1.75873214165672e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,40116,-0.0266457275198018,0.00377643421455258,-0.0340475385803249,-0.0192439164592787,1.82019039379344e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MITD1,MIT domain-containing protein 1,42495,-0.0686857564628321,0.00973922025798713,-0.0877746281684869,-0.0495968847571774,1.8442778469876e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,40449,-0.0740742429940863,0.0105184620311177,-0.094690428575077,-0.0534580574130956,2.00103258219745e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,40199,-0.0254511567278478,0.00361640915704745,-0.0325393186756608,-0.0183629947800348,2.07084236972123e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,42311,-0.0479135883919599,0.00681300235615659,-0.0612670730100269,-0.034560103773893,2.12661721407479e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAP3,Cytosol aminopeptidase,42370,-0.0346835053462682,0.00494182190726662,-0.0443694762845108,-0.0249975344080256,2.3546499471303e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAB33A,Ras-related protein Rab-33A,40116,-0.0472281659004841,0.00673068374823526,-0.0604203060470252,-0.034036025753943,2.40377407267105e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,40223,-0.0313904673601797,0.00447578821775097,-0.0401630122669716,-0.0226179224533878,2.46220199250228e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,42587,-0.0284141908526327,0.0040525799879813,-0.0363572476290761,-0.0204711340761894,2.47283676901734e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNX15,Sorting nexin-15,40283,-0.0390582873550778,0.00557150442222921,-0.049978436022647,-0.0281381386875085,2.51506929478083e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BOC,Brother of CDO,42357,0.0168162616150254,0.00240474820480874,0.0121029551336003,0.0215295680964505,2.82177349262091e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,42370,-0.0275279516408073,0.00393796617453012,-0.0352463653428863,-0.0198095379387283,2.87306281558561e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",42594,-0.0678417090761037,0.00971204410952125,-0.0868773155307653,-0.048806102621442,2.97626112408412e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLMP,CXADR-like membrane protein,42721,-0.0156489687668513,0.00224645383641972,-0.020052018286234,-0.0112459192474687,3.40968239287612e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,40223,-0.0170000435027128,0.0024404314169379,-0.0217832890799111,-0.0122167979255145,3.44653561722308e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,40451,-0.0271985587170133,0.00391510971598079,-0.0348721737603356,-0.0195249436736909,3.93513413681175e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,42794,-0.046489476011537,0.00670086902384931,-0.0596231792982816,-0.0333557727247924,4.16184776418809e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,40182,-0.057210962786528,0.00825452244349286,-0.073389826775774,-0.0410320987972819,4.41715092670125e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL2,C-C motif chemokine 2,42475,-0.0374953016895063,0.00542550194644875,-0.0481292855045458,-0.0268613178744667,5.03430296650097e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,40482,-0.0411862246804774,0.0059599192516018,-0.0528676664136169,-0.0295047829473379,5.08837705700693e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,42676,-0.0734018020632971,0.0106289706643971,-0.0942345845655154,-0.0525690195610789,5.21488612686572e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDHR5,Cadherin-related family member 5,42636,-0.0273568409749605,0.00396181919148406,-0.0351220065902693,-0.0195916753596517,5.24137079472283e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LPP,Lipoma-preferred partner,40116,-0.0465651022582483,0.00674690070437596,-0.0597890276388252,-0.0333411768776714,5.42306816001903e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,42636,-0.0479948263911068,0.00695939898584291,-0.0616352484033589,-0.0343544043788547,5.57189910025412e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PCDH9,Protocadherin-9,40449,-0.0243480997499998,0.00354035547900683,-0.0312871964888532,-0.0174090030111464,6.42278581932679e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,40519,-0.0178942873475485,0.00260383814819171,-0.0229978101180043,-0.0127907645770928,6.65037611406402e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,42476,-0.0164056143940667,0.00238781914092541,-0.0210857399102805,-0.0117254888778529,6.68081626114526e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,40511,-0.0635518165763518,0.00926204982480557,-0.0817054342329707,-0.0453981989197329,7.16842808899651e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AZU1,Azurocidin,42216,-0.0535597457515325,0.00780916440498711,-0.0688657079853072,-0.0382537835177578,7.26910368452473e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,42495,-0.0212747181766998,0.00310278698506798,-0.027356180667433,-0.0151932556859665,7.36067256576669e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,40451,-0.0363300882027164,0.00529814754672396,-0.0467144573942953,-0.0259457190111374,7.39357910742013e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",42794,-0.0205064779540095,0.00299171367120208,-0.0263702367495655,-0.0146427191584534,7.46854028889832e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLGN,Calmegin,40182,-0.032745395679275,0.00477656224411283,-0.0421074576777361,-0.0233833336808139,7.49092462009356e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,40199,-0.0680784441463688,0.00993146066732508,-0.087544107054326,-0.0486127812384117,7.52193564494889e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TP53,Cellular tumor antigen p53,42346,-0.0301407514225374,0.00440162153985651,-0.0387679296406561,-0.0215135732044186,7.84089540969036e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GZMH,Granzyme H,42357,-0.0543839406835102,0.00796403809657886,-0.0699934553528048,-0.0387744260142157,8.94550474847002e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ALPP,"Alkaline phosphatase, placental type",42587,-0.0703952605973135,0.0103194643775127,-0.0906214107772384,-0.0501691104173886,9.38981053250586e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NECTIN4,Nectin-4,42679,-0.0241078620032591,0.00353556163323723,-0.031037562804404,-0.0171781612021141,9.57925280818173e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,42443,-0.0798865613936021,0.0117168308874,-0.102851549932906,-0.056921572854298,9.6247538394127e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",42611,-0.0530475667306629,0.0077818629430848,-0.0683000180991091,-0.0377951153622167,9.70556276922959e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,42495,-0.064758066616193,0.00949997599102186,-0.0833780195585959,-0.0461381136737902,9.72022412120657e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINE2,Glia-derived nexin,40511,-0.044855234248164,0.00658034972728142,-0.0577527197136356,-0.0319577487826925,9.79991930741135e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,42594,-0.0425371253230733,0.00624174753492038,-0.0547709504915173,-0.0303033001546294,9.83358429054406e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RGMB,RGM domain family member B,42711,-0.0198300266954002,0.00291108878208173,-0.0255357607082804,-0.01412429268252,1.00396833206584e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,42370,-0.030078714765568,0.00442157960849891,-0.0387450107982258,-0.0214124187329101,1.07104153025004e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACYP1,Acylphosphatase-1,40250,-0.045786039085534,0.00673205130144788,-0.0589808596363719,-0.0325912185346962,1.09103837650722e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,40223,-0.036772122791632,0.00540833896445051,-0.047372467161955,-0.026171778421309,1.10673726445503e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HMOX2,Heme oxygenase 2,42311,-0.0317367619311696,0.00466990518286979,-0.0408897760895944,-0.0225837477727448,1.12197159285878e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMPRSS5,Transmembrane protease serine 5,42438,0.0264174961030522,0.00389089736176762,0.0187913372739877,0.0340436549321168,1.17267218527162e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UROD,Uroporphyrinogen decarboxylase,40283,-0.0480058141789025,0.00707534848704663,-0.0618734972135139,-0.0341381311442911,1.22052451198672e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TRAF2,TNF receptor-associated factor 2,42594,-0.0479218541447833,0.00706515863123941,-0.0617695650620125,-0.034074143227554,1.2277811246325e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COL1A1,Collagen alpha-1(I) chain,42794,0.017383925969902,0.00256902703432533,0.0123486329826243,0.0224192189571796,1.37112692565601e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,40482,-0.0455753093277835,0.00674954088096064,-0.0588044094544663,-0.0323462092011006,1.52601822804209e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,40116,-0.0197485562536275,0.00292532979485304,-0.0254822026515395,-0.0140149098557156,1.54401927135843e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPAG1,Sperm-associated antigen 1,40482,-0.0397212537818906,0.00588484752646703,-0.051255554933766,-0.0281869526300152,1.55356950904534e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GRAP2,GRB2-related adapter protein 2,42636,-0.087483782429677,0.0129635416155735,-0.112892323996201,-0.062075240863153,1.55559050845398e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,42495,-0.025122602703003,0.00372582528972859,-0.0324252202708711,-0.017819985135135,1.61744798425689e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,42458,-0.0238806160222624,0.00354633487686449,-0.0308314323809168,-0.0169297996636081,1.71993223168352e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BMP10,Bone morphogenetic protein 10,40283,0.0199276685517045,0.00296331458562527,0.014119571963879,0.02573576513953,1.84491725693251e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,40449,-0.0621851911338667,0.00925307006581338,-0.080321208462861,-0.0440491738048725,1.89859242074308e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MRC1,Macrophage mannose receptor 1,40532,-0.0202300442238105,0.00301155682168388,-0.0261326955943109,-0.0143273928533101,1.93755065651903e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RILP,Rab-interacting lysosomal protein,42674,-0.0407386525100292,0.00606803937779021,-0.052632009690498,-0.0288452953295604,1.97422060592278e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NUDC,Nuclear migration protein nudC,42754,-0.0424048142052419,0.00631840623628238,-0.0547888904283554,-0.0300207379821285,2.0054177534094e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,40223,-0.0372540095129315,0.00555484222169729,-0.0481415002674582,-0.0263665187584048,2.0897876474244e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",40199,-0.0251477701986016,0.00375081311798994,-0.0324993639098619,-0.0177961764873413,2.11819908999664e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CALB1,Calbindin,42587,-0.0312258668365425,0.00467222815501825,-0.0403834340203783,-0.0220682996527067,2.4287772264267e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,40302,-0.0450859651306039,0.00674711627256375,-0.0583103130248289,-0.031861617236379,2.46548663955279e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,42594,0.0409907789905074,0.00614562516108849,0.028945353674774,0.0530362043062408,2.65999230662075e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,40302,-0.0261769977861038,0.00392486663748008,-0.0338697363955648,-0.0184842591766429,2.68818599049361e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TSNAX,Translin-associated protein X,40116,-0.0270358065025977,0.00405434591941606,-0.0349823245046531,-0.0190892885005422,2.71180659945156e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCRIB,Protein scribble homolog,40223,-0.0620409142692684,0.00931628313997735,-0.080300829223624,-0.0437809993149128,2.88007651652266e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,40483,-0.0333610697735062,0.00501691791526532,-0.0431942288874262,-0.0235279106595861,3.07217674494043e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,40135,-0.0291376557496516,0.00438592425522367,-0.03773406728989,-0.0205412442094132,3.20978829147665e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,40199,-0.0238077102972677,0.00358394811775943,-0.0308322486080761,-0.0167831719864592,3.22141470714588e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,42346,-0.0384429932559281,0.0057934914867596,-0.0497982365699769,-0.0270877499418792,3.35962559775144e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,42794,-0.0156763012441757,0.00236375229626524,-0.0203092557448556,-0.0110433467434958,3.4378227384096e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,40449,-0.0313844717850741,0.00473280143677766,-0.0406607626011583,-0.0221081809689898,3.48055892974793e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MMP8,Neutrophil collagenase,42681,-0.0494437355953222,0.00746302563605912,-0.0640712658419981,-0.0348162053486463,3.60035583333845e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,40283,-0.0572744662986955,0.00865926626351646,-0.0742466281751878,-0.0403023044222032,3.90649141425633e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BPIFA2,BPI fold-containing family A member 2,39838,0.0769177430812857,0.0116325124785765,0.0541180186232758,0.0997174675392956,3.96508226247677e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CETN3,Centrin-3,40449,-0.051297436863131,0.00776139975953933,-0.066509780391828,-0.0360850933344339,4.03583303930313e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,42676,-0.0576322211418846,0.00872413979684985,-0.0747315351437103,-0.0405329071400589,4.09484255239655e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPON1,Spondin-1,42638,-0.0228732948344322,0.00347347466440804,-0.029681305176672,-0.0160652844921925,4.71365342742538e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,42711,-0.0309659893074541,0.00470252151654444,-0.0401829314798812,-0.021749047135027,4.71772687801355e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TBCC,Tubulin-specific chaperone C,42495,-0.053720066862334,0.00815905207156606,-0.0697118089226034,-0.0377283248020645,4.74810587963631e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC51B,Organic solute transporter subunit beta,40116,-0.0522238155115568,0.00793347439705923,-0.0677734253297929,-0.0366742056933207,4.83106067561348e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42594,-0.0285229876042924,0.00433935022124575,-0.037028114037934,-0.0200178611706507,5.11019954999011e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,42611,-0.0224255197074126,0.00341241679367997,-0.0291138566230254,-0.0157371827917999,5.15671498463142e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GFAP,Glial fibrillary acidic protein,42326,0.0329754421021614,0.00501878718318441,0.02313861922312,0.0428122649812029,5.20729232122069e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TLR1,Toll-like receptor 1,40199,-0.0181207344042364,0.00275868221632031,-0.0235277515482242,-0.0127137172602485,5.30744302239631e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DCTN2,Dynactin subunit 2,42587,-0.062809895811926,0.00957024319985475,-0.0815675724836414,-0.0440522191402107,5.46620853939483e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,40483,-0.0353794545706519,0.00539335805082755,-0.0459504363502739,-0.0248084727910299,5.62280379910853e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,42190,-0.081024927814515,0.0123552311678719,-0.105241180903544,-0.056808674725486,5.66183530909661e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,40511,-0.0605989724580459,0.00924241288825835,-0.0787141017190323,-0.0424838431970596,5.74370910108202e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LGALS7_LGALS7B,Galectin-7,42524,-0.0290154096340921,0.00443178984823165,-0.0377017177366261,-0.020329101531558,6.08104736647995e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TCN2,Transcobalamin-2,42771,-0.0206782756115811,0.00316054774249255,-0.0268729491868665,-0.0144836020362957,6.26160780688053e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UBXN1,UBX domain-containing protein 1,40283,-0.045940431676658,0.00702136334234886,-0.0597023038276617,-0.0321785595256542,6.29746060089065e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DBNL,Drebrin-like protein,42676,-0.0611043030222468,0.00934940530864577,-0.0794291374271925,-0.0427794686173011,6.56177461112713e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,YAP1,Transcriptional coactivator YAP1,40483,-0.0193136046216118,0.00295514527489581,-0.0251056893604075,-0.013521519882816,6.60903705424442e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,42657,-0.0684496621348289,0.010479882249857,-0.0889902313445486,-0.0479090929251092,6.74397842559665e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OPHN1,Oligophrenin-1,40483,-0.0713718256433713,0.010934330174075,-0.0928031127845583,-0.0499405385021843,6.98284237758944e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,42346,0.0256087544188681,0.00393080591568443,0.0179043748241267,0.0333131340136096,7.5393421740082e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",40482,-0.028731499564528,0.00441119825953383,-0.0373774481532143,-0.0200855509758417,7.66367316875141e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NME3,Nucleoside diphosphate kinase 3,42638,0.0159829452122811,0.00245494502013904,0.0111712529728086,0.0207946374517536,7.75557055890927e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATG4A,Cysteine protease ATG4A,42346,-0.0391743462798676,0.00601854891845941,-0.050970702160048,-0.0273779903996872,7.84311027231645e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COMP,Cartilage oligomeric matrix protein,42511,0.022439305061291,0.00345331095350073,0.0156708155924296,0.0292077945301524,8.43412782323176e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PGA4,Pepsin A-4,40532,-0.0540771319503219,0.00832209784598695,-0.0703884437284563,-0.0377658201721875,8.47965156304318e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAB44,Ras-related protein Rab-44,40451,-0.0280356849505639,0.00431604283986817,-0.0364951289167055,-0.0195762409844223,8.6136920272421e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,42586,-0.0125924535735431,0.00193919730508358,-0.0163932802915069,-0.00879162685557925,8.67422103549924e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HRG,Histidine-rich glycoprotein,40479,-0.0205853739481925,0.00317264325716573,-0.0268037547322373,-0.0143669931641476,9.03851922377136e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NT5E,5'-nucleotidase,42679,-0.0375106902295034,0.00578434253940997,-0.0488480016067469,-0.0261733788522598,9.19056061828377e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GLRX,Glutaredoxin-1,42546,-0.0371806083286444,0.00573543255773923,-0.0484220561418133,-0.0259391605154755,9.33148411836661e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",40302,-0.0326747562092765,0.00504019154544163,-0.0425535316383421,-0.0227959807802109,9.38279806327975e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ST13,Hsc70-interacting protein,40283,-0.0375473120182767,0.00579338495626743,-0.0489023465325608,-0.0261922775039925,9.4940437944548e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PKD2,Polycystin-2,40116,-0.0386855767104513,0.00598535287611681,-0.0504168683476402,-0.0269542850732623,1.06757246488427e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD36,Platelet glycoprotein 4,40199,-0.0297307612242059,0.00460053019787858,-0.0387478004120479,-0.0207137220363639,1.07365507656224e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,F10,Coagulation factor X,40532,-0.0188310126161833,0.00291949066048882,-0.0245532143107414,-0.0131088109216252,1.1632314222193e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,40527,0.0219330412399426,0.00340285424096109,0.0152634469276588,0.0286026355522263,1.19910071111689e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,42587,-0.0576546308993325,0.00895673337019796,-0.0752098283049205,-0.0400994334937445,1.25997890815744e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,42346,-0.0390952526012681,0.00607431181598525,-0.0510009037605992,-0.0271896014419371,1.2678373762414e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRG3,Proteoglycan 3,40527,0.0329342857180996,0.00511717253940418,0.0229046275408674,0.0429639438953318,1.27586538361215e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BAX,Apoptosis regulator BAX,42292,-0.0584848746819365,0.00908982084782504,-0.0763009235436736,-0.0406688258201994,1.28523460164047e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL17,C-C motif chemokine 17,42604,-0.0602132406129761,0.00936365227665489,-0.0785659990752197,-0.0418604821507325,1.31470932804695e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,40449,-0.0505729301396395,0.00786961885552767,-0.0659973830964737,-0.0351484771828052,1.35983979870687e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD69,Early activation antigen CD69,42585,-0.0574317961907862,0.00893836101833304,-0.0749509837867189,-0.0399126085948534,1.36048656421352e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,42587,-0.0360251517352878,0.00561229007307725,-0.0470252402785192,-0.0250250631920564,1.41818205786857e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINI2,Serpin I2,40449,-0.0369159338907419,0.00575858186107843,-0.0482027543384557,-0.0256291134430282,1.50752113541353e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RWDD1,RWD domain-containing protein 1,42711,-0.0409844326801572,0.00640457947549397,-0.0535374084521254,-0.028431456908189,1.6130381925613e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BAG6,Large proline-rich protein BAG6,42357,-0.023312884024328,0.00364379335205822,-0.0304547189943622,-0.0161710490542939,1.62785911138562e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PARK7,Parkinson disease protein 7,42611,-0.0337586380929496,0.00528089724009451,-0.0441091966835348,-0.0234080795023643,1.68491173724114e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ALCAM,CD166 antigen,42794,-0.0128631037325163,0.00201360159770227,-0.0168097628640128,-0.00891644460101986,1.73418273050046e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FSTL1,Follistatin-related protein 1,40223,-0.0148742258428229,0.00232895151017998,-0.0194389708027757,-0.0103094808828701,1.76367831459982e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42594,-0.0565767912440163,0.0088633440799434,-0.0739489456407054,-0.0392046368473273,1.79099921250333e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APP,Amyloid-beta precursor protein,42592,-0.0432138163426015,0.0067759609962259,-0.0564946998952042,-0.0299329327899987,1.85889664610791e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,40502,0.00996290189507704,0.00156251863485784,0.00690036537075567,0.0130254384193984,1.88633680059977e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TWF2,Twinfilin-2,40527,-0.0540208159504083,0.00848523702815505,-0.0706518805255922,-0.0373897513752244,2.00933240565378e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRELP,Prolargin,42618,-0.0158836047555436,0.00249551755782782,-0.0207748191688862,-0.0109923903422011,2.01830807607228e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DRAXIN,Draxin,42495,-0.0284995855778862,0.00448145833978687,-0.0372832439238685,-0.0197159272319039,2.0910705975286e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MINK1,Misshapen-like kinase 1,40483,-0.0601491728386443,0.00948552585485433,-0.0787408035141588,-0.0415575421631299,2.36761320919041e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,42711,-0.0150805072400687,0.00238177303398063,-0.0197487823866708,-0.0104122320934667,2.50254390195241e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,40511,-0.06914786289586,0.0109246024730751,-0.0905600837430872,-0.0477356420486328,2.55169337480989e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TBCA,Tubulin-specific chaperone A,40283,-0.0550646509984362,0.00870154961964917,-0.0721196882529485,-0.0380096137439238,2.57700833182643e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD22,B-cell receptor CD22,42754,-0.0281655172215821,0.00445461415244122,-0.0368965609603669,-0.0194344734827973,2.64962318565564e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,42587,-0.0221919760707671,0.00351602150657794,-0.0290833782236599,-0.0153005739178744,2.84736977382766e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLXNB3,Plexin-B3,42597,-0.0301640981948711,0.00478574551600679,-0.0395441594062444,-0.0207840369834978,3.01268831917619e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,40449,-0.0340604309014455,0.00540330342588301,-0.0446509056161762,-0.0234699561867148,3.01631088449087e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42613,-0.0209920801129146,0.00333264182657763,-0.0275240580930067,-0.0144601021328224,3.09059169318984e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,40116,-0.0253268628292872,0.00402211748143907,-0.0332102130929078,-0.0174435125656666,3.15325617485681e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,40511,-0.0210780179316385,0.00335777662881673,-0.0276592601241193,-0.0144967757391577,3.56941762453921e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ERI1,3'-5' exoribonuclease 1,40302,-0.0221732703054693,0.00353821102592521,-0.0291081639162827,-0.0152383766946559,3.82189791684631e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,40449,-0.0569072788088386,0.00910618823225711,-0.0747554077440625,-0.0390591498736146,4.27208499938171e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APRT,Adenine phosphoribosyltransferase,42480,-0.0301000696662686,0.00482691162570749,-0.0395608164526553,-0.0206393228798819,4.62837579424704e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,42721,-0.0389643671727844,0.00625930897989381,-0.0512326127733763,-0.0266961215721926,4.95697209665404e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RGCC,Regulator of cell cycle RGCC,40482,-0.0480250266747768,0.00772156119548854,-0.0631592866179344,-0.0328907667316193,5.16050841650091e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C4BPB,C4b-binding protein beta chain,42679,0.0256353225290947,0.00412232336390667,0.0175555687358376,0.0337150763223518,5.16222290138344e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,40482,-0.0721403188499559,0.0116073627927732,-0.0948907499237914,-0.0493898877761204,5.31184093979084e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],42365,-0.0304974768172158,0.00491113460350544,-0.0401233006400864,-0.0208716529943451,5.46246575837754e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPRY2,Protein sprouty homolog 2,42370,-0.0581599828132984,0.00937009435358228,-0.0765253677463197,-0.0397945978802772,5.56326874951171e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CACYBP,Calcyclin-binding protein,40267,-0.0649828261752855,0.0104692104449572,-0.0855024786474015,-0.0444631737031694,5.59229988739331e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,42721,0.0377136721958093,0.00607729299907688,0.0258021779176186,0.0496251664739999,5.60538337271666e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,42711,-0.029510435543675,0.00476005348605014,-0.0388401403763333,-0.0201807307110167,5.82529147521103e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAX,Protein max,42311,-0.0662775635155284,0.0106968066156956,-0.0872433044822918,-0.045311822548765,5.96436693034969e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,42346,-0.0290960103855037,0.00469868580913875,-0.0383054345714157,-0.0198865861995918,6.10298068739985e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,42711,0.0298147019019787,0.00481645425562953,0.0203744515609448,0.0392549522430126,6.18346166942197e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXCL16,C-X-C motif chemokine 16,42778,-0.0151159281638375,0.00244399501606033,-0.0199061583953158,-0.0103256979323593,6.39132389470953e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPD52L2,Tumor protein D54,40283,-0.0680597640065311,0.0110025324083269,-0.0896247275268519,-0.0464948004862103,6.39549734011252e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TTF2,Transcription termination factor 2,40182,-0.0310578243764308,0.00502169740018434,-0.0409003512807921,-0.0212152974720695,6.4421740117054e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STK24,Serine/threonine-protein kinase 24,42311,-0.0386691441698266,0.00627804671363968,-0.0509741157285604,-0.0263641726110929,7.51444369901476e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AIF1,Allograft inflammatory factor 1,42346,-0.032815061205774,0.00533049974237276,-0.0432628407008246,-0.0223672817107234,7.67293262219119e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",40283,-0.0654779356954415,0.0106382791046159,-0.0863289627404887,-0.0446269086503943,7.77025238401175e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,42587,-0.013374590271893,0.00217407261848804,-0.0176357726041295,-0.00911340793965642,7.87603722209389e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DLG4,Disks large homolog 4,40483,-0.0440591021943285,0.00717082987266046,-0.058113928744743,-0.030004275643914,8.30691586412545e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TEK,Angiopoietin-1 receptor,42679,-0.0137710433869628,0.00224683260265695,-0.0181748352881704,-0.00936725148575521,9.08453640533584e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LPO,Lactoperoxidase,42134,-0.0380276988412466,0.00620458140470279,-0.0501886783944641,-0.0258667192880292,9.10193626591784e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ICA1,Islet cell autoantigen 1,42370,-0.0490938260525834,0.00801114581924266,-0.064795671858299,-0.0333919802468678,9.141883712764e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,42357,-0.0339563636559064,0.00554197660050069,-0.0448186377928877,-0.023094089518925,9.20356393622945e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPART,Spartin,40283,-0.0481551850567912,0.00786533131504702,-0.0635712344342834,-0.032739135679299,9.52584946045486e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,40182,-0.0269578958233705,0.00440724203246464,-0.0355960902070011,-0.0183197014397398,9.87667204911881e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNC,Tenascin,42689,0.0302633910219357,0.00495117943297433,0.020559079333306,0.0399677027105654,1.00873032791312e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNX5,Sorting nexin-5,40223,-0.0182418339165635,0.00298542947716508,-0.024093275691807,-0.0123903921413199,1.02808441417656e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BLNK,B-cell linker protein,40199,-0.0256251776002251,0.00419776025922624,-0.0338527877083085,-0.0173975674921416,1.06606394597211e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COMT,Catechol O-methyltransferase,42214,-0.0519133202935571,0.00850529272588856,-0.0685836940362987,-0.0352429465508156,1.06619033719387e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,40482,-0.0299901649253966,0.00491948916577251,-0.0396323636903107,-0.0203479661604825,1.1217155693886e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",42292,-0.0292447537535111,0.00480236688710546,-0.0386573928522378,-0.0198321146547844,1.1632105121931e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,40223,-0.0260339525486395,0.0042773694776651,-0.0344175967248632,-0.0176503083724159,1.19285956217537e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,42346,-0.0375458058733299,0.00617445710526877,-0.0496477417996567,-0.0254438699470031,1.22876836865089e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",40116,-0.0387134538516848,0.00637909544118035,-0.0512164809163983,-0.0262104267869713,1.33145805041705e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MIF,Macrophage migration inhibitory factor,42586,-0.041859005896764,0.00689872042078726,-0.0553804979215071,-0.028337513872021,1.33297982374504e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GAS2,Growth arrest-specific protein 2,40302,-0.0328769464355526,0.00541961021178127,-0.0434993824506438,-0.0222545104204613,1.35158543932078e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WNT9A,Protein Wnt-9a,42370,-0.0184099058230219,0.00303728920240739,-0.0243629926597404,-0.0124568189863034,1.38717024054555e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,40116,-0.0426596042408142,0.00708291307570806,-0.056542113869202,-0.0287770946124264,1.76847101816721e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FIS1,Mitochondrial fission 1 protein,42624,-0.0462807619122417,0.00769254306875657,-0.0613581463270046,-0.0312033774974788,1.8307288662614e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,42636,-0.0410632744675891,0.0068280711445979,-0.054446293911001,-0.0276802550241772,1.85821383260644e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,JUN,Transcription factor AP-1,42370,-0.0294659921874242,0.0048997079998362,-0.0390694198671032,-0.0198625645077453,1.85991330235523e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DENR,Density-regulated protein,40199,-0.0352291123584648,0.00586097357934965,-0.0467166205739902,-0.0237416041429395,1.90467948851283e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANXA5,Annexin A5,42261,-0.0188617948108625,0.00314979448923331,-0.0250353920097598,-0.0126881976119652,2.17662676708367e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TF,Serotransferrin,40539,-0.0131097230380978,0.00219075677266539,-0.0174036063125219,-0.00881583976367359,2.24151764863255e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,40483,-0.0233681399135845,0.00390671309412827,-0.0310252975780759,-0.0157109822490931,2.27743340492485e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,42495,-0.0480438343311912,0.00803417625793932,-0.0637908197967523,-0.0322968488656301,2.28953752700652e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DXO,Decapping and exoribonuclease protein,40483,-0.0279862579929668,0.00467951348547864,-0.0371581044245049,-0.0188144115614286,2.29062056220195e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNX9,Sorting nexin-9,42636,-0.0408488542739227,0.00684711453622129,-0.0542691987649164,-0.027428509782929,2.49481770315335e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,42443,-0.0187047265082249,0.00313937249032278,-0.0248578965892576,-0.0125515564271923,2.61646945812512e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,S100A12,Protein S100-A12,42434,-0.0458898819881667,0.0077022871182622,-0.0609863647399606,-0.0307933992363728,2.6189848623897e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGF2,Fibroblast growth factor 2,42594,-0.0415205387659308,0.00697589704167931,-0.0551932969676223,-0.0278477805642394,2.71503739691971e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,40511,-0.017335842563178,0.00291797333159973,-0.0230550702931135,-0.0116166148332425,2.91525735422867e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TBCB,Tubulin-folding cofactor B,42495,-0.0600648609671966,0.0101318022998373,-0.0799231934748777,-0.0402065284595155,3.13578489152702e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MMP9,Matrix metalloproteinase-9,42594,-0.0364233483441723,0.00614614311148739,-0.0484697888426876,-0.024376907845657,3.1761609999669e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,40223,-0.0556015795848,0.00938294125844452,-0.0739921444513513,-0.0372110147182488,3.2004295433027e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACE,Angiotensin-converting enzyme,40532,-0.0163918160699902,0.00276958167588964,-0.0218201961547339,-0.0109634359852465,3.34257315335853e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGF19,Fibroblast growth factor 19,42676,-0.0469531437506127,0.00793430053245467,-0.0625043727942239,-0.0314019147070016,3.34314061043303e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APOA4,Apolipoprotein A-IV,40539,-0.0219519561850677,0.00371135584549965,-0.029226213642247,-0.0146776987278884,3.4184783208255e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCRL1,Fc receptor-like protein 1,42636,-0.0283929585091465,0.00481686339922084,-0.0378340107716193,-0.0189519062466736,3.84847471032345e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VEGFC,Vascular endothelial growth factor C,42679,-0.0333650265117612,0.00566802889825023,-0.0444743631523316,-0.0222556898711907,4.03760218913759e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,40302,-0.0225343789773691,0.00383004953859772,-0.0300412760730207,-0.0150274818817176,4.13088130070007e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CR2,Complement receptor type 2,42689,-0.0288942493855123,0.00491302776841659,-0.0385237838116088,-0.0192647149594158,4.17069473746668e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINB6,Serpin B6,42679,-0.0346554582021118,0.00589676274268959,-0.0462131131777834,-0.0230978032264402,4.2755452321822e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,42311,-0.0382336300061759,0.00650990958227129,-0.0509930527874276,-0.0254742072249242,4.37967609661102e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,42587,-0.0150611114405649,0.0025659017469439,-0.0200902788645749,-0.0100319440165548,4.46876393791812e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,40199,-0.0327193616244178,0.00557494790861209,-0.0436462595252975,-0.0217924637235381,4.51083592072083e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,40482,-0.0701356136370831,0.0119575891037169,-0.0935724882803683,-0.046698738993798,4.60718258462803e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MARCO,Macrophage receptor MARCO,42636,-0.0157363271897168,0.00268744007733347,-0.0210037097412904,-0.0104689446381432,4.8666004711869e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,REEP4,Receptor expression-enhancing protein 4,40482,-0.0371786916641658,0.00635082879877206,-0.049626316109759,-0.0247310672185725,4.92808771900811e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,40421,-0.0181639042957848,0.00310482336045278,-0.0242493580822723,-0.0120784505092974,5.04623902959117e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,42754,0.0168132586506603,0.00287995786673197,0.0111685412318656,0.0224579760694549,5.40325773781138e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EGFLAM,Pikachurin,40449,-0.0186210157658635,0.00318930222374611,-0.0248720481244058,-0.0123699834073211,5.41002169031005e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GNAS,Neuroendocrine secretory protein 55,40482,-0.0514871547671968,0.00882399437559109,-0.0687821837433553,-0.0341921257910382,5.53007107541328e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,40482,-0.0556476614008796,0.00954412138260245,-0.0743541393107803,-0.0369411834909788,5.6752048580696e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,40199,-0.0539040032723043,0.0092562261011246,-0.0720462064305085,-0.0357618001141001,5.92259480962435e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CIAPIN1,Anamorsin,42679,-0.0368399884490123,0.00632707460640402,-0.0492410546775641,-0.0244389222204604,5.92603416944995e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,42357,-0.0652113348123297,0.0112043377565067,-0.0871718368150829,-0.0432508328095765,6.01512479767254e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD226,CD226 antigen,40199,-0.0253575268837795,0.00435693040798278,-0.0338971104834258,-0.0168179432841333,6.0474254998872e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATRN,"Attractin, Isoform 2",40539,-0.010007769380948,0.00172020426235507,-0.0133793697351639,-0.00663616902673205,6.12460366090203e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,42674,-0.0207425178583523,0.00356790243742555,-0.0277356066357064,-0.0137494290809982,6.25109232412279e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,40451,-0.0351938833875627,0.00605634802281226,-0.0470643255122747,-0.0233234412628506,6.37566251744784e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",40483,0.0358946853022074,0.0061802423563145,0.0237814102838309,0.0480079603205838,6.4939495557247e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,42590,-0.0492913823249825,0.00850301126952403,-0.0659572844132496,-0.0326254802367154,6.90603084889627e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PREB,Prolactin regulatory element-binding protein,42370,-0.0174801247071963,0.00301538182161475,-0.0233902730775613,-0.0115699763368314,6.90641884977741e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PEPD,Xaa-Pro dipeptidase,40532,0.0157992031669364,0.0027267862628208,0.0104547020918076,0.0211437042420651,7.05269916205359e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42594,-0.0892506121554135,0.0154142220832593,-0.119462487438602,-0.0590387368722254,7.19012947837352e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KEL,Kell blood group glycoprotein,42311,-0.0215208982161238,0.00371694681461521,-0.0288061139727696,-0.014235682459478,7.20242247555188e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNN,Tenascin-N,40527,-0.0262115956057145,0.00452820185341323,-0.0350868712384045,-0.0173363199730246,7.289176434968e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PCDH7,Protocadherin-7,40449,-0.0215706243857289,0.00373074652506713,-0.0288828875748605,-0.0142583611965974,7.58469780348842e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CX3CL1,Fractalkine,42495,0.0203360545583614,0.00351907767124462,0.013438662322722,0.0272334467940009,7.6920351278479e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,40182,-0.0425317364434282,0.00735985420030422,-0.0569570506760245,-0.0281064222108319,7.72424606525127e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHRDL1,Chordin-like protein 1,42654,-0.019133595215277,0.00331296295908412,-0.0256270026150819,-0.0126401878154721,7.84793870227245e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL17A,Interleukin-17A,42347,-0.0255101601318129,0.00441727597466962,-0.0341680210421653,-0.0168522992214604,7.86515373389427e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCGB1A1,Uteroglobin,42646,-0.0329827808437176,0.00571485238838765,-0.0441838915249574,-0.0217816701624778,8.03420092701283e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINA7,Thyroxine-binding globulin,40539,-0.0109576795957943,0.00189955346327285,-0.0146808043838091,-0.0072345548077795,8.20435172096429e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",42611,-0.0222188923504581,0.00385982087293584,-0.0297841412614123,-0.0146536434395039,8.77772215155628e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPARC,SPARC,42679,-0.0411306887316011,0.00714655117284096,-0.0551379290303694,-0.0271234484328329,8.83589416878345e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,42569,-0.0520070813023196,0.00903809799062491,-0.0697217533639444,-0.0342924092406948,8.89575629296429e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,42587,-0.0247394506258802,0.00430342765488221,-0.0331741688294493,-0.0163047324223111,9.1850828196251e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLAMF7,SLAM family member 7,42594,-0.034917291589595,0.0060782956471143,-0.046830751057939,-0.023003832121251,9.41487028704247e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,40451,-0.0482849471407396,0.00841542018993815,-0.0647791707130183,-0.0317907235684608,9.846061455492e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,42794,-0.0419854679416366,0.00732557256723775,-0.0563435901734226,-0.0276273457098506,1.01744425396449e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCRL3,Fc receptor-like protein 3,42370,-0.0330656658330372,0.00577407346920347,-0.044382849832676,-0.0217484818333984,1.04715851119738e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD101,Immunoglobulin superfamily member 2,40449,-0.0256641563518544,0.00448322768097034,-0.0344512826065563,-0.0168770300971526,1.06402012783887e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,40185,-0.0163714097037078,0.00286048766101681,-0.0219779655193007,-0.0107648538881148,1.07212188433021e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DMD,Dystrophin,40223,-0.0302867325476709,0.00529316102113628,-0.040661328149098,-0.0199121369462438,1.08107719105725e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,42618,0.0222373778691721,0.0038904126226533,0.0146121691287717,0.0298625866095726,1.11417743665823e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CFHR5,Complement factor H-related protein 5,40382,0.0247870793802283,0.00435746787347721,0.016246442348213,0.0333277164122437,1.31441789163958e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,40511,-0.056638894081908,0.00996623244363464,-0.0761727096714319,-0.0371050784923841,1.35559023475746e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,42370,-0.0190321182239113,0.00335004614235515,-0.0255982086629274,-0.0124660277848952,1.36622515256542e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CST5,Cystatin-D,42357,-0.0330476571702806,0.00582547463007608,-0.0444655874452297,-0.0216297268953315,1.43311210500643e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LACTB2,Endoribonuclease LACTB2,42636,-0.0377141992716751,0.00664962998478269,-0.0507474740418491,-0.024680924501501,1.4436474011756e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",42676,-0.0634510082837819,0.0111915339729968,-0.0853864148708557,-0.0415156016967082,1.4610631641838e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NEXN,Nexilin,40532,-0.0401891224559531,0.00709015260132168,-0.0540858215545436,-0.0262924233573626,1.47740423386339e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CREG1,Protein CREG1,42445,-0.0222813661987644,0.00393264851133822,-0.0299893572809873,-0.0145733751165415,1.4943845755062e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STX7,Syntaxin-7,40199,-0.0291011156649504,0.00514552072381438,-0.0391863362836266,-0.0190158950462743,1.59155798451309e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,40329,-0.0324449130371655,0.00574048935401258,-0.0436962721710301,-0.0211935539033008,1.62544398319513e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CENPF,Centromere protein F,40302,-0.031709882641835,0.00561131396876628,-0.0427080580206169,-0.0207117072630531,1.63386179101001e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TCTN3,Tectonic-3,40511,-0.0173876788495791,0.00307708536958951,-0.0234187661739745,-0.0113565915251836,1.63658503383183e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXCL5,C-X-C motif chemokine 5,42605,-0.065312276586079,0.0115679396706536,-0.08798543834056,-0.0426391148315981,1.67581730248437e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,F12,Coagulation factor XII,40539,-0.0240410653199834,0.00426211869727094,-0.0323948179666344,-0.0156873126733324,1.73476313216277e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,42794,-0.0136219519374161,0.0024162599947888,-0.0183578215272021,-0.00888608234763003,1.75846973799541e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCRL5,Fc receptor-like protein 5,42611,-0.0339737886127737,0.00603359187456543,-0.0457996286869219,-0.0221479485386254,1.83003096281257e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",40511,-0.0420307303855458,0.00746529805617935,-0.0566627145756573,-0.0273987461954342,1.84343496935393e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,40449,-0.0236533575622118,0.00420589566271094,-0.0318969130611253,-0.0154098020632984,1.91192232861193e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,THBD,Thrombomodulin,42636,-0.0173658827926953,0.0030954030028117,-0.0234328726782062,-0.0112988929071844,2.06062443393212e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TREML2,Trem-like transcript 2 protein,42611,-0.0199279282692751,0.0035552516091451,-0.0268962214231995,-0.0129596351153507,2.121037342235e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPHB6,Ephrin type-B receptor 6,42476,-0.0192316560338466,0.0034316313166711,-0.025957653414522,-0.0125056586531713,2.13343593713817e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,42357,-0.0200949895820296,0.00358713912411041,-0.027125782265286,-0.0130641968987731,2.16197655789742e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RCOR1,REST corepressor 1,42357,-0.0254521736213349,0.00454713369072493,-0.0343645556551558,-0.0165397915875141,2.21925440081037e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,42346,-0.0518749149316612,0.00926987249383928,-0.0700438650195862,-0.0337059648437362,2.23638516642589e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,40482,0.015411172472364,0.00275758894197228,0.0100062981460984,0.0208160467986297,2.34162536073186e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,42636,-0.0473227976182468,0.00847712675223029,-0.0639379660526182,-0.0307076291838754,2.41801154909554e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPBP,Platelet basic protein,40471,-0.0481115425837359,0.00862947724276657,-0.0650253179795583,-0.0311977671879134,2.52851118432875e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,40449,-0.0203696920828658,0.00365532334321865,-0.0275341258355743,-0.0132052583301572,2.5672297969116e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYO9B,Unconventional myosin-IXb,42370,-0.0375057098070335,0.00673175362322038,-0.0506999469085454,-0.0243114727055215,2.57562814873231e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DCTN6,Dynactin subunit 6,42311,-0.0408313419281093,0.00733649828287336,-0.0552108785625411,-0.0264518052936775,2.66515626451437e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CASP2,Caspase-2,42594,-0.0380830371997641,0.00685307955248828,-0.0515150731226411,-0.024651001276887,2.79576589252654e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SYAP1,Synapse-associated protein 1,40283,-0.0327036221491269,0.00588579657548509,-0.0442397834370777,-0.0211674608611762,2.81812227157496e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,40483,-0.0221104315606338,0.00397972796817499,-0.0299106983782567,-0.0143101647430108,2.82662771330432e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TST,Thiosulfate sulfurtransferase,42277,-0.0423260446238441,0.00762291568692324,-0.0572669593702136,-0.0273851298774745,2.87141418345976e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CA2,Carbonic anhydrase 2,42573,-0.0393935564748858,0.00709598411643255,-0.0533016853430936,-0.025485427606678,2.88573586850506e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,42706,-0.01675896422239,0.00301901902967298,-0.0226762415205491,-0.010841686924231,2.89178375395147e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LY75,Lymphocyte antigen 75,42594,-0.0220580556316406,0.00397787890731592,-0.0298546982899798,-0.0142614129733014,2.99207672032214e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLSTN3,Calsyntenin-3,40483,-0.0174516573306571,0.00315180037214329,-0.023629186060058,-0.0112741286012563,3.14498674342947e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GTPBP2,GTP-binding protein 2,40182,-0.045799887870907,0.00827234043950424,-0.0620136751323353,-0.0295861006094786,3.15648428106043e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AMOTL2,Angiomotin-like protein 2,40404,-0.0274597406493787,0.00496163017372999,-0.0371845357898895,-0.0177349455088679,3.1928137822284e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RBP7,Retinoid-binding protein 7,40449,-0.0341882573120766,0.0061775363787849,-0.046296228614495,-0.0220802860096582,3.19493598804045e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,40283,-0.0672326670287268,0.0121540537242997,-0.0910546123283543,-0.0434107217290994,3.24322800626318e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,42667,-0.0625169504989468,0.0113209589397798,-0.0847060300209153,-0.0403278709769783,3.4091932916728e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMED8,Protein TMED8,40449,-0.0577711475033926,0.0104635583111663,-0.0782797217932785,-0.0372625732135067,3.44207235463659e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,40482,-0.0375151780129126,0.00680209997050417,-0.0508472939551007,-0.0241830620707244,3.55985348512012e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FOLR2,Folate receptor beta,42711,-0.0166397041361981,0.00302753357869164,-0.0225736699504337,-0.0107057383219624,3.95259348947994e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,42611,-0.06670766758507,0.0121448730490524,-0.0905116187612127,-0.0429037164089273,4.03131174656824e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,42679,-0.013191743381729,0.00240995418813684,-0.0179152535904772,-0.00846823317298084,4.48215814231865e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,42357,-0.0188307930205189,0.00344117309729638,-0.0255754922912199,-0.012086093749818,4.52608874443037e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIL1,Nucleotide exchange factor SIL1,40223,-0.0174050329900876,0.00318529094970539,-0.0236482032515101,-0.011161862728665,4.75135464171713e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VEGFD,Vascular endothelial growth factor D,42734,0.0201594174074586,0.00369171064028245,0.012923664552505,0.0273951702624122,4.82555005583931e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,40482,-0.0182567597743381,0.00334742917100535,-0.0248177209495086,-0.0116957985991676,5.02973985051418e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C1QA,Complement C1q subcomponent subunit A,42701,-0.0122877243504598,0.00225525644853462,-0.0167080269895877,-0.00786742171133198,5.16916593463014e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAB10,Ras-related protein Rab-10,40511,-0.0298699792042453,0.00548484921145899,-0.040620283658705,-0.0191196747497857,5.26194517467127e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDIA4,Protein disulfide-isomerase A4,40527,-0.0333349875421667,0.00613036630196555,-0.0453505054940192,-0.0213194695903142,5.50980366175975e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CA12,Carbonic anhydrase 12,42587,-0.0184297150157367,0.00339283547298861,-0.0250796725427944,-0.011779757488679,5.67147802694738e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,42658,-0.0284763692762433,0.00524354026380279,-0.0387537081932967,-0.0181990303591898,5.70908946040919e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",40483,-0.0539115914306892,0.00994837471338096,-0.0734104058689159,-0.0344127769924626,6.11189273730552e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL13,C-C motif chemokine 13,42734,-0.0382008834665605,0.0070509920014112,-0.0520208277893264,-0.0243809391437945,6.1367557005134e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GM2A,Ganglioside GM2 activator,40269,-0.0227772651112414,0.0042103259418244,-0.0310295039572172,-0.0145250262652656,6.43877606856362e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,40332,-0.0317003340779045,0.0058600672485747,-0.0431860658851109,-0.020214602270698,6.4490315520401e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,40302,-0.0375796385986364,0.00695617927570538,-0.051213749979019,-0.0239455272182539,6.71352280036923e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MGLL,Monoglyceride lipase,42654,-0.0473125296437189,0.00876198523085269,-0.0644860206961902,-0.0301390385912476,6.78668000857697e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,40166,-0.0311750766040393,0.00577544199666166,-0.0424949429174961,-0.0198552102905824,6.88420994800797e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,42311,-0.0287693007567469,0.00533584041096269,-0.0392275479622338,-0.01831105355126,7.09995926056891e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHGB,Secretogranin-1,42664,-0.0236736583446919,0.00439469535252003,-0.0322872612356312,-0.0150600554537527,7.28997210618356e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,42311,-0.0346339614482694,0.00643144459836837,-0.0472395928610715,-0.0220283300354674,7.3653373599034e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,40080,-0.0232010262492697,0.00430954948310324,-0.031647743236152,-0.0147543092623873,7.45149350901008e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANGPT1,Angiopoietin-1,42554,-0.0461086058000973,0.00857025514136884,-0.0629063058771803,-0.0293109057230144,7.57108424594269e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,40199,-0.0167023036859251,0.00310513885682366,-0.0227883758452995,-0.0106162315265507,7.64676494333478e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSDE1,Cold shock domain-containing protein E1,40116,-0.064458379985029,0.0119862373477509,-0.0879514051866208,-0.0409653547834372,7.69996357841399e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCN4B,Sodium channel subunit beta-4,40223,-0.0243192989752811,0.00452708454681883,-0.033192384687046,-0.0154462132635162,7.94711140215009e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,42654,0.0246036711844947,0.00459142193507904,0.0156044841917398,0.0336028581772496,8.52433523977428e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IST1,IST1 homolog,40375,-0.0542352012665994,0.010121821054745,-0.0740739705338996,-0.0343964319992991,8.57028736638685e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINA6,Corticosteroid-binding globulin,40539,0.00864609291384759,0.00161544412241185,0.00547982243392037,0.0118123633937748,8.86105732395618e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,40482,-0.0226247491563724,0.00423001797957802,-0.0309155843963453,-0.0143339139163994,9.03595650838209e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSPN,Persephin,42594,-0.0508470834255001,0.00950773750012087,-0.0694822489257371,-0.0322119179252632,9.04077071144623e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SELL,L-selectin,40539,0.0131225695502343,0.00245531470568458,0.0083101527270925,0.017934986373376,9.23945420320052e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,THTPA,Thiamine-triphosphatase,40436,-0.0481556898608572,0.00901630817774644,-0.0658276538892402,-0.0304837258324742,9.4261744486107e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RBM17,Splicing factor 45,40482,-0.0417767548953561,0.00782679788715605,-0.057117278754182,-0.0264362310365303,9.59801971654936e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,40482,-0.0464762794449232,0.00870976342494273,-0.0635474157578109,-0.0294051431320354,9.67982173192261e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDCD6,Programmed cell death protein 6,42636,0.0385066650289797,0.00722467971315676,0.0243462927911924,0.0526670372667669,9.98664713718834e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HDGF,Hepatoma-derived growth factor,42700,-0.0506038004426238,0.00949982542691356,-0.0692234582793743,-0.0319841426058732,1.01554261719151e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,40116,-0.0374462339092931,0.00704609114957748,-0.0512565725624649,-0.0236358952561212,1.09075194495349e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRUNE2,Protein prune homolog 2,40302,-0.0164428616537869,0.00309777036137415,-0.0225144915620802,-0.0103712317454935,1.1299087321423e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LIF,Leukemia inhibitory factor,42311,-0.0279765566213784,0.00527273906274067,-0.0383111251843501,-0.0176419880584067,1.13951065564723e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LY6D,Lymphocyte antigen 6D,42548,-0.0222125204332061,0.0041872097861466,-0.0304194516140534,-0.0140055892523588,1.14566383695305e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,42587,-0.0624432077300888,0.0117773607856775,-0.0855268348700167,-0.0393595805901608,1.16380204172029e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,42587,-0.0247574220496451,0.00466983435965401,-0.0339102973945669,-0.0156045467047232,1.16639012891607e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,40500,-0.0258927424560004,0.00488650872838718,-0.0354702995636393,-0.0163151853483616,1.18743130114957e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BMP6,Bone morphogenetic protein 6,42342,-0.0219766495604808,0.00415889382641175,-0.0301280814602478,-0.0138252176607138,1.28234919118055e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ELOB,Elongin-B,40116,-0.0217764146780316,0.00412631797493598,-0.0298639979089061,-0.013688831447157,1.33507980531895e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPP3R1,Calcineurin subunit B type 1,42495,-0.0215273219332817,0.00408542000818841,-0.029534745149331,-0.0135198987172324,1.39080503230828e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TYMP,Thymidine phosphorylase,42563,-0.0350195038627984,0.00665553012927636,-0.04806434291618,-0.0219746648094167,1.44922976769347e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,40449,-0.0315769525041008,0.00600267291053561,-0.0433421914087506,-0.019811713599451,1.46316101446942e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42737,-0.0186679969154161,0.00355692766801189,-0.0256395751447194,-0.0116964186861128,1.55786184141848e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,S100A11,Protein S100-A11,42531,-0.0244732462508447,0.00466859876993754,-0.0336236998399223,-0.0153227926617671,1.61185674238369e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,42565,-0.0140010259438678,0.00267512541828533,-0.019244271763707,-0.00875778012402851,1.68588543012073e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C7,Complement component C7,40251,-0.0177369239922147,0.00338944063018026,-0.024380227627368,-0.0110936203570614,1.69839982104592e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AMPD3,AMP deaminase 3,40483,-0.0380491697884665,0.00727663252648028,-0.0523113695403678,-0.0237869700365651,1.73520580365692e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNX2,Sorting nexin-2,40451,-0.0441546475640353,0.00844528575030136,-0.060707407634626,-0.0276018874934447,1.74123930595268e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,40483,-0.0205431369987307,0.00393024895486063,-0.0282464249502576,-0.0128398490472039,1.7542431966818e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ICAM2,Intercellular adhesion molecule 2,42794,-0.0173651221976987,0.00332454917364779,-0.0238812385780483,-0.010849005817349,1.78355318089086e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NRP2,Neuropilin-2,42611,0.0153396870566941,0.00293793107824009,0.00958134214334354,0.0210980319700447,1.80369817781755e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HMCN2,Hemicentin-2,40269,-0.0314968909451223,0.00603334833033609,-0.043322253672581,-0.0196715282176635,1.81705848023968e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GASK1A,Golgi-associated kinase 1A,40116,-0.0232181829574121,0.00444753511563634,-0.0319353517840593,-0.0145010141307648,1.81756691964914e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,42439,-0.0155288109940179,0.00297778952588449,-0.0213652784647514,-0.00969234352328427,1.86708383774395e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACRBP,Acrosin-binding protein,40451,-0.0209890561990537,0.00402790486822964,-0.0288837497407838,-0.0130943626573236,1.91239301664988e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPXM1,Probable carboxypeptidase X1,42679,-0.0370338263396689,0.00710831437280391,-0.0509661225103645,-0.0231015301689732,1.91695452792145e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TSPAN1,Tetraspanin-1,42357,-0.0363125592613331,0.00697114545330037,-0.0499760043498018,-0.0226491141728643,1.92746857011103e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,40449,-0.0464206014508068,0.00891523886380939,-0.0638944696238732,-0.0289467332777404,1.95427250249855e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,40302,-0.0366974525848831,0.00705009023435904,-0.0505156294442268,-0.0228792757255394,1.97198969880365e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",40451,-0.0284004398928474,0.00545784689641917,-0.0390978198098289,-0.0177030599758658,1.98905892738549e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,40451,-0.0183641358303718,0.0035344617966807,-0.025291680951866,-0.0114365907088776,2.07476301640467e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,40223,-0.0297316849379482,0.00572519470131615,-0.0409530665525279,-0.0185103033233685,2.10471736753433e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPA33,Cell surface A33 antigen,42587,-0.073903608432211,0.0142363447286396,-0.101806844100345,-0.0460003727640775,2.12009174464178e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,42679,-0.0380423568569356,0.00732900616748373,-0.0524072089452037,-0.0236775047686675,2.125978457222e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYL4,Myosin light chain 4,40223,-0.0278569403968172,0.00536963594376847,-0.0383814268466034,-0.017332453947031,2.16495701637832e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CAT,Catalase,40361,-0.0289812663487148,0.0055882859652779,-0.0399343068406595,-0.0180282258567701,2.18532783346625e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRYBB1,Beta-crystallin B1,40511,-0.0338996951990514,0.00654312124216788,-0.0467242128337005,-0.0210751775644024,2.24536456796108e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,40527,0.0113031846909542,0.00218202145211064,0.00702642264481738,0.0155799467370911,2.25521953752015e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGL1,Fibrinogen-like protein 1,40532,-0.0350871949646109,0.00677502580700276,-0.0483662455463363,-0.0218081443828855,2.2702269928037e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BLVRB,Flavin reductase,42611,-0.0348106480615689,0.00672403404091197,-0.0479897547817564,-0.0216315413413814,2.28682323517745e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VNN1,Pantetheinase,40532,-0.0388114068517631,0.00749635035968544,-0.0535042535567466,-0.0241185601467797,2.28885352632353e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLTA,Clathrin light chain A,42357,-0.0252462115736782,0.00488793514964617,-0.0348265644669847,-0.0156658586803717,2.43942668414514e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,42587,-0.011476500577072,0.00222575525402735,-0.0158389808749656,-0.00711402027917839,2.55566531287815e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,40302,-0.0369566321990637,0.00718143704644372,-0.0510322488100934,-0.022881015588034,2.70451466818486e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,42711,-0.0302270243896952,0.00587583159304597,-0.0417436543120653,-0.0187103944673251,2.72282527582063e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL22,Interleukin-22,40451,-0.0370698341031001,0.00721223543362963,-0.0512058155530142,-0.022933852653186,2.79563457049196e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PF4,Platelet factor 4,40463,-0.0517223053095065,0.0100650455353826,-0.0714497945588563,-0.0319948160601566,2.81119252539507e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,40199,-0.0479023732709324,0.00935509516048331,-0.0662383597854797,-0.0295663867563851,3.09946975791458e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,40283,-0.0315599887256062,0.00616646537857234,-0.043646260867608,-0.0194737165836044,3.13958345542068e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CASP7,Caspase-7,40483,-0.0438098239211909,0.00856065959342339,-0.0605887167243008,-0.0270309311180811,3.14576194085621e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,40116,-0.0324030128487195,0.00633348459204507,-0.0448166426491279,-0.0199893830483112,3.17141564716392e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTF1,Cardiotrophin-1,42357,-0.0439853051435755,0.00860019077524272,-0.0608416790630512,-0.0271289312240997,3.19066917546616e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DPP7,Dipeptidyl peptidase 2,42551,-0.0315623716107249,0.00617428933993257,-0.0436639787169927,-0.019460764504457,3.23336847521462e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,40511,-0.036786884851131,0.00720180963962565,-0.0509024317447973,-0.0226713379574648,3.30877664324299e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCN2,Ficolin-2,42597,-0.0214113547217078,0.00420350582528613,-0.0296502261392686,-0.013172483304147,3.55931517392228e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,40449,0.0267889293873664,0.00526020367026417,0.0164789301936487,0.0370989285810842,3.58608057581677e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,40482,-0.0560293787165181,0.0110248296110129,-0.0776380447541033,-0.0344207126789329,3.79242196008557e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATXN10,Ataxin-10,42311,-0.0376129532535969,0.00740186674662654,-0.0521206120769849,-0.0231052944302089,3.7951733278297e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,42654,-0.0393132296319163,0.00774108255650624,-0.0544857514426685,-0.0241407078211641,3.85475891309221e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,42794,0.0171208860189501,0.00337431038433898,0.0105072376656457,0.0237345343722545,3.94899888432525e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,40199,-0.0416131902242624,0.00820050576122018,-0.057686181516254,-0.0255401989322709,3.94927792607935e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HPCAL1,Hippocalcin-like protein 1,42754,-0.0374564150983442,0.00739382297681991,-0.0519483081329112,-0.0229645220637771,4.11804259600528e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TBC1D23,TBC1 domain family member 23,42587,-0.0462047265249984,0.00913007822012124,-0.0640996798364361,-0.0283097732135608,4.23223434904147e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,42722,-0.0147246645406733,0.00291266510799312,-0.0204334881523398,-0.00901584092900675,4.35120653122453e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SELENOP,Selenoprotein P,40539,0.0119681579782808,0.00236888656938545,0.00732514030228533,0.0166111756542763,4.43479017803362e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NOS1,"Nitric oxide synthase, brain",42311,-0.0281077225928156,0.00556402316738535,-0.0390132080008909,-0.0172022371847403,4.4380402356493e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPL,Periplakin,40199,-0.0173230266610826,0.0034326016087179,-0.0240509258141697,-0.0105951275079955,4.56885810879801e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNTN4,Contactin-4,42611,0.012377599097869,0.00246164432260607,0.00755277622556107,0.0172024219701768,5.01538252187747e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDIA3,Protein disulfide-isomerase A3,40283,-0.0128102863626463,0.00254906640166411,-0.0178064565099079,-0.00781411621538463,5.10004017295726e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,42679,-0.0427972275812238,0.00851782817191809,-0.0594921707981833,-0.0261022843642644,5.11395603160056e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HSPB1,Heat shock protein beta-1,42448,-0.0347013570009932,0.00692159733196351,-0.0482676877716417,-0.0211350262303447,5.4142081310778e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD58,Lymphocyte function-associated antigen 3,42600,0.00911922556914531,0.00181961728878235,0.00555277568313191,0.0126856754551587,5.46627170119976e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,S100G,Protein S100-G,40482,0.0248828616897844,0.00496714281500673,0.0151472617723712,0.0346184616071976,5.53998402491076e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,42587,-0.0286936264832321,0.00573719239367049,-0.0399385235748262,-0.0174487293916379,5.76553587892514e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,42346,-0.0431821576421477,0.00863844455973517,-0.0601135089792286,-0.0262508063050668,5.8420155191955e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPQ,Carboxypeptidase Q,40516,-0.0183312346326392,0.00366813500330954,-0.0255207792391259,-0.0111416900261525,5.89689720098432e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DOK1,Docking protein 1,40483,-0.0691180953963727,0.0139093998610607,-0.0963805191240517,-0.0418556716686936,6.82281441788792e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,40199,-0.0255267679683478,0.00514241028358315,-0.0356058921241708,-0.0154476438125248,7.01017531050497e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSNK1D,Casein kinase I isoform delta,40199,-0.0321093631077568,0.0064725513336995,-0.0447955637218078,-0.0194231624937058,7.12341604203512e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,42521,-0.0293801617834438,0.00592872146103276,-0.041000455847068,-0.0177598677198195,7.30062494848122e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GGH,Gamma-glutamyl hydrolase,42437,-0.0173492609060259,0.00350428244528797,-0.0242176544987903,-0.0104808673132615,7.47906470835545e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPHA4,Ephrin type-A receptor 4,40283,-0.0148872268906752,0.00300812383373768,-0.0207831496048011,-0.00899130417654934,7.56892898815974e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAGED1,Melanoma-associated antigen D1,42346,-0.0244891233939953,0.0049509015835702,-0.0341928904977929,-0.0147853562901977,7.65338896251877e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COL2A1,Collagen alpha-1(II) chain,40223,-0.0410133022899763,0.00830717167723674,-0.0572953587773603,-0.0247312458025923,8.04554619184293e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CASP1,Caspase-1,42311,-0.03492737996363,0.00708640909229013,-0.0488167417845187,-0.0210380181427414,8.37539964181263e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD2,T-cell surface antigen CD2,40116,-0.019541062109478,0.00396998653826871,-0.0273222357244847,-0.0117598884944713,8.68278353211316e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",40511,-0.0450080514628095,0.00916084462359348,-0.0629633069250527,-0.0270527960005663,9.09072778931546e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SDHB,Succinate dehydrogenase,40449,-0.0335446776992176,0.00682784343901541,-0.0469272508396878,-0.0201621045587474,9.09908455718675e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANXA1,Annexin A1,40235,-0.0210544662571088,0.00428565115832669,-0.0294543425274291,-0.0126545899867884,9.1081798104608e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GIMAP7,GTPase IMAP family member 7,40283,0.0161297833101183,0.00328329128907661,0.00969453238352817,0.0225650342367085,9.1119734367479e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGAM,Integrin alpha-M,42611,0.0158595912315858,0.00323739650783842,0.00951429407622253,0.0222048883869491,9.75128648958308e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,42587,0.0331818129464414,0.00678472967843376,0.0198837427767112,0.0464798831161715,1.01664838245218e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,40457,-0.0190045864997115,0.00389801068307662,-0.0266446874385417,-0.0113644855608813,1.10038620950012e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BGN,Biglycan,42328,0.060083660495718,0.0123266532181571,0.0359234201881301,0.0842439008033059,1.10477906495481e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,40199,-0.0103997689130429,0.00213536447910101,-0.0145850832920808,-0.00621445453400488,1.13005703806462e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,40223,-0.0247970034125439,0.00509176406297574,-0.0347768609759763,-0.0148171458491114,1.13135143451218e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLAU,Urokinase-type plasminogen activator,42611,0.0146821460065403,0.00301668124544774,0.00876945076546269,0.0205948412476178,1.14601874926316e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIFBP,KIF-binding protein,42587,-0.0405504840551721,0.00833214069750994,-0.0568814798222915,-0.0242194882880526,1.14738286079103e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMEM106A,Transmembrane protein 106A,40451,-0.0349482787508694,0.00719355249958064,-0.0490476416500475,-0.0208489158516914,1.2000666916679e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TK1,"Thymidine kinase, cytosolic",40302,-0.0227078817536034,0.00467811717272898,-0.0318769914121522,-0.0135387720950546,1.22602875847811e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,40223,-0.0261260889717355,0.00538499037239439,-0.0366806701016285,-0.0155715078418424,1.24113864577847e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,42346,-0.0217602048308728,0.00448742841222669,-0.0305555645188371,-0.0129648451429084,1.25411524695067e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STX16,Syntaxin-16,42346,-0.0287282224864592,0.00592748466615604,-0.040346092432125,-0.0171103525407933,1.27021278952326e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NID2,Nidogen-2,42611,-0.0366158036299187,0.00755599129038705,-0.0514255465590773,-0.0218060607007601,1.27429701031946e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",40223,-0.0241674097546929,0.00499707757755332,-0.0339616818066974,-0.0143731377026884,1.340603197929e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,40182,-0.0340946302086638,0.00705757811814229,-0.0479274833202227,-0.0202617770971049,1.3773609445303e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,40283,-0.0408123801182111,0.00846059844137296,-0.0573951530633021,-0.0242296071731201,1.42710938539612e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL18,C-C motif chemokine 18,42477,-0.0344181211809305,0.00714250816257871,-0.0484174371795848,-0.0204188051822762,1.46041258040678e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,42613,-0.0234552034393573,0.004872231224233,-0.033004776638854,-0.0139056302398606,1.49508342089679e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SAFB2,Scaffold attachment factor B2,40482,-0.0136035602755369,0.00282808932507735,-0.0191466153526885,-0.00806050519838529,1.52760118774172e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,40182,-0.0239353730089813,0.00497884372841068,-0.0336939067166662,-0.0141768393012963,1.54920443277183e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TXN,Thioredoxin,40384,-0.0220414748405436,0.00458913373331721,-0.0310361769578453,-0.0130467727232419,1.58356259388698e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GBP4,Guanylate-binding protein 4,42311,-0.0242611029959852,0.00506270619075923,-0.0341840071298733,-0.0143381988620971,1.66835570549e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STX6,Syntaxin-6,42346,-0.0324640923335863,0.00677782817326977,-0.045748635553195,-0.0191795491139775,1.68812250437954e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNR,Tenascin-R,42495,0.0207555862228495,0.00433479764646678,0.0122593828357746,0.0292517896099243,1.70153825473985e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,40511,-0.0134618535305661,0.0028125721939985,-0.0189744950308032,-0.00794921203032907,1.72021492987279e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",40511,-0.0258315878609749,0.0053969800048528,-0.0364096686704864,-0.0152535070514635,1.72029862039882e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIF1C,Kinesin-like protein KIF1C,40116,-0.0177096469128756,0.00370048397660648,-0.0249625955070243,-0.0104566983187269,1.72569687679905e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UNC79,Protein unc-79 homolog,40080,-0.0273583848444917,0.00572163357467684,-0.0385727866508583,-0.0161439830381251,1.76211834992356e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VCAN,Versican core protein,42711,0.0149402587936103,0.00312760386198481,0.00881015522412005,0.0210703623631005,1.79885910137619e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C7orf50,Uncharacterized protein C7orf50,40483,-0.0111433098516644,0.0023374800265817,-0.0157247707037645,-0.00656184899956423,1.89106761621767e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,40116,-0.0338198424227045,0.00709471035701168,-0.0477254747224474,-0.0199142101229616,1.89487942808166e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EDF1,Endothelial differentiation-related factor 1,40482,-0.0328021003675959,0.0068829763399222,-0.0462927339938434,-0.0193114667413484,1.90560572455282e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD300LF,CMRF35-like molecule 1,42721,-0.0296983679934771,0.00623648033140334,-0.0419218694430277,-0.0174748665439266,1.936333271806e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NRGN,Neurogranin,40532,-0.0444727565594916,0.00934059559664948,-0.0627803239289246,-0.0261651891900586,1.94794332130265e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CILP,Cartilage intermediate layer protein 1,40527,-0.0269601986870815,0.00567139215526331,-0.0380761273113976,-0.0158442700627654,2.02166996324166e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,40116,-0.0267802136502877,0.0056492178110645,-0.0378526805599741,-0.0157077467406013,2.15866642011273e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,42357,-0.0302594913578528,0.00639416613615627,-0.0427920569847191,-0.0177269257309865,2.24234230927365e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GMFG,Glia maturation factor gamma,40511,-0.0346451485477622,0.00732675235057213,-0.0490055831548835,-0.0202847139406408,2.28822967007294e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,42311,-0.024483124093779,0.00517859824693545,-0.0346331766577725,-0.0143330715297855,2.29381613522778e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPING1,Plasma protease C1 inhibitor,40516,0.00889723041587804,0.00188278518629809,0.00520697145073378,0.0125874893810223,2.32234734813871e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPME1,Protein phosphatase methylesterase 1,42587,-0.0288174426038006,0.00610238603369558,-0.0407781192298439,-0.0168567659777573,2.35529845232145e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,42587,-0.0220180251699481,0.00466635471612235,-0.0311640804135479,-0.0128719699263483,2.4003485718663e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANXA3,Annexin A3,42681,-0.0334196425915477,0.00708478120688433,-0.0473058137570409,-0.0195334714260544,2.41625592037096e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",40483,-0.0508923407254692,0.0108102601967271,-0.0720804507110544,-0.0297042307398841,2.53407289942388e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EGF,Pro-epidermal growth factor,42597,-0.0493799344821489,0.010490733956292,-0.0699417730364812,-0.0288180959278165,2.53898932557936e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,40451,-0.0235211811048749,0.00501149941390332,-0.0333437199561254,-0.0136986422536244,2.71814481879652e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,42346,-0.0278950153987648,0.00594565622727882,-0.0395485016042312,-0.0162415291932983,2.73722750267138e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PCDHB15,Protocadherin beta-15,40451,-0.0194563203358231,0.00415145921940755,-0.0275931804058619,-0.0113194602657843,2.81008362388926e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STC2,Stanniocalcin-2,42591,-0.0119330767602944,0.00254676302447939,-0.016924732288274,-0.00694142123231483,2.81906677059816e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,XRCC4,DNA repair protein XRCC4,42311,-0.0176720310602599,0.00377465029131649,-0.0250703456312403,-0.0102737164892796,2.87262503745632e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PADI4,Protein-arginine deiminase type-4,42292,-0.0344894346019933,0.00736977310864232,-0.0489341898949323,-0.0200446793090544,2.89960001741048e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NPPB,Natriuretic peptides B,42357,-0.0680090075947092,0.0145399886348598,-0.0965073853190344,-0.0395106298703841,2.93457894160301e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,40451,-0.0265017608693056,0.00566895258449179,-0.0376129079349095,-0.0153906138037017,2.97519105736814e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,42658,0.031178569649908,0.00667230112813774,0.0181008594387581,0.044256279861058,2.99946433047313e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRND,Prion-like protein doppel,40483,-0.0251507869327324,0.00538627590309715,-0.0357078877028028,-0.014593686162662,3.05532902789261e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,42794,-0.0130939616933467,0.00281102563561051,-0.0186035719391433,-0.00758435144755012,3.2220726655494e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL34,Interleukin-34,42292,-0.0174703899613736,0.0037515343787573,-0.0248233973437379,-0.0101173825790093,3.24215846154632e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,40451,-0.0196662416629182,0.00422315918036289,-0.0279436336564295,-0.011388849669407,3.24898698523027e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LYZL2,Lysozyme-like protein 2,40080,-0.0172359275632861,0.00371003172532078,-0.0245075897449148,-0.00996426538165735,3.42794985076936e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC39A14,Zinc transporter ZIP14,42311,-0.016439484319146,0.00354097922389412,-0.0233798035979785,-0.00949916504031355,3.47325150037683e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",42594,-0.0385885809828355,0.0083146778148127,-0.0548853494998684,-0.0222918124658026,3.4998136933344e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APOL1,Apolipoprotein L1,40532,0.027790784955694,0.00599762369202198,0.0160354425193309,0.0395461273920571,3.63308212946452e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,40532,-0.0129936515121589,0.0028118022682974,-0.0185047839580218,-0.00748251906629595,3.85898949301302e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHGA,Chromogranin-A,40527,-0.0464427874382751,0.0100636845844755,-0.0661676092238471,-0.0267179656527032,3.97622197403256e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LUZP2,Leucine zipper protein 2,40451,-0.0218373136258194,0.00473407634960025,-0.0311161032710359,-0.012558523980603,4.01676601201405e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NID1,Nidogen-1,42652,-0.0180818278071144,0.00392838398498831,-0.0257814604176915,-0.0103821951965373,4.20525469440628e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,40302,-0.0348938938912817,0.00758520631059141,-0.0497608982600409,-0.0200268895225225,4.26639377686412e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,40255,0.0229407531729967,0.00499265163735398,0.0131551559637829,0.0327263503822105,4.37737824663029e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GNLY,Granulysin,42611,-0.0251455482529465,0.00547942955219977,-0.035885230175258,-0.0144058663306349,4.49237418033103e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PARD3,Partitioning defective 3 homolog,40302,-0.0350588612915398,0.00764149978253068,-0.0500362008652999,-0.0200815217177797,4.52508907887698e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,40482,0.0211203424875975,0.00460584889133978,0.0120928786605716,0.0301478063146235,4.57665177434634e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPCAM,Epithelial cell adhesion molecule,42616,-0.0464387599317752,0.0101320570447878,-0.0662975917395593,-0.0265799281239911,4.61713440321998e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MATN2,Matrilin-2,42638,-0.0138637930751302,0.00303179086623946,-0.0198061031729595,-0.00792148297730083,4.85529891666659e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD276,CD276 antigen,42618,-0.0172130085070489,0.00376436235581908,-0.0245911587244543,-0.00983485828964349,4.85962124324446e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DAPK2,Death-associated protein kinase 2,40199,-0.0254713829893859,0.00557355397905146,-0.0363955487883267,-0.014547217190445,4.9293223829257e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,40451,-0.0441188875402212,0.00965690226690563,-0.0630464159833562,-0.0251913590970861,4.96122740304841e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRDX1,Peroxiredoxin-1,42261,0.041699562979295,0.00913576122116276,0.023793470985816,0.059605654972774,5.05415585938086e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,40302,-0.0357222099708278,0.00783559426031459,-0.0510799747210444,-0.0203644452206112,5.19553197563661e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,40080,-0.0306683743332003,0.00672928184364546,-0.0438577667467454,-0.0174789819196552,5.23419681480708e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TGFBR1,TGF-beta receptor type-1,40199,-0.0101411554955004,0.0022293643677828,-0.0145107096563547,-0.00577160133464612,5.45037922548802e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,42346,-0.0242936499420709,0.00534802177892946,-0.0347757726287726,-0.0138115272553692,5.60724804976359e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AHNAK2,Protein AHNAK2,40223,-0.0140825286592942,0.00311085020443979,-0.0201797950599962,-0.00798526225859218,6.04802566956587e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IFNGR1,Interferon gamma receptor 1,42676,-0.0101658992690404,0.00224643037034914,-0.0145689027949247,-0.0057628957431561,6.08092198187187e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,40483,-0.0218287881856521,0.00482511324761206,-0.0312860101509717,-0.0123715662203324,6.1302531135434e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,40283,-0.0577775292708813,0.012782511125219,-0.0828312510763105,-0.0327238074654522,6.24667150760253e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,40283,-0.0328007083392886,0.00726060202057042,-0.0470314882996067,-0.0185699283789706,6.31821756228848e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,40527,-0.0136403001074804,0.00302270916588865,-0.0195648100726222,-0.00771579014233868,6.46802180547546e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNPY4,Protein canopy homolog 4,42587,-0.0340260574321825,0.00755212898842161,-0.0488282302494889,-0.0192238846148762,6.6779763989122e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",40223,-0.0422955445498063,0.00939456405582192,-0.0607088900992173,-0.0238821990003953,6.79658930922313e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BCL2L1,Bcl-2-like protein 1,40483,-0.0456473883028891,0.0101530549186616,-0.0655473759434659,-0.0257474006623124,6.99579565499183e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MICALL2,MICAL-like protein 2,40182,-0.0317154805211173,0.00706167198685155,-0.0455563576153463,-0.0178746034268883,7.15405575755464e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMS,Spermine synthase,40136,-0.0294860924368565,0.00656821265203216,-0.0423597892348395,-0.0166123956388734,7.2218338351408e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",40449,-0.0404596463196907,0.00901561741283127,-0.05813025644884,-0.0227890361905415,7.27009937947857e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,40511,0.0148462434140538,0.00330936819203258,0.00835988175767,0.0213326050704377,7.32447620420056e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PZP,Pregnancy zone protein,40539,-0.0235240237487147,0.00524444719854613,-0.0338031402578651,-0.0132449072395643,7.3454405423643e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL10,Interleukin-10,42370,-0.0389855297609846,0.00869663133435579,-0.056030927176322,-0.0219401323456473,7.4280793599729e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TBC1D17,TBC1 domain family member 17,42311,-0.0207976763311168,0.00464791668882111,-0.0299075930412062,-0.0116877596210274,7.71904506386693e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MESD,LRP chaperone MESD,42611,-0.0548104470531919,0.0122644857879771,-0.078848839197627,-0.0307720549087568,7.92157888979146e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NTF3,Neurotrophin-3,42594,-0.016384316462817,0.00366816202834647,-0.0235739140383761,-0.00919471888725795,8.01122053313735e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,40136,-0.0453425365369132,0.0101721731038904,-0.0652799958205384,-0.0254050772532879,8.37431678022145e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,40511,-0.0130095117528397,0.00292252395766389,-0.0187376587098609,-0.00728136479581851,8.61026829663292e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,40302,-0.0415962706614392,0.00934733630716428,-0.0599170498234812,-0.0232754914993972,8.667949396403e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42676,-0.0261846967759112,0.00589356305710551,-0.037736080367838,-0.0146333131839844,8.94485654703654e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,40451,-0.0252100501083416,0.00567507166151427,-0.0363331905649096,-0.0140869096517736,8.98753464158007e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,40527,-0.0168762560078961,0.00380113359928327,-0.0243264778624913,-0.00942603415330093,9.0896127000185e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,42558,-0.0159465508716593,0.00359457563461417,-0.0229919191155031,-0.00890118262781558,9.22575319351644e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CASP3,Caspase-3,42794,-0.0392784344924244,0.0088610801095811,-0.0566461515072033,-0.0219107174776455,9.37926240687239e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNASE3,Eosinophil cationic protein,42578,-0.0496311390339186,0.0112696621325446,-0.0717196768137061,-0.0275426012541312,1.07117519072079e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,42439,0.0268998780526473,0.00612110362105301,0.0149025149553834,0.0388972411499112,1.11833744436087e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDK1,Cyclin-dependent kinase 1,40080,-0.0167017049408536,0.00380202052362883,-0.0241536651671661,-0.00924974471454108,1.12932277723703e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,42582,-0.0121605910109803,0.00277388616030381,-0.0175974078851758,-0.00672377413678488,1.17432593426341e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEMA3G,Semaphorin-3G,40283,-0.0202327612521992,0.00461897620058902,-0.0292859546053537,-0.0111795678990447,1.19573263793366e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,40182,-0.0281765756804693,0.00643418628469479,-0.0407875807984711,-0.0155655705624675,1.20219463932232e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,42587,-0.0169721228020489,0.00387681690688627,-0.024570683939546,-0.0093735616645518,1.20764374540279e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MILR1,Allergin-1,42370,-0.0230374258853965,0.00527181776190485,-0.03337018869873,-0.0127046630720629,1.25242764093981e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MKI67,Proliferation marker protein Ki-67,40199,-0.0174510627950336,0.00399430399461163,-0.0252798986244724,-0.00962222696559478,1.25967472303329e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,42679,0.0200404334965926,0.00459587801096936,0.0110325125950927,0.0290483543980926,1.30713859154946e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXCL1,Growth-regulated alpha protein,42607,-0.0425962640785317,0.00978072907459285,-0.0617664930647337,-0.0234260350923297,1.3397988473447e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",40482,-0.0212129459411472,0.00487128119432076,-0.0307606570820158,-0.0116652348002785,1.34427072319382e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",42495,-0.0261446505136183,0.00601055547036228,-0.0379253392355283,-0.0143639617917082,1.37283195599594e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,40482,-0.0359361577968186,0.00826131685652744,-0.0521283388356124,-0.0197439767580248,1.3737622675976e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,40283,-0.038476563847305,0.00885347429369718,-0.0558293734629515,-0.0211237542316585,1.39923313370186e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FST,Follistatin,42654,0.021857371173361,0.00503401419399018,0.0119907033531402,0.0317240389935817,1.42264412293261e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OPTC,Opticin,42587,0.0205892141974787,0.00475043814992831,0.0112783554236192,0.0299000729713382,1.47377358198488e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,40429,-0.0384976544094423,0.00888275717322948,-0.0559078584689721,-0.0210874503499125,1.47714241168302e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GFRAL,GDNF family receptor alpha-like,40109,0.0280082875669668,0.00647477630284269,0.0153177260133952,0.0406988491205385,1.53362647704341e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,42292,-0.0190480246803626,0.00440668044684035,-0.0276851183561697,-0.0104109310045555,1.55386419797047e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRYM,Ketimine reductase mu-crystallin,40136,-0.0337655993570308,0.00781141529088499,-0.0490759733271654,-0.0184552253868962,1.55567064204948e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",42636,0.0350538662657506,0.00811165504420415,0.0191550223791104,0.0509527101523907,1.56142632766462e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,40182,-0.0269615295027958,0.00625258793271688,-0.0392166018509209,-0.0147064571546707,1.63152232415905e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,42346,-0.0326087120348044,0.00756375191327895,-0.0474336657848312,-0.0177837582847777,1.6356617938505e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,40451,-0.0476153877048637,0.0110473027697278,-0.0692681011335302,-0.0259626742761973,1.64540460266173e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MERTK,Tyrosine-protein kinase Mer,42754,-0.0112423949143435,0.00261556604321768,-0.0163689043590501,-0.00611588546963682,1.73342047966348e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DCTD,Deoxycytidylate deaminase,40283,-0.0415346643430256,0.00966368916849253,-0.060475495113271,-0.0225938335727803,1.73807205326685e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HBQ1,Hemoglobin subunit theta-1,42721,0.0265131203899358,0.00617118552620164,0.0144175967585806,0.038608644021291,1.74903873429596e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UROS,Uroporphyrinogen-III synthase,40182,-0.0300052809276882,0.00698697174117233,-0.043699745540386,-0.0163108163149904,1.76622028282129e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,XG,Glycoprotein Xg,42734,-0.0151660283222561,0.00353374051083816,-0.0220921597234989,-0.00823989692101332,1.78480244936851e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,42603,-0.0132706466859248,0.00309311314909347,-0.019333148458148,-0.00720814491370158,1.7961366273614e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIF22,Kinesin-like protein KIF22,40116,-0.0551074525201654,0.0128484451136527,-0.0802904049429247,-0.0299245000974061,1.80992941497988e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,40080,-0.0352342088795501,0.00822910346842829,-0.0513632516776696,-0.0191051660814307,1.87095797722552e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACTA2,"Actin, aortic smooth muscle",42357,-0.0193074559109339,0.00451781833017601,-0.0281623798380789,-0.0104525319837889,1.93674273454039e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PCDH12,Protocadherin-12,40482,-0.0113462235409745,0.00265646484827762,-0.0165528946435986,-0.00613955243835033,1.96038824205747e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MIA,Melanoma-derived growth regulatory protein,42679,-0.016467557989355,0.00386036343665353,-0.024033870325196,-0.00890124565351413,2.00540656705369e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NEFL,Neurofilament light polypeptide,42262,-0.0202259078486626,0.00474713205966026,-0.0295302866855967,-0.0109215290117284,2.05253167035787e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SATB1,DNA-binding protein SATB1,40482,-0.0128327392143882,0.00301601538842494,-0.0187441293757011,-0.00692134905307528,2.10862839283062e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,42664,-0.0513513529311096,0.0121273414599434,-0.0751209421925986,-0.0275817636696205,2.30739350791754e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,40199,-0.0175512374613245,0.00414905129381089,-0.0256833779971938,-0.00941909692545513,2.35393857324311e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,42594,-0.0350687292351725,0.00829669170485659,-0.0513302449766915,-0.0188072134936536,2.38573755682492e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,40449,-0.0411625091715798,0.00974149673571192,-0.0602558427735752,-0.0220691755695845,2.40310242461062e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SUSD5,Sushi domain-containing protein 5,40235,0.0151505581201312,0.00359112341630869,0.00811195622416613,0.0221891600160962,2.47467910459867e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LACRT,Extracellular glycoprotein lacritin,40419,-0.0223511634702758,0.00530998159252624,-0.0327587273916272,-0.0119435995489244,2.58188616357945e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,42656,-0.0400284569328558,0.00951259407207507,-0.0586731413141229,-0.0213837725515887,2.59376126811028e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42611,-0.0153159487287648,0.00364016192470526,-0.0224506661011871,-0.00818123135634248,2.59900584025501e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",42346,-0.0214744285768737,0.00510508216426678,-0.0314803896188366,-0.0114684675349108,2.6109742223633e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,40223,0.00908497580796845,0.00216218878569139,0.00484708578801333,0.0133228658279236,2.66945221880421e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HMBS,Porphobilinogen deaminase,42721,-0.0185640676438414,0.00441884568513211,-0.0272250051867004,-0.00990313010098249,2.67309629004423e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PADI2,Protein-arginine deiminase type-2,42370,-0.0239458759921462,0.00570308504467545,-0.0351239226797101,-0.0127678293045823,2.70145526108543e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDH5,Cadherin-5,42794,0.0129658417505018,0.0030886572357203,0.00691207356848997,0.0190196099325135,2.71127153680148e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,42587,-0.0168733030286603,0.00402175725330308,-0.0247559472451343,-0.00899065881218626,2.74018429106608e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LXN,Latexin,42461,0.0290533280973785,0.00692682458621754,0.0154767519083921,0.0426299042863649,2.75468097499212e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPR15L,Protein GPR15L,40449,-0.0262561894033115,0.00626151316472004,-0.0385287552061628,-0.0139836236004602,2.77071736454181e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NEDD9,Enhancer of filamentation 1,40199,-0.0143842329160933,0.00343385842084805,-0.0211145954209555,-0.0076538704112311,2.82443950665384e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STX3,Syntaxin-3,40483,-0.0167156751200472,0.00399288287212913,-0.0245417255494203,-0.00888962469067407,2.85604013240938e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",42357,-0.0395543878848104,0.0094545963099818,-0.0580853966523747,-0.021023379117246,2.88771018525163e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPSAB1,Tryptase alpha/beta-1,42741,-0.0223662845525264,0.00536598207944372,-0.0328836094282361,-0.0118489596768167,3.08972987946964e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRTN3,Myeloblastin,42276,-0.0207894324109473,0.00499222086662632,-0.0305741853095349,-0.0110046795123597,3.14221575806625e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,42357,-0.015016966989557,0.00360799016057131,-0.0220886277042768,-0.00794530627483726,3.17281363558882e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,42370,-0.0279494436270619,0.00672485154707073,-0.0411301526593205,-0.0147687345948033,3.25710582577645e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,42618,-0.126406752347388,0.0304254898147498,-0.186040712384298,-0.0667727923104783,3.27827383844011e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,INSL4,Early placenta insulin-like peptide,40451,-0.0208445712731943,0.00501923210860586,-0.0306822662060618,-0.0110068763403268,3.30651690653128e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNX18,Sorting nexin-18,40449,-0.0187105044793531,0.00451422186463864,-0.0275583793340448,-0.00986262962466136,3.42615100321464e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,42636,-0.0489049424581807,0.0118289321068607,-0.0720896493876276,-0.0257202355287337,3.58121877472573e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STK4,Serine/threonine-protein kinase 4,42636,-0.0361962858043467,0.00876550338669234,-0.0533766724422637,-0.0190158991664297,3.65906064551492e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRSS27,Serine protease 27,42603,-0.0170475638684343,0.00413440892973434,-0.0251510053707136,-0.00894412236615503,3.75671203863377e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANXA11,Annexin A11,42570,-0.027965822051844,0.00679082375270506,-0.0412758366071459,-0.0146558074965421,3.84174567121436e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,40451,-0.0122333062870673,0.00297103550737866,-0.0180565358815295,-0.00641007669260516,3.85701138898041e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,42594,-0.0139012447270786,0.00338078100354936,-0.0205275754940354,-0.00727491396012191,3.94852221799653e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL8,C-C motif chemokine 8,42706,-0.0253657264256193,0.0061795326865772,-0.0374776104913106,-0.013253842359928,4.07048258761715e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,40449,-0.0477066448528967,0.0116270811237018,-0.0704957238553523,-0.0249175658504412,4.10589303207947e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAB37,Ras-related protein Rab-37,42370,-0.0339212177486357,0.00827174215682384,-0.0501338323760104,-0.0177086031212609,4.14097482695469e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,40223,-0.0141467437564176,0.00345141762646846,-0.0209115223042957,-0.00738196520853937,4.18234095721399e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRADD,Death domain-containing protein CRADD,42476,-0.0311541418579465,0.00761813968457376,-0.0460856956397111,-0.0162225880761819,4.34911138031327e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRSS53,Serine protease 53,40483,0.0157021879420344,0.00383957286267681,0.0081766251311878,0.0232277507528809,4.35178717383757e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,42495,0.0500333128860328,0.0122353220203169,0.0260520817262116,0.0740145440458539,4.35313296572925e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,42495,-0.025795976671703,0.00631771816844668,-0.0381787042818585,-0.0134132490615475,4.46957913394811e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,40482,-0.0415226095173423,0.0101813825371734,-0.0614781192902021,-0.0215670997444825,4.56800438532712e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,42721,0.0111085487218979,0.00272654813782042,0.00576451437176988,0.0164525830720259,4.64328277546138e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MB,Myoglobin,42794,-0.0221692981472174,0.00544438239764185,-0.0328402876465954,-0.0114983086478394,4.68835116327194e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,42346,-0.0277034414729902,0.00680703523244189,-0.0410452305285763,-0.0143616524174041,4.73234472227251e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AKAP12,A-kinase anchor protein 12,40283,0.00924150018287246,0.00227478156080113,0.00478292832370226,0.0137000720420427,4.88659087478797e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BTD,Biotinidase,40539,-0.00854398792940729,0.00211544095517254,-0.0126902522015455,-0.00439772365726911,5.40632507637425e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,40199,-0.0154022134206156,0.00381597423728735,-0.0228815229256988,-0.00792290391553238,5.46808406421866e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCRN1,Secernin-1,42594,-0.0227068918274337,0.00563764805079972,-0.0337566820070011,-0.0116571016478662,5.66298671664446e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CERT,Ceramide transfer protein,42311,-0.025143875873313,0.00624811174706461,-0.0373901748975596,-0.0128975768490664,5.74815112026489e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GRK5,G protein-coupled receptor kinase 5,42357,-0.0209670086387699,0.00521162574632553,-0.031181795101568,-0.0107522221759719,5.7752590752956e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,42346,-0.022386419319782,0.00557685305825474,-0.0333170513139613,-0.0114557873256027,5.99869874273888e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RCC1,Regulator of chromosome condensation,40451,-0.0217045289253529,0.00540869635402729,-0.0323055737792464,-0.0111034840714594,6.03670045385912e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,42346,-0.0402535917539079,0.0100380493187194,-0.059928168418598,-0.0205790150892178,6.10281140484452e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HLA_DRA,,42549,-0.0151244442229784,0.00377765130187509,-0.0225286407746535,-0.00772024767130318,6.27063785651756e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CST1,Cystatin-SN,39042,-0.0453855545511482,0.0113562111129311,-0.0676437283324932,-0.0231273807698031,6.47434857410044e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,40470,-0.0168039314170057,0.00421424365682026,-0.0250638489843734,-0.00854401384963803,6.72190260283386e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DBN1,Drebrin,40199,-0.0204973353342592,0.00514122616587574,-0.0305741386193756,-0.0104205320491427,6.73868759578017e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEPTIN9,Septin-9,42587,-0.011586202757134,0.00291360179394594,-0.017296862273268,-0.00587554324099994,7.02776640896003e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,40223,-0.0248573647858904,0.00625060229767195,-0.0371085452893274,-0.0126061842824534,7.02963479590977e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GZMB,Granzyme B,42594,-0.0269808222140242,0.0067852517977186,-0.0402799157375527,-0.0136817286904957,7.03361637426464e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,40482,-0.0159865651117436,0.00402316563723042,-0.0238719697607153,-0.00810116046277203,7.1226283120189e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,42311,-0.0296877784735571,0.00747473194277145,-0.0443382530813892,-0.0150373038657251,7.17272040306906e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLK10,Kallikrein-10,42636,-0.0164881874995088,0.00415946297164124,-0.0246407349239256,-0.00833564007509193,7.40798976832601e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,40116,-0.0186390989933269,0.00470470074558722,-0.0278603124546778,-0.00941788553197593,7.48586693283253e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,40223,-0.0297560958044357,0.00751536122371076,-0.0444862038029088,-0.0150259878059626,7.56196943418076e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSF3,Granulocyte colony-stimulating factor,42370,-0.0197696229796697,0.00500029358720803,-0.0295701984105975,-0.00996904754874197,7.73565282476229e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AHCY,Adenosylhomocysteinase,42636,-0.0271519107135949,0.00687243666282769,-0.0406218865727372,-0.0136819348544526,7.82746360398533e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OBP2B,Odorant-binding protein 2b,42462,0.0247993984029439,0.0062811260532107,0.0124883913386509,0.0371104054672369,7.9134074467047e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MPI,Mannose-6-phosphate isomerase,42587,-0.0340203759142781,0.00862400708121157,-0.0509234297934527,-0.0171173220351034,8.0258543036953e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PMVK,Phosphomevalonate kinase,42303,-0.0434452088000063,0.0110412339271476,-0.0650860272972157,-0.021804390302797,8.36904784633769e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HEPACAM2,HEPACAM family member 2,40483,0.0170243469071182,0.00433588809290398,0.00852600624502638,0.02552268756921,8.6746241054065e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SOD3,Extracellular superoxide dismutase,40532,0.0236712655123991,0.00603205595809293,0.011848435834537,0.0354940951902612,8.75159974856435e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CFB,Complement factor B,40344,-0.0130529844638616,0.00332885165565668,-0.0195775337089487,-0.00652843521877445,8.86487052099319e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AGT,Angiotensinogen,40532,-0.00959596094927369,0.00246615596444355,-0.0144296266395831,-0.00476229525896433,0.000100378050447209
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",40451,-0.0150732168099412,0.00387917305912117,-0.0226763960058187,-0.00747003761406368,0.000102629515500153
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,40483,-0.0282082654557655,0.00727446108410442,-0.0424662091806101,-0.0139503217309208,0.000106041269176718
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DGCR6,Protein DGCR6,40136,-0.0177117693556222,0.00457283781669647,-0.0266745314763472,-0.00874900723489708,0.000108016653363905
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD84,SLAM family member 5,42594,-0.0123883436925722,0.00320105114839902,-0.0186624039434343,-0.00611428344171014,0.000109312585007441
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HSBP1,Heat shock factor-binding protein 1,40223,-0.0375753353208387,0.00972723088860473,-0.056640707862504,-0.0185099627791735,0.000112689145055559
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCT,Secretin,40182,-0.0198236763735139,0.00514348835830799,-0.0299049135557976,-0.00974243919123024,0.000116802714386539
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,42346,-0.0227251158866134,0.00589688868503929,-0.0342830177092905,-0.0111672140639364,0.000116876756764878
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C2orf69,UPF0565 protein C2orf69,40182,-0.0241696627618296,0.00627231511825507,-0.0364634003936095,-0.0118759251300496,0.000117157340195395
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,40302,-0.0416172892473367,0.0108015390397413,-0.0627883057652297,-0.0204462727294438,0.000117381837806183
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,40483,-0.0186391877497376,0.00484478423748487,-0.0281349648552079,-0.00914341064426724,0.00012009920286788
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,42346,-0.0332162244669118,0.00863556392701624,-0.0501419297638636,-0.0162905191699599,0.000120409386695123
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAMA4,Laminin subunit alpha-4,42676,-0.0130469291124462,0.00339318227262838,-0.0196975663667978,-0.00639629185809453,0.000121085746482493
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,42636,-0.0193310575103927,0.00503746858469766,-0.0292044959364001,-0.00945761908438526,0.000124885061371086
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PKN3,Serine/threonine-protein kinase N3,40302,-0.029381344451591,0.00769171366269455,-0.0444571032304723,-0.0143055856727097,0.000134249106425917
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,QSOX1,Sulfhydryl oxidase 1,40342,-0.0170517902765356,0.00446633330097792,-0.0258058035464523,-0.00829777700661885,0.000135348602556906
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,40482,-0.0115853556788187,0.00303507780494739,-0.0175341081765156,-0.00563660318112184,0.000135721897407064
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEMA4D,Semaphorin-4D,42711,-0.0116432074777323,0.00305121348210624,-0.0176235859026605,-0.00566282905280403,0.000136277144516216
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXCL12,Stromal cell-derived factor 1,42370,0.0156882666335704,0.00411585943857241,0.00762118213396844,0.0237553511331723,0.000138663587726178
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,42346,-0.0294596467354465,0.00772896798499522,-0.0446084239860371,-0.0143108694848559,0.000138706065583598
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,40428,-0.0270019155970476,0.0071038550862306,-0.0409254715660596,-0.0130783596280356,0.000144861382258765
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PROCR,Endothelial protein C receptor,40116,0.0136897015808893,0.00360192865541642,0.00662992141627312,0.0207494817455055,0.000145095978611123
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PKD1,Polycystin-1,40511,-0.0104767159976675,0.00276217095892341,-0.0158905710771574,-0.00506286091817763,0.000149655848803024
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PALM,Paralemmin-1,40384,-0.0122902723731932,0.00324596052768511,-0.018652355007456,-0.00592818973893034,0.000153688859627166
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,42495,-0.0112224253949444,0.00296852448002677,-0.0170407333757968,-0.00540411741409189,0.000157215167678344
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",40223,-0.0099745435951105,0.00264004799097851,-0.0151490376574284,-0.00480004953279262,0.000158817760686607
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,40428,-0.0160780267115314,0.00426220542448744,-0.0244319493435268,-0.00772410407953598,0.000162624561220402
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,40223,0.0136867744173504,0.00363503656986205,0.00656210274042079,0.02081144609428,0.000167255286859802
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CA1,Carbonic anhydrase 1,42362,-0.0232442385381196,0.00617607453625822,-0.0353493446291857,-0.0111391324470535,0.000168215713343128
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SUSD1,Sushi domain-containing protein 1,42357,-0.0190051311582509,0.00505016505687619,-0.0289034546697283,-0.00910680764677362,0.00016843456192153
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",40182,-0.0149747680868053,0.0039841688862204,-0.0227837391037973,-0.00716579706981331,0.000171773762419498
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MSMB,Beta-microseminoprotein,42559,-0.0277334789868404,0.0074243288992034,-0.042285163629279,-0.0131817943444017,0.000188131842005837
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,40223,-0.024829324112626,0.00666603637077448,-0.037894755399344,-0.011763892825908,0.000196483130949823
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,40539,0.0102376015303677,0.00274892035230287,0.0048497176398541,0.0156254854208813,0.000196864237129064
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DPEP2,Dipeptidase 2,42587,0.0112570655178185,0.00302673427327787,0.00532466634219388,0.0171894646934431,0.000200661273517913
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,42490,-0.0383625769954864,0.0103306419721182,-0.0586106352608381,-0.0181145187301348,0.000205268679751537
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CFD,Complement factor D,40539,-0.00801670443615004,0.00215899281350435,-0.0122483303506186,-0.00378507852168151,0.000205660942857115
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,F11,Coagulation factor XI,40383,0.0114852322315926,0.00309812426585102,0.00541290867052457,0.0175575557926605,0.000210611186424071
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,42676,-0.044636196749546,0.0120496921020549,-0.0682535932695736,-0.0210188002295184,0.000212785597804589
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,42311,-0.0275225504059291,0.00744655947185142,-0.0421178069707579,-0.0129272938411003,0.000219906882105075
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APOA2,Apolipoprotein A-II,40532,0.0187401173131257,0.00507230181020393,0.00879840576512597,0.0286818288611254,0.000221270737301325
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMTN,Smoothelin,40460,-0.0349185654304797,0.00945857598245305,-0.0534573743560877,-0.0163797565048717,0.000223779963640608
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GBA,Lysosomal acid glucosylceramidase,40182,-0.0210732610278918,0.00570960495132378,-0.0322640867324864,-0.0098824353232972,0.000224592030105935
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UBQLN3,Ubiquilin-3,40116,-0.0206184873372694,0.00559354036589993,-0.0315818264544333,-0.00965514822010557,0.000228797203967812
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,42679,0.00950324625648787,0.00258093999048257,0.00444460387514204,0.0145618886378337,0.000232235328644159
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,42721,-0.0317009981530437,0.00861199605162491,-0.0485805104142286,-0.0148214858918589,0.000233198632709948
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LCN15,Lipocalin-15,40482,-0.0237285595620482,0.00644894172242151,-0.0363684853379944,-0.0110886337861021,0.000234824843518863
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,42459,-0.0112029684499437,0.00304775546221609,-0.0171765691558872,-0.00522936774400016,0.000238031404194298
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DGKZ,Diacylglycerol kinase zeta,42370,-0.0130751987671509,0.00356627780883611,-0.0200651032724697,-0.00608529426183214,0.000247010988381253
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STX5,Syntaxin-5,40199,-0.0155018365592791,0.00423467276054239,-0.0238017951699422,-0.00720187794861603,0.000252711664727814
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,40116,-0.0172365181262926,0.0047093585032129,-0.0264668607925899,-0.0080061754599953,0.00025334837212469
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,42587,-0.0347830430116797,0.00951130859297644,-0.0534252078539135,-0.0161408781694459,0.000256142381756303
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,42698,-0.0154594162580768,0.00423083381051087,-0.0237518505266781,-0.00716698198947549,0.000259176320435523
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MEP1B,Meprin A subunit beta,42636,0.0442293695823966,0.0121075957083459,0.0204984819940387,0.0679602571707545,0.000260152617236364
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CA3,Carbonic anhydrase 3,42770,-0.0223191972797269,0.00611205104400656,-0.0342988173259798,-0.0103395772334741,0.000261519246454162
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,42676,-0.0322622173453204,0.00885501205287973,-0.0496180409689647,-0.0149063937216761,0.000270085831292833
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,40199,-0.0116614270958094,0.00320422203393861,-0.0179417022823291,-0.00538115190928976,0.000274531841781694
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FABP6,Gastrotropin,42334,-0.0219026665877522,0.00603325101769244,-0.0337278385824294,-0.010077494593075,0.000284139175054776
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD200,OX-2 membrane glycoprotein,42594,0.010185233949414,0.00280696949282357,0.00468357374347981,0.0156868941553482,0.000286075539902941
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,40302,-0.0164531047183073,0.0045390023144147,-0.0253495492545601,-0.00755666018205449,0.000290445790540732
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,40302,-0.0272949325074545,0.00753156108108002,-0.0420567922263714,-0.0125330727885377,0.000291294129953916
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,40451,-0.0161341897072461,0.00446670286417199,-0.0248889273210232,-0.00737945209346903,0.000305046209622965
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,40483,-0.0201008117160128,0.00556543885902733,-0.0310090718797063,-0.00919255155231919,0.000305491567917327
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MSLN,Mesothelin,42553,-0.0220771253195878,0.00611473858232242,-0.0340620129409398,-0.0100922376982359,0.00030675284877048
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BIN2,Bridging integrator 2,42611,-0.033190893661064,0.00921301570140659,-0.0512484044358209,-0.0151333828863071,0.000316178154482798
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,42760,-0.0169081814606173,0.0046958476514661,-0.0261120428574909,-0.00770432006374374,0.000318535069617127
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGF5,Fibroblast growth factor 5,42370,-0.0121786595374879,0.00338395095297149,-0.018811203405312,-0.00554611566966374,0.000320680320631182
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VIM,Vimentin,42357,-0.0428559045297985,0.0119085457792652,-0.0661966542571583,-0.0195151548024386,0.000320921372475074
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CBX2,Chromobox protein homolog 2,40116,0.0148644292577912,0.00413874691924833,0.00675248529606451,0.022976373219518,0.000330187343403634
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,40065,-0.0324172522227866,0.00904782083227705,-0.0501509810540496,-0.0146835233915236,0.000341313188058711
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNU13,NHP2-like protein 1,40116,-0.023387907529629,0.00652968847563052,-0.0361860969418648,-0.0105897181173931,0.000342744574994017
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,40302,-0.0128497917331155,0.00359083642232961,-0.0198878311208815,-0.00581175234534947,0.000347049859577545
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NRTN,Neurturin,42370,-0.0180289600657573,0.00503890863284098,-0.0279052209861257,-0.00815269914538902,0.000347543024912167
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PMM2,Phosphomannomutase 2,40116,-0.0221041455026386,0.00617958763761142,-0.034216137272357,-0.00999215373292021,0.000349115131451391
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINB9,Serpin B9,42495,-0.0119905799473261,0.00335245169578936,-0.0185613852710733,-0.00541977462357899,0.00034924758215099
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINA12,Serpin A12,42249,-0.037858386542459,0.0106023598014998,-0.0586390117533985,-0.0170777613315194,0.000357238570761777
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MATN3,Matrilin-3,42475,0.0119389563691904,0.00335016479417448,0.00537263337260842,0.0185052793657724,0.00036695698838197
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COPB2,Coatomer subunit beta',40116,-0.0158819092684799,0.00446395607877763,-0.0246312631828841,-0.00713255535407579,0.000375544322741595
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDZD2,PDZ domain-containing protein 2,40116,-0.0220247419377763,0.00621423155842827,-0.0342046357922957,-0.00984484808325693,0.000395388699268699
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,40116,-0.0366843588175401,0.0103504703437278,-0.0569712806912465,-0.0163974369438337,0.000395419862404823
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GSR,"Glutathione reductase, mitochondrial",40490,-0.00821508752269869,0.00232020607626097,-0.0127626914321702,-0.00366748361322718,0.000400716618183277
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LIPF,Gastric triacylglycerol lipase,40223,-0.022664504852704,0.00640990979367617,-0.0352279280483093,-0.0101010816570987,0.000408126527769851
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PMS1,PMS1 protein homolog 1,40182,-0.0188911655775599,0.00535584198508208,-0.0293886158683208,-0.00839371528679905,0.000421680901264711
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,40199,-0.0141101429680882,0.00400163335831457,-0.0219533443503848,-0.00626694158579165,0.000423450024704201
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPM1F,Protein phosphatase 1F,40511,-0.0187740994221192,0.00534424182738207,-0.029248813403788,-0.00829938544045033,0.000444875646361086
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,40483,0.0255418631516406,0.00727631792310307,0.0112802800223586,0.0398034462809226,0.000449392407935483
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,42346,-0.0288982468728695,0.00826845305320332,-0.045104414857148,-0.012692078888591,0.000475621995091112
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,42644,-0.0176419255610199,0.00504918776072464,-0.0275383335720402,-0.00774551754999963,0.00047734899822127
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MMP3,Stromelysin-1,42611,0.0180488038692006,0.00516721502869583,0.00792106241295679,0.0281765453254444,0.000479261382347969
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,40451,-0.0179964758742906,0.00515228723515449,-0.0280949588551935,-0.00789799289338784,0.000479621729570865
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TXNL1,Thioredoxin-like protein 1,40124,-0.0355470638258654,0.0101789314068305,-0.0554977693832531,-0.0155963582684776,0.000480916987996713
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDHR1,Cadherin-related family member 1,42311,-0.015334108333294,0.00439149759626049,-0.0239414436219646,-0.00672677304462343,0.00048140637910984
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,42636,0.00913588465274201,0.00262503345778911,0.00399081907547535,0.0142809502300087,0.00050245478227868
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PAEP,Glycodelin,42495,-0.0319667131619039,0.00921747817390094,-0.0500329703827498,-0.0139004559410581,0.000525899968351481
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",40283,-0.0314661362481091,0.00907779363634115,-0.0492586117753378,-0.0136736607208805,0.000529720512731673
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",42311,-0.00995503242078374,0.00287927075593995,-0.015598403102426,-0.00431166173914144,0.000546973855323755
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,42311,-0.0148464566858805,0.00429631837490287,-0.0232672407006901,-0.00642567267107086,0.000550760209285095
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEP170,Centrosomal protein of 170 kDa,40223,-0.0273495058449881,0.00792293724981901,-0.0428784628546334,-0.0118205488353428,0.000558658078249631
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,40199,-0.0307160130245322,0.00890023754201417,-0.04816047860688,-0.0132715474421845,0.000560308951817004
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COMMD9,COMM domain-containing protein 9,40451,-0.0141206477420301,0.00409167208396183,-0.0221403250265953,-0.00610097045746496,0.000560417676517906
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PROC,Vitamin K-dependent protein C,42663,-0.00883619981641453,0.00257108091800549,-0.0138755184157053,-0.00379688121712376,0.000590484924753345
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,42370,-0.0151668940105562,0.00441785140663738,-0.0238258827675654,-0.00650790525354692,0.000598572638305703
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TRIM26,Tripartite motif-containing protein 26,40080,-0.0198934324115525,0.00580097326402027,-0.0312633400090322,-0.00852352481407275,0.000607323950163386
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CABP2,Calcium-binding protein 2,40182,-0.0227946823567753,0.00664871781956769,-0.035826169283128,-0.00976319543042267,0.000609304299224431
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HMOX1,Heme oxygenase 1,42500,0.0169159764702305,0.00495790756380606,0.00719847764517059,0.0266334752952904,0.000646993409355604
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,42636,-0.0110444939849106,0.00324980577730874,-0.0174141133084357,-0.00467487466138548,0.000679509068014178
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,42594,-0.01453867476506,0.00427968948927374,-0.0229268661640365,-0.00615048336608344,0.000682938111428558
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",40116,-0.0197648126920357,0.00582017330980153,-0.0311723523792467,-0.00835727300482469,0.00068643341651269
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,42311,-0.0168516755194685,0.00496454265667424,-0.02658217912655,-0.00712117191238703,0.000689812001875511
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,42594,-0.0413335670230355,0.0121845691642461,-0.0652153225849579,-0.0174518114611131,0.000695119995254879
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",42346,-0.0268632827061937,0.00793518051022784,-0.0424162365062402,-0.0113103289061471,0.00071298053777785
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLK8,Kallikrein-8,42154,-0.0129353846248351,0.00382172973999085,-0.0204259749152171,-0.00544479433445299,0.000714690201085749
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL17D,Interleukin-17D,42370,-0.0119311650399027,0.00352595340563323,-0.0188420337149438,-0.00502029636486155,0.000716951172364869
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,INSR,Insulin receptor,40199,-0.00605648198784735,0.00179141136264913,-0.00956764825863964,-0.00254531571705505,0.00072514937432643
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXCL14,C-X-C motif chemokine 14,42370,-0.0195225430263171,0.00578076236876397,-0.0308528372690945,-0.00819224878353977,0.000734510418194758
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CGN,Cingulin,40182,-0.0143412491019593,0.00424723973037267,-0.0226658389734898,-0.00601665923042889,0.000736409065205766
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYOM3,Myomesin-3,40283,0.0321399535083781,0.00955517284928021,0.0134118147237889,0.0508680922929673,0.000771884066141716
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,42698,-0.0224910468085588,0.00670235492544398,-0.035627662462429,-0.00935443115468856,0.000793845402285512
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,42370,-0.0199146647182391,0.00594032818539574,-0.0315577079616147,-0.00827162147486343,0.000803246092231488
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,42357,-0.0106777578209129,0.00319157209339744,-0.0169332391239718,-0.00442227651785388,0.00082331149934055
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,42495,0.012464338459017,0.00372618272574271,0.00516102031656127,0.0197676566014727,0.000824895934824027
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BCL2,Apoptosis regulator Bcl-2,40449,-0.0196922085790333,0.00589339918703772,-0.0312432709856273,-0.0081411461724394,0.000836281769694334
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,42619,-0.0200235195224418,0.00599675906675831,-0.0317771672932881,-0.00826987175159548,0.000842921560815154
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,40199,-0.0286783415161354,0.00859145710082396,-0.0455175974337504,-0.0118390855985205,0.000846616053520602
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,42311,-0.0375929485415509,0.0113211296561792,-0.059782362667662,-0.0154035344154397,0.000900691543954039
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SFRP1,Secreted frizzled-related protein 1,42457,-0.0149922004260974,0.00451809282937366,-0.0238476623716698,-0.006136738480525,0.000908244152000474
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",42476,-0.0246366026790172,0.00742723306317935,-0.0391939794828488,-0.0100792258751857,0.000912131892160542
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPC1,Glypican-1,42721,-0.0101208214609518,0.00306158362704474,-0.0161215253699595,-0.00412011755194409,0.000949700455800283
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SDK2,Protein sidekick-2,40283,-0.0137772883691141,0.00417140212196037,-0.0219532365281564,-0.00560134021007181,0.000960291193472485
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRL,Prolactin,42711,-0.0253012810487781,0.00766128499820137,-0.0403173996452528,-0.0102851624523034,0.000960808046727386
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,42607,-0.00752684676643637,0.00228613161638944,-0.0120076647345597,-0.00304602879831308,0.00099595084260814
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,42754,-0.0120090165921898,0.003656428036718,-0.0191756155441571,-0.00484241764022255,0.00102474278732718
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PALM3,Paralemmin-3,40116,-0.0242246374023462,0.00737775500540977,-0.0386850372129494,-0.0097642375917431,0.00102859955020823
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,42587,-0.0183475717321366,0.00558919473456266,-0.0293023934118794,-0.00739275005239375,0.00103086476065735
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,40449,0.0238381413856844,0.00726411001708119,0.0096004857522053,0.0380757970191636,0.00103522179406727
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EHD3,EH domain-containing protein 3,40223,-0.0393642555321467,0.012034233359394,-0.0629513529165589,-0.0157771581477345,0.00107488157751658
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",40116,-0.0131655670551841,0.0040258166262654,-0.0210561676426643,-0.00527496646770391,0.00107772066799891
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PODXL,Podocalyxin,42587,0.00511262595741659,0.00156603947861755,0.0020431885793262,0.00818206333550699,0.00109860828887091
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,40223,-0.0134450105848393,0.00411906089400625,-0.0215183699370915,-0.00537165123258706,0.0011014843717308
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",42611,0.00792548914998259,0.0024307805477695,0.00316115927635436,0.0126898190236108,0.00111504732076179
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NAA10,N-alpha-acetyltransferase 10,40116,-0.0172115999924833,0.00528993806292959,-0.0275798785958253,-0.00684332138914133,0.0011427943187618
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,40482,-0.0108844954327528,0.00334723103494549,-0.0174450682612459,-0.00432392260425959,0.00115016945456218
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,42679,-0.00820733792578643,0.00252550282572079,-0.0131573234641992,-0.00325735238737367,0.00115775877561826
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",40482,-0.0242216795319591,0.00746366265050539,-0.0388504583269497,-0.00959290073696858,0.00117676787163147
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NXPH1,Neurexophilin-1,42311,-0.0129449032600395,0.00399202779055998,-0.020769277729537,-0.00512052879054192,0.00118703478199238
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLU,Clusterin,40539,0.0105266703046033,0.00324737663542369,0.00416181209917285,0.0168915285100337,0.00119207146984921
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,40451,-0.0173960117386351,0.00537444922658552,-0.0279299322227427,-0.0068620912545275,0.00121228268165233
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SUSD4,Sushi domain-containing protein 4,40451,-0.0140017911259265,0.00432766580988403,-0.0224840161132993,-0.00551956613855385,0.00121817296066347
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,40532,-0.0239914277071698,0.0074202885132969,-0.0385351931932318,-0.00944766222110791,0.00122753298681018
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,S100A16,Protein S100-A16,42292,-0.02012944100994,0.00623444784880783,-0.0323489587936034,-0.00790992322627668,0.00124641103163346
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,40449,-0.0166180212561315,0.00515608450788616,-0.0267239468915884,-0.00651209562067462,0.00127220267575658
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STXBP1,Syntaxin-binding protein 1,40482,-0.0252669433445116,0.00787899856456914,-0.0407097805310672,-0.00982410615795613,0.00134560602282066
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",40511,-0.0236311883012104,0.0073820324442832,-0.0380999718920054,-0.0091624047104153,0.0013724582570798
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,40302,-0.0285013482892083,0.00890612085966012,-0.0459573451741421,-0.0110453514042745,0.00137719431331142
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GBP2,Guanylate-binding protein 2,42370,-0.0198694042326614,0.00621668889784718,-0.0320541144724419,-0.00768469399288094,0.00139608360993313
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLG,Plasminogen,40285,-0.00704778746059598,0.00220551351402081,-0.0113705939480768,-0.0027249809731152,0.00139964559019426
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLK6,Kallikrein-6,42656,-0.0103794255596983,0.0032523872421894,-0.0167541045543895,-0.00400474656500703,0.00141946909914225
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",40482,-0.0300931998089798,0.009429450149537,-0.0485749221020724,-0.0116114775158873,0.00141970142573572
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,42292,-0.0216005336896103,0.00679481907943827,-0.0349183790853093,-0.00828268829391128,0.001481426413307
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ABHD14B,Protein ABHD14B,42460,-0.0184736389086478,0.00581277500897127,-0.0298666779262314,-0.00708059989106408,0.00148578595994761
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NFIC,Nuclear factor 1 C-type,40482,-0.0155264854161312,0.00489034203291236,-0.0251115558006394,-0.00594141503162295,0.0015027623214068
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",40080,-0.0188930280594245,0.00599255878756935,-0.0306384432830604,-0.00714761283578852,0.00162180515982182
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STXBP3,Syntaxin-binding protein 3,42346,-0.0139495888880628,0.00444017658473643,-0.0226523349941462,-0.00524684278197943,0.00168357397415202
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,40527,-0.00902117971194098,0.00287962680021962,-0.0146652482403714,-0.00337711118351053,0.00173612174602718
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,40116,0.0125584356069127,0.00402272471862863,0.00467389515840057,0.0204429760554248,0.00180173509747782
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42676,0.013494674763433,0.00433846631067403,0.00499128079451193,0.0219980687323541,0.00187178716540994
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CASP9,Caspase-9,40199,-0.0200361084423339,0.00644238960867066,-0.0326631920753284,-0.00740902480933941,0.00187537993681785
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,42346,-0.0148643375714852,0.00478425724380861,-0.02424148176935,-0.00548719337362029,0.00189445689619343
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,40116,-0.0142655200966976,0.00461095701555502,-0.0233029958471854,-0.00522804434620974,0.00198089174323083
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FADD,FAS-associated death domain protein,42636,-0.0238393616724335,0.00772514093309949,-0.0389806379013085,-0.00869808544355854,0.00203318573512986
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PER3,Period circadian protein homolog 3,40199,-0.0391388022210026,0.0126864032563805,-0.0640041526035083,-0.0142734518384968,0.00203989503545544
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,42594,-0.037628545079359,0.0122078828554096,-0.0615559954759617,-0.0137010946827563,0.00205814031096884
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RBP1,Retinol-binding protein 1,40182,-0.0216879463376218,0.00704362126649942,-0.0354934440199607,-0.00788244865528295,0.00208145782858982
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,40199,-0.0322478229022092,0.0104847837682051,-0.0527979990878913,-0.0116976467165272,0.00210539331149682
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPMT,Thiopurine S-methyltransferase,42346,-0.0229194484742043,0.00746145303517804,-0.0375438964231533,-0.00829500052525534,0.00213268319246587
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RALB,Ras-related protein Ral-B,40199,-0.00950041944745039,0.00309346292145688,-0.0155636067735059,-0.00343723212139491,0.00213772143518082
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",40527,-0.0199244550332134,0.00648985146592951,-0.0326445639064352,-0.00720434615999154,0.00214497530267022
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,40511,-0.0235481013601155,0.00767073852722621,-0.0385827488734789,-0.00851345384675212,0.00214665587763489
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,40136,0.0091931302771121,0.00299714453385239,0.00331872699076142,0.0150675335634628,0.00216532140928325
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,40482,0.0143182313491572,0.00467004306419929,0.00516494694332663,0.0234715157549879,0.00217474841494877
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,40116,-0.0126266096479508,0.00412295752043654,-0.0207076063880064,-0.0045456129078952,0.00220021106254958
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PI16,Peptidase inhibitor 16,40532,0.00793971692513984,0.00259333034258592,0.00285678945367144,0.0130226443966082,0.00220679371039083
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,42587,-0.0165220230375831,0.00541137851735251,-0.027128324931594,-0.00591572114357214,0.00226858803741136
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TBC1D5,TBC1 domain family member 5,42594,-0.0243736882748172,0.00799061484071857,-0.0400352933626256,-0.00871208318700886,0.00229067555416752
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DSG4,Desmoglein-4,42543,0.015648311274976,0.00513760754578023,0.00557860048524679,0.0257180220647053,0.00232486795753368
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C1RL,Complement C1r subcomponent-like protein,40519,-0.00620903893694453,0.00203885452411019,-0.0102051938042005,-0.00221288406968855,0.00232938742437565
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,42594,0.0151155923894422,0.00497082033495659,0.00537278453292733,0.0248584002459571,0.00236355442341495
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,40116,0.00651162897410695,0.00214256160202221,0.00231220823414342,0.0107110497140705,0.00237784714057301
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RBM25,RNA-binding protein 25,40080,0.0148200983841212,0.00489978990157753,0.00521651017702924,0.0244236865912131,0.00249510086411747
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FBN2,Fibrillin-2,40182,-0.0189509528900806,0.00627614459544604,-0.0312521962971548,-0.00664970948300635,0.00253755707474915
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GAS6,Growth arrest-specific protein 6,42718,0.00783995158887589,0.00259709790284214,0.00274963969930531,0.0129302634784465,0.00254305065779237
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EDNRB,Endothelin receptor type B,40199,-0.0138472923346495,0.00460161337566859,-0.02286645455096,-0.00482813011833909,0.00262507619930737
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ELAVL4,ELAV-like protein 4,40136,-0.0263166353110971,0.00877135999741234,-0.0435085009060253,-0.00912476971616889,0.00270329041557819
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VGF,Neurosecretory protein VGF,40482,-0.00974095013954874,0.00324774763306736,-0.0161065355003608,-0.00337536477873673,0.00271196130704699
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL17RA,Interleukin-17 receptor A,42611,-0.0134690707418758,0.00450547286124866,-0.0222997975499232,-0.00463834393382842,0.00279949204645451
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENSA,Alpha-endosulfine,40451,-0.016327594188733,0.00546932657199607,-0.0270474742698453,-0.00560771410762073,0.00283907051215047
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RELB,Transcription factor RelB,40199,-0.0152796788828913,0.00512818754919306,-0.0253309264793097,-0.00522843128647293,0.00289304722261143
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLK13,Kallikrein-13,42381,-0.0140862383315417,0.00472824485724404,-0.02335359825174,-0.00481887841134335,0.00289558149209463
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,42636,-0.00883572794494095,0.00296831031306153,-0.0146536161585415,-0.00301783973134036,0.00291901239147924
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLXDC1,Plexin domain-containing protein 1,42346,-0.00959451121935707,0.00323959674007457,-0.0159441208299032,-0.00324490160881091,0.00306554721331415
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDIA5,Protein disulfide-isomerase A5,40080,-0.0187174352140312,0.00632371062537176,-0.0311119080397599,-0.00632296238830257,0.00308420372039493
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRYGD,Gamma-crystallin D,40483,-0.0296033600812082,0.0100061169594011,-0.0492153493216344,-0.00999137084078204,0.00309755089619901
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,40482,-0.0380146571880805,0.0128957245754797,-0.0632902773560207,-0.0127390370201402,0.00320647807997255
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GP6,Platelet glycoprotein VI,42590,-0.0261376648244563,0.00887732409919907,-0.0435372200588865,-0.00873810959002615,0.00324223206882689
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,42370,-0.0199185614532608,0.00678130052374581,-0.0332099104798026,-0.006627212426719,0.00331680858009009
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PCDH1,Protocadherin-1,42721,-0.0064811609641662,0.00222202461856224,-0.0108363292165482,-0.00212599271178421,0.00354244430519957
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VWF,von Willebrand factor,42794,-0.0214842801761721,0.00737049785418981,-0.0359304559703842,-0.00703810438196011,0.0035638040922411
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FSHB,Follitropin subunit beta,40223,0.0162490876444922,0.00557714698137631,0.00531787956099465,0.0271802957279898,0.00358105144256576
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,42689,-0.00826596835250977,0.00284231941747131,-0.0138369144107535,-0.002695022294266,0.00364134949063377
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD40LG,CD40 ligand,42754,-0.0230361179796277,0.00792266359648761,-0.0385645386287434,-0.00750769733051197,0.00364777623075844
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AK1,Adenylate kinase isoenzyme 1,42636,-0.0187678067081827,0.00645572997450513,-0.0314210374582128,-0.00611457595815263,0.00365328721506673
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CR1,Complement receptor type 1,40509,-0.0108498101537045,0.0037325867225883,-0.0181656801299775,-0.00353394017743141,0.00365878139759599
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,40483,-0.0716780199671275,0.0246707153010756,-0.120032621957236,-0.0233234179770193,0.00367509471010128
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RILPL2,RILP-like protein 2,40511,-0.028834919542658,0.00993297533327607,-0.0483035511958791,-0.00936628788943693,0.00370380911068834
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EFNB2,Ephrin-B2,40182,-0.0162957648015919,0.00562393726558472,-0.0273186818421379,-0.00527284776104582,0.00376806074553038
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,40451,-0.00998396841731425,0.00345059893696187,-0.0167471423337595,-0.00322079450086899,0.00381824827256132
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CFHR2,Complement factor H-related protein 2,40451,-0.0172146358423862,0.00595190600215024,-0.0288803716066007,-0.00554890007817173,0.00383177933466891
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,40223,-0.0301488011599627,0.0104515311654365,-0.0506338022442182,-0.00966380007570719,0.0039263277451964
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CASP8,Caspase-8,42674,-0.0180101964829813,0.00626225244868406,-0.0302842112824021,-0.00573618168356056,0.00403389416502483
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL33,Interleukin-33,42370,-0.0113965958078826,0.00397001820756884,-0.0191778314947175,-0.00361536012104766,0.00410260613107058
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,40482,-0.0111989385909306,0.00391335796827453,-0.0188691202087487,-0.00352875697311253,0.00422122236259425
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,40136,0.0100548661010797,0.00351372246009435,0.00316797007929481,0.0169417621228647,0.00422308559347001
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TJP3,Tight junction protein ZO-3,40136,0.0124085757159798,0.00434554387196625,0.00389130972692591,0.0209258417050336,0.0043053863841717
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NDRG1,Protein NDRG1,42311,-0.0190797279056762,0.00668301689900408,-0.0321784410277242,-0.00598101478362824,0.00431101224978889
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLK3,Prostate-specific antigen,40527,0.0287447621432585,0.01010267175457,0.0089435255043013,0.0485459987822156,0.00444542837009487
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,40182,-0.0160928864445123,0.00567173843331138,-0.0272094937738026,-0.00497627911522201,0.00455684930889767
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,40182,0.018490206613933,0.00653548798729661,0.00568065015883167,0.0312997630690344,0.00467489932862054
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SF3B4,Splicing factor 3B subunit 4,42587,-0.0210514263004418,0.00744432275946121,-0.0356422989089857,-0.00646055369189779,0.00469313334831383
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,40449,-0.0126399315945622,0.00446981373235567,-0.0214007665099793,-0.00387909667914509,0.00469455349184551
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,40451,-0.0133079241735209,0.00470926300636599,-0.0225380796659982,-0.00407776868104353,0.00472304603174363
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,42357,-0.0168716791648883,0.00597681036533149,-0.0285862274809381,-0.00515713084883862,0.00476692501624231
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,42679,0.0281784760175615,0.00998453569727818,0.0086087860508963,0.0477481659842268,0.00477634299413402
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TFRC,Transferrin receptor protein 1,42673,-0.0109348490820299,0.00388561028162004,-0.0185506452340052,-0.00331905293005466,0.00489710304442514
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TG,Thyroglobulin,40451,0.0333449146021215,0.0118757362934596,0.0100684714669407,0.0566213577373023,0.00499641290921775
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRTAP,Cartilage-associated protein,40182,-0.0138601429381604,0.00493628977260949,-0.023535270892475,-0.00418501498384576,0.00499682370122728
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FRMD4B,FERM domain-containing protein 4B,40116,-0.0202483701277861,0.00721345788693726,-0.0343867475861832,-0.00610999266938912,0.00500896641805154
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NPTX1,Neuronal pentraxin-1,42611,0.0115209022260404,0.00410456240520624,0.00347595991183621,0.0195658445402447,0.00501002423791141
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MSTN,Growth/differentiation factor 8,42357,-0.0153193850638164,0.00547406293073453,-0.0260485484080561,-0.00459022171957675,0.00514088266746835
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,42689,0.0131898777546838,0.00472900880957132,0.00392102048792396,0.0224587350214435,0.00529219152526935
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,42594,-0.0164610429164793,0.00590452721445457,-0.0280339162568102,-0.0048881695761483,0.00531308908900357
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,40532,-0.0077437529607751,0.00278149666484754,-0.0131954864238763,-0.00229201949767392,0.00537780469587929
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,40539,0.00730685631894388,0.00263338986600083,0.00214541218158226,0.0124683004563055,0.00553437197044917
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,42582,-0.00969662440516126,0.00349589917063322,-0.0165485867796024,-0.00284466203072016,0.00554971056223558
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,40283,-0.017820401067818,0.00642676485662225,-0.0304168601867977,-0.00522394194883843,0.00556619415954594
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,40483,-0.00573085091570328,0.00206710604598346,-0.00978237876583086,-0.00167932306557571,0.00557353167707754
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,42636,-0.0113431901146087,0.00409205497766309,-0.0193636178708284,-0.00332276235838909,0.00557891125423498
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",42357,-0.0248293547039466,0.00899373040651608,-0.0424570663007182,-0.00720164310717511,0.00577503467876255
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRTG,Protogenin,42721,-0.00700493408607751,0.00254950789607305,-0.0120019695623807,-0.00200789860977434,0.00601194438541247
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,40199,-0.0100306911443436,0.0036582736493246,-0.0172009074970198,-0.00286047479166736,0.00611800438294063
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SDC4,Syndecan-4,42636,0.0132404277264694,0.0048295862892129,0.00377443859961207,0.0227064168533266,0.00612357088794394
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSMG4,Proteasome assembly chaperone 4,40199,-0.0160938652417725,0.00587516530164508,-0.0276091892329969,-0.00457854125054816,0.00616685144973437
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ICAM5,Intercellular adhesion molecule 5,42636,-0.0128166052883304,0.00470734694227526,-0.0220430052951899,-0.00359020528147085,0.00648380185706145
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,40483,-0.007929427172947,0.00291282106763378,-0.0136385564655092,-0.0022202978803848,0.00649385948818496
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GJA8,Gap junction alpha-8 protein,40080,-0.0183027824240791,0.00673636319729756,-0.0315060542907823,-0.0050995105573759,0.00659782728739927
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLK1,Kallikrein-1,42505,0.0359796497266258,0.0132839117480569,0.00994318270043431,0.0620161167528173,0.00676718266835793
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RPA2,Replication protein A 32 kDa subunit,40199,-0.00883416979970608,0.00326930556649416,-0.0152420087100346,-0.00242633088937752,0.00689973040805338
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STX1B,Syntaxin-1B,40182,-0.0112768232767024,0.00418200359746907,-0.0194735503277417,-0.00308009622566298,0.00701766511507329
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SUGT1,Protein SGT1 homolog,42346,-0.0220998607426224,0.00819684425463942,-0.0381656754817156,-0.0060340460035291,0.00702369114524444
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,40199,-0.0176753002101098,0.00658758739428245,-0.0305869715029034,-0.00476362891731623,0.00730474278866434
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",40483,-0.0149233829179479,0.00559757270272709,-0.025894625415293,-0.0039521404206028,0.00768586471618715
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,INSL3,Insulin-like 3,40483,0.0213953572944552,0.00804959225343622,0.00561815647772022,0.0371725581111902,0.0078729960185699
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPP1,Osteopontin,42771,0.012877618359286,0.00484696040585653,0.00337757596380724,0.0223776607547648,0.00789681612371521
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AFP,Alpha-fetoprotein,42459,0.0181698575672365,0.00684940518874299,0.00474502339730023,0.0315946917371728,0.00799306550132015
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,40302,-0.0178137359819267,0.00672233212622834,-0.0309895069493343,-0.00463796501451917,0.00806215547817867
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL36G,Interleukin-36 gamma,40154,-0.0188230405856254,0.00710412887559971,-0.0327471331818008,-0.00489894798944997,0.008070475521208
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HGFAC,Hepatocyte growth factor activator,40428,0.00757740750919473,0.00286477711847878,0.00196244435697631,0.0131923706614131,0.00817985026292408
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,40527,0.0139728655016789,0.00528273537868305,0.00361870415946013,0.0243270268438977,0.00818021925451263
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,40451,-0.00996533570693701,0.00377549961323908,-0.0173653149488856,-0.00256535646498842,0.00831490566139063
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXCL3,C-X-C motif chemokine 3,42620,-0.0250436009394914,0.00952843707906732,-0.0437193376144633,-0.00636786426451944,0.0085910204733373
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,40199,-0.0157360164876306,0.0060346171097115,-0.0275638660226651,-0.00390816695259604,0.00912959445573482
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENO2,Gamma-enolase,42711,-0.0171289419689244,0.00658123091671508,-0.030028154565686,-0.00422972937216288,0.00925949599116999
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,40223,0.0106102214939068,0.00408102913402778,0.00261140439121234,0.0186090385966012,0.00933782994134059
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAMDC2,MAM domain-containing protein 2,40511,-0.00976731564268848,0.00376066968838715,-0.0171382282319273,-0.00239640305344965,0.00941012209015075
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RBP2,Retinol-binding protein 2,42587,0.0205418284322778,0.00791817561365386,0.00502220422951623,0.0360614526350394,0.00948972416118143
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BDNF,Brain-derived neurotrophic factor,40527,-0.0222783523920645,0.0086040045438581,-0.0391422012980263,-0.00541450348610258,0.00962941052147043
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,40116,-0.0161011241052774,0.00622161681144165,-0.028295493055703,-0.00390675515485172,0.00966817517333332
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMEM25,Transmembrane protein 25,40482,-0.0121312582075872,0.00469994656403571,-0.0213431534730972,-0.00291936294207725,0.00985973044399279
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",40302,-0.0188247422437916,0.00729412974493886,-0.0331212365438717,-0.00452824794371138,0.00986966989087368
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,40182,-0.0136190886494285,0.0052797255000044,-0.0239673506294371,-0.00327082666941983,0.00990701805879808
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,40527,-0.016807761562278,0.00652392642804241,-0.0295946573612411,-0.00402086576331486,0.00999818352976395
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,42594,-0.0259010729765899,0.0100884149139992,-0.0456743662080284,-0.00612777974515136,0.0102569582833015
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",40116,-0.010347640945552,0.00404064275333887,-0.0182673007420962,-0.00242798114900776,0.0104537628789862
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,40199,-0.0164054769783066,0.00641080539552442,-0.0289706555535345,-0.00384029840307879,0.0105095630725728
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,42781,-0.0155813942449839,0.0060926521959412,-0.0275229925490287,-0.00363979594093915,0.0105563211225153
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",42459,0.0108754611825458,0.00425330854303343,0.00253897643820025,0.0192119459268913,0.0105707261349795
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CORO1A,Coronin-1A,42353,-0.0233026917904363,0.00911794445121097,-0.0411738629148098,-0.00543152066606282,0.0106087123837315
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RP2,Protein XRP2,42587,-0.0109485546712653,0.00429429241895869,-0.0193653678124243,-0.00253174153010626,0.0107969496608992
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,42794,0.00827530541233184,0.00325179316309666,0.00190179081266239,0.0146488200120013,0.0109436170820376
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAB39B,Ras-related protein Rab-39B,40116,-0.0241426809364006,0.00952042987517101,-0.0428027234917358,-0.00548263838106544,0.0112302893820801
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLK4,Kallikrein-4,42721,-0.0165123651031409,0.00651422938964504,-0.0292802547068451,-0.00374447549943658,0.0112618522321023
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL1B,Interleukin-1 beta,42293,-0.0146817411584118,0.00581693197485901,-0.0260829278291354,-0.00328055448768812,0.0116156217620412
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GHRL,Appetite-regulating hormone,42636,-0.0219361052814047,0.00870501336417496,-0.0389979314751876,-0.00487427908762177,0.0117489961880938
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,40439,0.00707514026246116,0.00282134761382568,0.00154529893936284,0.0126049815855595,0.0121653838893237
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,42346,-0.0132352307243466,0.0052893030670611,-0.0236022647357863,-0.00286819671290682,0.0123522411870063
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,40283,-0.00942976927974292,0.00376872762019308,-0.0168164754153214,-0.00204306314416448,0.0123598581428011
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IFNW1,Interferon omega-1,40116,0.00950472073946021,0.00380199207000514,0.00205281628225014,0.0169566251966703,0.0124362717132043
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",40136,-0.00836513943695955,0.00334881636578281,-0.0149288195138939,-0.00180145936002525,0.0125063270793849
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,42583,-0.00840706033832875,0.00337901733431782,-0.0150299343135917,-0.00178418636306582,0.0128577435860454
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MUC16,Mucin-16,42587,-0.0488976871860588,0.0196896409731347,-0.0874893834934029,-0.0103059908787148,0.0130248247266619
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEMA6C,Semaphorin-6C,40199,-0.00671851396540857,0.00270907859157713,-0.0120283080048997,-0.00140871992591738,0.0131530974972709
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTSH,Pro-cathepsin H,42332,-0.0189535126293874,0.00765076096726766,-0.033949004125232,-0.00395802113354273,0.0132491697406189
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,42357,-0.00704105283651069,0.00285038816343137,-0.0126278136368362,-0.00145429203618521,0.0135160156499147
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD14,Monocyte differentiation antigen CD14,42416,-0.0105316161440577,0.00428472168752115,-0.0189296706515992,-0.00213356163651628,0.0139861386717606
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",40223,-0.0084771144231246,0.00345117248568681,-0.0152414124950708,-0.00171281635117845,0.0140528995088379
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FXN,"Frataxin, mitochondrial",42721,-0.0183639989692565,0.00747704495018565,-0.0330190070716204,-0.00370899086689262,0.0140598266051205
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD70,CD70 antigen,42594,0.0108264041413895,0.00442867139067465,0.00214620821566714,0.0195066000671118,0.0145134078763395
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCGB2A2,Mammaglobin-A,40116,0.0080028687452276,0.00327881358691372,0.00157639411487672,0.0144293433755785,0.0146712803133967
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACRV1,Acrosomal protein SP-10,40199,-0.02015120698139,0.00827424026908292,-0.0363687179087925,-0.00393369605398751,0.0148904972186062
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",40449,-0.0254876444414312,0.0104853654972969,-0.0460389608161332,-0.00493632806672923,0.0150817629482139
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,40511,-0.00740656926006609,0.00304703928210699,-0.0133787662529958,-0.00143437226713639,0.0150833291014463
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EP300,Histone acetyltransferase p300,40199,-0.00774958801235089,0.0031953650091177,-0.0140125034302216,-0.0014866725944802,0.0153134461790236
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRDX6,Peroxiredoxin-6,42721,0.0150159814353823,0.00620853765265855,0.00284724763617149,0.027184715234593,0.0155933920109267
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TEX101,Testis-expressed protein 101,40182,-0.0131901083476731,0.00545482151317162,-0.0238815585134895,-0.00249865818185677,0.0156194820717684
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PROK1,Prokineticin-1,42594,-0.0136576074493207,0.00565194243205947,-0.0247354146161573,-0.00257980028248419,0.0156861738681231
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42638,-0.00639775259582419,0.00265439785852669,-0.0116003723985365,-0.00119513279311188,0.0159550931733724
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENAH,Protein enabled homolog,42370,-0.0116267681188371,0.00482880052809002,-0.0210912171538935,-0.00216231908378063,0.0160627850666038
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC13A1,Solute carrier family 13 member 1,40451,-0.0154900513243957,0.00645254132687076,-0.0281370323250624,-0.00284307032372899,0.0163837870511663
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CFP,Properdin,40539,-0.00549883499420949,0.00229289339703886,-0.00999290605240565,-0.00100476393601333,0.0164915643672423
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42673,0.00797874567251709,0.00332998157939879,0.00145198177689546,0.0145055095681387,0.0165871467815416
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CST6,Cystatin-M,42332,-0.0124422616325314,0.00519584519337317,-0.0226261182115428,-0.00225840505352004,0.016649890522762
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRDX2,Peroxiredoxin-2,40333,-0.015434467880503,0.00644938452549421,-0.0280752615504717,-0.00279367421053439,0.0167199934055841
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAB2B,Ras-related protein Rab-2B,40451,-0.0148824564504405,0.00622317199170045,-0.0270798735541734,-0.00268503934670766,0.0167979054247455
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,42357,0.0075514976809152,0.00315793952272335,0.00136193621637744,0.013741059145453,0.0168039882924996
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,40449,-0.0238452791082308,0.00998455874456072,-0.0434150142475698,-0.0042755439688918,0.0169467915737724
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCNE1,G1/S-specific cyclin-E1,40199,-0.021794445927049,0.0091479559891799,-0.0397244396658416,-0.00386445218825638,0.0172152670671159
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPRING1,SREBP regulating gene protein,40080,-0.014524356671462,0.00610830237597009,-0.0264966293283634,-0.00255208401456064,0.017433159776801
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,42689,-0.0166313793551295,0.00700788709169029,-0.0303668380548425,-0.00289592065541657,0.0176468522953346
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PXDNL,Peroxidasin-like protein,40451,0.0135777412572983,0.00574813329692918,0.00231139999531711,0.0248440825192795,0.0181880163289208
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,40483,-0.00823679284931705,0.003487110306971,-0.0150715290509802,-0.0014020566476539,0.018190166005852
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYOC,Myocilin,42611,0.0108020217275044,0.0045781994802115,0.00182875074628988,0.019775292708719,0.0183164088977443
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FMR1,Synaptic functional regulator FMR1,42346,-0.00855654808236771,0.00364035243234145,-0.015691638849757,-0.00142145731497848,0.0187642845247507
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,42172,-0.0160941037126597,0.00685419466321169,-0.0295283252525546,-0.00265988217276477,0.0188860890981624
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MDM1,Nuclear protein MDM1,40182,-0.00756883587830066,0.00322407103618068,-0.0138880151092148,-0.00124965664738653,0.0189123374900256
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,40136,0.00765962784594714,0.00326945382217872,0.00125149835447686,0.0140677573374174,0.0191582211861976
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,40116,-0.00975047553243428,0.00416481177664324,-0.017913506614655,-0.00158744445021353,0.0192420013299023
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPESP1,Sperm equatorial segment protein 1,40511,-0.00765760927093952,0.00327186667570277,-0.014070467955317,-0.00124475058656209,0.0192782843047528
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,S100A13,Protein S100-A13,40199,-0.00858562907684651,0.00367091959840778,-0.0157806314897257,-0.00139062666396727,0.0193624267186879
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RRP15,RRP15-like protein,40136,0.0221708527809855,0.00948627932400332,0.00357774530593897,0.040763960256032,0.019449352193353
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNNI3,"Troponin I, cardiac muscle",42357,-0.0202685615261472,0.00867272114870932,-0.0372670949776174,-0.00327002807467691,0.0194516266107674
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,42292,-0.0115464574218273,0.00495966895371169,-0.0212674085711022,-0.00182550627255242,0.0199235243729608
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,42705,0.00482657220767959,0.00207377884501089,0.000761965671458252,0.00889117874390093,0.0199571599120523
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,F3,Tissue factor,42636,0.00650366542097885,0.0027950675594809,0.00102533300439628,0.0119819978375614,0.0199887459746713
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TAGLN3,Transgelin-3,40080,-0.0146960509057702,0.00632832767500728,-0.0270995731487845,-0.00229252866275592,0.020237045755306
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C1QL2,Complement C1q-like protein 2,40199,0.0105565691465962,0.00454890656654359,0.00164071227617078,0.0194724260170217,0.0203221552988743
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ERC2,ERC protein 2,40182,-0.0181109494153664,0.00782019647547806,-0.0334385345073034,-0.00278336432342945,0.0205809507551409
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,42311,-0.035475970462808,0.0153208370173472,-0.0655048110168085,-0.00544712990880741,0.0205988901526276
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,40136,0.0153791457224383,0.00664746935106703,0.0023501057943469,0.0284081856505297,0.0207117442281272
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITM2A,Integral membrane protein 2A,42594,-0.0146006558336603,0.00631424991957437,-0.0269765856760261,-0.00222472599129458,0.020774354178153
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,42689,0.0075031341730348,0.00324946193907897,0.00113418877244003,0.0138720795736296,0.0209564497821376
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,40451,-0.0111115485895145,0.00481621685203033,-0.020551333619494,-0.0016717635595351,0.0210666709511409
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGB5,Integrin beta-5,42679,0.00878010974620906,0.00381379794163895,0.00130506578059672,0.0162551537118214,0.0213392893484042
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],42587,0.0131469019427799,0.00572091102125644,0.00193391634111732,0.0243598875444425,0.0215746527507661
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLSTN2,Calsyntenin-2,42754,0.00933689833966743,0.00406350077110488,0.00137243682830186,0.017301359851033,0.0215913210481088
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GSTP1,Glutathione S-transferase P,42237,0.0164781195141154,0.00720914022564483,0.00234820467185158,0.0306080343563793,0.0222862566775153
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,40482,-0.0116344821745752,0.00509403096843815,-0.021618782872714,-0.00165018147643643,0.0223932988702834
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,42311,0.013127837650598,0.00577253920870729,0.00181366080153175,0.0244420144996643,0.0229707829253867
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CA13,Carbonic anhydrase 13,42483,-0.0239554966820837,0.0105344004200711,-0.0446029215054231,-0.00330807185874425,0.0229803188034789
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DCN,Decorin,42357,-0.00561692520981087,0.00247186972531415,-0.0104617898714266,-0.000772060548195136,0.0230821173643866
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,POMC,Pro-opiomelanocortin,40223,-0.0163306837839425,0.00719515555359981,-0.0304331886689981,-0.00222817889888685,0.023246366508432
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,42618,-0.0173833653730519,0.00766293254931007,-0.0324027131696997,-0.00236401757640421,0.0233145356121362
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,40223,-0.00660022432181966,0.00291060730615595,-0.0123050146418853,-0.000895434001753994,0.0233701090195485
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APPL2,DCC-interacting protein 13-beta,40283,-0.0258591265322262,0.0114091004808973,-0.0482209634747849,-0.00349728958966743,0.0234378213811149
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FAP,Prolyl endopeptidase FAP,42794,0.00634195225749763,0.00280070911709355,0.000852562387994276,0.011831342127001,0.0235646162515313
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,42635,-0.00871248977244176,0.00385871505209253,-0.0162755712745431,-0.0011494082703404,0.0239695303801869
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,40080,-0.0334025139300936,0.0147945428734587,-0.0623998179620725,-0.00440520989811461,0.0239804055318148
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,40199,-0.00566933455018315,0.0025113123342182,-0.0105915067252508,-0.000747162375115468,0.0239951978881954
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,40451,-0.00974770252803567,0.00432593149794248,-0.0182265282640029,-0.00126887679206842,0.0242582232196709
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FN1,Fibronectin,40539,-0.00615428189600215,0.0027390678855108,-0.0115228549516033,-0.000785708840400994,0.0246685935602123
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",40223,-0.0176301198111033,0.00785763593227541,-0.0330310862383631,-0.00222915338384345,0.0248719462447928
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANPEP,Aminopeptidase N,42666,0.00637867308668353,0.00284849737104706,0.000795618239431301,0.0119617279339358,0.0251519036098281
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CYB5A,Cytochrome b5,40080,-0.0168443523304855,0.00754617994795283,-0.0316348650284731,-0.00205383963249797,0.0256240296331519
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,42676,-0.00662051735767701,0.00297249525050431,-0.0124466080486655,-0.000794426666688553,0.0259464013420932
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,40080,-0.00845012584418003,0.00379491660275614,-0.0158881623855821,-0.00101208930277799,0.0259879727717553
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SH3GL3,Endophilin-A3,40250,-0.0195592023084991,0.00880550485265514,-0.0368179918197031,-0.002300412797295,0.0263544060783297
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARFIP1,Arfaptin-1,40482,-0.0155774456838494,0.00702138079951078,-0.0293393520508905,-0.00181553931680822,0.026535606982781
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",42603,-0.0246757194811447,0.0111307079880719,-0.0464919071377657,-0.00285953182452379,0.0266463112325128
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD93,Complement component C1q receptor,42141,0.00734486872836216,0.00331357505342384,0.000850261623651435,0.0138394758330729,0.0266677856741033
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,40116,-0.00766808351987422,0.00347152310676626,-0.0144722688091361,-0.000863898230612343,0.0272055650057301
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",42674,-0.0162162784799425,0.00734190767924159,-0.030606417531256,-0.00182613942862896,0.027210312632747
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GP5,Platelet glycoprotein V,40283,-0.00821986408764647,0.00372371413509071,-0.0155183437924243,-0.000921384382868667,0.0273039499446711
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,40302,-0.0101746965855127,0.00461392126583715,-0.0192179822665535,-0.0011314109044719,0.027459297850424
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEPTIN3,Neuronal-specific septin-3,40482,-0.0170158374735614,0.00772019204381889,-0.0321474138794464,-0.00188426106767641,0.0275395870227718
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLNS1A,Methylosome subunit pICln,40182,-0.00755831810188342,0.00343806857610955,-0.0142969325110581,-0.000819703692708707,0.0279399768154001
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AMIGO2,Amphoterin-induced protein 2,42587,-0.00528479106208865,0.0024062391063631,-0.0100010197105603,-0.000568562413616976,0.0280885051217458
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD5L,CD5 antigen-like,40479,-0.0107702268067715,0.00491605440258552,-0.0204056934358392,-0.00113476017770393,0.0284846624088409
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TP53BP1,TP53-binding protein 1,40199,-0.0196163252550743,0.00896111939079371,-0.03718011926103,-0.00205253124911864,0.0286142468059348
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLIC5,Chloride intracellular channel protein 5,40182,0.00710987391054026,0.0032607048750832,0.000718892355377188,0.0135008554657033,0.0292436739814898
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,40080,0.0106912586716169,0.00492146551229438,0.00104518626751989,0.0203373310757139,0.0298490477349219
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,42311,-0.00899018849388438,0.00414786908322225,-0.017120011897,-0.000860365090768771,0.0302205167495666
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,42357,-0.0078935816744393,0.00365278278619395,-0.0150530359353795,-0.00073412741349916,0.0307150497744681
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPM3,Tropomyosin alpha-3 chain,40116,0.00976903251246347,0.00452057048631609,0.00090871435928393,0.018629350665643,0.0307156437007764
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTRC,Chymotrypsin-C,42626,0.0146705508984421,0.00679489425825982,0.00135255815225286,0.0279885436446314,0.0308635441991597
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PKLR,Pyruvate kinase PKLR,42636,-0.0143922850912014,0.00669066983551576,-0.0275059979688123,-0.00127857221359055,0.0314862488510541
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRNN,Cornulin,42209,0.0151571627609974,0.00707980285263857,0.00128074916982584,0.029033576352169,0.0323004785677943
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MST1,Hepatocyte growth factor-like protein,40370,-0.0144083103194411,0.0067536203493439,-0.0276454062041552,-0.00117121443472709,0.03291198400988
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,F2,Prothrombin,40539,0.0032639446999741,0.0015301347762217,0.000264880538579562,0.00626300886136863,0.0329371601640527
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NCLN,Nicalin,42370,-0.0113252646790906,0.00531169486599162,-0.0217361866164342,-0.000914342741747015,0.0330139714403249
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,40283,-0.00829719864150384,0.00389567421521877,-0.0159327201033326,-0.000661677179675049,0.033206020433443
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",42754,-0.0143356516997779,0.00674957991895008,-0.02756482834092,-0.00110647505863573,0.0336938429175542
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,40199,-0.0117593044655948,0.0055383840657688,-0.0226145372345017,-0.000904071696687939,0.0337562125263827
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,42297,-0.0122813427325387,0.005801740569574,-0.0236527542489038,-0.000909931216173681,0.0342924260002846
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,42346,-0.0103621762209944,0.00489919342434541,-0.0199645953327114,-0.000759757109277422,0.0344420539148175
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,THPO,Thrombopoietin,42357,0.00845548043214221,0.00399876180475676,0.000617907294818955,0.0162930535694655,0.0344892282836085
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDH6,Cadherin-6,42636,-0.00837560281283095,0.00397350538256392,-0.0161636733626562,-0.000587532263005659,0.0350613525571351
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,40302,-0.0117126396937938,0.00557714083738009,-0.0226438357350588,-0.000781443652528831,0.0357411776762541
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,40302,-0.00823628493945839,0.00393351608833842,-0.0159459764726017,-0.000526593406315075,0.0362938647348914
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,42311,0.00841996095668421,0.00406108917592043,0.000460226171880167,0.0163796957414883,0.0381614434183793
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",42602,0.0120476470553434,0.00585027562372284,0.000581106832846673,0.0235141872778402,0.0394819188975461
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,40302,-0.012156096735863,0.0059116715523759,-0.0237429729785197,-0.000569220493206223,0.039778115853673
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",40116,0.0101357103502155,0.00494355383057674,0.00044634484228513,0.0198250758581459,0.0403601283977078
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,42370,-0.00941967910302533,0.00460624856635104,-0.0184479262930734,-0.000391431912977289,0.0408768060949801
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,40116,-0.0175890970899174,0.00862032798054407,-0.0344849399317838,-0.000693254248051063,0.0413324245034367
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CBLN4,Cerebellin-4,42721,-0.00679352556230132,0.00333117866489422,-0.013322635745494,-0.00026441537910864,0.0414319162059815
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPM1B,Protein phosphatase 1B,40199,-0.0128393169960813,0.00629758128180452,-0.0251825763084182,-0.000496057683744496,0.0414968800662723
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LMNB1,Lamin-B1,40434,-0.0125364998761151,0.00615646127450604,-0.0246031639741469,-0.000469835778083232,0.0417420386647534
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPN1,Epsin-1,40302,-0.00934374288416594,0.00459286114255591,-0.0183457507235755,-0.000341735044756354,0.0419344124752535
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,40302,-0.0113836055507392,0.00560259115104486,-0.0223646842067871,-0.00040252689469125,0.0421929423355978
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLSTN1,Calsyntenin-1,42311,0.0110765234838239,0.00545557051478932,0.000383605274836869,0.021769441692811,0.042344724907517
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,40080,-0.00562236089641563,0.00277705193764791,-0.0110653826942055,-0.000179339098625733,0.0429349831210978
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD86,T-lymphocyte activation antigen CD86,40449,0.00633378861585838,0.00312940169322011,0.000200161297146974,0.0124674159345698,0.0429976883215737
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLKB1,Plasma kallikrein,40293,0.0051086892479906,0.0025315462213081,0.000146858654226719,0.0100705198417545,0.0436140824244842
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ECE1,Endothelin-converting enzyme 1,42311,0.00735602936225339,0.00364928182469529,0.000203436985850626,0.0145086217386561,0.0438467766258339
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,42425,0.0354837903832822,0.0176172300604234,0.000954019464852289,0.070013561301712,0.0440137104178377
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",40199,-0.00973472894913398,0.00487190682964746,-0.019283666335243,-0.000185791563024958,0.0457265583035096
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,40287,0.010335260074429,0.00517784760176947,0.000186678774960801,0.0204838413738971,0.0459525192253649
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,40527,-0.0291682664974327,0.0146132688266517,-0.05781027339767,-0.000526259597195287,0.04595645529345
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,42676,-0.0042399625318843,0.00212666020767698,-0.00840821653893118,-7.1708524837428e-05,0.0462029004843214
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NLGN2,Neuroligin-2,40136,0.00987787293455892,0.00496492500245144,0.000146619929754092,0.0196091259393637,0.0466674593119647
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,40136,0.0121577732253694,0.00611685984801945,0.000168727923251221,0.0241468185274875,0.0468825939045556
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CA4,Carbonic anhydrase 4,42794,0.0049088388289909,0.00247306632438361,6.16288331990299e-05,0.00975604882478278,0.0471734294323228
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,40199,-0.0081784964334035,0.00414246160005515,-0.0162977211695116,-5.92716972954085e-05,0.0483716585672077
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HCG22,Protein PBMUCL2,40116,0.0116043516945186,0.00587992400578032,7.97006431891879e-05,0.0231290027458481,0.0484575644910412
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,40451,-0.0184333327702703,0.00934316196560979,-0.0367459302228655,-0.00012073531767515,0.0485288408352368
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UNC5D,Netrin receptor UNC5D,40199,0.00532563013856657,0.00270081608157372,3.2030618682081e-05,0.0106192296584511,0.0486506398162069
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NPTXR,Neuronal pentraxin receptor,42636,0.00687340221449575,0.00348845518557271,3.60300507732383e-05,0.0137107743782183,0.0488212407790644
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",40223,-0.0172152861611065,0.00873725812414516,-0.034340312084431,-9.02602377820215e-05,0.0488254801668734
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTNNA1,Catenin alpha-1,40136,0.00715049631040688,0.0036333079257873,2.92127758637715e-05,0.01427177984495,0.0490886157517211
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,40451,-0.010848089582295,0.00553677286412546,-0.0217001643959809,3.98523139087149e-06,0.050104623074207
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FZD8,Frizzled-8,40136,-0.00925998831686429,0.00472663158395181,-0.0185241862214098,4.20958768126804e-06,0.0501253344332643
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCP2,Non-specific lipid-transfer protein,42346,-0.0148611926956028,0.00759849711101123,-0.0297542470331848,3.18616419792105e-05,0.0505090520850388
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,40116,-0.00812045856178256,0.0041530673147764,-0.0162604704987443,1.9553375179197e-05,0.0505741009375953
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ERVV_1,,40116,0.00878045543638533,0.00450175933378054,-4.29928578245219e-05,0.0176039037305952,0.0511480781481445
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,40182,-0.0152078895671778,0.00783819557613842,-0.0305707528964091,0.000154973762053484,0.0523774902657363
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NOP56,Nucleolar protein 56,40116,-0.022381637486375,0.0115428616486534,-0.0450056463177357,0.000242371344985649,0.0525267587875483
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,42794,0.00686031997401338,0.00354750253222839,-9.27849891542562e-05,0.013813424937181,0.0531529131528176
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANXA4,Annexin A4,42584,-0.0141010062481261,0.00731055565275361,-0.0284296953275232,0.00022768283127092,0.0537699012199195
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SAA4,Serum amyloid A-4 protein,40539,-0.00642876054644941,0.00333608073682345,-0.0129674787906234,0.000109957697724546,0.0539996059233344
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPA4,Carboxypeptidase A4,40060,-0.00880518026223402,0.00457206466733718,-0.0177664270102149,0.000156066485746851,0.0541472675222062
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,40182,0.00722338853383984,0.00375770489367353,-0.000141713057760284,0.01458849012544,0.0545954377227456
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RPS10,40S ribosomal protein S10,40116,0.00806246713408608,0.00419991202343377,-0.000169360431844116,0.0162942947000163,0.0549249540645067
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,40182,-0.021213206883129,0.0110737882691864,-0.0429178318907343,0.000491418124476308,0.0554389858991829
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C1R,Complement C1r subcomponent,40539,0.00381848483151174,0.00200021299900685,-0.00010193264654168,0.00773890230956515,0.0562822505676724
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RGS10,Regulator of G-protein signaling 10,40482,-0.0116317357621994,0.00609741483561043,-0.0235826688399958,0.000319197315597033,0.0564617684978855
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC1A4,Neutral amino acid transporter A,40182,-0.0102389329957272,0.00537256356653979,-0.0207691575861452,0.000291291594690764,0.0567046117941037
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,40116,0.0104563689213728,0.00550619028622075,-0.00033576403961985,0.0212485018823655,0.0575880895528711
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DLGAP5,Disks large-associated protein 5,40482,0.00994052667538519,0.00523710712180537,-0.000324203283353341,0.0202052566341237,0.0577090575968411
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,42721,-0.00660262653136924,0.00347922977851531,-0.0134219168972592,0.000216663834520774,0.0577533911631433
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BRK1,Protein BRICK1,42311,-0.00874655227718792,0.00461009159105987,-0.0177823317956653,0.00028922724128942,0.0578152890812348
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,40182,0.00735393766913631,0.00390679278779179,-0.000303376194935601,0.0150112515332082,0.0598153886544079
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",40482,0.00867679133556984,0.0046152419823174,-0.000369082949772257,0.0177226656209119,0.0601297809589065
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARG2,"Arginase-2, mitochondrial",40451,-0.00827991913929962,0.00440656349604806,-0.0169167835915538,0.000356945312954578,0.0602707325139734
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,42357,-0.00934492633227834,0.00499336667133325,-0.0191319250080915,0.000442072343534831,0.0613023930518599
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,40302,-0.0101477181320571,0.00542413068627119,-0.0207790142771486,0.000483578013034431,0.0613925746414773
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,42370,-0.00699378413950593,0.00375218379348443,-0.0143480643747354,0.000360496095723553,0.0623546504730064
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,40451,-0.0185216924199963,0.00996553362200096,-0.0380541383191182,0.00101075347912559,0.0631134739774597
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,40482,-0.0220537909839076,0.0118794222169057,-0.0453374585290428,0.00122987656122765,0.0634126313917107
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NTF4,Neurotrophin-4,42346,-0.00744155838262076,0.0040106401819379,-0.015302413139219,0.00041929637397752,0.0635537789450313
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRP2BP,LRP2-binding protein,40182,-0.0164672018322674,0.00889690766932246,-0.0339051408641394,0.0009707371996046,0.0642121273082434
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,40116,-0.0083738750170441,0.00454333958272061,-0.0172788205991765,0.000531070565088302,0.0653400180042062
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATXN2,Ataxin-2,40136,-0.0210023315394251,0.0113990564874911,-0.0433444822549078,0.00133981917605747,0.0654345977585613
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",42311,-0.00997829456467691,0.00543191672082507,-0.020624851337494,0.000668262208140225,0.0662362149660441
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,THBS4,Thrombospondin-4,42652,-0.00860490733075249,0.00469734569304843,-0.0178117048891274,0.000601890227622439,0.066993492874722
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,40136,0.00569425602263586,0.00311773816050896,-0.000416510771961713,0.0118050228172334,0.0678163456507012
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,40182,-0.0192924486221985,0.0106069085786913,-0.0400819894364335,0.00149709219203645,0.0689604757220323
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDIA2,Protein disulfide-isomerase A2,40080,0.0078885974382833,0.00435118991071649,-0.000639734786721018,0.0164169296632876,0.0698632463400897
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,42587,-0.00761787593464934,0.00421192494567843,-0.0158732488281791,0.000637496958880371,0.0705286287375643
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APOB,Apolipoprotein B-100,40532,0.00416878794811454,0.00230492085283005,-0.000348856923432356,0.00868643281966145,0.0705323578417875
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LTB,Lymphotoxin-beta,40451,-0.00666788392856182,0.00369160830389592,-0.0139034362041978,0.000567668347074178,0.0709095294519136
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL28,C-C motif chemokine 28,42538,-0.0107939713761277,0.00600549717982548,-0.0225647458485857,0.000976803096330192,0.0723029115489633
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MUC2,Mucin-2,40527,-0.0171001745748213,0.00956569630597031,-0.0358489393345231,0.00164859018488048,0.0738582324396415
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PFDN2,Prefoldin subunit 2,42311,-0.010124200416311,0.00568172433681731,-0.0212603801164729,0.00101197928385095,0.0747905103981489
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,42346,-0.00752166911448598,0.0042259054840424,-0.0158044438632091,0.000761105634237121,0.0751161872953668
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HLA_A,,40482,-0.00606400925713728,0.00341940856810113,-0.0127660500506155,0.000638031536340933,0.0761879483818668
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LCP1,Plastin-2,40527,-0.00874631933804994,0.00493329531667771,-0.0184155781587382,0.000922939482638366,0.0762694434643703
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCND2,G1/S-specific cyclin-D2,40302,0.00674921576405612,0.00380826560042301,-0.000714984812772989,0.0142134163408852,0.0763797291236771
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,40182,-0.00900030325121758,0.00507922185797662,-0.0189555780928518,0.000954971590416586,0.0764248095304947
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",40182,-0.0153539024169985,0.0086670593280889,-0.0323413387000528,0.0016335338660557,0.0765013396237135
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHIT1,Chitotriosidase-1,42699,-0.028025505788584,0.0158282433465904,-0.0590488627479011,0.00299785117073321,0.0766496054688252
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPB41L5,Band 4.1-like protein 5,40182,-0.0111791402263819,0.0063178545002056,-0.0235621350467848,0.00120385459402113,0.0768462073092287
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEP164,Centrosomal protein of 164 kDa,42370,-0.011920711662587,0.00676198867778011,-0.025174209471036,0.00133278614586201,0.0779404899530028
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLASP1,CLIP-associating protein 1,40080,-0.0131324092068004,0.00749816415970681,-0.0278288109598257,0.00156399254622493,0.079902335158816
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRR4,Proline-rich protein 4,40198,-0.0125832280499515,0.00718580621775717,-0.0266674082367556,0.00150095213685254,0.0799526456992756
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCARB1,Scavenger receptor class B member 1,42311,-0.0104293653531571,0.00596965007761146,-0.0221298795052755,0.0012711487989614,0.0806495058819744
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,40136,0.00585025726369756,0.00335367852120375,-0.000722952637861801,0.0124234671652569,0.081112223366256
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,40302,-0.00940420964954302,0.00540056328180383,-0.0199893136818785,0.00118089438279248,0.0816519167511682
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCN3B,Sodium channel subunit beta-3,40136,0.00865333730797371,0.00497401699123182,-0.00109573599484066,0.0184024106107881,0.0819384162481316
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DCUN1D1,DCN1-like protein 1,40136,-0.0134594182060229,0.00774161400196845,-0.0286329816498811,0.00171414523783523,0.0821367276624218
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BTC,Probetacellulin,42346,-0.0133148893932889,0.00766637093474636,-0.0283409764253917,0.00171119763881401,0.0824473584191628
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,YY1,Transcriptional repressor protein YY1,40199,-0.00505423633639919,0.00291032954855598,-0.0107584822515689,0.000650009578770533,0.0824761905030266
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NENF,Neudesin,40451,-0.0196265872106663,0.0113512745553653,-0.0418750853391823,0.00262191091784967,0.0838328300570525
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRR5,Proline-rich protein 5,40199,-0.00852354505195024,0.00493431523242589,-0.018194802907505,0.0011477128036045,0.0841235834085753
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEP290,Centrosomal protein of 290 kDa,40302,-0.00970978821361347,0.00562697757225953,-0.0207386642552421,0.0013190878280152,0.084451187012609
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL7,Interleukin-7,42594,-0.0111604530886113,0.00647257626332636,-0.0238467025647309,0.00152579638750837,0.0846826206891542
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GAD1,Glutamate decarboxylase 1,40080,0.00463932147324827,0.00270229754824487,-0.000657181721311685,0.00993582466780822,0.0860430142620995
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,40136,0.0138845789100841,0.00810449948063121,-0.00200024007195308,0.0297693978921213,0.0867052043435733
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,40080,-0.0104242935141123,0.00609921221421086,-0.0223787494539656,0.00153016242574101,0.087456985185658
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC12A2,Solute carrier family 12 member 2,40116,0.00478997247260608,0.00280981730374727,-0.000717269442738565,0.0102972143879507,0.0882737217046523
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD55,Complement decay-accelerating factor,42201,-0.00477069238632592,0.00279916129433149,-0.0102570485232156,0.000715663750563809,0.0883434820510972
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,40483,0.00549717703721026,0.00322959292710381,-0.000832825099913211,0.0118271791743337,0.0887591123933415
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,40182,-0.00698591557204601,0.00411704306776902,-0.0150553199848733,0.00108348884078126,0.0897574313237503
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,42311,-0.0148948109979975,0.00878064288382176,-0.0321048710502882,0.00231524905429314,0.0898483576844711
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,42346,-0.00684518763218897,0.00406398336421141,-0.0148105950260433,0.00112021976166539,0.092136955680736
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RYR1,Ryanodine receptor 1,40116,0.00596227872036448,0.00355804334900739,-0.00101148624369001,0.012936043684419,0.0938219866587112
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RLN1,Prorelaxin H1,40482,-0.00833611703346382,0.0049908123483737,-0.0181181092362763,0.00144587516934863,0.0948892071154776
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TOP1,DNA topoisomerase 1,40449,-0.0192885118938186,0.0115690798252852,-0.0419639083513776,0.00338688456374032,0.0954931521221798
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NRXN3,Neurexin-3,40182,-0.00609786569989173,0.00366503597936281,-0.0132813362194428,0.00108560481965937,0.096182073986018
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,40283,0.00458769660274278,0.00275924504886569,-0.000820423693033981,0.00999581689851954,0.096408032506479
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEZ6,Seizure protein 6 homolog,40182,0.00536951363801125,0.00323466535811311,-0.000970430463890444,0.0117094577399129,0.0969449064389767
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSCA,Prostate stem cell antigen,40449,-0.0455206050607163,0.0274445624848904,-0.0993119475311015,0.00827073740966889,0.0972165445432155
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",40116,0.0074069427428113,0.00446756851153202,-0.00134949153979146,0.0161633770254141,0.0973590989181791
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",40223,-0.0117975024021522,0.00712189156333708,-0.0257564098662928,0.00216140506198852,0.0976465213256728
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,40182,-0.0131191584999769,0.00794388650551079,-0.028689176050778,0.00245085905082429,0.0986694639451559
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DKK3,Dickkopf-related protein 3,42794,0.00509965081926541,0.00309630782614526,-0.000969112519979291,0.0111684141585101,0.0995790362315635
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,40136,0.010467718346695,0.00636492752287954,-0.00200753959814888,0.0229429762915389,0.100082396912759
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGA6,Integrin alpha-6,42594,-0.00854157427244891,0.00519381520095828,-0.0187214520663271,0.00163830352142932,0.100082705337688
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TET2,Methylcytosine dioxygenase TET2,40286,-0.0173187672143313,0.0105656208082026,-0.0380273839984085,0.00338984956974579,0.101207824514446
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CBLN1,Cerebellin-1,40136,0.0160655261517019,0.00980370368152374,-0.00314973306408465,0.0352807853674884,0.101300318876644
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,40451,0.00889427024027323,0.00543470241775359,-0.0017577464985238,0.0195462869790703,0.101748329037984
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FBLN2,Fibulin-2,40527,-0.00549628695450425,0.00336046420477166,-0.0120827967958567,0.00109022288684821,0.101956603579781
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DDI2,Protein DDI1 homolog 2,40283,-0.013217044176945,0.00808744832949529,-0.0290684429027558,0.00263435454886573,0.102231334891639
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,40417,-0.00727148588780331,0.00446694734726816,-0.0160267026884489,0.00148373091284229,0.103586396719321
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNPO1,Transportin-1,40302,0.00594954486389005,0.00365660811584133,-0.00121740704315896,0.0131164967709391,0.103751321241511
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DCC,Netrin receptor DCC,40182,-0.00387306148775632,0.00238878505054786,-0.00855508018683013,0.000808957211317484,0.104970854740128
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MSLNL,Mesothelin-like protein,40182,0.00656616419914249,0.00405834766562942,-0.00138819722549117,0.0145205256237762,0.105704168996582
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,42311,0.0101232102186385,0.00629694358497576,-0.00221879920791396,0.022465219645191,0.107938398608741
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GKN1,Gastrokine-1,42017,-0.00462371949321833,0.00288553962593717,-0.0102793771600552,0.00103193817361852,0.109097115724172
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLPS,Colipase,42590,-0.0119147628903945,0.00746186935276914,-0.026540026821822,0.00271050104103303,0.110344345217723
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,JCHAIN,Immunoglobulin J chain,42370,-0.0102279098085292,0.0064165470385111,-0.022804342004011,0.00234852238695252,0.110962330315215
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SAT1,Diamine acetyltransferase 1,40116,0.00843779049680461,0.00530083532652207,-0.00195184674317866,0.0188274277367879,0.111461947024563
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,40482,-0.00388821817753559,0.00244660486320385,-0.00868356370941514,0.000907127354343961,0.112036450915519
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,40182,0.00605912258330464,0.00382580393068684,-0.00143945312084157,0.0135576982874508,0.113279066654104
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DHODH,Dihydroorotate dehydrogenase,40116,-0.00789715897681123,0.00501712827842679,-0.0177307304025277,0.00193641244890528,0.115507241137303
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPRR1B,Cornifin-B,40302,-0.0134898064563259,0.00857106094051693,-0.0302890858997391,0.00330947298708724,0.115544076898005
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,40451,-0.00649894498730773,0.00413926800404713,-0.0146119102752401,0.00161402030062466,0.116426681408048
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,42357,0.00534593972414671,0.00342060737304924,-0.0013584507270298,0.0120503301753232,0.118108928933819
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGB2,Integrin beta-2,42569,-0.0045803109883187,0.00293340021537555,-0.0103297754104548,0.00116915343381739,0.118445031489588
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,40449,-0.00439814350064547,0.00281706778174116,-0.00991959635285814,0.00112330935156721,0.118493190617777
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NXPH3,Neurexophilin-3,40199,0.00494900266210666,0.00317245961223556,-0.00126901817787504,0.0111670235020884,0.118791193327046
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,40451,-0.0105929654902515,0.00679722671836825,-0.0239155298582533,0.00272959887775027,0.119160734664938
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL31,Interleukin-31,40199,0.00905864465704394,0.00581821397767962,-0.00234505473920813,0.020462344053296,0.119512075257669
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SAG,S-arrestin,40136,0.00838093207526899,0.00541323468781074,-0.00222900791284006,0.018990872063378,0.121595863139114
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,42346,0.00488387878158648,0.00315581306821087,-0.00130151483210682,0.0110692723952798,0.121747083380538
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39940,-0.0169222571532494,0.0109712409284919,-0.0384258893730935,0.00458137506659466,0.123001104749749
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENO1,Alpha-enolase,42588,-0.0124042372992432,0.00805642152562731,-0.0281948234894727,0.00338634889098637,0.123664230923519
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MMP10,Stromelysin-2,42608,-0.00914376241656568,0.00602469244549138,-0.0209521596097288,0.00266463477659742,0.129109980925314
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,40302,0.0110223165220679,0.00727568185839805,-0.00323801992039226,0.0252826529645281,0.12981274406066
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,40223,-0.00623549964812992,0.0041215207628929,-0.0143136803434,0.00184268104714016,0.130330578488683
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,40199,0.0140975527923657,0.00935065864693255,-0.00422973815562213,0.0324248437403535,0.131671949243024
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,42495,0.0106198308510647,0.00705665860688788,-0.00321122001843557,0.0244508817205649,0.132363865599421
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,40136,0.00651348745488576,0.00433069263793994,-0.00197467011547652,0.015001645025248,0.132602753284124
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SOX9,Transcription factor SOX-9,40182,-0.00429380756204264,0.00285509310068957,-0.0098897900393942,0.00130217491530893,0.132632876685747
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,42346,-0.00733409388442035,0.00487812061345759,-0.0168952102867972,0.00222702251795654,0.132742643781318
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,40116,0.00634741819434465,0.00423397211227408,-0.00195116714571254,0.0146460035344018,0.133860016810658
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARG1,Arginase-1,42488,-0.00792740302562869,0.00529843330775727,-0.0183123323088329,0.00245752625757556,0.134630833922658
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDCL2,Phosducin-like protein 2,40080,-0.00818212771771201,0.0054779362365782,-0.0189188827414053,0.00255462730598126,0.135295711721303
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNTF,Ciliary neurotrophic factor,40136,0.00530146023625757,0.00355065034459201,-0.00165781443914277,0.0122607349116579,0.135441009195162
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SKIV2L,Helicase SKI2W,40116,-0.00611759378147398,0.00410724293911116,-0.0141677899421319,0.00193260237918389,0.136393890278379
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,40116,-0.010268007623576,0.00689724861227322,-0.0237866149036315,0.00325059965647951,0.136592445247801
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ICAM3,Intercellular adhesion molecule 3,42794,-0.00410908258135843,0.00276056399083578,-0.00951978800339656,0.00130162284067969,0.136643883537358
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,42587,0.00399098826601848,0.00268241947394536,-0.00126655390291443,0.00924853043495139,0.136818871609804
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GFRA2,GDNF family receptor alpha-2,42587,-0.00324715635705764,0.00218507429357881,-0.0075299019724721,0.00103558925835682,0.137286202258335
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TUBB3,Tubulin beta-3 chain,40136,0.00431521411948748,0.00290598909855326,-0.00138052451367691,0.0100109527526519,0.137589011969109
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ESR1,Estrogen receptor,40199,-0.00847744048664758,0.00571022677674315,-0.0196694849690641,0.00271460399576898,0.137676701270189
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HIP1,Huntingtin-interacting protein 1,40116,-0.00510169209110099,0.0034468350331037,-0.0118574887559842,0.00165410457378226,0.138872961707992
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42662,-0.00747738985037702,0.00505998945116896,-0.0173949691746682,0.00244018947391413,0.139498595648803
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,40199,-0.00831869433185322,0.00565975506858349,-0.0194118142662769,0.00277442560257042,0.141645170104697
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TXK,Tyrosine-protein kinase TXK,40302,-0.0113590011450072,0.00774287208737408,-0.0265350304362604,0.00381702814624599,0.142397065454485
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,42794,-0.00239734275607128,0.00163645359575526,-0.00560479180375159,0.000810106291609027,0.142954330978734
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,42721,0.00875510936823514,0.00599303072357051,-0.00299123084996307,0.0205014495864333,0.144071114903531
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NINJ1,Ninjurin-1,42346,-0.00807871296986298,0.00554628561747671,-0.0189494327801173,0.00279200684039138,0.145251031580787
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,42794,-0.00610576831912835,0.00422219922115443,-0.014381278792591,0.00216974215433434,0.148169142936701
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NOS2,"Nitric oxide synthase, inducible",40116,-0.00594222331939842,0.0041093738952485,-0.0139965961540855,0.00211214951528864,0.148201208959046
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL11,Interleukin-11,42370,0.00922355438301633,0.00642084517518634,-0.00336130216034889,0.0218084109263816,0.150883403227007
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENPEP,Glutamyl aminopeptidase,40116,0.00705551898697097,0.00492089828138734,-0.00258944164454821,0.0167004796184902,0.151661740441848
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,40080,-0.011469875469813,0.00802433301957606,-0.0271975681881821,0.00425781724855605,0.152921793710716
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STAM,Signal transducing adapter molecule 1,40451,-0.00549619264218676,0.00385256248033196,-0.0130472151036374,0.00205482981926388,0.153713449986331
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTX3,Pentraxin-related protein PTX3,42594,0.00712162767017846,0.00500080462770804,-0.00267994940012931,0.0169232047404862,0.154441865266671
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,40182,-0.00528967848373766,0.003732621403318,-0.0126056164342409,0.00202625946676561,0.156467894160296
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,40116,0.00874038293510275,0.00617963264883759,-0.00337169705661893,0.0208524629268244,0.157277244827631
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",40199,-0.00412396061186872,0.0029332362284322,-0.00987310361959582,0.00162518239585838,0.159769519826068
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NMI,N-myc-interactor,40421,-0.0103909269291783,0.00741387501985526,-0.0249221219680946,0.00414026810973806,0.161076891270051
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,40145,-0.00552013895942085,0.0039542332585166,-0.0132704361461134,0.00223015822727169,0.162740560468042
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DENND2B,DENN domain-containing protein 2B,40116,0.00717527939990981,0.00515298148982217,-0.00292456432014165,0.0172751231199613,0.163813913054041
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RUVBL1,RuvB-like 1,42346,-0.01508982138371,0.0108616672740343,-0.0363786892408174,0.00619904647339728,0.164773262284273
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MMP13,Collagenase 3,42311,0.00475378326733483,0.00342379534721777,-0.001956855613212,0.0114644221478817,0.165022338085867
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",40268,-0.00909977091379341,0.00655391161422536,-0.0219454376776751,0.0037458958500883,0.165028342866533
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",42311,-0.00723615383433728,0.00521433485955511,-0.0174562501590653,0.00298394249039073,0.165239057233457
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,40182,0.00531840246594252,0.00383387427304757,-0.00219599110923073,0.0128327960411158,0.165404780500739
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GC,Vitamin D-binding protein,40539,-0.00368231745091393,0.00266433045388277,-0.00890440514052415,0.0015397702386963,0.166974392953707
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PCNA,Proliferating cell nuclear antigen,40080,-0.00890224887782884,0.0064580979061113,-0.021560120773807,0.00375562301814931,0.168088717668987
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PALLD,Palladin,40199,0.00554342331014457,0.00402381051369427,-0.0023432452966962,0.0134300919169853,0.168337796456721
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYOM1,Myomesin-1,40136,-0.00684459427337529,0.00497237748246442,-0.0165904541390055,0.00290126559225496,0.168687794134352
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KCNIP4,Kv channel-interacting protein 4,42311,0.00693525626292628,0.00506384208527442,-0.00298987422421158,0.0168603867500641,0.170846462087975
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL20,Interleukin-20,42370,0.00686447230830576,0.00503822189850766,-0.00301044261276926,0.0167393872293808,0.173070006433304
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAGEA3,Melanoma-associated antigen 3,40302,-0.0121997303804919,0.00895945108897014,-0.0297602545148734,0.0053607937538896,0.173332677815759
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UPK3A,Uroplakin-3a,40136,0.00718334569708753,0.00528069302027471,-0.00316681262265091,0.017533504016826,0.173761893685454
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,40449,0.020800445313912,0.0153231061742057,-0.00923284278753115,0.0508337334153551,0.174663522269008
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,40302,-0.00661966313282796,0.00488571599656137,-0.0161956664860882,0.00295634022043232,0.175476547630442
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SUMF1,Formylglycine-generating enzyme,40199,-0.00894982826403196,0.00662477187767218,-0.0219343811442694,0.00403472461620551,0.176734741675841
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,40116,0.00545612957705819,0.00404031344772943,-0.00246288478049149,0.0133751439346079,0.176908526034778
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,40116,0.00452223499791122,0.00335023755513274,-0.00204423061014895,0.0110887006059714,0.177100041402103
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,40302,0.00972646209830394,0.00720791617614321,-0.00440105360693676,0.0238539778035446,0.177231568498377
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACTN2,Alpha-actinin-2,40116,0.00827801145562175,0.00613533170889853,-0.00374723869381937,0.0203032616050629,0.177289088966242
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ABO,Histo-blood group ABO system transferase,40532,0.0202516382719243,0.0150114969205394,-0.00917089569233284,0.0496741722361815,0.177339752599817
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CGA,Glycoprotein hormones alpha chain,42611,0.00862746603784045,0.00645513470807783,-0.00402459798999209,0.021279530065673,0.181399532104689
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PYDC1,Pyrin domain-containing protein 1,40223,-0.0058923295675883,0.00441016148098383,-0.0145362460703166,0.00275158693514001,0.18155061722799
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IMPA1,Inositol monophosphatase 1,42495,-0.00821557807507074,0.00617500179654186,-0.0203185815962928,0.00388742544615131,0.18339035635166
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NECTIN1,Nectin-1,40199,-0.00448802880148319,0.00337612577406007,-0.0111052353186409,0.00212917771567454,0.183762425462462
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BRDT,Bromodomain testis-specific protein,40116,-0.00508683916433279,0.00383214505802221,-0.0125978434780563,0.00242416514939073,0.184399846845312
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,40080,0.00419417826718853,0.00316232716839732,-0.00200398298287021,0.0103923395172473,0.184769873455359
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PFDN4,Prefoldin subunit 4,40080,0.00718594582205455,0.00542215003080945,-0.00344146823833198,0.0178133598824411,0.1851012934375
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,42636,0.00449817971145764,0.00339531157097387,-0.00215663096765115,0.0111529903905664,0.1852530838625
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,42654,-0.0119972784646198,0.00905666797549835,-0.0297483476965966,0.00575379076735694,0.185296445483417
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",40080,-0.0075793611139298,0.00573354811241971,-0.0188171154142724,0.00365839318641282,0.186218549643672
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYL6B,Myosin light chain 6B,40182,-0.0123247893849263,0.00937841535007545,-0.0307064834710742,0.00605690470122153,0.188817967026347
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCN2B,Sodium channel subunit beta-2,40182,0.00394554513936539,0.00300386616518383,-0.00194203254439492,0.0098331228231257,0.189045653284861
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD99L2,CD99 antigen-like protein 2,42611,-0.00325385380138361,0.00247994973716636,-0.00811455528622968,0.00160684768346247,0.189520848406189
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,H2AP,Huntingtin-interacting protein M,40080,0.00711891456970299,0.0054386103021221,-0.00354076162245633,0.0177785907618623,0.190576077005696
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,40223,0.00533274159835519,0.00407902623296413,-0.00266214981825451,0.0133276330149649,0.1911189055941
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEP112,Centrosomal protein of 112 kDa,40116,-0.00601754935279986,0.00462804244075851,-0.0150885125366865,0.00305341383108682,0.19354738688012
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,42357,-0.010391701200096,0.00799632457197808,-0.026064497361173,0.00528109496098103,0.193774676734808
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CALCB,Calcitonin gene-related peptide 2,40483,-0.00545576749819647,0.00422321340493357,-0.0137332657718663,0.00282173077547333,0.196434782651783
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TCN1,Transcobalamin-1,40337,-0.00453748976746587,0.00353169662507093,-0.0114596151526049,0.00238463561767315,0.198892259463433
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PGR,Progesterone receptor,40199,-0.0129086187275915,0.0100984660014251,-0.0327016120903846,0.00688437463520156,0.201179365093016
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UNG,Uracil-DNA glycosylase,40451,-0.00449673982537213,0.00351902894820268,-0.0113940365638494,0.00240055691310512,0.201333813308728
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,40116,0.00340757483731863,0.00266836173469701,-0.00182241416268751,0.00863756383732477,0.201619220297958
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,40116,-0.00646447490265329,0.0050638026954087,-0.0163895281856543,0.00346057838034777,0.201768943279043
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TCP11,T-complex protein 11 homolog,40302,0.00772768164311956,0.00610904614685872,-0.00424604880472352,0.0197014120909626,0.205913222848504
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HRAS,GTPase Hras,40286,-0.0130113485879946,0.0102889512182889,-0.0331776929758408,0.00715499579985165,0.20604338382342
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BTLA,B- and T-lymphocyte attenuator,40080,-0.0114666949722296,0.00909359660001737,-0.0292901443082636,0.00635675436380447,0.207348958787927
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",40182,0.0102053581512976,0.00812678999376285,-0.00572315023647758,0.0261338665390728,0.209227006467146
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TEX33,Testis-expressed protein 33,40302,0.00494213645813328,0.00393722478671807,-0.00277482412383413,0.0126590970401007,0.209420412731132
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",40482,-0.00932787566328842,0.00743223525242169,-0.0238950567580349,0.00523930543145809,0.209484208109482
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,40136,-0.00963321309413328,0.00768344650410851,-0.024692768242186,0.00542634205391941,0.209955318611986
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CASQ2,Calsequestrin-2,40116,0.00634893101304337,0.00506604845468306,-0.00358052395813542,0.0162783859842222,0.210148332170455
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,42636,-0.00225082720996305,0.00179636023707736,-0.00577169327463467,0.00127003885470858,0.210229967258721
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,42346,-0.00678386309004701,0.0054381651848401,-0.0174426668523336,0.00387494067223958,0.212253141702951
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYOM2,Myomesin-2,40116,0.00648356274146305,0.00519911898674156,-0.00370671047255041,0.0166738359554765,0.212405805968255
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C5,Complement C5,40539,-0.00193084626829526,0.0015500454967856,-0.00496893544199503,0.00110724290540451,0.212911037218561
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,40177,-0.0048814891193438,0.00392548439149622,-0.0125754385266764,0.00281246028798879,0.213696178960404
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,40182,0.00651351152717714,0.00525247469085883,-0.00378133886690616,0.0168083619212604,0.214970687150164
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",40136,-0.0072820909505333,0.00588431238696142,-0.0188153432289777,0.00425116132791108,0.215912031133053
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,40136,0.00937436145704536,0.00757746770338443,-0.00547747524158811,0.0242261981556788,0.216062980753236
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HEBP1,Heme-binding protein 1,42357,0.00670974402515726,0.00542445035128225,-0.00392217866335595,0.0173416667136705,0.216129755308528
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,40182,-0.0106745558443465,0.00866558919433034,-0.027659110665234,0.00630999897654096,0.218037958566092
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FH,"Fumarate hydratase, mitochondrial",40136,-0.0108745120388847,0.00884338214331122,-0.0282075410397747,0.0064585169620053,0.218844165929137
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EXOSC10,Exosome component 10,40116,0.00766178470080652,0.00623083566053196,-0.00455065319383613,0.0198742225954492,0.218852422824483
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PROS1,Vitamin K-dependent protein S,40539,-0.00329904030698125,0.00268737780923599,-0.00856630081308379,0.0019682201991213,0.219620492867855
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARTN,Artemin,42370,-0.00559905305820613,0.00458086303953024,-0.0145775446156854,0.00337943849927314,0.221627273187141
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CA7,Carbonic anhydrase 7,40302,0.00442346235955601,0.00363377557393976,-0.00269873776536591,0.0115456624844779,0.223508905006967
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPSD1,Tryptase delta,40482,-0.00481799709313717,0.00395863513101729,-0.0125769219499311,0.00294092776365672,0.223597162613944
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,40116,0.00934519180445414,0.00768454732304804,-0.00571652094872002,0.0244069045576283,0.223972428212825
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,40302,0.0101423248417995,0.00837195174258984,-0.00626670057367656,0.0265513502572756,0.22574308851681
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,40136,-0.00875429007871667,0.00724931761635997,-0.0229629526067822,0.00545437244934887,0.227226510881838
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NGF,Beta-nerve growth factor,42495,0.00147573053625492,0.00122865385035208,-0.000932431010435151,0.003883892082945,0.229735569373803
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C9orf40,Uncharacterized protein C9orf40,40449,-0.0100543468975789,0.00837636602938663,-0.0264720243151767,0.00636333052001887,0.230039086697937
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LPA,Apolipoprotein(a),40324,0.0224343422761317,0.0187501428136481,-0.0143159376386186,0.0591846221908819,0.231531219871939
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTTG1,Securin,40302,-0.00505632439639009,0.00422702748395466,-0.0133412982649412,0.00322864947216105,0.231648287565463
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPLX2,Complexin-2,40080,0.0038956751559926,0.00327886462715473,-0.00253089951323067,0.0103222498252159,0.234813195635961
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ALMS1,Alstrom syndrome protein 1,40302,0.00546323386222394,0.00460230406664404,-0.00355728210839838,0.0144837498328463,0.235227386137194
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BMP4,Bone morphogenetic protein 4,42475,-0.00561721881374088,0.00476807603532125,-0.0149626478429705,0.00372821021548877,0.23878216132005
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GAD2,Glutamate decarboxylase 2,40199,0.00560194531993222,0.00476081970733116,-0.00372926130643686,0.0149331519463013,0.239350046688878
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,42357,0.00721914894991041,0.00615931970768037,-0.00485311767714311,0.0192914155769639,0.241190485502675
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CA8,Carbonic anhydrase-related protein,40199,-0.00345555224743283,0.00295683489934622,-0.00925094865015141,0.00233984415528576,0.242563562814471
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGF9,Fibroblast growth factor 9,40065,0.00497149106642536,0.00425439279243702,-0.0033671188067512,0.0133101009396019,0.242608677764304
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KHDC3L,KH domain-containing protein 3,40080,0.00831836307513706,0.00712708206453717,-0.0056507177713558,0.0222874439216299,0.243175973122918
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,40080,0.00303769438834203,0.0026037985906673,-0.00206575084936588,0.00814113962604994,0.243381524800912
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DUOX2,Dual oxidase 2,42357,0.00858035117725049,0.00735498934791556,-0.005835427944664,0.022996130299165,0.243391946377454
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAMA1,Laminin subunit alpha-1,40116,0.00648294167958918,0.00556233537655807,-0.00441923565846463,0.017385119017643,0.243839217991914
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,40302,-0.0075982656662385,0.00654034957121296,-0.0204173508258159,0.0052208194933389,0.245361087142091
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,40302,0.00346005590664357,0.00298916942545576,-0.00239871616724972,0.00931882798053687,0.247080420769114
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,42311,-0.0100007788958886,0.00865017066602176,-0.0269551134012913,0.00695355560951402,0.247646344497051
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PGM2,Phosphoglucomutase-2,40182,0.00711407058744294,0.00616493528775859,-0.00496920257656389,0.0191973437514498,0.248542872773363
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,REST,RE1-silencing transcription factor,40080,0.00408726752755881,0.00354217753030501,-0.002855400431839,0.0110299354869566,0.248572419179102
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FZD10,Frizzled-10,40182,-0.00719471097176354,0.00625650883384868,-0.0194574682861069,0.00506804634257986,0.250186949038445
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NPHS1,Nephrin,40199,0.00397969847719882,0.00346846154934672,-0.00281848615952075,0.0107778831139184,0.251242988011516
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,40283,-0.00510221828789526,0.00446993498892234,-0.013863290866183,0.00365885429039252,0.253706333083203
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,40302,-0.00748380186063653,0.00656788320021898,-0.0203568529330657,0.00538924921179267,0.254538346167203
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,40080,-0.00401686528548575,0.00352822794283351,-0.0109321920534394,0.00289846148246793,0.254939441946727
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPR101,Probable G-protein coupled receptor 101,40136,0.00710322804651863,0.00623994813864385,-0.00512707030522332,0.0193335263982606,0.25500041810517
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,40136,0.00630095352779036,0.00553645902854098,-0.00455050616814996,0.0171524132237307,0.255110470718864
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,40182,-0.00637673562648079,0.00562028187362116,-0.0173924880987783,0.0046390168458167,0.256570402463293
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TBR1,T-box brain protein 1,40182,0.00566375722675317,0.0050028722816443,-0.00414187244526965,0.015469386898776,0.257616635971148
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BRD3,Bromodomain-containing protein 3,40116,-0.00579970462852689,0.00513029980818118,-0.015855092252562,0.00425568299550822,0.258298574112121
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,42292,0.00653007713860314,0.0057773659618806,-0.00479356014668284,0.0178537144238891,0.258376335799031
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,40136,-0.0140363654150583,0.0124696285046785,-0.0384768372842281,0.0104041064541116,0.260340825992527
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MMP15,Matrix metalloproteinase-15,40511,-0.0056604774509379,0.00503269379206783,-0.0155245572833908,0.00420360238151505,0.260722622777396
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,42572,0.00392545590560223,0.00350549128983206,-0.0029453070224686,0.0107962188336731,0.262818281030521
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,42113,0.00432729652891775,0.00386583068181179,-0.00324973160743335,0.0119043246652689,0.263002954129764
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NEO1,Neogenin,40482,-0.00256323517092134,0.00229021723069163,-0.00705206094307693,0.00192559060123425,0.263074162128367
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,40116,0.00587661831944049,0.00525130033300743,-0.00441593033325407,0.0161691669721351,0.263131178808233
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINB5,Serpin B5,42357,-0.00560195629425404,0.00500648213295708,-0.0154146612748499,0.00421074868634184,0.263185884596292
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,42594,-0.0041055645390637,0.00367632743464675,-0.0113111663109713,0.00310003723284393,0.26411824601928
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLK12,Kallikrein-12,42346,-0.0160046767984834,0.0143489591287202,-0.044128636690775,0.0121192830938083,0.26470397294146
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZNF75D,Zinc finger protein 75D,40302,-0.00705125817907604,0.00633144893243557,-0.0194608980866498,0.00535838172849767,0.265437192048552
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,42346,0.00411067070411375,0.00370954057091402,-0.00316002881487773,0.0113813702231052,0.26782390231612
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGB7,Integrin beta-7,42721,-0.00522084042065908,0.00472216585378185,-0.0144762854940715,0.00403460465275335,0.268918082619611
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DKKL1,Dickkopf-like protein 1,42587,0.00992995409495603,0.0090210210720558,-0.00775124720627334,0.0276111553961854,0.27102211748506
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BRD2,Bromodomain-containing protein 2,40136,-0.00405468186812925,0.0036945502203767,-0.0112960003000676,0.00318663656380909,0.272457319459047
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL1A,Interleukin-1 alpha,42370,-0.00654590920500068,0.0059735698532587,-0.0182541061173877,0.00516228770738636,0.273181108344063
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KDM3A,Lysine-specific demethylase 3A,40199,-0.00989744451249083,0.00904774562218552,-0.0276310259319744,0.00783613690699279,0.274017178484279
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCIN,Adseverin,40136,-0.008191280554122,0.00753374025513183,-0.0229574114541804,0.00657485034593638,0.276937301091379
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DAND5,DAN domain family member 5,40199,-0.00618658320577934,0.00572286201503062,-0.0174033927552393,0.00503022634368067,0.279707637786415
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42649,-0.00237782036664215,0.0021996098009761,-0.00668905557655532,0.00193341484327101,0.27970796037397
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LMOD1,Leiomodin-1,40482,0.00397200179939385,0.0036837490505573,-0.00324814633969845,0.0111921499384861,0.280945318874508
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",40116,-0.00776281481195517,0.00721212316070725,-0.0218985762069414,0.00637294658303103,0.281791674940854
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MTR,Methionine synthase,40116,-0.00736682012347847,0.00684607773847732,-0.020785132490894,0.00605149224393708,0.281922251034618
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OTOA,Otoancorin,40136,0.00604172724865548,0.0056453955724546,-0.00502324807335554,0.0171067025706665,0.284550915240619
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,40429,-0.00435600456687728,0.00407216388922994,-0.012337445789768,0.00362543665601341,0.284776146910777
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPBGL,Trophoblast glycoprotein-like,40182,0.00462192727807355,0.00433129433995315,-0.00386740962823463,0.0131112641843817,0.285949804437033
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,40080,0.00338185742748051,0.0031749960528661,-0.00284113483613705,0.00960484969109806,0.286830200497057
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EVPL,Envoplakin,40302,0.00386070993891153,0.00363236342451112,-0.00325872237313026,0.0109801422509533,0.28786653423884
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",40199,-0.00474801343551836,0.00447114907939995,-0.0135114656311423,0.00401543876010555,0.288294210250047
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FOLR3,Folate receptor gamma,42629,-0.0202092114580397,0.0190375777939005,-0.0575228639340847,0.0171044410180054,0.288462187955944
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,40080,-0.00947112312874157,0.00893909676575047,-0.0269917527896125,0.00804950653212935,0.289387993510211
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAP1A,Ras-related protein Rap-1A,40199,-0.00776270170232174,0.00733058894076709,-0.0221306560262252,0.00660525262158175,0.289647374701096
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,40449,-0.00606640755085369,0.00574073305365202,-0.0173182443360116,0.00518542923430427,0.290657294593945
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,40080,0.00462958077930816,0.00438394478120597,-0.00396295099185555,0.0132221125504719,0.290977571880087
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OSTN,Osteocrin,40182,-0.00455470689935783,0.00431350748888523,-0.0130091815775729,0.00389976777885722,0.291029244619537
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGF20,Fibroblast growth factor 20,40199,0.0049188721501666,0.00465945397936111,-0.00421365764938117,0.0140514019497144,0.291139595853899
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,40116,0.00523970775222439,0.00497477278202671,-0.00451084690054797,0.0149902624049967,0.292247119871252
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGFL4,Insulin growth factor-like family member 4,40199,-0.00799632462391583,0.00760032321600331,-0.0228929581272823,0.00690030887945066,0.29277528974102
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FOSB,Protein fosB,42311,-0.00413887272735616,0.00393615648157105,-0.0118537394312354,0.0035759939765231,0.29304789174998
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LTO1,Protein LTO1 homolog,42370,-0.00452904587343719,0.00431347854504824,-0.0129834638217317,0.00392537207485736,0.293748732490316
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APOH,Beta-2-glycoprotein 1,42611,-0.00390349721932801,0.00373132722897329,-0.0112168985881157,0.00340990414945965,0.29551443519135
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDH23,Cadherin-23,40483,0.00280546276445934,0.00268972043618045,-0.00246638929045434,0.00807731481937303,0.296956103862203
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DCUN1D2,DCN1-like protein 2,40080,0.00860442447638959,0.00827531242876617,-0.0076151878839921,0.0248240368367713,0.298469701419518
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,40302,-0.00719132034026011,0.00691769926563515,-0.020750010900905,0.00636737022038479,0.298569891922902
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDC123,Cell division cycle protein 123 homolog,40080,-0.00677245204954331,0.00651954043489343,-0.0195507513019344,0.00600584720284782,0.298924154907734
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,40482,-0.00364938264834891,0.0035309073238202,-0.0105699610030365,0.00327119570633868,0.30136695376894
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,42618,0.00271872181844556,0.00264065275983805,-0.00245695759083701,0.00789440122772813,0.303233129180045
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,40451,-0.00469697153667918,0.00457766039025601,-0.013669185901581,0.00427524282822259,0.30488356757287
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,40223,0.00248884986852662,0.00243094706002204,-0.00227580636911657,0.00725350610616981,0.305943213890643
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,40136,-0.0118282266487963,0.0115720266221339,-0.0345093988281788,0.0108529455305862,0.306737430939433
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPC5,Glypican-5,42495,0.00585528144260557,0.00575169790547311,-0.00541804645212172,0.0171286093373329,0.308692095244618
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,40199,0.00306687673963495,0.00302618139648184,-0.00286443879746946,0.00899819227673936,0.310868619944497
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINA11,Serpin A11,42794,0.00424900616538942,0.00419466740606025,-0.00397254195048868,0.0124705542812675,0.311100035785636
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",40199,-0.00672987611296472,0.00664868346548014,-0.0197612957053058,0.00630154347937635,0.311459030764396
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APCS,Serum amyloid P-component,40419,-0.00354979606467736,0.00351129408025367,-0.0104319324619746,0.00333234033261982,0.31205488480823
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,42370,-0.00382543364836433,0.00379863107257968,-0.0112707505506205,0.00361988325389185,0.313926428677333
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PMCH,Pro-MCH,40116,-0.00880029706692088,0.0087422263264141,-0.0259350606666925,0.00833446653285076,0.314128876114774
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TSPAN7,Tetraspanin-7,40136,0.00978527460484022,0.00973793348488166,-0.00930107502552783,0.0288716242352083,0.314985758209502
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FAM171B,Protein FAM171B,40451,-0.0027296227807342,0.00272448165358961,-0.00806960682176984,0.00261036126030144,0.316419701762725
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,40116,0.00374383836838956,0.00374032413228224,-0.00358719693088362,0.0110748736676627,0.31687820712315
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,40284,0.00552791809689035,0.00552373770894914,-0.00529860781264997,0.0163544440064307,0.316966232362081
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRG2,Bone marrow proteoglycan,40527,0.0054265871983596,0.00543458914197419,-0.00522520751990981,0.016078381916629,0.318044911757044
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,40199,-0.00459244798480072,0.00460547888417205,-0.013619186597778,0.0044342906281765,0.31870365002976
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL17F,Interleukin-17F,42370,-0.00761174073640497,0.00774418620531951,-0.0227903456988312,0.00756686422602127,0.325675969171866
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,40511,-0.00335719550557884,0.00342779829711228,-0.0100756801679189,0.00336128915676122,0.327401893266511
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIF20B,Kinesin-like protein KIF20B,40136,-0.00790109732505351,0.00808345589903486,-0.0237446708871618,0.00794247623705481,0.32837272087531
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,42311,-0.00774507518440291,0.00793186382909694,-0.0232915282894329,0.0078013779206271,0.328859100062679
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,40539,-0.00198743658508342,0.00203704607579042,-0.00598004689363264,0.0020051737234658,0.32926054558397
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,40283,0.00281068029575781,0.0028808825580117,-0.00283584951794512,0.00845721010946074,0.32926830083077
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NLGN1,Neuroligin-1,40182,0.0070154567597167,0.0072051936895486,-0.00710672287179855,0.021137636391232,0.330243517949627
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FOS,Proto-oncogene c-Fos,40065,-0.00358851638604077,0.00368939286561986,-0.0108197264026557,0.00364269363057416,0.330745095458556
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,42315,-0.00287695247911427,0.00298615322211718,-0.00872981279446394,0.00297590783623539,0.335349048347651
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,42495,-0.00512277931932394,0.00532403883087396,-0.0155578954278369,0.00531233678918903,0.335967663619719
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SHPK,Sedoheptulokinase,40302,-0.00405606170950572,0.00423857350088961,-0.0123636657712494,0.00425154235223793,0.338618225195001
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,40223,-0.00547480893006662,0.0057358194252139,-0.0167170150034859,0.00576739714335262,0.339854237639564
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,40116,0.00665147532974023,0.00697331569648798,-0.00701622343537622,0.0203191740948567,0.3401822712877
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDH4,Cadherin-4,40136,0.00487071276328646,0.00513947603885785,-0.00520266027287493,0.0149440857994478,0.343300026530242
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,40199,-0.00283940892728871,0.003003297570682,-0.00872587216582544,0.00304705431124802,0.344459927240305
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CADPS,Calcium-dependent secretion activator 1,40182,0.00417250098443151,0.0044164054517662,-0.00448365370103023,0.0128286556698933,0.34479551141478
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD99,CD99 antigen,42611,0.00195342463843029,0.00206997223613157,-0.00210372094438759,0.00601057022124817,0.345341981735574
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL2,Interleukin-2,42370,-0.00310076349947237,0.00328746151234009,-0.00954418806365894,0.00334266106471421,0.34559127145289
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",42311,-0.00290863837091147,0.00308810818730213,-0.00896133041802364,0.00314405367620071,0.346269597635637
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,42711,-0.00273984095392236,0.00291565069263741,-0.00845451631149169,0.00297483440364696,0.347387553174508
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AOC3,Membrane primary amine oxidase,42689,-0.00290916336565971,0.00310190060589684,-0.00898888855321753,0.00317056182189811,0.348330683236327
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BLMH,Bleomycin hydrolase,42794,-0.00299097614352742,0.00320613377983729,-0.00927499835200851,0.00329304606495366,0.350892360680371
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLA2G1B,Phospholipase A2,42782,0.0043521327540698,0.00468031716253996,-0.00482128888450852,0.0135255543926481,0.352449801299384
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,42346,-0.0045785743539859,0.0049640059618848,-0.0143080260392801,0.00515087733130831,0.356360496998184
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAG,Myelin-associated glycoprotein,40182,0.00465320864314332,0.00505850002490011,-0.00526145140566091,0.0145678686919475,0.357656115324419
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",40116,-0.0056869707792667,0.00618619933343542,-0.0178119214728001,0.00643797991426671,0.357959171344403
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TP73,Tumor protein p73,40182,0.00325654954922113,0.00356476318440013,-0.00373038629220313,0.0102434853906454,0.360979271199601
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,40136,-0.00418245278351335,0.00458819138423967,-0.0131753078966231,0.00481040232959641,0.362015757753087
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PVALB,Parvalbumin alpha,42654,-0.0102343340484106,0.0112368442022729,-0.0322585486848655,0.0117898805880444,0.362425685460786
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,42370,-0.0036630906996358,0.00402264861838787,-0.011547481991676,0.00422130059240443,0.362514067078998
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",40483,-0.0024432893324255,0.00269106697052373,-0.00771778059465201,0.002831201929801,0.363936766801517
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",40080,-0.00864751389540013,0.00954096715924004,-0.0273478095275106,0.0100527817367103,0.364767455344343
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ROBO4,Roundabout homolog 4,40223,-0.00168815359013678,0.001875663609152,-0.0053644542640747,0.00198814708380113,0.36812391626544
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,40302,-0.00374928361448497,0.0041817456750813,-0.0119455051376443,0.00444693790867437,0.369960707166973
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,40116,0.00437787214039823,0.00490880357653835,-0.00524338286961695,0.0139991271504134,0.372497825719933
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLB,Beta-klotho,42311,0.00679415179728648,0.00765072904521543,-0.00820127713133577,0.0217895807259087,0.374535632730291
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,40136,0.00557457410499966,0.00630231307027004,-0.00677795951272962,0.0179271077227289,0.376430541735216
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,40116,-0.00905482667186889,0.0103111177595338,-0.0292646174805552,0.0111549641368174,0.37987539744801
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,40527,-0.00228416979665108,0.00260141530166613,-0.00738294378791669,0.00281460419461453,0.379935806186207
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINI1,Neuroserpin,40267,0.00273468456506728,0.00312088179055692,-0.00338224374442429,0.00885161287455885,0.380911076775655
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,40182,0.0037940493388458,0.00433328074984312,-0.00469918093084672,0.0122872796085383,0.381288160721318
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,40136,-0.00547634775822921,0.00625602205079076,-0.0177381509777791,0.00678545546132068,0.381390637928357
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGF16,Fibroblast growth factor 16,40199,-0.00426772458228951,0.00488758650005741,-0.013847394122402,0.00531194495782301,0.382586055160595
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,40136,0.00298451629997602,0.0034366445906443,-0.0037513070976868,0.00972033969763884,0.385173081963286
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL5,Interleukin-5,42370,0.0123302031278295,0.0142842839264524,-0.0156669933680173,0.0403273996236763,0.388042869790614
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,40283,0.00472645778501765,0.0054864498455194,-0.00602698391220036,0.0154798994822357,0.38899326509065
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TSLP,Thymic stromal lymphopoietin,42357,-0.00538272666160971,0.00627797757626744,-0.0176875627110939,0.00692210938787447,0.391240464726799
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,40116,-0.00518346993474144,0.00610755513253603,-0.0171542779945121,0.00678733812502918,0.396067949550691
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BPIFB2,BPI fold-containing family B member 2,40473,-0.00599120034124574,0.00707957940983423,-0.0198671759845208,0.00788477530202936,0.397422876250645
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TSPAN15,Tetraspanin-15,40116,0.00454310870046438,0.00537637508534527,-0.00599458646681235,0.0150808038677411,0.398121897395623
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HDAC8,Histone deacetylase 8,40199,-0.0051549112470442,0.00610257493370716,-0.0171159581171102,0.00680613562302184,0.398290664078222
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FRMD7,FERM domain-containing protein 7,40182,0.00291499433583421,0.00345118297341315,-0.00384932429205557,0.00967931296372398,0.398332337750817
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NPTX2,Neuronal pentraxin-2,40527,0.00282461107939748,0.00338009419095661,-0.00380037353487749,0.00944959569367244,0.403363560353218
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD109,CD109 antigen,42611,-0.00287707334717685,0.00344648986958387,-0.00963219349156125,0.00387804679720754,0.403854404012716
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEPTIN7,Septin-7,40302,-0.0046845977644854,0.00561500780837696,-0.0156900130689042,0.00632081753993345,0.404130219125743
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,S100A3,Protein S100-A3,40451,-0.003734496339159,0.00448894451974413,-0.0125328275978575,0.00506383491953949,0.405465007211953
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,40136,0.00347037813461713,0.00419742948317566,-0.00475658365240717,0.0116973399216414,0.408376097859012
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC4A1,Band 3 anion transport protein,40527,-0.00398847699167827,0.00482617878523028,-0.0134477874107296,0.00547083342737309,0.408580187560709
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FRZB,Secreted frizzled-related protein 3,42454,0.00210097767038243,0.00254766721421565,-0.00289245006948024,0.00709440541024509,0.409575373940297
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NEB,Nebulin,40116,-0.00326284666345861,0.0039616187972607,-0.0110276195060896,0.00450192617917237,0.410176620938641
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRC1,Protein regulator of cytokinesis 1,40451,-0.00378036581472975,0.00459281339450643,-0.0127822800679623,0.00522154843850285,0.410465951393168
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,40116,0.00608314150312508,0.00739394003524022,-0.00840898096594575,0.0205752639721959,0.410685265457059
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,42346,-0.00269108336873462,0.00327429273690633,-0.00910869713307103,0.0037265303956018,0.411158765015415
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",40482,0.00345960260650571,0.00420968633232858,-0.00479138260485832,0.0117105878178697,0.411196952190388
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CAPS,Calcyphosin,40483,0.00874361707346071,0.0106630546272229,-0.0121559699958961,0.0296432041428176,0.412238109290838
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,40080,-0.00480750331520901,0.00592799599155596,-0.0164263754586587,0.00681136882824067,0.417393226949591
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NPTN,Neuroplastin,42346,0.00655070817599148,0.00808349519995029,-0.00929294241591109,0.0223943587678941,0.417736092445454
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,40451,-0.00526718606521605,0.00657279880563856,-0.0181498717242676,0.00761549959383552,0.422939473370096
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,F13B,Coagulation factor XIII B chain,40479,-0.00213314457197515,0.00266386243925999,-0.00735431495292473,0.00308802580897443,0.42328091850411
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,40080,-0.00238223307055405,0.00298676591372917,-0.00823629426146322,0.00347182812035512,0.425122267913674
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,40199,0.00401034071355985,0.00505452755621339,-0.00589653329661839,0.0139172147237381,0.427552865158015
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,42679,-0.00223880986305431,0.00282436847076038,-0.00777457206574465,0.00329695233963603,0.427980404739027
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYL3,Myosin light chain 3,40223,-0.00599156544650885,0.00755949714357349,-0.0208081798479129,0.00882504895489519,0.428035048998965
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MUCL3,Mucin-like protein 3,40080,-0.0034720094327177,0.00439592955531252,-0.0120880313611302,0.00514401249569484,0.429647927810433
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TLR2,Toll-like receptor 2,40302,-0.00190870974498891,0.00241663174029731,-0.00664530795597164,0.00282788846599381,0.429648387644415
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,40116,0.00392907246809821,0.00499338107514213,-0.00585795443918035,0.0137160993753768,0.431383168616035
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TTN,Titin,40116,-0.00529549663675976,0.00677108912641308,-0.0185668313245294,0.00797583805100987,0.434187702919869
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,40223,-0.00203785819200302,0.00264176206578692,-0.00721571184094538,0.00313999545693934,0.440485743273233
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,40302,0.00589216277470099,0.0076424493140574,-0.0090870378808515,0.0208713634302535,0.440736177383945
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,40182,-0.00532925817585963,0.00695907267735836,-0.018969040623482,0.00831052427176274,0.44381173625849
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,40182,0.00362754795383929,0.00475208784311837,-0.00568654421867273,0.0129416401263513,0.44526584762243
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,40136,0.00452974941270008,0.00594524125356325,-0.00712292344428389,0.0161824222696841,0.446129073898282
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,42311,-0.00520920710643922,0.0068645875146474,-0.0186637986351481,0.00824538442226969,0.447954631074
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TSC1,Hamartin,40199,-0.00572781369407237,0.0075780892977339,-0.0205808687176308,0.00912524132948608,0.449762046201963
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDSN,Corneodesmosin,42710,0.00343622442765399,0.00456658920116161,-0.00551429040662276,0.0123867392619307,0.451781167015447
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,40182,-0.00331826961770049,0.00441450258991093,-0.0119706946939259,0.00533415545852493,0.452262847922107
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEMA4C,Semaphorin-4C,42587,0.00213561437576448,0.00285394458359422,-0.00345811700808019,0.00772934575960916,0.454290749280083
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,42346,-0.00938869988335366,0.0126187717830485,-0.0341214925781287,0.0153440928114214,0.456873769979921
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGA,Fibrinogen alpha chain,40284,0.00237144944711356,0.0031910614533499,-0.00388303100145224,0.00862592989567936,0.457404312312053
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLSPN,Claspin,42292,-0.00265248290926882,0.00359707883791946,-0.00970275743159097,0.00439779161305332,0.460892856017145
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRYBB2,Beta-crystallin B2,40483,-0.00619222512379261,0.00841046387514272,-0.0226767343190723,0.0102922840714871,0.461592340642813
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,40116,0.00369185051975778,0.00501755049714701,-0.00614254845465036,0.0135262494941659,0.461875880671167
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,40532,0.0028656088732218,0.00389788781930003,-0.00477425125260626,0.0105054689990499,0.462251378597113
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,40223,-0.0204163959148301,0.0279226026491638,-0.0751446971071912,0.034311905277531,0.464685900589406
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",40080,-0.00388419600320533,0.00531840701381813,-0.0143082737502889,0.0065398817438782,0.465203773504522
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",40080,0.00367195145868868,0.00505555640230687,-0.00623693908983279,0.0135808420072102,0.467658269832186
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,40116,-0.00392454347241154,0.00540752118064709,-0.0145232849864798,0.00667419804165677,0.468003628521279
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,40136,0.00476320034958462,0.00658989591637834,-0.00815299564651693,0.0176793963456862,0.469816017198314
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,42754,0.00270096418089972,0.00374576966087906,-0.00464074435442324,0.0100426727162227,0.470878541992772
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,40116,-0.0028137554429307,0.0039091896793542,-0.0104757672144649,0.00484825632860353,0.471676036395234
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",40116,-0.00367844366473561,0.00511144948194131,-0.0136968846493406,0.00633999731986936,0.471757236793921
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",40182,-0.00370060315716089,0.00514435851689167,-0.0137835458502686,0.00638233953594678,0.4719395336248
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,40511,-0.0020571666824942,0.00286913335477595,-0.00768066805785505,0.00356633469286666,0.473389309503416
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NPHS2,Podocin,40199,0.00768975229589916,0.0108455860251047,-0.013567596313306,0.0289471009051043,0.478326233101085
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDH22,Cadherin-22,40302,0.00205523505535218,0.00290038245711078,-0.00362951456058495,0.0077399846712893,0.478582460085443
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACTN4,Alpha-actinin-4,42370,-0.00236405607639906,0.00335478734003267,-0.00893943926286308,0.00421132711006496,0.481021014469632
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,40080,0.002288179702259,0.00325723818345364,-0.00409600713731013,0.00867236654182813,0.48238818741817
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TLR4,Toll-like receptor 4,40199,0.0021232434943512,0.00302545553028115,-0.00380664934499986,0.00805313633370225,0.482823109633741
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",40136,-0.00320539791477968,0.00460805215883073,-0.0122371801460879,0.00582638431652855,0.486689131915859
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,40136,-0.00357802652780094,0.00515952848621893,-0.01369070236079,0.00653464930518817,0.488023492494276
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APOE,Apolipoprotein E,40539,-0.00517439032293576,0.00748470612002927,-0.0198444143181931,0.00949563367232161,0.489373299089013
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,40110,-0.00245121367475331,0.0035487288512336,-0.00940672222317116,0.00450429487366454,0.489749884962738
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,42357,-0.00222069521523188,0.00325388635529914,-0.0085983124716182,0.00415692204115444,0.494950825284534
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HBZ,Hemoglobin subunit zeta,40511,0.00743993053290037,0.0109581440536136,-0.0140380318121823,0.028917892877983,0.497189289046918
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,40136,-0.00408500131056676,0.00604128259753425,-0.0159259152017339,0.00775591258060036,0.498939941472849
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,40116,-0.00226664317049394,0.0033603059626493,-0.00885284285728656,0.00431955651629868,0.499985672318467
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHP1,Calcineurin B homologous protein 1,40136,-0.0051493434261882,0.0076577966769998,-0.0201586249131078,0.00985993806073141,0.501323257033992
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENG,Endoglin,42794,0.00119249187330559,0.00178450946893568,-0.00230514668580835,0.00469013043241952,0.50398771759555
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STEAP4,Metalloreductase STEAP4,40136,0.00500322426191529,0.00752392133911156,-0.00974366156274337,0.019750110086574,0.506080101101913
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLXDC2,Plexin domain-containing protein 2,40483,-0.00186170224845696,0.00281122894566856,-0.00737171098196735,0.00364830648505342,0.507832310777048
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,42448,-0.00148038509213917,0.00224090901883315,-0.00587256676905215,0.0029117965847738,0.508868730048492
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEP152,Centrosomal protein of 152 kDa,40080,-0.00283217926221792,0.00430357975493157,-0.0112671955818838,0.00560283705744795,0.510488773791964
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EXTL1,Exostosin-like 1,40116,-0.003203962446618,0.00488305762567058,-0.0127747553929323,0.00636683049969634,0.511748791960274
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMEM132A,Transmembrane protein 132A,40223,0.00423428281550343,0.00645794070162427,-0.00842328095968014,0.016891846590687,0.512049670096298
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENOPH1,Enolase-phosphatase E1,40451,0.00371491211049209,0.00567174097521269,-0.00740170020092479,0.014831524421909,0.512490017540018
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRX,Cone-rod homeobox protein,42357,0.00707344093460235,0.0109332486653415,-0.0143557264494669,0.0285026083186716,0.517665183834227
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNTN2,Contactin-2,42721,0.00293775227618447,0.00456983305948342,-0.00601912052040302,0.011894625072772,0.520327348404837
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCARF2,Scavenger receptor class F member 2,42711,-0.00198944280868027,0.00310188635449588,-0.0080691400634922,0.00409025444613166,0.521296134544828
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD82,CD82 antigen,40302,0.00267489433822463,0.00422751632010141,-0.00561103764917414,0.0109608263256234,0.526920228781621
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEP350,Centrosome-associated protein 350,40080,-0.00246664245779173,0.00392565446526969,-0.0101609252097203,0.00522764029413686,0.529794960728254
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NME1,Nucleoside diphosphate kinase A,40199,-0.0014191135331387,0.00227262581486687,-0.00587346013027776,0.00303523306400036,0.532353031857544
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,40182,-0.00192877547768304,0.00310130886329534,-0.0080073408497419,0.00414978989437583,0.534005369152315
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PODXL2,Podocalyxin-like protein 2,42679,0.00179659549717374,0.00290177973259965,-0.00389089277872157,0.00748408377306906,0.535837409732082
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZNF174,Zinc finger protein 174,40199,-0.00239203222275896,0.00386541464852366,-0.00996824493386533,0.00518418048834741,0.536041561500723
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SHC1,SHC-transforming protein 1,40080,0.00754519950295752,0.0121992180134479,-0.0163652678034005,0.0314556668093155,0.536259647963363
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BCAM,Basal cell adhesion molecule,42611,-0.00155723292430686,0.0025251325447494,-0.00650649271201569,0.00339202686340197,0.537447347563991
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,40483,-0.0023971915234845,0.00388728894021253,-0.0100162778463011,0.00522189479933206,0.537461954273734
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,42636,0.00178154627815413,0.00291482643530126,-0.00393151353503635,0.00749460609134461,0.54107652841768
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,40451,0.00282896146269601,0.00463118989744416,-0.00624817073629454,0.0119060936616866,0.541311348447708
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ECM1,Extracellular matrix protein 1,40269,0.00233958228828249,0.00384912608276221,-0.00520470483393143,0.00988386941049642,0.543318210733011
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LBP,Lipopolysaccharide-binding protein,42689,-0.00364836939333724,0.00602615962741588,-0.0154596422630724,0.00816290347639788,0.544908842173949
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,40302,-0.00392108562370919,0.00649458141290752,-0.0166504651930079,0.00880829394558954,0.546024028130413
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DUSP29,Dual specificity phosphatase 29,40182,0.00417834503019557,0.00694402481384021,-0.00943194360493124,0.0177886336653224,0.547374251130778
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,42587,-0.00122682894623809,0.00205268282686388,-0.0052500872868913,0.00279642939441512,0.550069601121853
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,40136,0.00480699600631457,0.00805064632214555,-0.0109722707850907,0.0205862627977198,0.550456696937683
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,40482,-0.00463485366359529,0.00777898329664447,-0.0198816609250184,0.0106119535978279,0.551309159143297
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42653,0.00300979877219036,0.00505195983673708,-0.00689204250781432,0.012911640052195,0.551339876458584
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RBM19,Probable RNA-binding protein 19,40116,-0.00295432242172051,0.00498135730321191,-0.0127177827360159,0.00680913789257484,0.553142711252863
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IFNL2,Interferon lambda-2,40136,-0.00378834742950326,0.00639626609632223,-0.0163250289782948,0.00874833411928832,0.553678804320534
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SHH,Sonic hedgehog protein,40199,-0.00257781731927041,0.00436159551163739,-0.0111265445220797,0.00597090988353887,0.554514989311392
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",40116,-0.00239736464959408,0.00406706477290181,-0.0103688116044816,0.00557408230529347,0.555566142069072
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,40136,-0.00327275251903528,0.00556376008917006,-0.0141777222938086,0.00763221725573804,0.556392244565968
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IKZF2,Zinc finger protein Helios,42346,-0.00530279199743521,0.00904140505098012,-0.0230239458973562,0.0124183619024858,0.557549037770974
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRKCQ,Protein kinase C theta type,42370,0.00260867123147136,0.00448859540543313,-0.00618897576317757,0.0114063182261203,0.561130685057234
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ROBO2,Roundabout homolog 2,42711,0.00138733422399629,0.00239702272634749,-0.00331083031964479,0.00608549876763737,0.562751378800556
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SOX2,Transcription factor SOX-2,40461,0.00140627584093219,0.00246684468095403,-0.00342873973373771,0.00624129141560208,0.568641122705117
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,40080,0.00388390020905713,0.00681496416284066,-0.00947342955011056,0.0172412299682248,0.568752096795562
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CENPJ,Centromere protein J,40302,-0.00414870010183886,0.00731080959494358,-0.0184778869079283,0.0101804867042506,0.570403121462424
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,40199,-0.00254515490489392,0.00449288232146903,-0.0113512042549732,0.00626089444518537,0.571075003978523
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC44A4,Choline transporter-like protein 4,40182,0.00413800541173373,0.0073533538842503,-0.0102745682013969,0.0185505790248643,0.573625363673288
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,40116,0.00225257491101205,0.00400880891807402,-0.00560469056841304,0.0101098403904371,0.574191404309831
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,40080,0.00339680463274556,0.00606263272358759,-0.00848595550548611,0.0152795647709772,0.575296310363923
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,39633,-0.00316052576065857,0.00564924123986155,-0.0142330385907872,0.00791198706947008,0.575859673809167
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGF7,Fibroblast growth factor 7,40080,0.00456531858833008,0.00818735288319428,-0.0114818930627307,0.0206125302393909,0.577124799130349
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,42586,-0.00342770846288511,0.00622044273884267,-0.0156197762310167,0.00876435930524653,0.581615921292901
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,42475,-0.00192895455661616,0.00351246249048087,-0.00881338103795867,0.00495547192472634,0.582894989092224
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PFDN6,Prefoldin subunit 6,40182,-0.00366354594241311,0.00668004371992911,-0.0167564316334742,0.00942933974864794,0.583406841043558
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,40182,0.00203261997454553,0.00374066756449875,-0.00529908845187201,0.00936432840096307,0.586876265728239
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGB6,Integrin beta-6,42370,0.00171622793239808,0.00319738214095922,-0.00455064106388198,0.00798309692867814,0.591442231315465
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,40080,-0.00249925341822847,0.00466999345717539,-0.0116524405942922,0.00665393375783529,0.59254131298268
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL9,Interleukin-9,40302,0.00303562589077132,0.0058048575991463,-0.00834189500355542,0.0144131467850981,0.601022402937465
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,40080,-0.00344807840798721,0.00661011308404777,-0.0164039000527208,0.00950774323674642,0.601933830146014
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COPE,Coatomer subunit epsilon,42311,-0.00254014981819594,0.00487099615753694,-0.0120873022869683,0.00700700265057645,0.60203798722636
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",40223,-0.00236640613977294,0.00454757378435488,-0.0112796507571085,0.00654683847756263,0.602818433241825
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,40527,0.00210680467692844,0.00407484707610403,-0.00587989559223547,0.0100935049460923,0.605147620477541
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CAPN3,Calpain-3,40451,0.00202842571212536,0.0039437500781189,-0.00570132444098768,0.0097581758652384,0.607024876359153
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CASP4,Caspase-4,40302,-0.00903082217858749,0.0178267268244192,-0.0439712067544492,0.0259095623972742,0.61245334345392
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,40302,0.00208506990844234,0.00412122099483682,-0.00599252324143783,0.0101626630583225,0.612912326938472
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYH4,Myosin-4,40116,0.00232728293506099,0.00467836912682525,-0.0068423205535165,0.0114968864236385,0.618877516393887
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRH,Corticoliberin,42322,-0.004382929991188,0.00882079477981339,-0.0216716877596222,0.0129058277772462,0.619277720686244
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,40136,0.00464775844636151,0.0093857798808391,-0.0137483701200831,0.0230438870128062,0.620474891594595
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,40199,0.00209798239294114,0.0042420475262772,-0.00621643075856218,0.0104123955444445,0.620914729280596
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSMA1,Proteasome subunit alpha type-1,42346,-0.00234942765350282,0.00475147175454332,-0.0116623122924077,0.0069634569854021,0.620987389253596
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEZ6L,Seizure 6-like protein,42679,0.0014179559297079,0.00287926961120364,-0.00422541250825123,0.00706132436766704,0.622394645517568
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLK15,Kallikrein-15,40429,-0.00269412138885472,0.00550618801092093,-0.0134862498902597,0.00809800711255032,0.624646124417898
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PAPPA,Pappalysin-1,42370,0.00233755631997537,0.00478757850626505,-0.00704609755230413,0.0117212101922549,0.625377774255384
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANK2,Ankyrin-2,40116,0.00365604810500703,0.00759618187899211,-0.0112324683778175,0.0185445645878316,0.630312399742034
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AFAP1,Actin filament-associated protein 1,40283,0.00412484902436603,0.00857238875026195,-0.0126770329261474,0.0209267309748794,0.630399145469714
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPGN,Epigen,40451,-0.00225709574108837,0.0046941750096461,-0.0114576787599947,0.00694348727781798,0.630647341963574
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZNF830,Zinc finger protein 830,40451,-0.00384576395811749,0.00799860291676406,-0.019523025674975,0.0118314977587401,0.630664824115461
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ESPL1,Separin,40080,0.00284394852859912,0.00593991018768338,-0.0087982754392603,0.0144861724964585,0.632100171447193
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD33,Myeloid cell surface antigen CD33,42679,-0.00393227441434726,0.00822172655937336,-0.020046858470719,0.0121823096420245,0.632459804975691
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MORN4,MORN repeat-containing protein 4,40080,-0.0037842087008054,0.00793985541397552,-0.0193463253121974,0.0117779079105866,0.633649946656648
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HK2,Hexokinase-2,42357,0.00134097358852169,0.00283856121818718,-0.00422260639912518,0.00690455357616855,0.636639766506862
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL21R,Interleukin-21 receptor,40199,0.00271148165591597,0.00577765372236972,-0.00861271963992868,0.0140356829517606,0.638860954593397
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,40449,-0.00123934630344162,0.00264566365835696,-0.00642484707382125,0.00394615446693802,0.639475900637243
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,40116,-0.00461818017021668,0.00986823782866021,-0.0239599263143907,0.0147235659739573,0.639805169786996
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,40182,-0.00343712429586819,0.00734933942870986,-0.0178418295761395,0.0109675809844031,0.640024157780455
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,42587,-0.00162362979699226,0.0034789263280587,-0.0084423253999873,0.00519506580600278,0.640719060670796
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GSAP,Gamma-secretase-activating protein,42346,0.00409963197152232,0.00879766660928565,-0.0131437945826776,0.0213430585257222,0.641229780894965
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,40116,-0.00161588081476091,0.00350153927682186,-0.00847889779733176,0.00524713616780994,0.644465409732322
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,42594,-0.00226079286187262,0.00490702937378725,-0.0118785704344956,0.00735698471075039,0.645003136795076
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,42592,-0.00230857667386876,0.00502210482037996,-0.0121519021218135,0.00753474877407596,0.645751165951291
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DEFB116,Beta-defensin 116,40136,0.0036322727268693,0.00795582353222174,-0.0119611413962853,0.0192256868500239,0.647999837346521
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",40199,-0.0013332319595482,0.00293588663404861,-0.00708756976228347,0.00442110584318707,0.64975457175411
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPHA10,Ephrin type-A receptor 10,42311,0.00307614717747815,0.00687683399257141,-0.0104024474479618,0.0165547418029181,0.654651226230501
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AMBN,Ameloblastin,42370,0.00130990752984741,0.00293560140031436,-0.00444387121476873,0.00706368627446356,0.655449736244324
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",40136,0.00252248195542579,0.00567127733406548,-0.00859322161934254,0.0136381855301941,0.656486116441883
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,40182,-0.00236677546509254,0.00534147393600357,-0.0128360643796595,0.00810251344947447,0.657706412058926
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,40302,-0.00198923796837683,0.00452977194561139,-0.0108675909817752,0.0068891150450215,0.660563214138527
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",41948,-0.00131635354026081,0.0030148697248809,-0.00722549820102738,0.00459279112050575,0.662394077237437
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",42311,0.00182712255611902,0.0042011844527588,-0.00640719897128822,0.0100614440835263,0.663637428715952
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,40136,0.00229607463418867,0.00530704184788523,-0.00810572738766638,0.0126978766560437,0.665279916389379
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,40080,0.00255042210431434,0.00595528836411759,-0.00912194308935613,0.0142227872979848,0.668469050006923
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,40136,-0.00273512647155607,0.00638740338099813,-0.0152544370983124,0.00978418415520026,0.66850934635208
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,40116,0.00166663188081857,0.00389308799195053,-0.00596382058340448,0.00929708434504162,0.668586587552128
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VIT,Vitrin,40511,0.00169033424445821,0.00396845439278857,-0.0060878363654074,0.00946850485432381,0.670157687849487
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RASA1,Ras GTPase-activating protein 1,42311,-0.00141348883675287,0.00332571832613153,-0.00793189675597067,0.00510491908246493,0.670830812991809
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,40080,0.00368457912892751,0.00873394536720294,-0.0134339537907903,0.0208031120486453,0.673129108397863
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NXPE4,NXPE family member 4,40116,-0.00145472697268451,0.00347794750240903,-0.0082715040774062,0.00536205013203718,0.675756710697003
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNPY2,Protein canopy homolog 2,42357,-0.00263155447602723,0.00634398041905233,-0.0150657560973698,0.00980264714531534,0.678286840255446
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,40080,0.00214571260169605,0.00522034978736905,-0.00808617298154729,0.0123775981849394,0.681059719244435
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,40199,-0.00207576346389123,0.00505595892787336,-0.011985442962523,0.00783391603474056,0.681404792684456
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCS,Copper chaperone for superoxide dismutase,42495,0.00197616060255113,0.00485494027086039,-0.00753952232833523,0.0114918435334375,0.683984295268233
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD177,CD177 antigen,42595,-0.00549274805604255,0.0135033852064268,-0.031959383060639,0.0209738869485539,0.684184721150427
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,40182,-0.00328855769748536,0.00810209879755454,-0.0191686713406923,0.0125915559457215,0.684831618219139
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DLL4,Delta-like protein 4,40223,-0.00355392508193865,0.0088353514440976,-0.0208712139123699,0.0137633637484926,0.687515758504377
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,42346,-0.00238020558284777,0.00592547721165309,-0.0139941409176878,0.00923372975199228,0.687918632043369
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINF2,Alpha-2-antiplasmin,40317,0.000555671584764826,0.00138906367657712,-0.00216689322132633,0.00327823639085598,0.689139747153044
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TAP1,Antigen peptide transporter 1,40302,-0.00253872467520348,0.00635858329140637,-0.01500154792636,0.009924098575953,0.689709694035979
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,40136,-0.00206546908200539,0.00519694438156176,-0.0122514800698664,0.00812054190585566,0.69105141347429
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DSG3,Desmoglein-3,42651,0.00142732974270429,0.00360215515454496,-0.00563289436020383,0.00848755384561241,0.691931854655613
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CYTL1,Cytokine-like protein 1,40527,0.00104230772373855,0.00263112543705303,-0.00411469813288539,0.00619931358036248,0.692005369969858
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ISM2,Isthmin-2,40527,0.00176668313395566,0.00446020831954453,-0.00697532517235161,0.0105086914402629,0.69203960524049
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NRN1,Neuritin,40482,-0.00148455691363436,0.00375017619931761,-0.00883490226429688,0.00586578843702815,0.692213399829595
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,40080,0.00236008707128407,0.00597964278322105,-0.00936001278382918,0.0140801869263973,0.693081654939979
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,40302,-0.00149339377526202,0.00380210959859868,-0.00894552858851544,0.0059587410379914,0.694489287874818
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,40302,-0.00321393887471207,0.00824590951925322,-0.0193759215324484,0.0129480437830242,0.696720315016116
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FAM171A2,Protein FAM171A2,40482,0.00641744084861407,0.0164865538483217,-0.0258962046940964,0.0387310863913245,0.697096329637632
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DCLRE1C,Protein artemis,40080,-0.00125305191658493,0.00322702681707964,-0.00757802447806103,0.00507192064489117,0.697802225789937
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,INHBB,Inhibin beta B chain,40283,-0.00218390963077725,0.0056332083440515,-0.0132249979851182,0.00885717872356369,0.698256696660156
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,40449,0.00185444681613219,0.00480250985202007,-0.00755847249382716,0.0112673661260915,0.69939941287804
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C1S,Complement C1s subcomponent,40539,-0.000824465458990448,0.00213992842945291,-0.00501872518071815,0.00336979426273725,0.700039335356578
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SHD,SH2 domain-containing adapter protein D,40083,-0.0034674486155789,0.00906334764958197,-0.0212316100087596,0.0142967127776018,0.702039235672871
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGF3,Fibroblast growth factor 3,40199,-0.00114914354287976,0.0030042485192782,-0.00703747064066503,0.00473918355490551,0.702093352819074
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,42346,-0.00176608707584192,0.00463368863689747,-0.010848116804161,0.00731594265247712,0.703105045635276
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",40199,0.00166242572466318,0.00438389754744688,-0.0069300134683327,0.0102548649176591,0.704537898418956
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNAP25,Synaptosomal-associated protein 25,40136,0.00184755814450862,0.00488454415407419,-0.00772614839747679,0.011421264686494,0.705255367861498
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,40182,0.00143688553867847,0.00380092988287382,-0.00601293703175422,0.00888670810911117,0.705411698636499
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TERF1,Telomeric repeat-binding factor 1,40199,0.00115402998736805,0.00305313666834192,-0.00483011788258211,0.00713817785731821,0.705451430116779
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,42794,-0.00106239832878412,0.00282489541815532,-0.00659919334836856,0.00447439669080031,0.70686022023499
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MN1,Transcriptional activator MN1,40182,0.00225611440664137,0.00611380330548649,-0.00972694007211214,0.0142391688853949,0.712120084739746
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EVI2B,Protein EVI2B,40080,0.00155773410962487,0.00422796151364197,-0.00672907045711338,0.00984453867636313,0.712555167174246
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LEG1,Protein LEG1 homolog,39926,-0.0026347267562902,0.00721626335019579,-0.0167786029226739,0.0115091494100936,0.715036817693341
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,42173,0.00317050517404022,0.00883761482929322,-0.0141512198913745,0.0204922302394549,0.719787036584306
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPB2,Carboxypeptidase B2,40516,0.000818906404619771,0.00228282178898915,-0.00365542430179896,0.0052932371110385,0.719807133283839
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,40182,-0.00264727321457977,0.0073940210012979,-0.0171395543771236,0.0118450079479641,0.72032856252346
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,40223,-0.00136641202998014,0.00382028119761171,-0.00885416317729909,0.00612133911733881,0.720594769105109
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,40449,-0.00641777861878203,0.018063507876597,-0.0418222540569122,0.0289866968193482,0.72237921530978
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GLI2,Zinc finger protein GLI2,40199,-0.00117191023256584,0.00331366159042928,-0.00766668694980722,0.00532286648467554,0.723600325160844
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGLON5,IgLON family member 5,40080,0.00343993524592898,0.00978637377385061,-0.0157413573508182,0.0226212278426762,0.725218169704594
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LHB,Lutropin subunit beta,42346,0.00302406177614065,0.00865759035226172,-0.0139448153142923,0.0199929388665736,0.726872684906305
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPT1,Translationally-controlled tumor protein,42370,0.00231562713635395,0.00669721502828676,-0.0108109143190881,0.015442168591796,0.729528825420691
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HMMR,Hyaluronan mediated motility receptor,40059,-0.00176152648718659,0.00513079136349722,-0.0118178775596411,0.00829482458526795,0.731360978289979
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,42346,-0.00197987740521148,0.00581958977761405,-0.013386273369335,0.00942651855891205,0.73370449834954
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,42711,-0.00165113501702494,0.00487672629735484,-0.0112095185598404,0.00790724852579055,0.73493557732217
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SULT1A1,Sulfotransferase 1A1,42711,-0.00440216828900514,0.0130486776018763,-0.0299775763886827,0.0211732398106724,0.735846936396733
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,40527,0.00104026982519934,0.00309302808183698,-0.00502206521520114,0.00710260486559982,0.736630282078588
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",40116,-0.00301201028869095,0.00907727814758673,-0.0208034754579609,0.014779454880579,0.740032558660646
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NUP50,Nuclear pore complex protein Nup50,40116,0.00118363365625243,0.00358147263013663,-0.00583605269881536,0.00820332001132022,0.741037612325207
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,42346,-0.00176371280591917,0.00536085515536518,-0.0122709889104349,0.00874356329859657,0.742162130658592
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPR158,Probable G-protein coupled receptor 158,40482,0.00120215186847746,0.00371259824325885,-0.00607454068830988,0.0084788444252648,0.746092894241522
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,40116,0.00204081973073222,0.00632334836272671,-0.0103529430602121,0.0144345825216766,0.746895665494146
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL24,Interleukin-24,42370,0.00165668939054549,0.00517899597077494,-0.00849414271217339,0.0118075214932644,0.749059664191031
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BRD1,Bromodomain-containing protein 1,40302,0.0010064976133866,0.00315642938649886,-0.00518010398415117,0.00719309921092437,0.74982941410862
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CYTH3,Cytohesin-3,40080,-0.00241614164284293,0.00771315744086527,-0.0175339302269389,0.012701646941253,0.754097220342704
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RGMA,Repulsive guidance molecule A,42711,0.00101454162535578,0.00328066627464351,-0.00541556427294551,0.00744464752365707,0.757137153474958
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,40182,0.001301271795045,0.00422638562281338,-0.00698244402566921,0.00958498761575922,0.758170084030162
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,42794,-0.000707140596963046,0.00233502311191679,-0.00528378589631996,0.00386950470239387,0.762015712741431
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MANSC4,MANSC domain-containing protein 4,40116,-0.00220869186139508,0.00738625662222498,-0.016685754840956,0.0122683711181659,0.7649249579926
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYO6,Unconventional myosin-VI,40482,0.00109948017075506,0.00374699150700577,-0.00624462318297624,0.00844358352448636,0.769198799374838
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",40116,0.00157149353316161,0.00536206651075831,-0.00893815682792467,0.0120811438942479,0.76946955348326
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RTKN2,Rhotekin-2,40116,0.00154760462746055,0.0053239632323772,-0.00888736330799877,0.0119825725629199,0.77129656070524
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGF12,Fibroblast growth factor 12,40199,0.0013851494793811,0.0048347322736937,-0.00809092577705856,0.0108612247358208,0.774500795265945
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATP1B4,Protein ATP1B4,40080,-0.00123619722945631,0.00436601823404227,-0.00979359296817917,0.00732119850926655,0.777074407599139
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLC,Galectin-10,42611,-0.00190820093482293,0.00676451378171063,-0.0151666479469758,0.0113502460773299,0.777878937663474
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,40136,-0.00156771953112404,0.00558124158563668,-0.0125069530389719,0.00937151397672386,0.778799451983084
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,METAP1,Methionine aminopeptidase 1,42311,-0.000830740012932471,0.00299775632851105,-0.00670634241681412,0.00504486239094918,0.781691876346474
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINC1,Antithrombin-III,40516,0.000404081511008739,0.00151418123027829,-0.0025637137003367,0.00337187672235418,0.789578201236694
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDC25A,M-phase inducer phosphatase 1,40080,-0.00106286014670249,0.00402565422362767,-0.00895314242501273,0.00682742213160775,0.791768181072374
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",40482,-0.00100644551591038,0.00382630067920453,-0.00850599484715127,0.00649310381533051,0.792529507736424
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,40532,-0.000772666437402333,0.00294584253776395,-0.00654651781141967,0.005001184936615,0.793102270334938
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",40199,0.000953566532534467,0.00364391071191225,-0.00618849846281354,0.00809563152788248,0.793567138607741
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,40136,-0.00154216218978586,0.00599611926394619,-0.0132945559471204,0.0102102315675487,0.797034329007548
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,40302,-0.00182574429183878,0.00730514919796101,-0.0161438367198424,0.0124923481361648,0.802649454616847
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MANSC1,MANSC domain-containing protein 1,42679,-0.000718240976826814,0.00288015297938294,-0.00636334081641737,0.00492685886276374,0.803073760362225
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCG3,Secretogranin-3,42638,-0.000873951779495814,0.00350720105988511,-0.00774806585687063,0.006000162297879,0.803219308826539
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SSB,Lupus La protein,42311,-0.00147846653930396,0.00598018010429246,-0.0131996195437172,0.0102426864651093,0.804735830905134
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL3,Interleukin-3,40080,-0.00154564258378905,0.00638110810065336,-0.0140526144610696,0.0109613292934915,0.808612976916733
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,40080,0.00232555039258059,0.00994194559428895,-0.0171606629722257,0.0218117637573869,0.815056913537716
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PCARE,Photoreceptor cilium actin regulator,40136,-0.00201730039713322,0.00868476900037806,-0.0190394476378742,0.0150048468436078,0.816324687878797
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CA11,Carbonic anhydrase-related protein 11,42346,-0.000771248209613929,0.00333793676436792,-0.00731360426777506,0.0057711078485472,0.817275381756631
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLINT1,Clathrin interactor 1,40080,-0.00110145799740614,0.00477009202265476,-0.0104508383618095,0.00824792236699718,0.817389704761884
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDAN1,Codanin-1,40483,0.000536640893142431,0.00232985103396705,-0.00402986713343298,0.00510314891971785,0.817837421604115
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HSP90B1,Endoplasmin,42247,0.00155927314122751,0.0068513551362397,-0.0118693829258023,0.0149879292082573,0.819971597589596
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TREML1,Trem-like transcript 1 protein,40532,-0.00122640396494147,0.00540935588992352,-0.0118287415091916,0.00937593357930862,0.820646309455413
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,42475,-0.000933420220522544,0.00414916544015729,-0.00906578448323084,0.00719894404218575,0.822009360193487
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,42559,-0.000494347345360987,0.00221953677274766,-0.0048446394199464,0.00385594472922443,0.823752589539309
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ICOSLG,ICOS ligand,42587,-0.000437781195706303,0.00198557082852994,-0.00432950001962499,0.00345393762821238,0.825499711592802
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,42611,0.000767477001267626,0.00352988605060618,-0.00615109965792049,0.00768605366045574,0.827882326654008
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MLLT1,Protein ENL,40080,0.00148952101529357,0.00685528716151512,-0.0119468418212761,0.0149258838518632,0.827993734696449
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL4,Interleukin-4,42370,0.00207770698200526,0.00959799023267278,-0.0167343538740334,0.0208897678380439,0.82862231947599
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GBP6,Guanylate-binding protein 6,40116,-0.00100611501458333,0.00475994113979608,-0.0103355996485836,0.00832336961941699,0.832601482611238
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,40483,-0.000868935765748567,0.00411227310525885,-0.00892899105205592,0.00719111952055878,0.832654633178242
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL36A,Interleukin-36 alpha,40199,-0.00125294997562497,0.00594412574844871,-0.0129034364425844,0.0103975364913345,0.833056658318574
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,40511,0.000850513673126157,0.00406697209549123,-0.00712075163403665,0.00882177898028896,0.834352861760614
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BEX3,Protein BEX3,40080,-0.00103129602782772,0.00493689884014833,-0.0107076177545184,0.008645025698863,0.834533713599856
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BTNL10,Butyrophilin-like protein 10,40080,0.000915722227882003,0.00440403636062565,-0.00771618903894427,0.00954763349470828,0.835289119122633
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DBH,Dopamine beta-hydroxylase,40515,-0.00235511061109499,0.0113289280077123,-0.0245598095062111,0.0198495882840211,0.835322748275366
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,40136,0.00118694893065033,0.00580572715281814,-0.0101922762888732,0.0125661741501739,0.838009968218788
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLHL41,Kelch-like protein 41,40482,-0.00100926844947581,0.00493980552659667,-0.0106912872816053,0.00867275038265367,0.838112284625436
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,40136,0.00130746182142668,0.00646788940847778,-0.0113696014191898,0.0139845250620431,0.839805880141286
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TSHB,Thyrotropin subunit beta,42636,-0.00162007315753785,0.00813801155372206,-0.0175705758028331,0.0143304294877574,0.842207231323144
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGF6,Fibroblast growth factor 6,40199,-0.000824976489637364,0.00428225844724739,-0.00921820304624225,0.00756825006696752,0.847236748628775
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,40136,-0.000747873907925864,0.00391957839201823,-0.0084302475562816,0.00693449974042987,0.848682160428131
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,40116,-0.00134687914692166,0.00717609161951784,-0.0154120187211766,0.0127182604273333,0.851123319063559
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,40199,-0.00117813333000293,0.0063510927641834,-0.0136262751478024,0.0112700084877965,0.85283960462116
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGAX,Integrin alpha-X,40302,0.00102986503850492,0.00561709273789877,-0.00997963672777667,0.0120393668047865,0.854530790066406
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],42370,-0.00104926327370463,0.00582226788406723,-0.0124609083264764,0.0103623817790671,0.856986113918739
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SYT1,Synaptotagmin-1,40483,0.000784616302980298,0.00436400954990078,-0.00776884241482523,0.00933807502078582,0.857318677862349
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RGS8,Regulator of G-protein signaling 8,42370,0.00118535704162211,0.00660726505400571,-0.0117648824642291,0.0141355965474733,0.857624763078152
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAB6B,Ras-related protein Rab-6B,42311,-0.000893707789295825,0.00505950393783593,-0.0108103355074542,0.0090229199288626,0.859794363357012
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,40116,0.00102212990080506,0.00591226949278958,-0.0105659183050625,0.0126101781066726,0.862746729053472
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GUK1,Guanylate kinase,40116,0.000684254287488441,0.00396386903199842,-0.00708492901522847,0.00845343759020535,0.862951104602537
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",42370,-0.00192464932882033,0.0116764610737093,-0.0248105130332906,0.02096121437565,0.869079088734332
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL26,C-C motif chemokine 26,42594,-0.0015532048726085,0.00953280365616977,-0.0202375000387013,0.0171310902934842,0.870573927618472
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,42689,0.000598055946648678,0.00369498894569991,-0.00664412238692315,0.00784023428022051,0.871421715121515
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL25,Interleukin-25,40036,-0.000580574934290648,0.00361012852776122,-0.00765642684870264,0.00649527698012134,0.872239463749802
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AMIGO1,Amphoterin-induced protein 1,40182,0.000831574710891704,0.00521388244695686,-0.00938763488514375,0.0110507843069272,0.873283864034386
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,40065,-0.000836405943565773,0.00537355008927669,-0.0113685641185481,0.00969575223141654,0.87630991260213
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,40080,0.000403030815204262,0.00269990721122053,-0.00488878731878797,0.0056948489491965,0.881338773472163
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,42346,-0.00191477996815189,0.0130400558979548,-0.0274732895281433,0.0236437295918395,0.883261884073597
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,40302,-0.000981103761202441,0.00679129225293859,-0.0142920365769621,0.0123298290545572,0.885135945156821
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EFHD1,EF-hand domain-containing protein D1,40482,0.000537279605449972,0.00371992588800541,-0.00675377513504064,0.00782833434594058,0.885161233817512
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLK7,Kallikrein-7,40009,0.000576744153226628,0.00404760643119186,-0.00735656445190941,0.00851005275836266,0.886695492845117
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL13,Interleukin-13,42370,-0.000690985205172263,0.0048655070784758,-0.0102273790789848,0.00884540866864031,0.88706867009371
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNM1,Dynamin-1,40449,-0.00165144748721932,0.0117165211241302,-0.0246158288905145,0.0213129339160759,0.887911706008237
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,40482,-0.000383165187463522,0.00280157308832188,-0.00587424844057441,0.00510791806564736,0.891216719072579
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AMY2A,Pancreatic alpha-amylase,42114,-0.000659298069120976,0.00501498813752001,-0.0104886748186602,0.00917007868041824,0.895409100611012
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNLZ,DNL-type zinc finger protein,40136,0.00123124116098237,0.00940586467626249,-0.0172042536044921,0.0196667359264568,0.895855687853914
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,40136,0.000577611792945944,0.00446771482987488,-0.00817910927360883,0.00933433285950071,0.897133935267439
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAPT,Microtubule-associated protein tau,42311,0.000703164916216324,0.00546590018135434,-0.0100099994392382,0.0114163292716708,0.897639923356557
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,40080,-0.000734671804744133,0.0057371270580773,-0.0119794408385756,0.0105100972290874,0.898107261332836
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GFRA3,GDNF family receptor alpha-3,42474,0.000361552412264824,0.00294640321335927,-0.00541339788591935,0.006136502710449,0.902338796855509
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39845,0.000647074169626059,0.00533591244949095,-0.0098113142313762,0.0111054625706283,0.903481240030236
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGA2,Integrin alpha-2,40283,-0.000430816871896049,0.00359888356744423,-0.00748462866408675,0.00662299492029465,0.904716253306723
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,42711,0.000869927402020993,0.00730660032965206,-0.013451009244097,0.015190864048139,0.905229203190489
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,40182,-0.000676088641079267,0.00576928582259269,-0.0119838888533609,0.0106317115712024,0.906713551014583
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,40281,0.000649046321630098,0.00562144682655679,-0.0103689894584212,0.0116670821016814,0.908083450660852
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL24,C-C motif chemokine 24,42654,-0.000957311357056604,0.00848433994255217,-0.0175866176444589,0.0156719949303457,0.91016484077195
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,42594,0.000986650422901438,0.00923138923024153,-0.017106872468372,0.0190801733141748,0.914885819343051
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DEFB118,Beta-defensin 118,40136,-0.000603264090063675,0.00589092529827521,-0.0121494776746831,0.0109429494945557,0.918436568214217
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MELTF,Melanotransferrin,40511,0.000318218398751176,0.00310967051697929,-0.00577673581452824,0.00641317261203059,0.918495072596535
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,42311,-0.000687436608813419,0.00673953492899273,-0.0138969250696392,0.0125220518520123,0.918757757684611
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPSG1,Tryptase gamma,40199,-0.000270675077367846,0.00274525962550661,-0.00565138394336081,0.00511003378862512,0.92145984126452
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMOD4,Tropomodulin-4,40080,-0.000411749812060023,0.004260192161348,-0.0087617264483021,0.00793822682418206,0.923005709741928
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,40136,0.000488174321523677,0.00532971777722429,-0.00995807252183593,0.0109344211648833,0.92702167653064
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AMY2B,Alpha-amylase 2B,41779,0.000464727083194969,0.00513210782615374,-0.00959420425606637,0.0105236584224563,0.927849324871635
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GAGE2A,G antigen 2A,40080,-0.000620058942788906,0.00688396461988253,-0.0141126295977587,0.0128725117121809,0.928230908417739
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,40136,0.000640565039245629,0.00735656094824354,-0.0137782944193117,0.015059424497803,0.930614301253275
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,40182,0.000283673424922211,0.0032691589663739,-0.00612387814917063,0.00669122499901505,0.930853848206961
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CORO6,Coronin-6,40136,0.000331553685670781,0.00384447350798648,-0.00720361438998271,0.00786672176132428,0.931275911047249
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,40116,-0.000381127211030816,0.00495509739233902,-0.0100931181000153,0.00933086367795367,0.938691627039792
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,42370,0.000232608468329158,0.00304907361750636,-0.00574357582198331,0.00620879275864163,0.939190937763351
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",40116,-0.000300162564745236,0.00420851414650251,-0.00854885029189015,0.00794852516239968,0.943142240253042
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TEF,Thyrotroph embryonic factor,40116,-0.000316947804459573,0.00448164992273482,-0.00910098165301981,0.00846708604410066,0.94362091716052
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,40539,0.00013267088354082,0.001930094876603,-0.00365031507460105,0.00391565684168269,0.945199372463438
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,42570,0.00129301534791849,0.0188128511427585,-0.0355801728918882,0.0381662035877252,0.945205223212867
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,40080,-0.000337553852721665,0.00492540088680621,-0.00999133959086183,0.0093162318854185,0.945362391537341
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,42794,0.000474660095927965,0.0072113538193958,-0.0136595933900878,0.0146089135819437,0.947521130366493
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,40136,0.000498679354291154,0.00781227926086799,-0.0148133879970101,0.0158107467055924,0.949104558014344
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINA1,Alpha-1-antitrypsin,40327,5.2146579439412e-05,0.000842411289111394,-0.00159897954721892,0.00170327270609774,0.95064233025793
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,40080,-0.000185933523355037,0.00357192606528611,-0.0071869086113158,0.00681504156460573,0.958486513064725
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,40449,0.000231652849380296,0.00452994600197829,-0.00864704131449716,0.00911034701325775,0.959216380653672
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZPR1,Zinc finger protein ZPR1,40136,0.000507556549905051,0.0100734165172933,-0.0192363398239899,0.0202514529238,0.959815919118238
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,40080,-0.000308182490501436,0.00653949108942591,-0.0131255850257762,0.0125092200447734,0.96241337325236
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BGLAP,Osteocalcin,40527,0.000430375373725502,0.00930202556849986,-0.0178015947405342,0.0186623454879852,0.963098380177611
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,40116,-0.000172928880927747,0.00390024263868797,-0.00781740445275617,0.00747154669090068,0.964635808140179
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PITHD1,PITH domain-containing protein 1,40065,-0.000349106418979226,0.00833614216160451,-0.0166879450557241,0.0159897322177656,0.966596201654326
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,40302,0.000324833302738614,0.00831564609443881,-0.0159738330423615,0.0166234996478387,0.968840937004767
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BSND,Barttin,40080,0.000130926109105498,0.00352547667465313,-0.00677900817321464,0.00704086039142563,0.970376342605357
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RSPO1,R-spondin-1,42495,-0.000128252949699937,0.00347195235987318,-0.00693327957505137,0.00667677367565149,0.970533623328047
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,40199,0.000155256035673337,0.00430511525014629,-0.00828276985461339,0.00859328192596006,0.971232655870144
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPM1A,Protein phosphatase 1A,42346,-0.000116955171981998,0.00327012035761339,-0.00652639107290424,0.00629248072894024,0.971470450372137
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYH7B,Myosin-7B,40080,0.000164731966471666,0.00463198633537065,-0.0089139612508548,0.00924342518379813,0.971630665291415
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,40116,-0.000387973827865828,0.0113728293946182,-0.0226787194413175,0.0219027717855858,0.972786789043176
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LMOD2,Leiomodin-2,40136,0.000208846903988801,0.00644500359136837,-0.0124233601350932,0.0128410539430708,0.974150091514063
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,42311,0.000143069314192351,0.00468222984964796,-0.00903410119111765,0.00932023981950235,0.975624251020341
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OMP,Olfactory marker protein,40136,-0.000155211176485223,0.00519946096195364,-0.0103461546619143,0.0100357323089439,0.976186112075026
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,40511,9.85945958970597e-05,0.00381011764673987,-0.00736923599171309,0.00756642518350721,0.979355863488582
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,40451,-0.000189670260231209,0.00790424377147439,-0.015681988052321,0.0153026475318586,0.980856221954436
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GH2,Growth hormone variant,42346,-0.000399951338500481,0.0171464105559722,-0.0340069160282061,0.0332070133512051,0.981390857625912
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MTPN,Myotrophin,42357,-6.94877365499476e-05,0.00341325702271249,-0.00675947150106642,0.00662049602796653,0.983757944680371
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,40302,4.64018535613697e-05,0.0044819323304596,-0.00873818551413946,0.00883098922126219,0.99173976197389
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",40059,2.58312743047606e-05,0.00273430380495336,-0.00533340418340382,0.00538506673201335,0.992462580751015
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HDAC9,Histone deacetylase 9,40136,-5.87157270815669e-05,0.00678039630422262,-0.0133482924833579,0.0132308610291948,0.993090858691501
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,40116,4.00656467296161e-05,0.00501674266484829,-0.00979274997637303,0.00987288126983226,0.993627998980725
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,42570,-1.40797311109807e-05,0.00884932603778869,-0.0173587587651768,0.0173305993029549,0.998730549047225
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FABP9,Fatty acid-binding protein 9,42594,8.33463227730409e-06,0.0058094000826401,-0.0113780895296973,0.0113947587942519,0.998855312429753
